<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD004398.pub3" GROUP_ID="EPOC" ID="313203052014043084" MERGED_FROM="" MODIFIED="2015-03-10 14:18:24 +0000" MODIFIED_BY="Julia Worswick" REVIEW_NO="02" REVMAN_SUB_VERSION="5.3.5 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="11.0">
<COVER_SHEET MODIFIED="2015-03-10 14:18:24 +0000" MODIFIED_BY="Julia Worswick">
<TITLE MODIFIED="2012-09-10 11:19:24 -0400" MODIFIED_BY="Anne Lawson">Printed educational materials: effects on professional practice and healthcare outcomes</TITLE>
<CONTACT MODIFIED="2015-03-10 14:18:24 +0000" MODIFIED_BY="Julia Worswick"><PERSON ID="2FDF112982E26AA20139CB72EA4C566C" ROLE="AUTHOR"><FIRST_NAME>Anik</FIRST_NAME><LAST_NAME>Giguère</LAST_NAME><EMAIL_1>anikgiguere@videotron.ca</EMAIL_1><ADDRESS><DEPARTMENT>Health Information Research Unit (HIRU)</DEPARTMENT><ORGANISATION>Department of Clinical Epidemiology, McMaster University</ORGANISATION><ADDRESS_1>CRL-139</ADDRESS_1><ADDRESS_2>1280 Main Street West</ADDRESS_2><CITY>Hamilton</CITY><ZIP>L8S 4K1</ZIP><REGION>ON</REGION><COUNTRY CODE="CA">Canada</COUNTRY></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2015-03-10 14:18:24 +0000" MODIFIED_BY="Julia Worswick"><PERSON ID="2FDF112982E26AA20139CB72EA4C566C" ROLE="AUTHOR"><FIRST_NAME>Anik</FIRST_NAME><LAST_NAME>Giguère</LAST_NAME><EMAIL_1>anikgiguere@videotron.ca</EMAIL_1><ADDRESS><DEPARTMENT>Health Information Research Unit (HIRU)</DEPARTMENT><ORGANISATION>Department of Clinical Epidemiology, McMaster University</ORGANISATION><ADDRESS_1>CRL-139</ADDRESS_1><ADDRESS_2>1280 Main Street West</ADDRESS_2><CITY>Hamilton</CITY><ZIP>L8S 4K1</ZIP><REGION>ON</REGION><COUNTRY CODE="CA">Canada</COUNTRY></ADDRESS></PERSON><PERSON ID="13479" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>France</FIRST_NAME><LAST_NAME>Légaré</LAST_NAME><POSITION>Full Professor</POSITION><EMAIL_1>france.legare@mfa.ulaval.ca</EMAIL_1><ADDRESS><ORGANISATION>Population Health and Optimal Health Practices Research Axis, CHU de Québec Research Center, Université Laval</ORGANISATION><ADDRESS_1>10 Rue de l'Espinay, D6-727</ADDRESS_1><CITY>Québec City</CITY><ZIP>G1L 3L5</ZIP><REGION>Québec</REGION><COUNTRY CODE="CA">Canada</COUNTRY><PHONE_1>418 525 4437</PHONE_1><FAX_1>418 525 4194</FAX_1></ADDRESS></PERSON><PERSON ID="7557" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Jeremy</FIRST_NAME><LAST_NAME>Grimshaw</LAST_NAME><POSITION>Senior Scientist</POSITION><EMAIL_1>jgrimshaw@ohri.ca</EMAIL_1><ADDRESS><DEPARTMENT>Clinical Epidemiology Program</DEPARTMENT><ORGANISATION>Ottawa Hospital Research Institute</ORGANISATION><ADDRESS_1>The Ottawa Hospital - General Campus</ADDRESS_1><ADDRESS_2>501 Smyth Road, Box 711</ADDRESS_2><CITY>Ottawa</CITY><ZIP>K1H 8L6</ZIP><REGION>ON</REGION><COUNTRY CODE="CA">Canada</COUNTRY><PHONE_1>+1 613 737-8899 X73810</PHONE_1><PHONE_2>+1 613 737-8899 X73822</PHONE_2><FAX_1>+1 613 739-3968</FAX_1></ADDRESS></PERSON><PERSON ID="935E005182E26AA20038D3415ED0476C" ROLE="AUTHOR"><FIRST_NAME>Stéphane</FIRST_NAME><LAST_NAME>Turcotte</LAST_NAME><POSITION>MSc. Biostatistician</POSITION><EMAIL_1>Stephane.Turcotte@crchul.ulaval.ca</EMAIL_1><ADDRESS><ORGANISATION>Centre de Recherche du CHU de Québec (CRCHUQ) - Hôpital St-François d'Assise</ORGANISATION><ADDRESS_1>10 Rue de l'Espinay, D6-727</ADDRESS_1><CITY>Québec City</CITY><ZIP>G1L 3L5</ZIP><REGION>QC</REGION><COUNTRY CODE="CA">Canada</COUNTRY><PHONE_1>418-525-4444 ext 52402</PHONE_1></ADDRESS></PERSON><PERSON ID="CFC509B582E26AA200AED56433A24E97" ROLE="AUTHOR"><FIRST_NAME>Michelle</FIRST_NAME><LAST_NAME>Fiander</LAST_NAME><EMAIL_1>michelle.fiander@gmail.com</EMAIL_1><ADDRESS><ORGANISATION>Information Specialist, Consultant</ORGANISATION><CITY>Ottawa</CITY><REGION>Ontario</REGION><COUNTRY CODE="CA">Canada</COUNTRY><PHONE_1>204-895-3263</PHONE_1><PHONE_2>Skype: michelle.fiander</PHONE_2></ADDRESS></PERSON><PERSON ID="14317617717507005464120404205655" ROLE="AUTHOR"><FIRST_NAME>Agnes</FIRST_NAME><LAST_NAME>Grudniewicz</LAST_NAME><EMAIL_1>agrudniewicz@gmail.com</EMAIL_1><ADDRESS><DEPARTMENT>Institute of Health Policy, Management and Evaluation, University of Toronto</DEPARTMENT><ORGANISATION>Li Ka Shing Knowledge Institute, St. Michael's Hospital</ORGANISATION><CITY>Toronto</CITY><REGION>ON</REGION><COUNTRY CODE="CA">Canada</COUNTRY></ADDRESS></PERSON><PERSON ID="32461797906641996617120404205911" ROLE="AUTHOR"><FIRST_NAME>Sun</FIRST_NAME><LAST_NAME>Makosso-Kallyth</LAST_NAME><EMAIL_1>Sun.Makosso-Kallyth@crchuq.ulaval.ca</EMAIL_1><ADDRESS><DEPARTMENT>Research Centre of the CHU de Quebec</DEPARTMENT><ORGANISATION>St-François d'Assise Hospital</ORGANISATION><CITY>Québec City</CITY><REGION>QC</REGION><COUNTRY CODE="CA">Canada</COUNTRY></ADDRESS></PERSON><PERSON ID="6924" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Fredric</FIRST_NAME><MIDDLE_INITIALS>M</MIDDLE_INITIALS><LAST_NAME>Wolf</LAST_NAME><POSITION>Professor</POSITION><EMAIL_1>wolf@u.washington.edu</EMAIL_1><ADDRESS><DEPARTMENT>Department of Medical Education &amp; Biomedical Informatics</DEPARTMENT><ORGANISATION>University of Washington School of Medicine</ORGANISATION><ADDRESS_1>E-312 Health Sciences</ADDRESS_1><ADDRESS_2>Box 357240</ADDRESS_2><CITY>Seattle</CITY><ZIP>98195-7240</ZIP><REGION>WA</REGION><COUNTRY CODE="US">USA</COUNTRY><PHONE_1>+1 206 616 6782</PHONE_1><FAX_1>+1 206 543 3461</FAX_1></ADDRESS></PERSON><PERSON ID="13444" ROLE="AUTHOR"><FIRST_NAME>Anna</FIRST_NAME><MIDDLE_INITIALS>P</MIDDLE_INITIALS><LAST_NAME>Farmer</LAST_NAME><EMAIL_1>anna.farmer@ualberta.ca</EMAIL_1><ADDRESS><DEPARTMENT>Department of Agricultural, Food and Nutritional Science and The Centre for Health Promotion Studies</DEPARTMENT><ORGANISATION>University of Alberta</ORGANISATION><ADDRESS_1>4-10 Agricultural and Forestry Centre</ADDRESS_1><CITY>Edmonton</CITY><ZIP>T6H 4J1</ZIP><REGION>AB</REGION><COUNTRY CODE="CA">Canada</COUNTRY><PHONE_1>+1.780.492.2693</PHONE_1><FAX_1>+1.780.492.4265</FAX_1></ADDRESS></PERSON><PERSON ID="9522974D82E26AA200831C19739D171E" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Marie-Pierre</FIRST_NAME><LAST_NAME>Gagnon</LAST_NAME><POSITION>Associate Professor</POSITION><EMAIL_1>Marie-Pierre.Gagnon@fsi.ulaval.ca</EMAIL_1><ADDRESS><DEPARTMENT>Centre de recherche du CHU de Québec, Axe Santé des populations - Pratiques optimales en santé</DEPARTMENT><ORGANISATION>Traumatologie &#8211; Urgence &#8211; Soins Intensifs</ORGANISATION><ADDRESS_1>10 Rue de l'Espinay, D6-727</ADDRESS_1><CITY>Québec</CITY><ZIP>G1L 3L5</ZIP><REGION>QC</REGION><COUNTRY CODE="CA">Canada</COUNTRY><PHONE_1>418 525-4444 ext. 53169</PHONE_1><FAX_1>418 525-4194</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2012-12-04 09:33:29 -0500" MODIFIED_BY="Anik Giguère">
<UP_TO_DATE>
<DATE DAY="21" MONTH="6" YEAR="2011"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="21" MONTH="6" YEAR="2011"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="2" MONTH="9" YEAR="2014"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="3" YEAR="2003"/>
<REVIEW_PUBLISHED ISSUE="3" YEAR="2008"/>
<LAST_CITATION_ISSUE ISSUE="10" YEAR="2012"/>
</DATES>
<WHATS_NEW MODIFIED="2015-03-06 09:50:37 -0500" MODIFIED_BY="Julia Worswick">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2015-03-06 09:50:37 -0500" MODIFIED_BY="Julia Worswick">
<DATE DAY="6" MONTH="3" YEAR="2015"/>
<DESCRIPTION>
<P>Standard median effect size range corrected in the summary of findings table</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2015-03-06 09:42:28 -0500" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2015-03-06 09:42:28 -0500" MODIFIED_BY="[Empty name]">
<DATE DAY="2" MONTH="4" YEAR="2013"/>
<DESCRIPTION>
<P>Edits to contact details</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2013-04-02 13:38:40 -0400" MODIFIED_BY="Alain Mayhew">
<DATE DAY="10" MONTH="9" YEAR="2012"/>
<DESCRIPTION>
<P>Review has been updated</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2013-04-02 13:38:35 -0400" MODIFIED_BY="Alain Mayhew">
<DATE DAY="10" MONTH="9" YEAR="2012"/>
<DESCRIPTION>
<P>New authors, now has 45 studies.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2012-05-01 12:50:18 -0400" MODIFIED_BY="[Empty name]">
<DATE DAY="16" MONTH="6" YEAR="2011"/>
<DESCRIPTION>
<P>Minor edits</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2011-06-16 08:16:50 -0400" MODIFIED_BY="[Empty name]">
<DATE DAY="18" MONTH="2" YEAR="2009"/>
<DESCRIPTION>
<P>Minor edits</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-02-18 16:42:41 -0500" MODIFIED_BY="[Empty name]">
<DATE DAY="12" MONTH="11" YEAR="2008"/>
<DESCRIPTION>
<P>Minor changes</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2008-11-12 16:00:03 -0500" MODIFIED_BY="[Empty name]">
<DATE DAY="23" MONTH="4" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2012-09-13 08:27:10 -0400" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES MODIFIED="2012-09-12 19:06:02 -0400" MODIFIED_BY="[Empty name]">
<SOURCE>
<NAME>Institute of Population Health, University of Ottawa</NAME>
<COUNTRY CODE="CA">Canada</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Canadian Foundation for Innovation - Canadian Research Chair</NAME>
<COUNTRY CODE="CA">Canada</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2012-09-10 11:20:28 -0400" MODIFIED_BY="Anne Lawson">
<NAME>Centre de Recherche, Centre Hospitalier Universitaire de Québec</NAME>
<COUNTRY CODE="CA">Canada</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Health Services Research Unit, University of Aberdeen</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>University of Leeds</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Department of Medical Education, University of Washington</NAME>
<COUNTRY CODE="US">USA</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2008-05-14 13:59:47 -0400" MODIFIED_BY="[Empty name]">
<NAME>Ottawa Hospital Research Institute</NAME>
<COUNTRY CODE="CA">Canada</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2012-09-12 19:06:02 -0400" MODIFIED_BY="Alain Mayhew">
<NAME>Health Information Research Unit, McMaster University</NAME>
<COUNTRY CODE="CA">Canada</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES MODIFIED="2012-09-13 08:27:10 -0400" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2012-09-13 08:27:10 -0400" MODIFIED_BY="Anne Lawson">
<NAME>NIHR Cochrane Review Incentive Scheme 2011</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>The Wellcome Trust and Chief Scientist Office, Scottish Executive Health Department</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2012-09-10 11:19:47 -0400" MODIFIED_BY="Anne Lawson">
<NAME>CCOHTA'S 2004 Health Technology Assessment Capacity Building Grants Program</NAME>
<COUNTRY CODE="CA">Canada</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2008-05-14 14:00:15 -0400" MODIFIED_BY="[Empty name]">
<NAME>Canadian Institutes for Health Research</NAME>
<COUNTRY CODE="CA">Canada</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2012-09-12 19:06:51 -0400" MODIFIED_BY="Alain Mayhew">
<NAME>Knowledge Translation Canada Research Network</NAME>
<COUNTRY CODE="CA">Canada</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2012-09-13 12:40:00 -0400" MODIFIED_BY="Anik Giguere">
<SUMMARY MODIFIED="2012-09-10 10:52:52 -0400" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2012-09-10 10:52:52 -0400" MODIFIED_BY="[Empty name]">Printed educational materials: effects on professional practice and healthcare outcomes</TITLE>
<SUMMARY_BODY MODIFIED="2012-09-10 09:56:55 -0400" MODIFIED_BY="[Empty name]">
<P>Medical journals and clinical practice guidelines are common channels to distribute scientific information to healthcare providers, as they allow a wide distribution at relatively low costs. Delivery of printed educational materials is meant to improve healthcare professionals' awareness, knowledge, attitudes, and skills, and ultimately improve professional practice and patients' health outcomes. Results of this review suggest that printed educational materials slightly improve healthcare professional practice compared to no intervention, but a lack of results prevent any conclusion on their impact on patient outcomes.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2012-09-10 10:52:51 -0400" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2012-04-30 23:29:45 -0400" MODIFIED_BY="[Empty name]">
<P>Printed educational materials are widely used passive dissemination strategies to improve the quality of clinical practice and patient outcomes. Traditionally they are presented in paper formats such as monographs, publication in peer-reviewed journals and clinical guidelines.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2012-09-10 10:52:51 -0400" MODIFIED_BY="[Empty name]">
<P>To assess the effect of printed educational materials on the practice of healthcare professionals and patient health outcomes.</P>
<P>To explore the influence of some of the characteristics of the printed educational materials (e.g. source, content, format) on their effect on professional practice and patient outcomes.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2012-09-10 09:56:08 -0400" MODIFIED_BY="[Empty name]">
<P>For this update, search strategies were rewritten and substantially changed from those published in the original review in order to refocus the search from published material to printed material and to expand terminology describing printed materials. Given the significant changes, all databases were searched from start date to June 2011. We searched: MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials (CENTRAL), HealthStar, CINAHL, ERIC, CAB Abstracts, Global Health, and the EPOC Register. <B>
<BR/>
</B>
</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2012-09-10 09:56:13 -0400" MODIFIED_BY="[Empty name]">
<P>We included randomised controlled trials (RCTs), quasi-randomised trials, controlled before and after studies (CBAs) and interrupted time series (ITS) analyses that evaluated the impact of printed educational materials (PEMs) on healthcare professionals' practice or patient outcomes, or both. We included three types of comparisons: (1) PEM versus no intervention, (2) PEM versus single intervention, (3) multifaceted intervention where PEM is included versus multifaceted intervention without PEM. There was no language restriction. Any objective measure of professional practice (e.g. number of tests ordered, prescriptions for a particular drug), or patient health outcomes (e.g. blood pressure) were included.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2012-09-10 09:56:21 -0400" MODIFIED_BY="[Empty name]">
<P>Two review authors undertook data extraction independently, and any disagreement was resolved by discussion among the review authors. For analyses, the included studies were grouped according to study design, type of outcome (professional practice or patient outcome, continuous or dichotomous) and type of comparison. For controlled trials, we reported the median effect size for each outcome within each study, the median effect size across outcomes for each study and the median of these effect sizes across studies. Where the data were available, we re-analysed the ITS studies and reported median differences in slope and in level for each outcome, across outcomes for each study, and then across studies. We categorised each PEM according to potential effects modifiers related to the source of the PEMs, the channel used for their delivery, their content, and their format.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2012-09-10 09:56:32 -0400" MODIFIED_BY="[Empty name]">
<P>The review includes 45 studies: 14 RCTs and 31 ITS studies. Almost all the included studies (44/45) compared the effectiveness of PEM to no intervention. One single study compared paper-based PEM to the same document delivered on CD-ROM. Based on seven RCTs and 54 outcomes, the median absolute risk difference in categorical practice outcomes was 0.02 when PEMs were compared to no intervention (range from 0 to +0.11). Based on three RCTs and eight outcomes, the median improvement in standardised mean difference for continuous profession practice outcomes was 0.13 when PEMs were compared to no intervention (range from -0.16 to +0.36). Only two RCTs and two ITS studies reported patient outcomes. In addition, we re-analysed 54 outcomes from 25 ITS studies, using time series regression and observed statistically significant improvement in level or in slope in 27 outcomes. From the ITS studies, we calculated improvements in professional practice outcomes across studies after PEM dissemination (standardised median change in level = 1.69). From the data gathered, we could not comment on which PEM characteristic influenced their effectiveness.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2012-09-09 17:44:41 -0400" MODIFIED_BY="[Empty name]">
<P>The results of this review suggest that when used alone and compared to no intervention, PEMs may have a small beneficial effect on professional practice outcomes. There is insufficient information to reliably estimate the effect of PEMs on patient outcomes, and clinical significance of the observed effect sizes is not known. The effectiveness of PEMs compared to other interventions, or of PEMs as part of a multifaceted intervention, is uncertain.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2012-09-13 12:40:00 -0400" MODIFIED_BY="Anik Giguere">
<BACKGROUND MODIFIED="2012-09-12 22:37:03 -0400" MODIFIED_BY="[Empty name]">
<CONDITION MODIFIED="2012-08-13 08:36:16 -0400" MODIFIED_BY="[Empty name]">
<P>Most research findings are not making their way into practice in a timely fashion despite the considerable resources devoted to health sciences research (<LINK REF="REF-Graham-2006" TYPE="REFERENCE">Graham 2006</LINK>). Recommendations are frequently not applied in practice and many patients do not benefit from evidence-based research (<LINK REF="REF-Grol-2001" TYPE="REFERENCE">Grol 2001</LINK>; <LINK REF="REF-Schuster-2005" TYPE="REFERENCE">Schuster 2005</LINK>).</P>
</CONDITION>
<INTERVENTION MODIFIED="2012-09-10 10:52:56 -0400" MODIFIED_BY="[Empty name]">
<P>Printed educational materials (PEMs) are probably one of the most common approaches to translate research findings into clinical practice (<LINK REF="REF-Bero-1998" TYPE="REFERENCE">Bero 1998</LINK>). This review focuses on the passive dissemination of PEMs, defined as the distribution of published or printed recommendations for clinical care including clinical practice guidelines, monographs, and publications in peer-reviewed journals, delivered personally or through mass mailing (<LINK REF="REF-Grimshaw-2003" TYPE="REFERENCE">Grimshaw 2003</LINK>).</P>
</INTERVENTION>
<THEORY MODIFIED="2012-09-10 09:57:19 -0400" MODIFIED_BY="[Empty name]">
<P>PEMs have the potential to improve the care received by patients by promoting clinical practice of proven benefit and discouraging ineffective procedures (<LINK REF="REF-Woolf-1999" TYPE="REFERENCE">Woolf 1999</LINK>). Given that PEMs are familiar, accessible, inexpensive, and convenient to use, they could be a cost-effective intervention within healthcare settings (<LINK REF="REF-Grimshaw-2004" TYPE="REFERENCE">Grimshaw 2004</LINK>; <LINK REF="REF-Grimshaw-2006" TYPE="REFERENCE">Grimshaw 2006</LINK>).</P>
<P>Potential factors influencing the implementation of PEMs can be derived from various theories on quality-improvement and implementation of change in health care (<LINK REF="REF-Grol-2007" TYPE="REFERENCE">Grol 2007</LINK>; <LINK REF="REF-Gross-2001" TYPE="REFERENCE">Gross 2001</LINK>; <LINK REF="REF-Stergiou_x002d_Kita-2010" TYPE="REFERENCE">Stergiou-Kita 2010</LINK>). Cognitive theories suggest that PEMs should take into account healthcare professionals' decision processes and learning styles to support their decisions in practice better. Educational and adult learning theories propose that change is driven by the desire to learn and be professionally competent, suggesting that PEMs should be linked to professionals' needs and motivation, define personal targets for improvement and contain individual 'learning plans' related to desired performance. Attitudinal and motivational theories suggest that PEMs should address professionals' attitudes, beliefs, perceived social norms, and experienced control related to desired performance to influence their motivations to change. Professional development theories emphasise the importance of professional loyalty, pride, consensus, and that change be endorsed by a professional body; thus, PEMs should incorporate these elements and define professional standards for the desired behaviour. Social influence theories suggest that the content or message of the PEMs be endorsed or reinforced by recognised leaders in their field. Literature on communication design might also be useful to appraise some of the more visual aspects of PEMs (<LINK REF="REF-Ancker-2007" TYPE="REFERENCE">Ancker 2007</LINK>; <LINK REF="REF-Rosenbaum-2010" TYPE="REFERENCE">Rosenbaum 2010</LINK>).</P>
<P>The persuasive communication theory proposes five input variables that may possibly affect communication effectiveness: source, message, channel, receiver, and destination (<LINK REF="REF-Wilson-2010" TYPE="REFERENCE">Wilson 2010</LINK>). For the purpose of this review, we chose to focus on the three variables to characterise the intervention itself, namely source, message and channel. In addition, to acknowledge the possible importance of PEMs' visual aspects to explain their effectiveness, we added a variable that we labelled 'format'. With regards to source, we considered credibility and proximity of the source. Source credibility influences the extent to which a message is believed (<LINK REF="REF-Tseng-1999" TYPE="REFERENCE">Tseng 1999</LINK>; <LINK REF="REF-Wathen-2002" TYPE="REFERENCE">Wathen 2002</LINK>), so that PEMs that are endorsed by a credible organisation, such as a national professional organisation might have more impact on practice. Proximity of the source to the target audience (i.e. when the information is locally tailored to the audience) can also affect health behaviour change more positively than can targeted, personalised, or generic interventions (<LINK REF="REF-Revere-2001" TYPE="REFERENCE">Revere 2001</LINK>). For channel, we considered the mode, frequency, and duration of PEM delivery. The mode of delivery must be appropriate to the target audience - widest audiences should be reached via mass communication and local audiences via personalised channels (<LINK REF="REF-Marriott-2000" TYPE="REFERENCE">Marriott 2000</LINK>). Frequently delivered PEMs that lead to a more frequent exposure of the professional to the message, following principles of persuasive communication, might be more effective to improve professional practice performance (<LINK REF="REF-Davis-2009" TYPE="REFERENCE">Davis 2009</LINK>; <LINK REF="REF-McGuire-1989" TYPE="REFERENCE">McGuire 1989</LINK>). For message, we considered the PEM's clinical area, type of targeted behaviour, purpose, level of evidence, and educational component. Compatibility of PEMs with existing beliefs, for example, if PEM's purpose is to increase an established management, could possibly increase their acceptability to users (<LINK REF="REF-Rogers-1995" TYPE="REFERENCE">Rogers 1995</LINK>), but evidence has demonstrated that clinical recommendations that are more compatible with clinician beliefs were less effective to change professional practice, which is likely to be because of ceiling effects (<LINK REF="REF-Foy-2002" TYPE="REFERENCE">Foy 2002</LINK>). Evidence-based recommendations are better followed in practice than recommendations that are not based on scientific evidence (<LINK REF="REF-Foy-2002" TYPE="REFERENCE">Foy 2002</LINK>; <LINK REF="REF-Grol-1998" TYPE="REFERENCE">Grol 1998</LINK>). For format, we considered format, appearance, and length. Shorter and simpler documents have the potential to facilitate more effective and efficient uptake of key information, as professionals often do not have time to screen, organise, and appraise new scientific literature (<LINK REF="REF-Grandage-2002" TYPE="REFERENCE">Grandage 2002</LINK>; <LINK REF="REF-Marriott-2000" TYPE="REFERENCE">Marriott 2000</LINK>; <LINK REF="REF-Wang-2009" TYPE="REFERENCE">Wang 2009</LINK>).</P>
</THEORY>
<IMPORTANCE MODIFIED="2012-09-12 22:37:03 -0400" MODIFIED_BY="[Empty name]">
<P>The first version of the present review on the effectiveness of the passive dissemination of PEMs included nine studies comparing PEMs to no intervention and it concluded that this strategy had little impact on professional practice (<LINK REF="REF-Freemantle-1997" TYPE="REFERENCE">Freemantle 1997</LINK>). These results were then supported by another broader review of 44 reviews covering a wide range of interventions that concluded that passive dissemination is generally ineffective (<LINK REF="REF-NHS-1999" TYPE="REFERENCE">NHS 1999</LINK>). These early results led researchers to use PEMs as a control condition for evaluating the impacts of more complex and intensive quality improvement interventions (e.g. <LINK REF="STD-Jain-2006" TYPE="STUDY">Jain 2006</LINK>; <LINK REF="STD-Maiman--1988" TYPE="STUDY">Maiman 1988</LINK>; <LINK REF="STD-Mettes-2010" TYPE="STUDY">Mettes 2010</LINK>), instead of evaluating PEMs per se. However, subsequent reviews (<LINK REF="REF-Grimshaw-2004" TYPE="REFERENCE">Grimshaw 2004</LINK>; <LINK REF="REF-Hakkennes-2008" TYPE="REFERENCE">Hakkennes 2008</LINK>) and the first update of the present review published in 2008 showed that PEMs led to modest, but significant, improvement in professional practice (<LINK REF="REF-Farmer-2008" TYPE="REFERENCE">Farmer 2008</LINK>). The first update included nine randomised controlled trials (RCTs) comparing PEMs to no intervention and observed a median absolute improvement in performance of 4.3% for categorical process outcomes (six studies: <LINK REF="STD-Bearcroft-1994" TYPE="STUDY">Bearcroft 1994</LINK>; <LINK REF="STD-Beaulieu-2004" TYPE="STUDY">Beaulieu 2004</LINK>; <LINK REF="STD-Bjornson-1990" TYPE="STUDY">Bjornson 1990</LINK>; <LINK REF="STD-Croudace--2003" TYPE="STUDY">Croudace 2003</LINK>; <LINK REF="STD-Kottke-1989" TYPE="STUDY">Kottke 1989</LINK>; <LINK REF="STD-Oakeshott-1994" TYPE="STUDY">Oakeshott 1994</LINK>) and a relative improvement of 13.6% for continuous process outcomes (three studies: <LINK REF="STD-Azocar-2003" TYPE="STUDY">Azocar 2003</LINK>; <LINK REF="STD-Denig-1990" TYPE="STUDY">Denig 1990</LINK>; <LINK REF="STD-Oakeshott-1994" TYPE="STUDY">Oakeshott 1994</LINK>).</P>
<P>Since the last update, several new studies of the passive dissemination of PEMs have been published, but no other review on the effectiveness of this strategy to improve any professional behaviour has, to our knowledge, been done. Several reviews have studied the passive dissemination of PEMs alongside other types of quality improvement strategies to improve specific behaviours, such as antibiotic prescribing (<LINK REF="REF-Arnold-2005" TYPE="REFERENCE">Arnold 2005</LINK>), use of imaging (<LINK REF="REF-French-2010" TYPE="REFERENCE">French 2010</LINK>), management of diabetes (<LINK REF="REF-de-Belvis-2009" TYPE="REFERENCE">de Belvis 2009</LINK>; <LINK REF="REF-Seitz-2011" TYPE="REFERENCE">Seitz 2011</LINK>), or psychiatric care (<LINK REF="REF-Weinmann-2007" TYPE="REFERENCE">Weinmann 2007</LINK>). However, these reviews included few studies that compared the passive dissemination of PEMs to no intervention, limiting conclusions on their effectiveness.</P>
<P>In addition, the small number of trials included in the first update prevented exploration of which PEM characteristics were associated with greater effectiveness. The larger number of studies gathered through this second update should allow us to assess the impact of potential effect modifiers of PEMs (to then suggest strategies to optimise them).  It should also allow us to generalise the review conclusions to a larger set of conditions.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2012-09-10 09:57:46 -0400" MODIFIED_BY="Anik Giguere">
<OL>
<LI>To assess the effect of PEMs on the practice of healthcare professionals and patient health outcomes.</LI>
<LI>To explore the influence of some of the characteristics of the PEMs (e.g. mode of delivery, source of information, format) on their effect on professional practice and patient outcomes.</LI>
</OL>
<P>To address the first objective, we included the following types of comparisons: (1) PEM only compared to no intervention, (2) PEM only versus single intervention, and (3) multifaceted intervention where PEM is included versus multifaceted intervention without PEM.</P>
<P>To address the second objective, we classified each included intervention according to potential effect modifiers related the source of the PEMs, the channel used for their delivery, the message, and their format.</P>
</OBJECTIVES>
<METHODS MODIFIED="2012-09-10 10:00:58 -0400" MODIFIED_BY="Anik Giguere">
<SELECTION_CRITERIA MODIFIED="2012-09-10 09:59:41 -0400" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2012-09-10 09:57:54 -0400" MODIFIED_BY="[Empty name]">
<P>RCTs, quasi-randomised studies, controlled before and after studies (CBAs) and interrupted time series (ITS) analyses were included. For CBAs, we considered only the trials that used contemporaneous data collection (i.e. pre- and post-intervention periods for study and control sites are the same); that selected appropriate control site for studies using second site as controls (i.e. study and control sites are comparable with respect to dominant reimbursement system, level of care, setting of care, and academic status); and that used a minimum number of sites (i.e. there was a minimum of two intervention sites and two control sites). We used two criteria for inclusion of studies with an ITS design: a clearly defined point in time when the intervention occurred, and at least three data points before and three after the intervention. We included studies published in all languages.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2012-09-10 09:59:41 -0400" MODIFIED_BY="[Empty name]">
<P>Any healthcare professionals provided with PEMs to improve their practice or patient outcomes, or both. We included studies in which the participants were students and healthcare professionals only if we could separate the outcomes from students and qualified healthcare professionals.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2012-09-10 09:59:41 -0400" MODIFIED_BY="[Empty name]">
<P>We included studies of the distribution of published or printed recommendations for clinical care and evidence to inform practice, comprising clinical practice guidelines, journal articles, and monographs. We included PEMs delivered personally (i.e. addressed to a specific individual), through mass mailings, or passively delivered through broader communication channels (e.g. printable documents available on the Internet, mass media). Interventions to provide increased access to electronically retrievable information were considered to be outside of the scope of this review.</P>
<P>We included multifaceted interventions that comprised PEM only if they were compared to the same multifaceted intervention without the studied PEM.<BR/>
</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2012-09-10 09:59:41 -0400" MODIFIED_BY="[Empty name]">
<P>Any objective measure either of professional practice (e.g. the number of tests ordered, prescriptions for a particular drug) or of patient health outcomes (e.g. blood pressure, complications after surgery). Studies that only reported the impact of PEMs on healthcare professionals' attitudes, awareness, knowledge, or opinions were excluded.</P>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2012-09-10 09:59:41 -0400" MODIFIED_BY="[Empty name]">
<ELECTRONIC_SEARCHES MODIFIED="2012-09-10 09:59:41 -0400" MODIFIED_BY="[Empty name]">
<P>Primary studies and related systematic reviews were identified using the following bibliographic databases, sources and approaches.</P>
<SUBSECTION>
<HEADING LEVEL="4">Databases</HEADING>
<P>MEDLINE, OVID (1948 to June 2011)</P>
<P>EMBASE, OVID (1947 to June 2011)</P>
<P>The Cochrane Central Register of Controlled Trials (CENTRAL)</P>
<P>Cumulative Index to Nursing and Allied Health Literature CINAHL, EbscoHost (1980 to June 2011)</P>
<P>The EPOC Specialised Register, Reference Manager</P>
<P>CAB Abstracts, EbscoHost (1973 to June 2011)</P>
<P>ERIC: Educational Resources Information Center, Wilson (1966 to June 2011)</P>
<P>Global Health, CAB Direct (1973 to June 2011)</P>
<P>HealthStar, OVID (1999 to June 2011)</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Strategy</HEADING>
<P>For this update, the original search strategy was revised and refined to describe the concept of PEMs better and to incorporate methodological changes for identifying non-RCT study designs such as CBA and ITS. Given the significant changes to the strategy, each database was searched from its start date to June 2011. The finalised strategies reflect an iterative development process whereby results of test strategies written by the EPOC Trials Search Co-ordinator were screened by authors for relevance. Based on this feedback, terms were added to or deleted from the final strategies. Strategies for this update are in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>; the original strategy is in <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>.</P>
<P>The search strategy included both controlled vocabulary terms and keywords. One portion of the search was a focused keyword search using high-value phrases such as <I>printed educational materials</I>, or <I>print intervention</I>,<I> print/written material</I> in proximity to <I>education </I>terms; results from this portion of the strategy were not combined with methodological filters and all citations were screened. The second part of the strategy used Medical Subject Headings (MeSH) for <I>continuing education</I> and <I>in-service training</I> and combined these concepts with terms describing health professionals and a broad array of synonyms for print material. This strategy also incorporated two methodological search filters - the Cochrane RCT Sensitivity/Precision Maximizing Filter (cf. <I>Cochrane Handbook for Systematic Reviews of Interventions</I> Chapter 6.4d); and the EPOC Filter. Strategies were developed for OVID MEDLINE and were translated for other databases.  </P>
</SUBSECTION>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2012-09-10 09:59:41 -0400" MODIFIED_BY="[Empty name]">
<P>Additional information was identified as follows:</P>
<UL>
<LI>reviewed reference lists of included studies, relevant systematic reviews, or other publications;</LI>
<LI>conducted cited reference searches in ISI Web of Science/Web of Knowledge.</LI>
</UL>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2012-09-10 10:00:58 -0400" MODIFIED_BY="Anik Giguere">
<STUDY_SELECTION MODIFIED="2012-09-10 09:59:41 -0400" MODIFIED_BY="Anik Giguere">
<P>Two review authors (from LC, AGi, MF, AGr, LC) independently screened the titles and abstract of all the retrieved reports to assess which studies met the inclusion criteria. We then retrieved full-text copies of all papers that were either potentially relevant or for which the inclusion criteria were not clear in the title or abstract. Any disagreements on selection were resolved by discussion among the review authors and arbiters (JG, FL).</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2012-09-10 10:00:22 -0400" MODIFIED_BY="Anik Giguere">
<P>For multi-arm studies, we selected the intervention groups as those that could be included in a pair-wise comparison of intervention groups that, if investigated alone, would meet the criteria for including studies in the review. Where more than two arms met these inclusion criteria, we selected the most intensive intervention among the experimental arms.</P>
<P>Two review authors extracted outcome data independently (from LC, JO, LN) and disagreements were resolved by discussion between the review authors and arbiters (AGi, ST). New in this update, we gathered the actual PEMs to allow a better description of their characteristics. For the extraction of the data on the characteristics of the studies and interventions, we used a modified version of the EPOC data collection checklist. A single review author initially extracted the data and a second review author double-checked the extracted data (MS, LC). All modifications proposed by the second review author to the initial extraction were verified by a third review author (JO). Disagreements were resolved by discussion between the review authors and arbiters (AGi).</P>
<P>We categorised each PEM according to potential effects modifiers by reading the study report and by assessing, where available, the PEM itself (<LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>). We chose the characteristics (effect modifiers) that we hypothesised would be most important in explaining differences in the effectiveness of the PEM. Effects modifiers related either to the source of the PEMs, the channel used to deliver them, their message, or their format, as described hereafter:</P>
<SUBSECTION>
<HEADING LEVEL="4">Source</HEADING>
<UL>
<LI>Source of information: researchers/clinicians, university, local expert body, national professional expert body, national government expert body, local clinicians, international professional expert body, international government expert body (<LINK REF="REF-Tseng-1999" TYPE="REFERENCE">Tseng 1999</LINK>; <LINK REF="REF-Wathen-2002" TYPE="REFERENCE">Wathen 2002</LINK>).</LI>
</UL>
<UL>
<LI>Endorsement: endorsed by an official source, not endorsed (<LINK REF="REF-Marriott-2000" TYPE="REFERENCE">Marriott 2000</LINK>; <LINK REF="REF-Wathen-2002" TYPE="REFERENCE">Wathen 2002</LINK>).</LI>
</UL>
<UL>
<LI>Tailoring: tailored to individuals based on diagnostic, behavioural, or motivational characteristics; tailored to groups of individuals; personalised but not tailored; generic (<LINK REF="REF-Baker-2010" TYPE="REFERENCE">Baker 2010</LINK>; <LINK REF="REF-Bull-2001" TYPE="REFERENCE">Bull 2001</LINK>; <LINK REF="REF-Kreuter-1996" TYPE="REFERENCE">Kreuter 1996</LINK>; <LINK REF="REF-Revere-2001" TYPE="REFERENCE">Revere 2001</LINK>).</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Channel</HEADING>
<UL>
<LI>Mode of delivery: publication in peer-reviewed journal, passive dissemination, direct mailing, mass mailing, media, hand delivery (<LINK REF="REF-Grol-1998" TYPE="REFERENCE">Grol 1998</LINK>).</LI>
</UL>
<UL>
<LI>Frequency of delivery: once, twice, three times, more than three times, indeterminate (<LINK REF="REF-Davis-2009" TYPE="REFERENCE">Davis 2009</LINK>).</LI>
<LI>Duration of delivery: once, one to three months, four to six months, over six months, indeterminate.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Message</HEADING>
<UL>
<LI>Clinical area: e.g. cardiovascular disease, antibiotic treatment, hypertension, diabetes, oestrogen replacement therapy, statin therapy, chest radiography, prostheses, orthopaedic surgery (<LINK REF="REF-Marriott-2000" TYPE="REFERENCE">Marriott 2000</LINK>; <LINK REF="REF-Grol-2003" TYPE="REFERENCE">Grol 2003</LINK>).</LI>
</UL>
<UL>
<LI>Type of targeted behaviour: prescribing/treatment, financial, general management of a problem, diagnosis, procedures, referrals, test ordering, surgery, patient education/advice, clinical prevention, screening, reporting, professional-patient communication, record keeping, discharge planning (<LINK REF="REF-Arnold-2005" TYPE="REFERENCE">Arnold 2005</LINK>).</LI>
</UL>
<UL>
<LI>Purpose: initiation of new management, stopping the introduction of new management, increase of established management, cessation of established management, reduction of established management, modification of management (<LINK REF="REF-Foy-2002" TYPE="REFERENCE">Foy 2002</LINK>; <LINK REF="REF-Grol-1998" TYPE="REFERENCE">Grol 1998</LINK>; <LINK REF="REF-Rogers-1995" TYPE="REFERENCE">Rogers 1995</LINK>).</LI>
</UL>
<UL>
<LI>Level of evidence: system, summary, systematic review of RCTs, clinical practice guidelines, other synthesis, original RCT, original non-RCT study, expert opinion (<LINK REF="REF-Burgers-2003a" TYPE="REFERENCE">Burgers 2003a</LINK>; <LINK REF="REF-Foy-2002" TYPE="REFERENCE">Foy 2002</LINK>; <LINK REF="REF-Grol-1998" TYPE="REFERENCE">Grol 1998</LINK>; <LINK REF="REF-Haynes-2007" TYPE="REFERENCE">Haynes 2007</LINK>).</LI>
</UL>
<UL>
<LI>Educational component: continuing professional development credits to recipients, delivered as part of a formal education programme, clear statement that intended for education, no evidence of educational component (<LINK REF="REF-Davis-2009" TYPE="REFERENCE">Davis 2009</LINK>).</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Format</HEADING>
<UL>
<LI>Format: publication of RCT in peer-reviewed journal, quick reference of clinical practice guidelines, full clinical practice guidelines, newsletter/bulletin, manual of article reprints, other (<LINK REF="REF-Grandage-2002" TYPE="REFERENCE">Grandage 2002</LINK>).</LI>
</UL>
<UL>
<LI>Appearance: black and white with figures/tables, enhanced communication format (<LINK REF="REF-Bull-2001" TYPE="REFERENCE">Bull 2001</LINK>; <LINK REF="REF-Hoffman-2004" TYPE="REFERENCE">Hoffman 2004</LINK>).</LI>
</UL>
<UL>
<LI>Length: more than two pages, two pages or less (<LINK REF="REF-Wang-2009" TYPE="REFERENCE">Wang 2009</LINK>).</LI>
</UL>
<P>A single review author initially categorised each PEM and a second review author double-checked the categories chosen (MS, LC). All modifications proposed by the second review author to the initial classification were verified by a third review author (JO). Disagreements were resolved by discussion between the review authors and arbiters (AGi).</P>
<P>We contacted the primary authors of the studies to complete missing data relative to outcomes, study design, and mode of delivery. We also asked them for the actual PEM that had been evaluated within the study if it was unavailable within the report and could be not found on the Internet.</P>
</SUBSECTION>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2012-09-10 09:59:41 -0400" MODIFIED_BY="Anik Giguere">
<P>At least two review authors (from AGi, NB, JO, SG) assessed the risk of bias for each included study using the criteria described in the EPOC module (see 'Additional information', 'Assessment of methodological quality' under Group Details). We resolved any discrepancies in quality ratings by discussion among review authors. We contacted the primary authors of the studies to complete missing data regarding sequence generation and allocation concealment.</P>
</QUALITY_ASSESSMENT>
<UNIT_OF_ANALYSIS MODIFIED="2012-08-13 15:13:15 -0400" MODIFIED_BY="Anik Giguere">
<P>We noted whether studies randomised healthcare providers or clusters of providers, such as practices. If the analysis did not allow for clustering of healthcare providers, we recorded a unit of analysis error, as such analysis tends to overestimate the precision of the effect of treatment (<LINK REF="REF-Donner-2001" TYPE="REFERENCE">Donner 2001</LINK>).</P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2012-04-30 21:43:27 -0400" MODIFIED_BY="Anik Giguere">
<P>When required information to perform the calculations on an outcome was missing, this outcome was not included in the analyses.</P>
</MISSING_DATA>
<DATA_SYNTHESIS MODIFIED="2012-09-10 10:00:58 -0400" MODIFIED_BY="Anik Giguere">
<P>We structured data analysis using the statistical methods developed by Grimshaw and colleagues (<LINK REF="REF-Grimshaw-2004" TYPE="REFERENCE">Grimshaw 2004</LINK>). Studies were grouped according to study design (ITS or controlled studies), type of end point (professional practice or patient outcome, continuous or dichotomous) and type of comparison (PEM only versus no intervention or PEM only versus other intervention). For studies where the quantitative data were absent or insufficient to calculate effect sizes, we presented the qualitative data as presented by the authors and conducted a descriptive analysis of the effectiveness of the included PEMs. The hypothesised direction of effect differed between studies, with some studies expecting an increase in end point and others expecting a decrease. In all cases, the effect size was standardised so that a positive difference between post-intervention percentages or means was a favourable end point.</P>
<SUBSECTION>
<HEADING LEVEL="4">Interrupted time series</HEADING>
<P>Descriptive statistics for each study were tabulated, and we re-analysed the results where possible. For the purpose of re-analysis, data on individual observations over time were derived from tables of results or graphs presented in the original study, by reading the corresponding values from the images. This approach shows good consistency between data derived from graphs and those explicitly reported in papers (<LINK REF="REF-Grilli-2002" TYPE="REFERENCE">Grilli 2002</LINK>).</P>
<P>Following recommendations of Ramsay and colleagues (<LINK REF="REF-Ramsay-2003" TYPE="REFERENCE">Ramsay 2003</LINK>), time regression analyses were used to re-analyse the results of each study. We first identified the best statistical model to use by testing for autocorrelation using the Durbin-Watson statistic. We then compared the results of the autoregressive integrated moving average (ARIMA) model and segmented linear regression analysis. We found the ARIMA model to be more appropriate in only two of the 54 included outcomes, and both models gave comparable results in these cases, so we decided to use only the segmented linear regression model.</P>
<P>We estimated two effect sizes: (1) the change in the level, which tells us the short-term change in the level of the outcome immediately after the introduction of the PEM and (2) the change in the slope (trend) of the regression line, which estimates the effect size with increasing time after the PEM intervention as the per cent change in level at each time point. If the PEM had an effect, it may have produced a change in level, a change in slope, or both. Using the estimated change in level and its standard error, we calculated standardised effect sizes by dividing each estimated change in level by its standard error. We used these standardised changes in level to calculate median level differences for each study, and then for each type of outcome (professional practice or patient outcomes).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Studies with a control group (C-RCT, RCT and CBA)</HEADING>
<P>Where studies reported more than one measure of each end point, the primary measure (as defined by the authors of the study) or the median measure was abstracted. For example, if the study reported multiple dichotomous professional practice variables, and none of them was denoted the primary variable, then the effect sizes of all the variables were ranked and the median value was taken. For dichotomous end points, we calculated the median absolute risk difference (ARD) between the intervention of interest and the control intervention. The ARD represents the difference in end point between intervention and control group (intervention minus control). A positive ARD indicates that performance improved more in the group that received the PEM than in the control group (e.g. an ARD of 0.11 indicates an absolute improvement in compliance with the targeted behaviours of 11%). For continuous end points, we calculated standardised mean difference (SMD) by dividing the mean score difference of the intervention and comparison groups in each study by the pooled estimate standard deviation for the two groups. For dichotomous and continuous end points, we constructed the 95% confidence intervals (CI) according to the recommendations of Review Manager 5 (<LINK REF="REF-RevMan-2011" TYPE="REFERENCE">RevMan 2011</LINK>). When no baseline was reported, we considered groups to be similar prior to the intervention. When the baseline was different for the two groups, we extracted a qualitative quote from the primary study report on the effectiveness of the intervention and on any confounding factors when available.</P>
<P>Analyses were carried out using the SAS software package (version 9.2), and Review Manager (version 5.1) (<LINK REF="REF-RevMan-2011" TYPE="REFERENCE">RevMan 2011</LINK>). We interpreted P &lt; 0.05 as indicating statistical significance.</P>
</SUBSECTION>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2012-09-10 10:00:58 -0400" MODIFIED_BY="Anik Giguere">
<P>We considered the PEM characteristics that were listed previously (<LINK TAG="DATA_EXTRACTION" TYPE="SECTION">Data extraction and management</LINK>) as potential sources of heterogeneity to explain variations in the results of the included studies. We prepared box plots (displaying median effect sizes, interquartile ranges, and outliers) and visually explored the size of the observed effects in relationship to each of these characteristics. Based on the work of various authors outlined in the Background section (<LINK TAG="THEORY" TYPE="SECTION">How the intervention might work</LINK>), we hypothesised that endorsement (<LINK REF="REF-Tseng-1999" TYPE="REFERENCE">Tseng 1999</LINK>; <LINK REF="REF-Wathen-2002" TYPE="REFERENCE">Wathen 2002</LINK>), tailoring (<LINK REF="REF-Revere-2001" TYPE="REFERENCE">Revere 2001</LINK>), increased frequency (<LINK REF="REF-Davis-2009" TYPE="REFERENCE">Davis 2009</LINK>; <LINK REF="REF-McGuire-1989" TYPE="REFERENCE">McGuire 1989</LINK>), better quality of evidence (<LINK REF="REF-Foy-2002" TYPE="REFERENCE">Foy 2002</LINK>; <LINK REF="REF-Grol-1998" TYPE="REFERENCE">Grol 1998</LINK>), educational component, enhanced communication format, and shorter length (<LINK REF="REF-Grandage-2002" TYPE="REFERENCE">Grandage 2002</LINK>; <LINK REF="REF-Marriott-2000" TYPE="REFERENCE">Marriott 2000</LINK>; <LINK REF="REF-Wang-2009" TYPE="REFERENCE">Wang 2009</LINK>) would enhance the PEM effectiveness. We did not have a priori hypotheses for the other potential effect modifiers.</P>
</SUBGROUP_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2012-09-13 12:40:00 -0400" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2012-09-13 12:37:33 -0400" MODIFIED_BY="[Empty name]">
<SEARCH_RESULTS MODIFIED="2012-09-10 14:36:08 -0400" MODIFIED_BY="[Empty name]">
<P>We identified 3715 potentially relevant reports, of which we excluded 3101 based on their titles and abstracts. The complete texts of the remaining 614 reports were retrieved and screened against our inclusion criteria. This second detailed screening led to the exclusion of 564 reports, leaving 50 included reports of 45 studies. One study was published in three reports (<LINK REF="STD-Avorn-1983" TYPE="STUDY">Avorn 1983</LINK>), and three studies were published in two reports (<LINK REF="STD-Azocar-2003" TYPE="STUDY">Azocar 2003</LINK>; <LINK REF="STD-Kajita-2010" TYPE="STUDY">Kajita 2010</LINK>; <LINK REF="STD-Perria-2007" TYPE="STUDY">Perria 2007</LINK>). Fifty-two PEM interventions were evaluated by the 45 included studies (some studies evaluated more than one PEM).</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2012-09-10 10:01:45 -0400" MODIFIED_BY="[Empty name]">
<P>Twenty-nine new studies were added to this review since the previous update, and four studies were removed. Two studies were removed because they did not use a PEM on its own as the intervention (PEM combined with one or multiple co-interventions versus no intervention). One study was removed and combined to an included study because they were, in fact, two reports on the same RCT (<LINK REF="STD-Avorn-1983" TYPE="STUDY">Avorn 1983</LINK>). A study that had been included as a CBA trial was removed from this review, because the report did not provide pre-intervention data, and the authors of the primary study did not answer our requests for this information (<LINK REF="STD-Steffensen-1997" TYPE="STUDY">Steffensen 1997</LINK>).</P>
<P>A total of 45 studies were included, comprising eight C-RCTs (<LINK REF="STD-Bearcroft-1994" TYPE="STUDY">Bearcroft 1994</LINK>; <LINK REF="STD-Dormuth-2004" TYPE="STUDY">Dormuth 2004</LINK>; <LINK REF="STD-Jousimaa-2002" TYPE="STUDY">Jousimaa 2002</LINK>, <LINK REF="STD-Kajita-2010" TYPE="STUDY">Kajita 2010</LINK>, <LINK REF="STD-Oakeshott-1994" TYPE="STUDY">Oakeshott 1994</LINK>; <LINK REF="STD-Perria-2007" TYPE="STUDY">Perria 2007</LINK>, <LINK REF="STD-Tsuji-2009" TYPE="STUDY">Tsuji 2009</LINK>, <LINK REF="STD-Watson-2001" TYPE="STUDY">Watson 2001</LINK>) and six RCTs (<LINK REF="STD-Avorn-1983" TYPE="STUDY">Avorn 1983</LINK>, <LINK REF="STD-Azocar-2003" TYPE="STUDY">Azocar 2003</LINK>; <LINK REF="STD-Beaulieu-2004" TYPE="STUDY">Beaulieu 2004</LINK>; <LINK REF="STD-Bjornson-1990" TYPE="STUDY">Bjornson 1990</LINK>; <LINK REF="STD-Denig-1990" TYPE="STUDY">Denig 1990</LINK>; <LINK REF="STD-Kottke-1989" TYPE="STUDY">Kottke 1989</LINK>). Thirty-one studies used ITS (<LINK REF="STD-Austin-2003" TYPE="STUDY">Austin 2003</LINK>; <LINK REF="STD-Austin-2004A" TYPE="STUDY">Austin 2004A</LINK>; <LINK REF="STD-Austin-2004B" TYPE="STUDY">Austin 2004B</LINK>; <LINK REF="STD-Austin-2005" TYPE="STUDY">Austin 2005</LINK>; <LINK REF="STD-Barbaglia-2009" TYPE="STUDY">Barbaglia 2009</LINK>; <LINK REF="STD-Black-2002" TYPE="STUDY">Black 2002</LINK>; <LINK REF="STD-Buyle-2010" TYPE="STUDY">Buyle 2010</LINK>; <LINK REF="STD-Coopersmith-2002" TYPE="STUDY">Coopersmith 2002</LINK>; <LINK REF="STD-Fijn-2000" TYPE="STUDY">Fijn 2000</LINK>; <LINK REF="STD-Fonarow-2009" TYPE="STUDY">Fonarow 2009</LINK>; <LINK REF="STD-Fukuda-2009" TYPE="STUDY">Fukuda 2009</LINK>; <LINK REF="STD-Guay-2007" TYPE="STUDY">Guay 2007</LINK>; <LINK REF="STD-Haas-2004" TYPE="STUDY">Haas 2004</LINK>; <LINK REF="STD-Hersh-2004" TYPE="STUDY">Hersh 2004</LINK>; <LINK REF="STD-Jackevicius-2001" TYPE="STUDY">Jackevicius 2001</LINK>; <LINK REF="STD-Jameson-2010" TYPE="STUDY">Jameson 2010</LINK>; <LINK REF="STD-Juurlink-2004" TYPE="STUDY">Juurlink 2004</LINK>; <LINK REF="STD-Kabir-2007" TYPE="STUDY">Kabir 2007</LINK>; <LINK REF="STD-Lam-2009" TYPE="STUDY">Lam 2009</LINK>; <LINK REF="STD-Majumdar-2003" TYPE="STUDY">Majumdar 2003</LINK>; <LINK REF="STD-Majumdar-2004" TYPE="STUDY">Majumdar 2004</LINK>; <LINK REF="STD-Mason-1998_x002f_99" TYPE="STUDY">Mason 1998/99</LINK>; <LINK REF="STD-Mason-2001" TYPE="STUDY">Mason 2001</LINK>; <LINK REF="STD-Matowe-2002" TYPE="STUDY">Matowe 2002</LINK>; <LINK REF="STD-Meyer-2007" TYPE="STUDY">Meyer 2007</LINK>; <LINK REF="STD-Roberts-2007" TYPE="STUDY">Roberts 2007</LINK>; <LINK REF="STD-Santerre-1996" TYPE="STUDY">Santerre 1996</LINK>; <LINK REF="STD-Shah-2008" TYPE="STUDY">Shah 2008</LINK>; <LINK REF="STD-Stafford-2004" TYPE="STUDY">Stafford 2004</LINK>; <LINK REF="STD-Wang-2005" TYPE="STUDY">Wang 2005</LINK>; <LINK REF="STD-Weiss-2011" TYPE="STUDY">Weiss 2011</LINK>).</P>
<P>Almost all the included studies addressed comparison group #1 (PEM only compared to no intervention); only one included study addressed comparison group #2 (PEM only versus single intervention) and it compared paper-based PEM to PEM on CD-ROM (<LINK REF="STD-Jousimaa-2002" TYPE="STUDY">Jousimaa 2002</LINK>). No studies addressed comparison group #3 (multifaceted intervention where PEM is included versus multifaceted intervention without PEM).</P>
<P>Most of the included studies took place in North America (12 in Canada, 11 in the US and one in both countries). We also included 18 studies conducted in Europe (including 11 in the UK), two in Japan, and one in Brazil. Ten studies took place in general or family medicine practices, nine in outpatient (ambulatory) settings, six in hospitals, three in mixed settings, one in a municipal health centre, and one in a managed behavioural healthcare organisation. The clinical settings of 15 studies were unclear; rather, participants were selected from within a specific geographic region. In most studies (42/45), participants were physicians. In three studies, participants combined physicians and nurses, physicians and pharmacists, or psychologists. In one study, the participants were nurses, public health nurses, and allied health professionals in the field of community health. It was unclear which type of health professionals participated in the remaining study.</P>
<SUBSECTION>
<HEADING LEVEL="3">Description of printed educational materials</HEADING>
<P>Most studies (36/45) evaluated a single PEM. Two studies evaluated simultaneously several PEMs (respectively 12 and 11 distinct PEMs) that presented similar characteristics (<LINK REF="STD-Dormuth-2004" TYPE="STUDY">Dormuth 2004</LINK>; <LINK REF="STD-Weiss-2011" TYPE="STUDY">Weiss 2011</LINK>), and three ITS studies assessed more than two or three PEMs with very similar characteristics (<LINK REF="STD-Austin-2005" TYPE="STUDY">Austin 2005</LINK>; <LINK REF="STD-Hersh-2004" TYPE="STUDY">Hersh 2004</LINK>; <LINK REF="STD-Wang-2005" TYPE="STUDY">Wang 2005</LINK>). Because we did not have the data required to analyse the effectiveness of each of these PEMs separately, we considered the effectiveness of the combined PEMs as they were a single intervention. Lastly, a few ITS studies evaluated the impact of multiple distinct PEMs that were delivered successively over time, by looking at the trends before and after each of the delivered PEM. For instance, a single study evaluated the impact of four PEMs (<LINK REF="STD-Fonarow-2009" TYPE="STUDY">Fonarow 2009</LINK>) and three studies evaluated two PEMs each (<LINK REF="STD-Haas-2004" TYPE="STUDY">Haas 2004</LINK>; <LINK REF="STD-Kabir-2007" TYPE="STUDY">Kabir 2007</LINK>; <LINK REF="STD-Majumdar-2003" TYPE="STUDY">Majumdar 2003</LINK>). PEMs evaluated using ITS designs were different from those evaluated with RCT designs. These PEMs were more homogenous regarding their source, endorsement, and format, as they were generally reports of an RCT published in a peer review journal. They also often target prescribing. PEMs tested by means of RCT designs were more diverse. In the following section, we describe the characteristics of these 52 PEMs.</P>
<SUBSECTION>
<HEADING LEVEL="4">PEM characteristics (potential effect modifiers)</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Source</HEADING>
<P>Various sources produced the studied PEMs (<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>). Twenty-four PEMs were produced by researchers or clinicians. Fourteen PEMs were produced by national professional expert bodies, such as the Women's Health Initiative, the College des Médecins du Quebec, the Society for Obstetrics and Gynecology, or the Royal College of Radiologists. Four PEMs came from local expert bodies.</P>
<P>Three-quarters of the studied PEMs (39/52) were endorsed, for example by a college of physicians, corporate source, or other key stakeholder. A large proportion of the endorsed PEMs (22/39) were peer-reviewed journal publications that were considered to be endorsed.</P>
<P>Three PEMs were tailored to participating professionals and two were tailored to groups of individuals. Three PEMs were personalised, that is the recipient's name appeared on the printed information (<LINK REF="STD-Beaulieu-2004" TYPE="STUDY">Beaulieu 2004</LINK>; <LINK REF="STD-Denig-1990" TYPE="STUDY">Denig 1990</LINK>; <LINK REF="STD-Dormuth-2004" TYPE="STUDY">Dormuth 2004</LINK>). However, most were generic, without any tailoring (44/52).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Channel</HEADING>
<P>Thirty-three PEMs were disseminated passively, of which 23 by publication in a peer-reviewed journal (<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>). The frequency and duration of exposure of professionals to these documents was indeterminate. Nine PEMs were disseminated actively through direct mailing, eight of which were delivered only once and the last one four times during a four- to six-month period. Six PEMs were disseminated through mass mailing, with variable frequencies and durations of delivery: four were delivered once, one was delivered twice, and the other consisted in a series of evidence-based bulletins mailed out regularly over a three-year period. Four PEMs were delivered a single time through a mode that is unclear in the reviewed study. No PEMs were disseminated solely by electronic means, but those that were disseminated passively probably used electronic dissemination channels, such as the journal's website in the case of the articles published in scientific journals.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Message</HEADING>
<P>The PEMs covered a broad range of clinical areas, including cardiovascular diseases (10 PEMs), oestrogen replacement therapy for menopausal women (eight PEMs), hypertension (five PEMs), and diabetes (four PEMs) (<LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>).</P>
<P>Most PEMs (38/52) targeted a single type of clinical behaviour and 13 addressed two or more behaviours. Thirty-nine PEMs targeted providers' prescribing or treatment behaviour, eight targeted the general management of a problem, and six addressed procedures. There were five PEMs for test ordering, five regarding referrals, five directed at surgery, four targeted at patient education/advice, and four on diagnoses. Three PEMs targeted clinical prevention services; two covered screening and two discharge planning; and a single PEM was aimed at reporting.</P>
<P>Almost all the PEMs (51/52) were intended to modify an already established management, either to increase it (16 PEMs), to decrease it (15 PEMs), or to increase management in one activity and reduce it in another activity (20 PEMs). A single PEM was intended to cease an established practice.</P>
<P>The level of evidence used was clear for 48 PEMs, including 20 clinical practice guidelines developed through a formal consensus process, 22 original RCTs, four summaries, and one systematic review of RCTs. A single PEM was based on expert opinion.</P>
<P>Only six PEMs specified that they were intended for educational purposes; most were unclear in that respect.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Format</HEADING>
<P>Twenty-three PEMs consisted of a publication in a peer-reviewed journal, and were thus printed in black and white with figures or tables (<LINK REF="TBL-03" TYPE="TABLE">Table 3</LINK>). Most of these (22/23) were longer than two pages: one was two pages long, and the length was not specified for one.</P>
<P>Sixteen PEMs consisted of full sets of evidence-based guidelines, and their appearance was not specified except for four of them: three were published in black and white and the other consisted of 11 two-page highly graphic colour-PEM presenting with clinical information on diagnosis and recommendations on antibiotic treatments (<LINK REF="STD-Weiss-2011" TYPE="STUDY">Weiss 2011</LINK>).</P>
<P>Six PEMs were newsletters or bulletins: four were published in black and white, one in colour, and the format of one was unclear. The coloured one consisted of 12 issues of an evidence-based drug therapy series in an enhanced communication format named <I>Therapeutics Letter</I> (<LINK REF="STD-Dormuth-2004" TYPE="STUDY">Dormuth 2004</LINK>).</P>
<P>Three PEMs were brief summaries of clinical guidelines and one PEM was a black and white manual of peer-reviewed clinical article reprints.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2012-09-13 12:37:33 -0400" MODIFIED_BY="[Empty name]">
<P>The complete list of excluded full-text papers assessed for eligibility can be found in <LINK REF="APP-04" TYPE="APPENDIX">Appendix 4</LINK>. Among the 564 excluded studies, 381 studies were excluded due to ineligible study design, 28 studies due to ineligible study participants, 144 studies were excluded due to non-PEM intervention, and 17 studies due to inappropriate outcomes.</P>
<P>Reasons for exclusion for 27 studies are found in the excluded studies table (<LINK TAG="EXCLUDED_STUDIES_DESCR" TYPE="SECTION">Excluded studies</LINK>). Five studies were excluded due to ineligible study design (<LINK REF="STD-Kulkarni-1998" TYPE="STUDY">Kulkarni 1998</LINK>; <LINK REF="STD-Martino-2011" TYPE="STUDY">Martino 2011</LINK>; <LINK REF="STD-Mollon-2009" TYPE="STUDY">Mollon 2009</LINK>; <LINK REF="STD-Morse-2009" TYPE="STUDY">Morse 2009</LINK>; <LINK REF="STD-Ozgun-2010" TYPE="STUDY">Ozgun 2010</LINK>). Five studies were excluded for not having objective outcomes (<LINK REF="STD-Evans-2010" TYPE="STUDY">Evans 2010</LINK>; <LINK REF="STD-Hunskaar-1996" TYPE="STUDY">Hunskaar 1996</LINK>; <LINK REF="STD-Jackevicius-1999" TYPE="STUDY">Jackevicius 1999</LINK>; <LINK REF="STD-Mockiene-2011" TYPE="STUDY">Mockiene 2011</LINK>; <LINK REF="STD-Richardson-2002" TYPE="STUDY">Richardson 2002</LINK>). One study was excluded because pre-intervention data was not provided (<LINK REF="STD-Steffensen-1997" TYPE="STUDY">Steffensen 1997</LINK>). Two studies were excluded for not having PEM as an intervention (<LINK REF="STD-Fontaine-2006" TYPE="STUDY">Fontaine 2006</LINK>; <LINK REF="STD-Perez_x002d_Jauregui-2008" TYPE="STUDY">Perez-Jauregui 2008</LINK>). One study was excluded due to the intervention being aimed at patients rather than health care professionals (<LINK REF="STD-Janmeja-2009" TYPE="STUDY">Janmeja 2009</LINK>). One study was excluded because it focused on evaluating the validity of the guideline rather than the effectiveness to change professional practice (<LINK REF="STD-Kocher-2003" TYPE="STUDY">Kocher 2003</LINK>). Twelve studies were excluded for not reporting data from comparison groups (<LINK REF="STD-Bishop-2010" TYPE="STUDY">Bishop 2010</LINK>; <LINK REF="STD-Croudace--2003" TYPE="STUDY">Croudace 2003</LINK>; <LINK REF="STD-Emslie-1993" TYPE="STUDY">Emslie 1993</LINK>; <LINK REF="STD-Engers-2005" TYPE="STUDY">Engers 2005</LINK> <LINK REF="STD-Ferrari-2005" TYPE="STUDY">Ferrari 2005</LINK>; <LINK REF="STD-Hazard--1997" TYPE="STUDY">Hazard 1997</LINK>; <LINK REF="STD-Jain-2006" TYPE="STUDY">Jain 2006</LINK>; <LINK REF="STD-Maiman--1988" TYPE="STUDY">Maiman 1988</LINK>; <LINK REF="STD-Majumdar-2008" TYPE="STUDY">Majumdar 2008</LINK>; <LINK REF="STD-Mettes-2010" TYPE="STUDY">Mettes 2010</LINK>; <LINK REF="STD-Schwartz-2007" TYPE="STUDY">Schwartz 2007</LINK>; <LINK REF="STD-Simon-2007" TYPE="STUDY">Simon 2007</LINK>). Six of these studies included multi-faceted comparisons and it was difficult to determine the effectiveness of PEM (<LINK REF="STD-Bishop-2010" TYPE="STUDY">Bishop 2010</LINK>; <LINK REF="STD-Croudace--2003" TYPE="STUDY">Croudace 2003</LINK>; <LINK REF="STD-Engers-2005" TYPE="STUDY">Engers 2005</LINK>; <LINK REF="STD-Hazard--1997" TYPE="STUDY">Hazard 1997</LINK>; <LINK REF="STD-Jain-2006" TYPE="STUDY">Jain 2006</LINK>; <LINK REF="STD-Mettes-2010" TYPE="STUDY">Mettes 2010</LINK>).</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2012-09-13 12:40:00 -0400" MODIFIED_BY="[Empty name]">
<P>Among the 14 RCTs included in this review, we found the randomisation process to be appropriate in eight studies and the concealment of allocation to be appropriate in 10 studies (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>). All studies, except for two, reported appropriate means to blind outcome assessment. There was a low risk of attrition bias in seven studies, but the risk was unclear in the other seven RCTs. Inappropriate protection against contamination (high risk in three studies, unclear in three studies) was the main bias for the RCTs. A potential unit of analysis error was identified in one C-RCT in which the analyses did not account for clustering (<LINK REF="STD-Bearcroft-1994" TYPE="STUDY">Bearcroft 1994</LINK>).</P>
<P>Thirty-one of the included studies were ITS designs. Most had low risk of the intervention affecting data collection and low risks of detection, attrition, and reporting biases (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>). For four ITS studies, there were high risks that the intervention effects were affected by other changes happening at the same time as the intervention. This risk was low in four studies, but unclear in the remaining 23. The direction of the intervention effect was only specified in 10 studies. A single study scored all items appropriately (<LINK REF="STD-Black-2002" TYPE="STUDY">Black 2002</LINK>).</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2012-09-10 17:07:51 -0400" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Comparison group #1: PEM only compared to no intervention</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Professional practice outcomes</HEADING>
<P>Seventy-three categorical professional practice outcomes were evaluated within nine RCTs that compared PEM to no intervention. Data from seven of these studies (69 outcomes) were available for re-analysis. The median ARD across all outcomes from these studies was 0.02 (range 0 to 0.11) (<LINK REF="TBL-04" TYPE="TABLE">Table 4</LINK>), indicating a 2% absolute improvement in professional practice in groups that received PEMs compared to groups that received no intervention. In five of the seven studies, the observed median effect was statistically significant. A unit of analysis error was observed in one study (<LINK REF="STD-Bearcroft-1994" TYPE="STUDY">Bearcroft 1994</LINK>), and so we cannot estimate the statistical significance of the effects reported in that study. Four outcomes from three studies could not be included in this analysis because of incomplete data sets. Among these, three were reported by study authors to have improved after exposure of study participants to a PEM intervention (<LINK REF="STD-Beaulieu-2004" TYPE="STUDY">Beaulieu 2004</LINK>; <LINK REF="STD-Dormuth-2004" TYPE="STUDY">Dormuth 2004</LINK>), whereas it is difficult to draw any conclusions from the report for the fourth outcome (<LINK REF="STD-Bjornson-1990" TYPE="STUDY">Bjornson 1990</LINK>).</P>
<P>Thirteen continuous professional practice outcomes were compared to no intervention within five of the included RCTs. We had the complete data to calculate effect sizes for three studies (eight outcomes). We calculated a 0.13 improvement in the standard median effect size for these outcomes (range -0.16 to 0.36) (<LINK REF="TBL-05" TYPE="TABLE">Table 5</LINK>). In two of the eight outcomes the observed effect size was statistically significant. For the two other RCTs, the data set was incomplete and we were unable to re-analyse the results - study authors reported an improvement in outcomes after exposure of participants to the PEM in one instance (<LINK REF="STD-Avorn-1983" TYPE="STUDY">Avorn 1983</LINK>) and no effect in the other (<LINK REF="STD-Azocar-2003" TYPE="STUDY">Azocar 2003</LINK>).</P>
<P>We included 62 professional practice outcomes from the 31 ITS studies (<LINK REF="TBL-06" TYPE="TABLE">Table 6</LINK>). The minimum amount of observations needed for re-analysis was missing for eight of these outcomes. Two of these missing outcomes (rates of lipid-lowering agent use for all patients and for patients initiating treatment) came from the <LINK REF="STD-Fonarow-2009" TYPE="STUDY">Fonarow 2009</LINK> study, for which we were able to re-analyse nine other outcomes. Therefore, we were able to re-analyse 54 outcomes from 25 studies using time series regressions. For 27 of these outcomes (from 16 ITS studies) we calculated statistically significant improvements in slopes or levels, or both, between the periods before PEM and after PEM disseminations. For 11 of these outcomes (extracted from seven ITS studies) we calculated a significant improvement in one measure and a deterioration in the other between the periods before and after the disseminations of the PEM (<LINK REF="STD-Austin-2003" TYPE="STUDY">Austin 2003</LINK>; <LINK REF="STD-Fonarow-2009" TYPE="STUDY">Fonarow 2009</LINK>; <LINK REF="STD-Haas-2004" TYPE="STUDY">Haas 2004</LINK>; <LINK REF="STD-Majumdar-2003" TYPE="STUDY">Majumdar 2003</LINK>; <LINK REF="STD-Mason-1998_x002f_99" TYPE="STUDY">Mason 1998/99</LINK>; <LINK REF="STD-Roberts-2007" TYPE="STUDY">Roberts 2007</LINK>; <LINK REF="STD-Shah-2008" TYPE="STUDY">Shah 2008</LINK>). We found a significant deterioration in both the slope and level between the periods before and after PEM disseminations in a single outcome from the <LINK REF="STD-Roberts-2007" TYPE="STUDY">Roberts 2007</LINK> study.</P>
<P>Data from these ITS studies allowed us to calculate an overall improvement in professional practice outcomes across studies immediately after the introduction of the PEM, with a standardized median change in level of 1.69 (range from -6.96 to +14.26). This increase in level at the time of the introduction of the PEM is a standardized value and so it has no units. Standardization was performed by dividing the change in level by the standard deviation of the change in level. In a study such as <LINK REF="STD-Mason-2001" TYPE="STUDY">Mason 2001</LINK>, where the study authors measured a standard deviation of 0.08 for the observed change in level, the 1.69 increase would represent a 0.13 increase in the number of procedures per 1000 habitants under 15 years old right after the introduction of the PEM, here a bulletin. Among the eight outcomes that we could not re-analyse, seven were reported by study authors to have improved after exposure of the study participants to the PEMs (<LINK REF="STD-Barbaglia-2009" TYPE="STUDY">Barbaglia 2009</LINK>; <LINK REF="STD-Fijn-2000" TYPE="STUDY">Fijn 2000</LINK>; <LINK REF="STD-Fonarow-2009" TYPE="STUDY">Fonarow 2009</LINK>; <LINK REF="STD-Fukuda-2009" TYPE="STUDY">Fukuda 2009</LINK>; <LINK REF="STD-Hersh-2004" TYPE="STUDY">Hersh 2004</LINK>; <LINK REF="STD-Santerre-1996" TYPE="STUDY">Santerre 1996</LINK>), whereas one was reported not to have been affected by the PEM intervention (<LINK REF="STD-Wang-2005" TYPE="STUDY">Wang 2005</LINK>) (<LINK REF="TBL-06" TYPE="TABLE">Table 6</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Patient health outcomes</HEADING>
<P>A single categorical patient outcome was evaluated in an RCT (<LINK REF="STD-Tsuji-2009" TYPE="STUDY">Tsuji 2009</LINK>) and gave an ARD of 0.13 (<LINK REF="TBL-07" TYPE="TABLE">Table 7</LINK>), indicating an improvement of 13% in this outcome in the group exposed to the PEM only compared to the no intervention group. Another RCT reported five continuous patient health outcomes: one significantly improved while the others were not significantly changed in the group exposed to the PEM only compared to the no intervention group (<LINK REF="TBL-08" TYPE="TABLE">Table 8</LINK>). Overall, we calculated an overall median standardised effect size of -0.14 across these five outcomes. Two ITS studies reported four patient health outcomes, and our calculations showed an overall standardised median improvement in level of 3.79 across these four outcomes (<LINK REF="TBL-09" TYPE="TABLE">Table 9</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Comparison group #2: PEM only versus single intervention</HEADING>
<P>A single RCT compared a group exposed to a PEM (paper-based guidelines) to a group exposed to another type of intervention (computerised guidelines). This study measured nine categorical professional outcomes, none of which showed significant changes between groups. The standardised median ARD across all these outcomes was -0.02 (<LINK REF="TBL-10" TYPE="TABLE">Table 10</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Effects modifiers</HEADING>
<P>We prepared box plots to explore whether various PEM characteristics might influence their effectiveness to change professional practice. Visual inspection of these graphs suggests that some characteristics may have more potential to influence effectiveness. For example, we observed that effectiveness varied more among the following categories: source of information (<LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>), tailoring (<LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK>), clinical areas (<LINK REF="FIG-09" TYPE="FIGURE">Figure 9</LINK>), type of targeted behaviour (<LINK REF="FIG-10" TYPE="FIGURE">Figure 10</LINK>), purpose (<LINK REF="FIG-11" TYPE="FIGURE">Figure 11</LINK>), level of evidence (<LINK REF="FIG-12" TYPE="FIGURE">Figure 12</LINK>), and format (<LINK REF="FIG-14" TYPE="FIGURE">Figure 14</LINK>). Visual inspection of the bar graphs also suggested that PEMs' effectiveness does not vary much depending on the mode, frequency, or duration of delivery (<LINK REF="FIG-06" TYPE="FIGURE">Figure 6</LINK>; <LINK REF="FIG-07" TYPE="FIGURE">Figure 7</LINK>; <LINK REF="FIG-08" TYPE="FIGURE">Figure 8</LINK>, respectively). Some potential effect modifiers did not vary across the studied PEMs. For instance, most of the PEMs were endorsed (<LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>), most did not specify any educational component (<LINK REF="FIG-13" TYPE="FIGURE">Figure 13</LINK>), they were generally all black and white with a few figures and tables (appearance, <LINK REF="FIG-15" TYPE="FIGURE">Figure 15</LINK>), and most were longer than two pages (length, <LINK REF="FIG-16" TYPE="FIGURE">Figure 16</LINK>). This lack of variability prevents any conclusion on the importance of these characteristics to determine PEMs' effectiveness. For RCT studies, there were often only one or two studies in each category of effect modifier (<LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>; <LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>; <LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK>; <LINK REF="FIG-06" TYPE="FIGURE">Figure 6</LINK>; <LINK REF="FIG-07" TYPE="FIGURE">Figure 7</LINK>; <LINK REF="FIG-08" TYPE="FIGURE">Figure 8</LINK>; <LINK REF="FIG-09" TYPE="FIGURE">Figure 9</LINK>; <LINK REF="FIG-10" TYPE="FIGURE">Figure 10</LINK>; <LINK REF="FIG-11" TYPE="FIGURE">Figure 11</LINK>; <LINK REF="FIG-12" TYPE="FIGURE">Figure 12</LINK>; <LINK REF="FIG-13" TYPE="FIGURE">Figure 13</LINK>; <LINK REF="FIG-14" TYPE="FIGURE">Figure 14</LINK>; <LINK REF="FIG-15" TYPE="FIGURE">Figure 15</LINK>; <LINK REF="FIG-16" TYPE="FIGURE">Figure 16</LINK>). For example, there is a range of clinical areas that are covered by the included PEMs, but only a few studies tested PEMs in each clinical area (<LINK REF="FIG-09" TYPE="FIGURE">Figure 9</LINK>). For ITS studies, PEMs were more homogenous and many studies were thus grouped within the same characteristic with only a few studies that tested PEMs with different characteristics (<LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>; <LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>; <LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK>; <LINK REF="FIG-06" TYPE="FIGURE">Figure 6</LINK>; <LINK REF="FIG-07" TYPE="FIGURE">Figure 7</LINK>; <LINK REF="FIG-08" TYPE="FIGURE">Figure 8</LINK>; <LINK REF="FIG-09" TYPE="FIGURE">Figure 9</LINK>; <LINK REF="FIG-10" TYPE="FIGURE">Figure 10</LINK>; <LINK REF="FIG-11" TYPE="FIGURE">Figure 11</LINK>; <LINK REF="FIG-12" TYPE="FIGURE">Figure 12</LINK>; <LINK REF="FIG-13" TYPE="FIGURE">Figure 13</LINK>; <LINK REF="FIG-14" TYPE="FIGURE">Figure 14</LINK>; <LINK REF="FIG-15" TYPE="FIGURE">Figure 15</LINK>; <LINK REF="FIG-16" TYPE="FIGURE">Figure 16</LINK>; ). For example, almost all the PEMs tested with ITS study designs were tailored (<LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK>).</P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2012-09-12 22:37:38 -0400" MODIFIED_BY="[Empty name]">
<SUMMARY_OF_RESULTS MODIFIED="2012-09-10 10:01:45 -0400" MODIFIED_BY="[Empty name]">
<P>Overall, the results of this review suggest that when used alone, and compared to a 'no intervention' control, PEMs can have a small beneficial effect on professional practice outcomes. Various measures of effectiveness have been gathered through this review process, and although some analyses present limitations regarding internal or external validity, overall they make a good case that PEMs can have an impact on professional practice.</P>
<P>More weight should be given to the data collected from the 14 RCTs. For categorical outcomes, the overall effect size (ARD 0.02) was derived from a larger set of studies (seven studies) and outcomes (69 outcomes). Thus, we can have more confidence in the median effect size estimated from this larger data set. These results are somewhat reflected in the descriptive results from the RCTs that could not be re-analysed: study authors reported improvements in three out of the five studies. For continuous outcomes, re-analysis allowed calculating a relatively important standardised effect size of 0.13, but it was derived from only three studies. When taken individually, continuous outcomes did not show consistent statistical differences among them (two out of eight were statistically significant).</P>
<P>Data collected from ITS studies represent a larger data set that is prone to important risks of bias, especially since the studies were conducted retrospectively, often without pre-specifying the expected effect of the intervention. Nevertheless, results from these studies were consistent across studies and support the conclusions gathered from more robust study designs, that PEMs can change professional practice outcomes. Results of ITS were more positive that results of RCTs, which could be a function of the design, or that different types of PEMs are being evaluated in different designs. For instance, ITS are more likely to be evaluated in peer-review publications, and are prone to more important publication bias as high-profile papers are likely to be chosen.</P>
<P>Because we cannot ascribe CIs to the observed effect sizes, we cannot rule out the possibility that these effects might have occurred by chance alone. Clinical significance of the observed effect sizes is unknown, but they fall below the range of effects of other quality improvement systematic reviews that reported median effect sizes ranging from 0.04 to 0.09 for categorical professional outcomes and from 10% to 16% for continuous outcomes (<LINK REF="REF-Flodgren-2011" TYPE="REFERENCE">Flodgren 2011</LINK>; <LINK REF="REF-Forsetlund-2009" TYPE="REFERENCE">Forsetlund 2009</LINK>; <LINK REF="REF-Jamtvedt-2006" TYPE="REFERENCE">Jamtvedt 2006</LINK>; <LINK REF="REF-O_x0027_Brien-2007" TYPE="REFERENCE">O'Brien 2007</LINK>; <LINK REF="REF-Shojania-2010" TYPE="REFERENCE">Shojania 2010</LINK>). Clinical significance of the observed 13% improvement in continuous outcomes may be easier to judge if, for instance, we consider the results of <LINK REF="STD-Denig-1990" TYPE="STUDY">Denig 1990</LINK>: an 11% improvement corresponded in this case to a change from 27 defined daily doses (DDDs) of undesirable antispasmodic per 1000 prescriptions before the PEM delivery to 26 DDDs/1000 prescriptions after the PEM delivery.</P>
<P>Insufficient information was collected to make a conclusion on effectiveness of PEMs to improve patient outcomes.</P>
<P>A few characteristics of the PEMs seem promising to increase their impact on professional practice, but the limited number of studies prevents any conclusion. These findings are exploratory should be interpreted with caution.<BR/>
</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2012-09-10 10:01:45 -0400" MODIFIED_BY="[Empty name]">
<P>Although PEMs were distributed to many types of healthcare professionals, participants in the included studies were generally physicians (90% physicians only, 6% mix of health professionals, 4% unclear).Therefore, the findings of our review need to be confirmed for other types of professionals. The included studies were performed in developed countries (almost all in North America and Europe), primarily in outpatient practices and in some hospitals. The applicability of the observed results to other settings is unknown.</P>
<P>Compared to previous reviews of clinical practice guidelines (<LINK REF="REF-Grimshaw-2004" TYPE="REFERENCE">Grimshaw 2004</LINK>), we have included more diverse types of PEMs, including full clinical guidelines, guideline summaries, publications in peer-reviewed journals, bulletins, or newsletters. Therefore, our results can be generalised to a broader category of PEMs. More studies are needed to draw conclusions on many of the potential effect modifiers that we have decided to study. For instance, most PEMs were are not explicit about their educational intent, so it is difficult from the set of included studies to evaluate whether an intervention developed specifically as educational would be more efficient.</P>
<P>Even though PEMs are often used as an add-on to a single or multifaceted intervention, no evidence can be used to support this practice as we were not able to find any studies comparing the addition of a PEM to another intervention compared to the intervention alone. To improve the applicability of this review, we chose to exclude the many studies that compared multifaceted intervention including PEMs to a 'no intervention' control, as these comparisons do not allow isolation of the 'PEM effect' from the effect of the other interventions.</P>
<P>We did not restrict our review to specific outcomes or clinical areas, allowing for a greater number of included studies. Thus, were able to review and pool a relatively wide variety of professional practice outcomes. This breadth of outcomes also allows for generalisability to any clinical situation. However, a relatively small number of studies looked at patient outcomes. Our inclusion criteria (any objective measure of professional practice or patient outcomes) also led to the exclusion of many educational interventions that are typically evaluated with non-clinical outcomes (e.g. knowledge, attitudes). The benefits of PEMs should be interpreted in the context of their costs and span of coverage. Unfortunately, no studies undertook a formal economic evaluation of the effects of the PEMs.</P>
<P>The level and slope estimates were evaluated with time series analyses, from a limited number of data points considering that this type of analysis would be best performed with a minimum of 50 to 100 data points (<LINK REF="REF-Chatfield-2001" TYPE="REFERENCE">Chatfield 2001</LINK>; <LINK REF="REF-Lagarde-2012" TYPE="REFERENCE">Lagarde 2012</LINK>). Thus, the pooling of level differences is also prone to substantial imprecision.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2012-09-10 12:27:43 -0400" MODIFIED_BY="[Empty name]">
<P>The methodological quality of the 14 RCTs was variable; the proportion of quality criteria met varied from two to eight out of nine. The items 'Random sequence generation' and 'Allocation concealment' were evaluated as having unclear or high risk of bias in 43% and 36% of studies, respectively, resulting in risks of selection bias for these studies, and possibly leading to an overestimation of effects (<LINK REF="REF-Wood-2008" TYPE="REFERENCE">Wood 2008</LINK>). This is likely to be a consequence of the randomisation issues, as only four RCTs reported comparable baseline data. As we included only objective outcomes, it was to be expected that most studies would have blinded assessment of outcomes (12 of 14 outcomes). The completeness of outcome data was unclear in many RCTs (seven of 14 RCTs), which is likely to be because of the inclusion of older trials published before the CONSORT statement, and these can often make study interpretation difficult (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). To limit this potential attrition bias, we were able to get additional information by contacting the authors directly. Most of the reviewed RCTs were clustered (nine of 14 RCTs), avoiding contamination problems so that changes in the comparison group could be more dependably ascribed to the intervention effect. However, the risk of contamination bias was uncertain in two C-RCTs, and one C-RCT did not take into account clustering in analysis potentially leading to a unit of analysis error.</P>
<P>Inclusion of ITS studies allows considerably more experimental studies to be reviewed, with the drawback and challenge of having to weight methodological quality in the review conclusions. As mentioned earlier, ITS studies are conducted retrospectively, often without pre-specifying the expected effect of the intervention, or acknowledging the presence of a secular trend. It is still important to include these studies since finding an equivalent control group of practitioners who is not exposed can be challenging when recommendations are disseminated widely on a national level - or when consensus recommendations are directed at the entire population of practitioners (<LINK REF="REF-Kanouse-1995" TYPE="REFERENCE">Kanouse 1995</LINK>). We avoided the problem of inappropriate analyses in reviewed ITS studies by re-analysing all the results using times series regressions (<LINK REF="REF-Ramsay-2003" TYPE="REFERENCE">Ramsay 2003</LINK>).</P>
<P>Quality assessment items were not consistently described in all the included studies, suggesting that there remains room for improvement in the level of reporting on quality assessment criteria in publications.</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2012-09-10 10:01:45 -0400" MODIFIED_BY="[Empty name]">
<P>Our approach focused on the observed effect sizes and does not consider statistical significance or weight by study size. However, it provides information on the effect size of the intervention, which is more informative than the vote counting approach. It is also possible that our review suffered from publication bias, so the reader should consider the possibility that we are overestimating the effectiveness of the intervention.</P>
<P>We were often limited by missing information from the primary studies. For instance, frequency of the PEM delivery was generally not reported in primary studies, and the messages and formats of the PEMs were not clearly and consistently described across the primary literature. To complete the missing information, we attempted to obtain a copy of the actual PEM tested within each study; despite our best efforts, we were not able to obtain copies of all the PEMs and some information remained missing.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2012-09-12 22:37:38 -0400" MODIFIED_BY="[Empty name]">
<P>The findings from this review differ from the last update of this Cochrane review that concluded that "PEMs when used alone may have a beneficial effect on process outcomes but not on patient outcomes" (<LINK REF="REF-Farmer-2008" TYPE="REFERENCE">Farmer 2008</LINK>). Inclusion of more studies in the present update may have led to more conservative estimates of effect. The results are not yet stable and further research might be needed. Before this review, Grimshaw and colleagues (<LINK REF="REF-Grimshaw-2004" TYPE="REFERENCE">Grimshaw 2004</LINK>) had conducted the most comprehensive systematic review on the effectiveness of guideline dissemination and implementation strategies. Their review results concur with the present work, as they found that PEMs have a moderate effect across health conditions.</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2012-09-10 10:01:45 -0400" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2012-04-30 11:48:30 -0400" MODIFIED_BY="[Empty name]">
<P>PEMs are a commonly used method of disseminating information to healthcare professionals. They can be distributed to large numbers of healthcare professionals and are relatively inexpensive. Studies of the effects of PEMs generally show modest, but potentially important, improvements in professional practice. Only a few studies have shown small deteriorations of uncertain clinical significance. Those interested in using PEMs should be aware of the potentially small effects and limitations of the current evidence. Further, there is preliminary evidence about how to optimise educational materials.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2012-09-10 10:01:45 -0400" MODIFIED_BY="[Empty name]">
<P>Authors of future primary studies are encouraged to provide a detailed description of the PEM studied and to publish it with their report to allow further message and format analysis. This would allow for replication, comparison across studies, and more robust analyses of effect modifiers. Future studies should also consider evaluating head-to-head comparisons of PEMs with different characteristics.</P>
<P>More PEM versus control two-arm studies are needed to obtain a more definite answer on the effectiveness of PEMs to improve professional practice. More research is also required to address the effectiveness of PEMs on improving patient outcomes.</P>
<P>Studies should be sufficiently powered to detect smaller effects.</P>
<P>Quasi-experimental designs such as ITS may increasingly be used for evaluating PEMs and other interventions for change in healthcare practice, given their low cost, convenience, and value for informing policy decisions. However, it is important that appropriate statistical methods be used to analyse time series data, preferably time series regression models.</P>
<P>In many studies, PEMs serve as a control group rather than an intervention of interest, or some studies used PEMs alongside other interventions for investigating additive effects of interventions. Future intervention studies examining the effect of PEMs should consider the impact of PEMs on their own.</P>
<P>Economic evaluations of PEMs are needed. Future studies should provide information about the resources required for development, dissemination, and implementation of PEMs (<LINK REF="REF-Grimshaw-2004" TYPE="REFERENCE">Grimshaw 2004</LINK>).</P>
<P>We chose to describe some PEMs' characteristics that may have affected their effectiveness, based on broader categories of the persuasive communication theory (source, channel, and message). However, each of these characteristics could only be evaluated in a limited number of included studies. This prevented any conclusion on the relative importance of these potential effect modifiers to improve professional practice, and calls for more research on the characteristics of PEM that truly lead to a change in behaviour.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2012-09-12 11:43:08 -0400" MODIFIED_BY="Anik Giguere">
<P>We would like to acknowledge the contributions of all the people who helped during the review process: Ms. Laurie Carignan and Ms. Michele Shemilt contributed to study selection and data extraction, Mr. Lawrence Ndoh and Ms. Yasmin Banu contributed to data extraction, Ms. Sandy Gill and Ms. Norma Brown contributed to risk of bias evaluations, Ms. Angela Barbara contributed to data analysis and writing of the first draft, Mr. Jamie O'Donnell contributed to data extraction, risk of bias evaluation, data analysis and helped coordinate the study. We would like to acknowledge the help of Dr Robby Nieuwlaat for translation of articles. We would like to acknowledge the help from the librarians at the Centre Hospitalier Saint-François d'Assise, Ms. Michelle Petitclerc and Mrs. Jacinte Biron. We would also like to acknowledge the authors from previous versions of the review: Dr. Lisa Bero, Dr. Nick Freemantle, Dr. Andy Oxman, Ms. Lucile Turcot, Dr. Emma Harvey, and Dr Jessie McGowan. We would like to thank the peer reviewers, and EPOC editors who provided input, particularly Dr. Gillian Leng who was the referee editor for this review.</P>
<P>A special thank you is extended to the primary study authors who responded to our requests for more information: Dr. Francisca Azocar, Dr. Marie-Dominic Beaulieu, Kim Gans, Dr. Rowland Hazard, Dr. John Holden, Dr. Eileen Kaner, Dr. Thomas Kottke, Dr. Karmeen Kulkarni, Dr. Sumit Majumdar, Dr. James Mason, Dr. Sujivia Ratnaike, Dr. Stephen Soumerai, Dr. Peter Austin, Dr. Francesc Macià, Dr. Franky Buyle, Dr. Gregg Fonarow, Dr Simon Jameson, Dr. Zubair Kabir, Dr Kathleen Bennett, Dr. Amit Garg, Dr. Sumit Majumdar, Dr. Elisabeth Meyer, Dr. Baiju Shah, and Dr. Karl Weiss.</P>
<P>Thank you to Dr. Craig Ramsay for helpful comments on the statistical analysis of the ITS studies.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2008-05-13 10:26:35 -0400" MODIFIED_BY="[Empty name]">
<P>JG is author of one of the included studies.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2012-09-10 16:57:14 -0400" MODIFIED_BY="[Empty name]">
<P>MF developed the search strategy. AGi, MF, AGr, FL, and JG identified the eligible studies. AGi and ST participated in data extraction; AGi, ST and SMK participated in data analysis; and AGi wrote the first draft of the review report. All authors revised the first draft and the final version of the review report.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES MODIFIED="2012-09-12 22:38:19 -0400" MODIFIED_BY="Anik Giguere">
<P>This review replaces the reviews that is now withdrawn by Freemantle et al (<LINK REF="REF-Freemantle-1997" TYPE="REFERENCE">Freemantle 1997</LINK>) and is an update of the review by Farmer et al (<LINK REF="REF-Farmer-2008" TYPE="REFERENCE">Farmer 2008</LINK>).</P>
<P>The first version of the review (<LINK REF="REF-Freemantle-1997" TYPE="REFERENCE">Freemantle 1997</LINK>) considered the following comparisons: (1) PEMs against a non-intervention control and (2) multifaceted intervention plus PEMs versus PEMs alone. In the subsequent version (<LINK REF="REF-Farmer-2008" TYPE="REFERENCE">Farmer 2008</LINK>), we modified the proposed comparisons to separate the effect of PEM from the effect of other interventions. We thus do not include any more studies that compare PEMs with PEMs as part of a multifaceted intervention, but will compare PEMs as part of a multifaceted intervention versus multifaceted interventions not including PEMs.</P>
<P>In the present update of the review, we excluded three studies that had been previously included because they compared PEM as part of a multifaceted intervention to a control condition, which is not one of the studied comparisons. <LINK REF="STD-Croudace--2003" TYPE="STUDY">Croudace 2003</LINK> compared PEM plus educational meeting to usual care, and <LINK REF="STD-Hazard--1997" TYPE="STUDY">Hazard 1997</LINK> compared PEM plus reminder at the point of care to the delayed intervention. Also, two reports that were included as distinct studies in the previous version of the review have been included as two reports of the same study in this version (<LINK REF="STD-Avorn-1983" TYPE="STUDY">Avorn 1983</LINK>). The CBA that had been included in both the previous updates of this review (<LINK REF="STD-Steffensen-1997" TYPE="STUDY">Steffensen 1997</LINK>) was removed because of a lack of pre-intervention data.</P>
</PUBLIC_NOTES>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2015-03-09 12:23:24 -0400" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2012-09-11 12:20:05 -0400" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2012-09-11 12:14:26 -0400" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Austin-2003" MODIFIED="2012-09-11 11:27:02 -0400" MODIFIED_BY="[Empty name]" NAME="Austin 2003" YEAR="2003">
<REFERENCE MODIFIED="2012-09-11 11:27:02 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Austin, Peter C&lt;br&gt;Mamdani, Muhammad M&lt;br&gt;Tu, Karen&lt;br&gt;Jaakkimainen, Liisa&lt;br&gt;Comment&lt;br&gt;Letter&lt;br&gt;Research Support, Non-U.S. Gov't&lt;br&gt;United States&lt;br&gt;JAMA : the journal of the American Medical Association&lt;br&gt;JAMA. 2003 Jun 25;289(24):3241-2.&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 11:27:02 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="OTHER">
<AU>Austin PC, Mamdani MM, Tu K, Jaakkimainen L</AU>
<TI>Prescriptions for estrogen replacement therapy in Ontario before and after publication of the Women's Health Initiative Study</TI>
<SO>Journal of the American Medical Association</SO>
<YR>2003</YR>
<VL>289</VL>
<NO>24</NO>
<PG>3241-2</PG>
<EN>2003/06/26</EN>
<IDENTIFIERS MODIFIED="2012-09-11 11:21:37 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Austin-2004A" MODIFIED="2012-02-29 09:04:41 -0500" MODIFIED_BY="[Empty name]" NAME="Austin 2004A" YEAR="2004">
<REFERENCE MODIFIED="2008-05-13 13:28:51 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Austin PC, Mamdani MM, Tu K</AU>
<TI>The impact of the Women's Health Initiative study on incident clonidine use in Ontario, Canada</TI>
<SO>Canadian Journal of Clinical Pharmacology</SO>
<YR>2004</YR>
<VL>11</VL>
<NO>2</NO>
<PG>e191-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Austin-2004B" MODIFIED="2012-09-11 11:27:47 -0400" MODIFIED_BY="[Empty name]" NAME="Austin 2004B" YEAR="">
<REFERENCE MODIFIED="2012-09-11 11:27:47 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;INCstudstrat ---  JC - 7501160&lt;br&gt;JAMA : the journal of the American Medical Association&lt;br&gt;ML1.8a - InclStud Strat&lt;br&gt;PMID:14709573&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 11:27:47 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Austin PC, Mamdani MM, Tu K, Zwarenstein M</AU>
<TI>Changes in prescribing patterns following publication of the ALLHAT trial</TI>
<SO>Journal of the American Medical Association</SO>
<YR>2004</YR>
<VL>291</VL>
<NO>1</NO>
<PG>44-5</PG>
<IDENTIFIERS MODIFIED="2012-09-11 11:27:31 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Austin-2005" MODIFIED="2012-02-29 09:05:51 -0500" MODIFIED_BY="[Empty name]" NAME="Austin 2005" YEAR="2005">
<REFERENCE MODIFIED="2008-04-23 16:49:33 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Austin PC, Mamdani MM</AU>
<TI>Impact of the pravastatin or avorstatin evaluation and infection therapy-thrombolysis in myocardial infarction</TI>
<SO>Circulation</SO>
<YR>2005</YR>
<VL>112</VL>
<NO>9</NO>
<PG>1296-300</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2008-04-23 16:49:53 -0400" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Avorn-1983" MODIFIED="2012-09-11 11:31:28 -0400" MODIFIED_BY="[Empty name]" NAME="Avorn 1983" YEAR="1983">
<REFERENCE MODIFIED="2012-09-11 11:31:28 -0400" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Avorn J, Soumerai SB</AU>
<TI>Improving drug-therapy decisions through educational outreach. A randomized controlled trial of academically based "detailing"</TI>
<SO>New England Journal of Medicine</SO>
<YR>1983</YR>
<VL>308</VL>
<NO>24</NO>
<PG>1457-63</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-09-11 11:28:18 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Soumerai, S B&lt;br&gt;Avorn, J&lt;br&gt;HS 03880/HS/AHRQ HHS/United States&lt;br&gt;HS 04933/HS/AHRQ HHS/United States&lt;br&gt;Clinical Trial&lt;br&gt;Randomized Controlled Trial&lt;br&gt;Research Support, U.S. Gov't, P.H.S.&lt;br&gt;United states&lt;br&gt;Medical care&lt;br&gt;Med Care. 1986 Apr;24(4):313-31.&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 11:28:18 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Soumerai SB, Avorn J</AU>
<TI>Economic and policy analysis of university-based drug "detailing"</TI>
<SO>Medical Care</SO>
<YR>1986</YR>
<VL>24</VL>
<NO>4</NO>
<PG>313-31</PG>
<IDENTIFIERS MODIFIED="2012-09-11 11:28:18 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE MODIFIED="2012-09-11 11:28:34 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;KW --- JC - 0230027, lsm&lt;br&gt;Medical care&lt;br&gt;ML1.8a - KW&lt;br&gt;PMID:3821226&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 11:28:34 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Soumerai SB, Avorn J</AU>
<TI>Predictors of physician prescribing change in an educational experiment to improve medication use</TI>
<SO>Medical Care</SO>
<YR>1987</YR>
<VL>25</VL>
<NO>3</NO>
<PG>210-21</PG>
<IDENTIFIERS MODIFIED="2012-09-11 11:28:34 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Azocar-2003" MODIFIED="2012-09-11 11:32:55 -0400" MODIFIED_BY="[Empty name]" NAME="Azocar 2003" YEAR="2003">
<REFERENCE MODIFIED="2012-09-11 11:32:55 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;AZOCAR F, CUFFEL B, GOLDMAN W, MCCARTER L. The impact of evidence-based guideline dissemination for the assessment and treatment of major depression in a managed behavioral health care organization. J Behav Health Serv Res 2003;30:109-18.&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 11:32:55 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Azocar F, Cuffel B, Goldman W, McCarter L</AU>
<TI>The impact of evidence-based guideline dissemination for the assessment and treatment of major depression in a managed behavioral health care organization</TI>
<SO>Journal of Behavioral Health Services and Research</SO>
<YR>2003</YR>
<VL>30</VL>
<NO>1</NO>
<PG>109-18</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-09-11 11:29:20 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;INCstudstrat ---  JC - 9502838, b8t&lt;br&gt;Psychiatric services (Washington, D.C.)&lt;br&gt;ML1.8a - InclStud Strat&lt;br&gt;PMID:11474040&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 11:29:20 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Azocar F, Cuffel BD, Goldman W, McCulloch J</AU>
<TI>Best practices: dissemination of guidelines for the treatment of major depression in a managed behavioral health care network</TI>
<SO>Psychiatric Services</SO>
<YR>2001</YR>
<VL>52</VL>
<NO>8</NO>
<PG>1014-6</PG>
<IDENTIFIERS MODIFIED="2012-09-11 11:29:20 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Barbaglia-2009" MODIFIED="2012-09-11 11:33:39 -0400" MODIFIED_BY="[Empty name]" NAME="Barbaglia 2009" YEAR="2009">
<REFERENCE MODIFIED="2012-09-11 11:33:39 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;INCstudstrat ---  JC - c5b, 9433353&lt;br&gt;Menopause (New York, N.Y.)&lt;br&gt;ML1.8a - InclStud Strat&lt;br&gt;PMID:19369903&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 11:33:39 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Barbaglia G, Macia F, Comas M, Sala M, del MV, Casamitjana M, et al</AU>
<TI>Trends in hormone therapy use before and after publication of the Women's Health Initiative trial: 10 years of follow-up</TI>
<SO>Menopause</SO>
<YR>2009</YR>
<VL>16</VL>
<NO>5</NO>
<PG>1061-4</PG>
<IDENTIFIERS MODIFIED="2012-09-11 11:33:39 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bearcroft-1994" MODIFIED="2012-09-11 11:34:24 -0400" MODIFIED_BY="[Empty name]" NAME="Bearcroft 1994" YEAR="1994">
<REFERENCE MODIFIED="2012-09-11 11:34:24 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bearcroft PWP, Small JH, Flower CDR</AU>
<TI>Chest radiography guidelines for general practitioners: a practical approach</TI>
<SO>Clinical Radiology</SO>
<YR>1994</YR>
<VL>49</VL>
<NO>1</NO>
<PG>56-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Beaulieu-2004" MODIFIED="2012-09-11 11:40:05 -0400" MODIFIED_BY="[Empty name]" NAME="Beaulieu 2004" YEAR="2004">
<REFERENCE MODIFIED="2012-09-11 11:40:05 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Beaulieu M-D, Brophy J, Jacques A, Blais R, Battista R, Lebeau R</AU>
<TI>Drug treatment of stable angina pectoris and mass dissemination of therapeutic guidelines: a randomized controlled trial</TI>
<SO>QJM: monthly journal of the Association of Physicians</SO>
<YR>2004</YR>
<VL>97</VL>
<NO>1</NO>
<PG>21-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bjornson-1990" MODIFIED="2012-09-11 11:37:50 -0400" MODIFIED_BY="[Empty name]" NAME="Bjornson 1990" YEAR="1990">
<REFERENCE MODIFIED="2012-09-11 11:37:50 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bjornson DC, Rector TS, Daniels CE, Wertheimer AI, Snowdon DA, Litman TJ</AU>
<TI>Impact of a drug-use review program intervention on prescribing after publication of a randomized clinical trial</TI>
<SO>American Journal of Hospital Pharmacy</SO>
<YR>1990</YR>
<VL>47</VL>
<NO>7</NO>
<PG>1541-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Black-2002" MODIFIED="2012-09-11 11:40:52 -0400" MODIFIED_BY="[Empty name]" NAME="Black 2002" YEAR="2002">
<REFERENCE MODIFIED="2012-09-11 11:40:52 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Black N, Hutchings A</AU>
<TI>Reduction in the use of surgery for glue ear: did national guidelines have an impact?</TI>
<SO>Quality and Safety in Health Care</SO>
<YR>2002</YR>
<VL>11</VL>
<NO>2</NO>
<PG>121-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Buyle-2010" MODIFIED="2012-09-11 11:41:12 -0400" MODIFIED_BY="[Empty name]" NAME="Buyle 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-09-11 11:41:12 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Buyle, Franky&lt;br&gt;Vogelaers, Dirk&lt;br&gt;Peleman, Renaat&lt;br&gt;Van Maele, Georges&lt;br&gt;Robays, Hugo&lt;br&gt;Comparative Study&lt;br&gt;Netherlands&lt;br&gt;Pharmacy world &amp;amp; science : PWS&lt;br&gt;Pharm World Sci. 2010 Jun;32(3):404-10. Epub 2010 Apr 1.&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 11:41:12 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Buyle F, Vogelaers D, Peleman R, Van Maele G, Robays H</AU>
<TI>Implementation of guidelines for sequential therapy with fluoroquinolones in a Belgian hospital</TI>
<SO>Pharmacy World &amp; Science</SO>
<YR>2010</YR>
<VL>32</VL>
<NO>3</NO>
<PG>404-10</PG>
<IDENTIFIERS MODIFIED="2012-09-11 11:41:12 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Coopersmith-2002" MODIFIED="2012-09-11 11:41:35 -0400" MODIFIED_BY="[Empty name]" NAME="Coopersmith 2002" YEAR="">
<REFERENCE MODIFIED="2012-09-11 11:41:35 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;EPOC --- JC - dtf, 0355501&lt;br&gt;Critical care medicine&lt;br&gt;ML1.8a - EPOC&lt;br&gt;PMID:11902288&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 11:41:35 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Coopersmith CM, Rebmann TL, Zack JE, Ward MR, Corcoran RM, Schallom ME, et al</AU>
<TI>Effect of an education program on decreasing catheter-related bloodstream infections in the surgical intensive care unit</TI>
<SO>Critical Care Medicine</SO>
<YR>2002</YR>
<VL>30</VL>
<NO>1</NO>
<PG>59-64</PG>
<IDENTIFIERS MODIFIED="2012-09-11 11:41:35 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Denig-1990" MODIFIED="2012-09-11 11:43:06 -0400" MODIFIED_BY="[Empty name]" NAME="Denig 1990" YEAR="1990">
<REFERENCE MODIFIED="2012-09-11 11:43:06 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Denig P, Haaijer-Ruskamp FM, Zijsling DH</AU>
<TI>Impact of a drug bulletin on the knowledge, perception of drug utility, and prescribing behavior of physicians</TI>
<SO>DICP: the annals of pharmacotherapy</SO>
<YR>1990</YR>
<VL>24</VL>
<NO>1</NO>
<PG>87-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dormuth-2004" MODIFIED="2012-09-11 12:14:26 -0400" MODIFIED_BY="[Empty name]" NAME="Dormuth 2004" YEAR="2004">
<REFERENCE MODIFIED="2012-09-11 12:14:26 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dormuth CR, Maclure M, Bassett K, Jauca C, Whiteside C, Wright JM</AU>
<TI>Effect of periodic letters on evidence-based drug therapy on prescribing behaviour: a randomized trial</TI>
<SO>CMAJ: Canadian Medical Association Journal</SO>
<YR>2004</YR>
<VL>171</VL>
<NO>9</NO>
<PG>1057-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fijn-2000" MODIFIED="2012-09-11 11:44:37 -0400" MODIFIED_BY="[Empty name]" NAME="Fijn 2000" YEAR="2000">
<REFERENCE MODIFIED="2012-09-11 11:44:37 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;INCstudstrat ---  CP - Germany&lt;br&gt;EM1.1 - InclStud Strat&lt;br&gt;EM #: 2001096273&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 11:44:37 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Fijn R, Stuurman-Bieze AGG, Van Den Berg PB, Brouwers JRBJ, De Graeff PA, De Jong-van Den B</AU>
<TI>Predictors for prophylactic antithrombotic prescribing in ischaemic heart disease and the impact of national guidelines</TI>
<SO>European Journal of Clinical Pharmacology</SO>
<YR>2000</YR>
<VL>56</VL>
<NO>9-10</NO>
<PG>739-46</PG>
<MD>EM Entry Date: 200100</MD>
<IDENTIFIERS MODIFIED="2012-09-11 11:44:37 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fonarow-2009" MODIFIED="2012-09-11 11:44:48 -0400" MODIFIED_BY="[Empty name]" NAME="Fonarow 2009" YEAR="2009">
<REFERENCE MODIFIED="2012-09-11 11:44:48 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;INCstudstrat ---  JC - 0370465&lt;br&gt;American heart journal&lt;br&gt;ML1.8a - InclStud Strat&lt;br&gt;PMID:19081417&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 11:44:48 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Fonarow GC, French WJ, Frederick PD</AU>
<TI>Trends in the use of lipid-lowering medications at discharge in patients with acute myocardial infarction: 1998 to 2006</TI>
<SO>American Heart Journal</SO>
<YR>2009</YR>
<VL>157</VL>
<NO>1</NO>
<PG>185-94</PG>
<IDENTIFIERS MODIFIED="2012-09-11 11:44:48 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fukuda-2009" MODIFIED="2012-09-11 11:45:03 -0400" MODIFIED_BY="[Empty name]" NAME="Fukuda 2009" YEAR="2009">
<REFERENCE MODIFIED="2012-09-11 11:45:03 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;INCstudstrat ---  CP - United Kingdom&lt;br&gt;EM1.1 - InclStud Strat&lt;br&gt;EM #: 2009514014&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 11:45:03 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Fukuda H, Imanaka Y, Ishizaki T, Okuma K, Shirai T</AU>
<TI>Change in clinical practice after publication of guidelines on breast cancer treatment</TI>
<SO>International Journal for Quality in Health Care</SO>
<YR>2009</YR>
<VL>21</VL>
<NO>5</NO>
<PG>372-8</PG>
<MD>EM Entry Date: 200900</MD>
<IDENTIFIERS MODIFIED="2012-09-11 11:45:03 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Guay-2007" MODIFIED="2012-09-11 11:45:34 -0400" MODIFIED_BY="[Empty name]" NAME="Guay 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-09-11 11:45:34 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;INCstudstrat ---  CP - United Kingdom&lt;br&gt;EM1.1 - InclStud Strat&lt;br&gt;EM #: 2007056450&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 11:45:34 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Guay MP, Dragomir A, Pilon D, Moride Y, Perreault S</AU>
<TI>Changes in pattern of use, clinical characteristics and persistence rate of hormone replacement therapy among postmenopausal women after the WHI publication</TI>
<SO>Pharmacoepidemiology and Drug Safety</SO>
<YR>2007</YR>
<VL>16</VL>
<NO>1</NO>
<PG>17-27</PG>
<MD>EM Entry Date: 200700</MD>
<IDENTIFIERS MODIFIED="2012-09-11 11:45:34 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Haas-2004" MODIFIED="2012-09-11 11:45:48 -0400" MODIFIED_BY="[Empty name]" NAME="Haas 2004" YEAR="2004">
<REFERENCE MODIFIED="2012-09-11 11:45:48 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;INCstudstrat ---  CM - Comment in: Ann Intern Med. 2004 Feb 3;140(3):I50; PMID: 14757633, Comment in: Ann Intern Med. 2004 Feb 3;140(3):226-8; PMID: 14757622&lt;br&gt;Annals of internal medicine&lt;br&gt;ML1.8a - InclStud Strat&lt;br&gt;PMID:14757616&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 11:45:48 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Haas JS, Kaplan CP, Gerstenberger EP, Kerlikowske K</AU>
<TI>Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results</TI>
<SO>Annals of Internal Medicine</SO>
<YR>2004</YR>
<VL>140</VL>
<NO>3</NO>
<PG>184-8</PG>
<IDENTIFIERS MODIFIED="2012-09-11 11:45:48 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hersh-2004" MODIFIED="2012-09-11 11:46:19 -0400" MODIFIED_BY="[Empty name]" NAME="Hersh 2004" YEAR="2004">
<REFERENCE MODIFIED="2012-09-11 11:46:19 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;INCstudstrat ---  IN - Stanford Prevention Research Center, Program on Prevention Outcomes and Practices, Stanford University School of Medicine, Stanford, Calif 94305, USA&lt;br&gt;HS - InclStud Strat&lt;br&gt;UI - 14709575&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 11:46:19 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Hersh AL, Stefanick ML, Stafford RS</AU>
<TI>National use of postmenopausal hormone therapy: annual trends and response to recent evidence</TI>
<SO>Journal of the American Medical Association</SO>
<YR>2004</YR>
<VL>291</VL>
<NO>1</NO>
<PG>47-53</PG>
<IDENTIFIERS MODIFIED="2012-09-11 11:46:19 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jackevicius-2001" MODIFIED="2012-09-11 11:47:10 -0400" MODIFIED_BY="[Empty name]" NAME="Jackevicius 2001" YEAR="2001">
<REFERENCE MODIFIED="2012-09-11 11:47:10 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;INCstudstrat ---  JC - 0372440, 7fs&lt;br&gt;Archives of internal medicine&lt;br&gt;ML1.8a - InclStud Strat&lt;br&gt;PMID:11176731&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 11:47:10 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Jackevicius CA, Anderson GM, Leiter L, Tu JV</AU>
<TI>Use of the statins in patients after acute myocardial infarction: does evidence change practice?</TI>
<SO>Archives of Internal Medicine</SO>
<YR>2001</YR>
<VL>161</VL>
<NO>2</NO>
<PG>183-8</PG>
<IDENTIFIERS MODIFIED="2012-09-11 11:47:10 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jameson-2010" MODIFIED="2012-09-11 11:47:45 -0400" MODIFIED_BY="[Empty name]" NAME="Jameson 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-09-11 11:47:45 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;INCstudstrat ---  CP - United Kingdom&lt;br&gt;EM1.1 - InclStud Strat&lt;br&gt;EM #: 2010082706&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 11:47:45 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Jameson SS, Bottle A, Malviya A, Muller SD, Reed MR</AU>
<TI>The impact of national guidelines for the prophylaxis of venous thromboembolism on the complications of arthroplasty of the lower limb</TI>
<SO>Journal of Bone and Joint Surgery - Series B</SO>
<YR>2010</YR>
<VL>92</VL>
<NO>1</NO>
<PG>123-9</PG>
<MD>EM Entry Date: 201010</MD>
<IDENTIFIERS MODIFIED="2012-09-11 11:47:45 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jousimaa-2002" MODIFIED="2012-09-11 11:49:47 -0400" MODIFIED_BY="[Empty name]" NAME="Jousimaa 2002" YEAR="2002">
<REFERENCE MODIFIED="2012-09-11 11:49:47 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;JC - gti, 8508113 International journal of technology assessment in health care ML1.8a - RCT PMID:12391951&lt;br&gt;yesfinal-mf&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 11:49:47 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Jousimaa J, Makela M, Kunnamo I, MacLennan G, Grimshaw JM</AU>
<TI>Primary care guidelines on consultation practices: the effectiveness of computerized versus paper-based versions. A cluster randomized controlled trial among newly qualified primary care physicians</TI>
<SO>International Journal of Technology Assessment Health Care</SO>
<YR>2002</YR>
<VL>18</VL>
<NO>3</NO>
<PG>586-96</PG>
<MD>Temp ID 3415</MD>
<IDENTIFIERS MODIFIED="2012-09-11 11:49:47 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Juurlink-2004" MODIFIED="2012-09-11 11:50:00 -0400" MODIFIED_BY="[Empty name]" NAME="Juurlink 2004" YEAR="2004">
<REFERENCE MODIFIED="2012-09-11 11:50:00 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;INCstudstrat ---  IN - Department of Medicine University of Toronto, Toronto. dnj@ices.on.ca&lt;br&gt;HS - InclStud Strat&lt;br&gt;UI - 15295047&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 11:50:00 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Juurlink DN, Mamdani MM, Lee DS, Kopp A, Austin PC, Laupacis A, et al</AU>
<TI>Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study</TI>
<SO>New England Journal of Medicine</SO>
<YR>2004</YR>
<VL>354</VL>
<NO>6</NO>
<PG>543-51</PG>
<IDENTIFIERS MODIFIED="2012-09-11 11:50:00 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kabir-2007" MODIFIED="2012-09-11 11:50:17 -0400" MODIFIED_BY="[Empty name]" NAME="Kabir 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-09-11 11:50:17 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;INCstudstrat ---  JC - au9, 7503323&lt;br&gt;British journal of clinical pharmacology&lt;br&gt;ML1.8a - InclStud Strat&lt;br&gt;PMID:17610535&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 11:50:17 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Kabir Z, Feely J, Bennett K</AU>
<TI>Primary care prescribing patterns in Ireland after the publication of large hypertension trials</TI>
<SO>British Journal of Clinical Pharmacology</SO>
<YR>2007</YR>
<VL>64</VL>
<NO>3</NO>
<PG>381-5</PG>
<IDENTIFIERS MODIFIED="2012-09-11 11:50:17 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kajita-2010" MODIFIED="2012-09-11 11:51:44 -0400" MODIFIED_BY="[Empty name]" NAME="Kajita 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-09-11 11:51:28 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;EPOC --- LG - English EM1.1 - EPOC EM #: 70225811&lt;br&gt;yesfinal-mf; look for study report?&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 11:51:28 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Kajita E, Nakatani Y, Tamaki J, Ito N, Iki M</AU>
<SO>Evidence-based assessment of the effectiveness of a clinical practice guideline for prevention of osteoporosis and osteoporotic fracture. IOF World Congress on Osteoporosis and 10th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, IOF WCO - ECCEO 10; 2010 May 5-8; Florence, Italy</SO>
<YR>2010</YR>
<MD>EM Entry Date: 201032;Temp ID 855</MD>
<IDENTIFIERS MODIFIED="2012-09-11 11:51:28 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE MODIFIED="2012-09-11 11:51:44 -0400" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="OTHER">
<AU>Nakatani Y, Tamaki J, Komatsu M, Iki M, Kajita E</AU>
<TI>Effect of distributing an evidence-based guideline for prevention of osteoporosis on health education programs in municipal health centers: a randomized controlled trial</TI>
<SO>Journal of Epidemiology</SO>
<YR>2012</YR>
<VL>22</VL>
<NO>2</NO>
<PG>103-12</PG>
<IDENTIFIERS MODIFIED="2012-09-11 11:51:44 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kottke-1989" MODIFIED="2012-09-11 11:58:19 -0400" MODIFIED_BY="[Empty name]" NAME="Kottke 1989" YEAR="1989">
<REFERENCE MODIFIED="2012-09-11 11:58:19 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kottke TE, Brekke ML, Solberg LI, Hughes JR</AU>
<TI>Use smoking intervention by physicians. Doctors Helping Smokers, Round I</TI>
<SO>Journal of the American Medical Association</SO>
<YR>1989</YR>
<VL>261</VL>
<NO>14</NO>
<PG>2101-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lam-2009" MODIFIED="2012-09-11 11:52:31 -0400" MODIFIED_BY="[Empty name]" NAME="Lam 2009" YEAR="2009">
<REFERENCE MODIFIED="2012-09-11 11:52:31 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;INCstudstrat ---  CM - Comment in: Kidney Int. 2010 Jul;78(1):111-2; author reply 112; PMID: 20551929&lt;br&gt;Kidney international&lt;br&gt;ML1.8a - InclStud Strat&lt;br&gt;PMID:19776719&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 11:52:31 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Lam NN, Jain AK, Hackam DG, Cuerden MS, Suri RS, Huo CY, et al</AU>
<TI>Results of a randomized controlled trial on statin use in dialysis patients had no influence on statin prescription</TI>
<SO>Kidney International</SO>
<YR>2009</YR>
<VL>76</VL>
<NO>11</NO>
<PG>1172-9</PG>
<IDENTIFIERS MODIFIED="2012-09-11 11:52:31 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Majumdar-2003" MODIFIED="2012-09-11 11:59:00 -0400" MODIFIED_BY="[Empty name]" NAME="Majumdar 2003" YEAR="2003">
<REFERENCE MODIFIED="2012-09-11 11:59:00 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Majumdar SR, McAlister FA, Soumerai SB</AU>
<TI>Synergy between publication and promotion: comparing adoption of new evidence in Canada and the United States</TI>
<SO>American Journal of Medicine</SO>
<YR>2003</YR>
<VL>115</VL>
<NO>6</NO>
<PG>467-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Majumdar-2004" MODIFIED="2012-09-11 11:59:42 -0400" MODIFIED_BY="[Empty name]" NAME="Majumdar 2004" YEAR="2004">
<REFERENCE MODIFIED="2012-09-11 11:59:42 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Majumdar SR, Almasi EA, Stafford RS</AU>
<TI>Promotion and prescribing of hormone therapy after report of harm by the Women's Health Initiative</TI>
<SO>Journal of the American Medical Association</SO>
<YR>2004</YR>
<VL>292</VL>
<NO>16</NO>
<PG>1983-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mason-1998_x002f_99" MODIFIED="2012-02-29 09:43:33 -0500" MODIFIED_BY="[Empty name]" NAME="Mason 1998/99" YEAR="1998/">
<REFERENCE MODIFIED="2008-05-13 13:36:34 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mason J, Freemantle N, Young P</AU>
<TI>The effect of the distribution of Effective Health Care Bulletins on prescribing selective serotonin reuptake inhibitors in primary care</TI>
<SO>Health Trends</SO>
<YR>1998/99</YR>
<VL>30</VL>
<PG>120-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mason-2001" MODIFIED="2012-09-11 12:01:03 -0400" MODIFIED_BY="[Empty name]" NAME="Mason 2001" YEAR="2001">
<REFERENCE MODIFIED="2012-09-11 12:01:03 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mason J, Freemantle N, Browning G</AU>
<TI>Impact of effective health care bulletin on treatment of persistent glue ear in children: time series analysis</TI>
<SO>BMJ</SO>
<YR>2001</YR>
<VL>323</VL>
<NO>7321</NO>
<PG>1096-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Matowe-2002" MODIFIED="2012-09-11 12:02:47 -0400" MODIFIED_BY="[Empty name]" NAME="Matowe 2002" YEAR="2002">
<REFERENCE MODIFIED="2012-09-11 12:02:47 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Matowe L, Ramsay CR, Grimshaw JM, Gilbert FJ, Macleod MJ, Needham G</AU>
<TI>Effects of mailed dissemination of the Royal College of Radiologists' guidelines on general practitioner referrals for radiography: a time series analysis</TI>
<SO>Clinical Radiology</SO>
<YR>2002</YR>
<VL>57</VL>
<NO>7</NO>
<PG>575-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Meyer-2007" MODIFIED="2012-09-11 12:03:02 -0400" MODIFIED_BY="[Empty name]" NAME="Meyer 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-09-11 12:03:02 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;INCstudstrat ---  CP - United Kingdom&lt;br&gt;EM1.1 - InclStud Strat&lt;br&gt;EM #: 2007347401&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 12:03:02 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Meyer E, Buttler J, Schneider C, Strehl E, Schroeren-Boersch B, Gastmeier P, et al</AU>
<TI>Modified guidelines impact on antibiotic use and costs: Dduration of treatment for pneumonia in a neurosurgical ICU is reduced</TI>
<SO>Journal of Antimicrobial Chemotherapy</SO>
<YR>2007</YR>
<VL>59</VL>
<NO>6</NO>
<PG>1148-54</PG>
<MD>EM Entry Date: 200700</MD>
<IDENTIFIERS MODIFIED="2012-09-11 12:03:02 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Oakeshott-1994" MODIFIED="2012-09-11 12:03:34 -0400" MODIFIED_BY="[Empty name]" NAME="Oakeshott 1994" YEAR="1994">
<REFERENCE MODIFIED="2012-09-11 12:03:34 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Oakeshott P, Kerry SM, Williams JE</AU>
<TI>Randomized controlled trial of the effect of the Royal College of Radiologists' guidelines on general practitioners' referrals for radiographic examination</TI>
<SO>British Journal of General Practice</SO>
<YR>1994</YR>
<VL>44</VL>
<NO>382</NO>
<PG>197-200</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Perria-2007" MODIFIED="2012-09-11 12:04:05 -0400" MODIFIED_BY="[Empty name]" NAME="Perria 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-09-11 12:03:57 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;INCstudstrat ---  JC - 101088677&lt;br&gt;BMC health services research&lt;br&gt;ML1.8a - InclStud Strat&lt;br&gt;PMID:15196307&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 12:03:57 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Perria C, Group IS</AU>
<TI>Strategies for the introduction and implementation of a guideline for the treatment of type 2 diabetics by general practitioners (GPs) of the Lazio region of Italy (IMPLEMEG study): protocol for a cluster randomised controlled trial</TI>
<SO>BMC Health Services Research</SO>
<YR>2004</YR>
<VL>4</VL>
<NO>1</NO>
<PG>13</PG>
<IDENTIFIERS MODIFIED="2012-09-11 12:03:57 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE MODIFIED="2012-09-11 12:04:05 -0400" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="OTHER">
<AU>Perria C, Mandolini D, Guerrera C, Jefferson T, Billi P, Calzini V, et al</AU>
<TI>Implementing a guideline for the treatment of type 2 diabetics: results of a cluster - randomized controlled trial (C-RCT)</TI>
<SO>BMC Health Services Research</SO>
<YR>2007</YR>
<VL>7</VL>
<NO>79</NO>
<IDENTIFIERS MODIFIED="2012-09-11 12:04:05 -0400" MODIFIED_BY="Alain Mayhew"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Roberts-2007" MODIFIED="2012-09-11 12:04:20 -0400" MODIFIED_BY="[Empty name]" NAME="Roberts 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-09-11 12:04:20 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;INCstudstrat ---  CP - United Kingdom&lt;br&gt;EM1.1 - InclStud Strat&lt;br&gt;EM #: 2007421252&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 12:04:20 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Roberts VI, Esler CN, Harper WM</AU>
<TI>What impact have NICE guidelines had on the trends of hip arthroplasty since their publication? The results from the Trent Regional Arthroplasty Study between 1990 and 2005</TI>
<SO>Journal of Bone and Joint Surgery - Series B</SO>
<YR>2007</YR>
<VL>89</VL>
<NO>7</NO>
<PG>864-7</PG>
<MD>EM Entry Date: 200700</MD>
<IDENTIFIERS MODIFIED="2012-09-11 12:04:20 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Santerre-1996" MODIFIED="2012-09-11 12:05:03 -0400" MODIFIED_BY="[Empty name]" NAME="Santerre 1996" YEAR="1996">
<REFERENCE MODIFIED="2012-09-11 12:05:03 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Santerre RE</AU>
<TI>The effect of the ACOG guideline on vaginal births after cesarean</TI>
<SO>Medical Care Research and Review</SO>
<YR>1996</YR>
<VL>53</VL>
<NO>3</NO>
<PG>315-29</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shah-2008" MODIFIED="2012-09-11 12:05:19 -0400" MODIFIED_BY="[Empty name]" NAME="Shah 2008" YEAR="2008">
<REFERENCE MODIFIED="2012-09-11 12:05:19 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;INCstudstrat ---  CP - United Kingdom&lt;br&gt;EM1.1 - InclStud Strat&lt;br&gt;EM #: 2009179103&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 12:05:19 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Shah BR, Juurlink DN, Austin PC, Mamdani MM</AU>
<TI>New use of rosiglitazone decreased following publication of a meta-analysis suggesting harm</TI>
<SO>Diabetic Medicine</SO>
<YR>2008</YR>
<VL>25</VL>
<NO>7</NO>
<PG>871-4</PG>
<MD>EM Entry Date: 200900</MD>
<IDENTIFIERS MODIFIED="2012-09-11 12:05:19 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stafford-2004" MODIFIED="2012-09-11 12:05:43 -0400" MODIFIED_BY="[Empty name]" NAME="Stafford 2004" YEAR="2004">
<REFERENCE MODIFIED="2012-09-11 12:05:43 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;INCstudstrat ---  CM - Comment in: JAMA. 2004 Jan 7;291(1):104-6; PMID: 14709583&lt;br&gt;JAMA : the journal of the American Medical Association&lt;br&gt;ML1.8a - InclStud Strat&lt;br&gt;PMID:14709576&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 12:05:43 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Stafford RS, Furberg CD, Finkelstein SN, Cockburn IM, Alehegn T, Ma J</AU>
<TI>Impact of clinical trial results on national trends in alpha-blocker prescribing, 1996-2002</TI>
<SO>Journal of the American Medical Association</SO>
<YR>2004</YR>
<VL>291</VL>
<NO>1</NO>
<PG>54-62</PG>
<IDENTIFIERS MODIFIED="2012-09-11 12:05:43 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tsuji-2009" MODIFIED="2012-09-11 12:06:01 -0400" MODIFIED_BY="[Empty name]" NAME="Tsuji 2009" YEAR="2009">
<REFERENCE MODIFIED="2012-09-11 12:06:01 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;INCstudstrat ---  JC - cwd, 9609066&lt;br&gt;Journal of evaluation in clinical practice&lt;br&gt;ML1.8a - InclStud Strat&lt;br&gt;PMID:19239608&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 12:06:01 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Tsuji SR, Atallah AN, Aranha FC, Tonhom AP, Siqueira AC, Jr., et al</AU>
<TI>Cluster randomized clinical trial (ISRCTN23732000) to evaluate the effectiveness of a diagnosis recognition and treatment guide for depressive disorders in primary care</TI>
<TO>MEDLINE</TO>
<SO>Journal of Evaluation in Clinical Practice</SO>
<YR>2009</YR>
<VL>15</VL>
<NO>1</NO>
<PG>222-5</PG>
<IDENTIFIERS MODIFIED="2012-09-11 12:06:01 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2005" MODIFIED="2012-09-11 12:06:21 -0400" MODIFIED_BY="[Empty name]" NAME="Wang 2005" YEAR="2005">
<REFERENCE MODIFIED="2012-09-11 12:06:21 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;INCstudstrat ---  CP - United States&lt;br&gt;EM1.1 - InclStud Strat&lt;br&gt;EM #: 2006301704&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 12:06:21 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Wang YR, Alexander GC, Meltzer DO</AU>
<TI>Lack of effect of guideline changes on LDL cholesterol reporting and control for diabetes visits in the U.S., 1995-2004</TI>
<SO>Diabetes Care</SO>
<YR>2005</YR>
<VL>28</VL>
<NO>12</NO>
<PG>2942-4</PG>
<MD>EM Entry Date: 200600</MD>
<IDENTIFIERS MODIFIED="2012-09-11 12:06:21 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Watson-2001" MODIFIED="2012-09-11 12:06:32 -0400" MODIFIED_BY="[Empty name]" NAME="Watson 2001" YEAR="2001">
<REFERENCE MODIFIED="2012-09-11 12:06:32 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;JC - c34, 9604936&lt;br&gt;Journal of health services research &amp;amp; policy&lt;br&gt;ML1.8a - RCT&lt;br&gt;PMID:11685784&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 12:06:32 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Watson M, Gunnell D, Peters T, Brookes S, Sharp D</AU>
<TI>Guidelines and educational outreach visits from community pharmacists to improve prescribing in general practice: a randomised controlled trial</TI>
<SO>Journal of Health Services Research &amp; Policy</SO>
<YR>2001</YR>
<VL>6</VL>
<NO>4</NO>
<PG>207-13</PG>
<IDENTIFIERS MODIFIED="2012-09-11 12:06:32 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Weiss-2011" MODIFIED="2012-09-11 12:06:44 -0400" MODIFIED_BY="[Empty name]" NAME="Weiss 2011" YEAR="2011">
<REFERENCE MODIFIED="2012-09-11 12:06:44 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Clinical infectious diseases : an official publication of the Infectious Diseases Society of America&lt;br&gt;Clin Infect Dis. 2011 Jul 25.&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 12:06:44 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Weiss K, Blais R, Fortin A, Lantin S, Gaudet M</AU>
<TI>Impact of a multipronged education strategy on antibiotic prescribing in Quebec, Canada</TI>
<SO>Clinical Infectious Diseases</SO>
<YR>2011</YR>
<VL>53</VL>
<NO>5</NO>
<PG>433-9</PG>
<IDENTIFIERS MODIFIED="2012-09-11 12:06:44 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2012-09-11 12:19:10 -0400" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Bishop-2010" MODIFIED="2012-09-11 12:07:31 -0400" MODIFIED_BY="[Empty name]" NAME="Bishop 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-09-11 12:07:31 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;INCstudstrat --- JC - 101130732 The spine journal : official journal of the North American Spine Society ML1.8a - InclStud Strat PMID:20889389&lt;br&gt;yesfinal-mf; intervention is application of the GL vs method of GL dissemination so this is likely not relevant&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 12:07:31 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Bishop PB, Quon JA, Fisher CG, Dvorak MF</AU>
<TI>The Chiropractic Hospital-based Interventions Research Outcomes (CHIRO) study: a randomized controlled trial on the effectiveness of clinical practice guidelines in the medical and chiropractic management of patients with acute mechanical low back pain</TI>
<SO>The Spine Journal</SO>
<YR>2010</YR>
<VL>10</VL>
<NO>12</NO>
<PG>1055-64</PG>
<MD>Temp ID 2061</MD>
<IDENTIFIERS MODIFIED="2012-09-11 12:07:31 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Croudace--2003" MODIFIED="2012-09-10 11:30:11 -0400" MODIFIED_BY="[Empty name]" NAME="Croudace  2003" YEAR="2003">
<REFERENCE MODIFIED="2012-09-10 11:30:11 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Croudace T, Evans J, Harrison G, Sharp DJ, Wilkinson E, McCann G, et al</AU>
<TI>Impact of the ICD-10 primary health care (PHC) diagnostic and management guidelines for mental disorders on detection and outcome in primary care</TI>
<SO>British Journal of Psychiatry</SO>
<YR>2003</YR>
<VL>182</VL>
<PG>20-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Emslie-1993" MODIFIED="2012-09-11 12:08:05 -0400" MODIFIED_BY="[Empty name]" NAME="Emslie 1993" YEAR="1993">
<REFERENCE MODIFIED="2012-09-11 12:08:05 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;INCstudstrat ---  CM - Comment in: BMJ. 1993 Sep 4;307(6904):627; PMID: 8401038, Comment in: BMJ. 2001 May 26;322(7297):1258-9; PMID: 11375213&lt;br&gt;BMJ (Clinical research ed.)&lt;br&gt;ML1.8a - InclStud Strat&lt;br&gt;PMID:8280213&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 12:08:05 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Emslie C, Grimshaw J, Templeton A</AU>
<TI>Do clinical guidelines improve general practice management and referral of infertile couples?</TI>
<SO>BMJ</SO>
<YR>1993</YR>
<VL>306</VL>
<NO>6894</NO>
<PG>1728-31</PG>
<IDENTIFIERS MODIFIED="2012-09-11 12:08:05 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Engers-2005" MODIFIED="2012-09-08 17:59:44 -0400" MODIFIED_BY="[Empty name]" NAME="Engers 2005" YEAR="2005">
<REFERENCE MODIFIED="2012-09-08 17:59:44 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;1528-1159 (Electronic)&lt;/p&gt;" NOTES_MODIFIED="2012-09-08 17:59:44 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Engers AJ, Wensing M, van Tulder MW, Timmermans A, Oostendorp RA, Koes BW, et al</AU>
<TI>Implementation of the Dutch low back pain guideline for general practitioners: a cluster randomized controlled trial</TI>
<SO>Spine</SO>
<YR>2005</YR>
<VL>30</VL>
<NO>6</NO>
<PG>559-600</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Evans-2010" MODIFIED="2012-09-11 12:08:22 -0400" MODIFIED_BY="[Empty name]" NAME="Evans 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-09-11 12:08:22 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;CIN - RCT&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 12:08:22 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Evans DW, Breen AC, Pincus T, Sim J, Underwood M, Vogel S, et al</AU>
<TI>The effectiveness of a posted information package on the beliefs and behavior of musculoskeletal practitioners: the UK Chiropractors, Osteopaths, and Musculoskeletal Physiotherapists Low Back Pain ManagemENT (COMPLeMENT) randomized trial</TI>
<SO>Spine</SO>
<YR>2010</YR>
<VL>35</VL>
<NO>8</NO>
<PG>858-66</PG>
<MD>Temp ID 55173</MD>
<IDENTIFIERS MODIFIED="2012-09-11 12:08:22 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ferrari-2005" MODIFIED="2008-05-13 13:41:09 -0400" MODIFIED_BY="[Empty name]" NAME="Ferrari 2005" YEAR="2005">
<REFERENCE MODIFIED="2008-05-13 13:41:09 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;1553-2712 (Electronic)&lt;/p&gt;" NOTES_MODIFIED="2008-05-13 13:41:09 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ferrari R, Rowe BH, Majumdar SR, Cassidy JD, Blitz S, Wright SC, et al</AU>
<TI>Simple educational intervention to improve the recovery from acute whiplash: results of a randomized, controlled trial</TI>
<SO>Academic Emergency Medicine</SO>
<YR>2005</YR>
<VL>12</VL>
<NO>8</NO>
<PG>699-706</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fontaine-2006" MODIFIED="2012-09-11 12:08:41 -0400" MODIFIED_BY="[Empty name]" NAME="Fontaine 2006" YEAR="2006">
<REFERENCE MODIFIED="2012-09-11 12:08:41 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Fontaine, A&lt;br&gt;Mahe, I&lt;br&gt;Bergmann, J F&lt;br&gt;Fiessinger, J N&lt;br&gt;Dhote, R&lt;br&gt;Cohen, P&lt;br&gt;Vinceneux, P&lt;br&gt;England&lt;br&gt;J Intern Med. 2006 Oct;260(4):369-76.&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 12:08:41 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Fontaine A, Mahe I, Bergmann JF, Fiessinger JN, Dhote R, Cohen P, et al</AU>
<TI>Effectiveness of written guidelines on the appropriateness of thromboprophylaxis prescriptions for medical patients: a prospective randomized study</TI>
<SO>Journal of Internal Medicine</SO>
<YR>2006</YR>
<VL>260</VL>
<NO>4</NO>
<PG>369-76</PG>
<MD>Randomized Controlled Trial</MD>
<IDENTIFIERS MODIFIED="2012-09-11 12:08:41 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hazard--1997" MODIFIED="2012-09-11 12:09:15 -0400" MODIFIED_BY="[Empty name]" NAME="Hazard  1997" YEAR="1997">
<REFERENCE MODIFIED="2012-09-11 12:09:15 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hazard RG, Haugh LD, Reid S, McFarlane G, MacDonald L</AU>
<TI>Early physician notification of patient disability risk and clinical guidelines after low back injury: a randomized controlled trial</TI>
<SO>Spine</SO>
<YR>1997</YR>
<VL>22</VL>
<NO>24</NO>
<PG>2951-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hunskaar-1996" MODIFIED="2012-09-11 12:09:38 -0400" MODIFIED_BY="[Empty name]" NAME="Hunskaar 1996" YEAR="1996">
<REFERENCE MODIFIED="2012-09-11 12:09:38 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;INCstudstrat ---  JC - 8510679, sif&lt;br&gt;Scandinavian journal of primary health care&lt;br&gt;ML1.8a - InclStud Strat&lt;br&gt;PMID:8956447&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 12:09:38 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Hunskaar S, Hannestad YS, Backe B, Matheson I</AU>
<TI>Direct mailing of consensus recommendations did not alter GPs' knowledge and prescription of oestrogen in the menopause</TI>
<SO>Scandinavian Journal of Primary Health Care</SO>
<YR>1996</YR>
<VL>14</VL>
<NO>4</NO>
<PG>203-8</PG>
<IDENTIFIERS MODIFIED="2012-09-11 12:09:38 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jackevicius-1999" MODIFIED="2012-09-11 12:09:55 -0400" MODIFIED_BY="[Empty name]" NAME="Jackevicius 1999" YEAR="1999">
<REFERENCE MODIFIED="2012-09-11 12:09:55 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;JC - c1w, 9433332&lt;br&gt;Canadian respiratory journal : journal of the Canadian Thoracic Society&lt;br&gt;ML1.8a - RCT&lt;br&gt;PMID:10393285&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 12:09:55 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Jackevicius CA, Chapman KR</AU>
<TI>Inhaler education for hospital-based pharmacists: how much is required?</TI>
<SO>Canadian Respiratory Journal</SO>
<YR>1999</YR>
<VL>6</VL>
<NO>3</NO>
<PG>237-44</PG>
<IDENTIFIERS MODIFIED="2012-09-11 12:09:55 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jain-2006" MODIFIED="2012-09-11 12:10:58 -0400" MODIFIED_BY="[Empty name]" NAME="Jain 2006" YEAR="2006">
<REFERENCE MODIFIED="2012-09-11 12:10:58 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;INCstudstrat --- JC - dtf, 0355501 Critical care medicine ML1.8a - InclStud Strat PMID:16850001&lt;br&gt;yesfinal-mf&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 12:10:58 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Jain MK, Heyland D, Dhaliwal R, Day AG, Drover J, Keefe L, et al</AU>
<TI>Dissemination of the Canadian clinical practice guidelines for nutrition support: results of a cluster randomized controlled trial</TI>
<SO>Critical Care Medicine</SO>
<YR>2006</YR>
<VL>34</VL>
<NO>9</NO>
<PG>2362-9</PG>
<MD>Temp ID 1976</MD>
<IDENTIFIERS MODIFIED="2012-09-11 12:10:58 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Janmeja-2009" MODIFIED="2012-09-11 12:11:10 -0400" MODIFIED_BY="[Empty name]" NAME="Janmeja 2009" YEAR="2009">
<REFERENCE MODIFIED="2012-09-11 12:11:10 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;INCstudstrat --- JC - 8405380 Lung India : official organ of Indian Chest Society ML1.8a - InclStud Strat PMID:20531989&lt;br&gt;yesfinal-mf&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 12:11:10 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Janmeja AK, Mohapatra PR, Kumar M</AU>
<TI>The impact of "World Health Organization - Government of India guidelines on chronic obstructive pulmonary diseases-2003" on quality of life</TI>
<SO>Lung India</SO>
<YR>2009</YR>
<VL>26</VL>
<NO>4</NO>
<PG>102-5</PG>
<MD>Temp ID 2034</MD>
<IDENTIFIERS MODIFIED="2012-09-11 12:11:10 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kocher-2003" MODIFIED="2012-09-11 12:11:36 -0400" MODIFIED_BY="[Empty name]" NAME="Kocher 2003" YEAR="0000">
<REFERENCE MODIFIED="2012-09-11 12:11:36 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;INCstudstrat ---  CIN - InclStud Strat&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 12:11:36 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Kocher MS, Mandiga R, Murphy JM, Goldmann D, Harper M, Sundel R, et al</AU>
<TI>A clinical practice guideline for treatment of septic arthritis in children: efficacy in improving process of care and effect on outcome of septic arthritis of the hip</TI>
<SO>Journal of Bone &amp; Joint Surgery, American Volume</SO>
<YR>2003</YR>
<VL>85A</VL>
<NO>6</NO>
<PG>994-9</PG>
<MD>Temp ID 54614</MD>
<IDENTIFIERS MODIFIED="2012-09-11 12:11:36 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kulkarni-1998" MODIFIED="2012-09-10 11:31:52 -0400" MODIFIED_BY="[Empty name]" NAME="Kulkarni 1998" YEAR="1998">
<REFERENCE MODIFIED="2012-09-10 11:31:52 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kulkarni K, Castle G, Gregory R, Holmes A, Leontos C, Powers M, et al</AU>
<TI>Nutrition practice guidelines for type 1 diabetes mellitus positively affect dietician practices and patient outcomes. The Diabetes Care and Education Dietetic Practice Group</TI>
<SO>Journal of the American Dietetic Association</SO>
<YR>1998</YR>
<VL>98</VL>
<NO>1</NO>
<PG>62-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Maiman--1988" MODIFIED="2012-09-11 12:11:51 -0400" MODIFIED_BY="[Empty name]" NAME="Maiman  1988" YEAR="1988">
<REFERENCE MODIFIED="2012-09-11 12:11:51 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;JC - 3gs, 0370471&lt;br&gt;American journal of diseases of children (1960)&lt;br&gt;ML1.8a - RCT&lt;br&gt;PMID:3381783&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 12:11:51 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Maiman LA, Becker MH, Liptak GS, Nazarian LF, Rounds KA</AU>
<TI>Improving pediatricians' compliance-enhancing practices. A randomized trial</TI>
<SO>American Journal of Diseases of Children</SO>
<YR>1988</YR>
<VL>142</VL>
<NO>7</NO>
<PG>773-9</PG>
<IDENTIFIERS MODIFIED="2012-09-11 12:11:51 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Majumdar-2008" MODIFIED="2012-09-11 12:13:27 -0400" MODIFIED_BY="[Empty name]" NAME="Majumdar 2008" YEAR="2008">
<REFERENCE MODIFIED="2012-09-11 12:13:27 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;KW --- JC - 9711805&lt;br&gt;CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne&lt;br&gt;ML1.8a - KW&lt;br&gt;PMID:18299546&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 12:13:27 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Majumdar SR, Johnson JA, McAlister FA, Bellerose D, Russell AS, Hanley DA, et al</AU>
<TI>Multifaceted intervention to improve diagnosis and treatment of osteoporosis in patients with recent wrist fracture: a randomized controlled trial</TI>
<SO>CMAJ: Canadian Medical Association Journal</SO>
<YR>2008</YR>
<VL>178</VL>
<NO>5</NO>
<PG>569-75</PG>
<IDENTIFIERS MODIFIED="2012-09-11 12:12:07 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Martino-2011" MODIFIED="2012-09-11 12:16:19 -0400" MODIFIED_BY="[Empty name]" NAME="Martino 2011" YEAR="2011">
<REFERENCE MODIFIED="2012-09-11 12:16:19 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;EPOC --- Accession Number: 20113057975. Publication Type: Journal Article. Language: English. Number of References: 28 ref. Subject Subsets: Public Health&lt;br&gt;CAB - EPOC&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 12:16:19 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Martino P, Ban KM, Bartoloni A, Fowler KE, Saint S, Mannelli F</AU>
<TI>Assessing the sustainability of hand hygiene adherence prior to patient contact in the emergency department: a 1-year postintervention evaluation</TI>
<SO>AJIC - American Journal of Infection Control</SO>
<YR>2011</YR>
<VL>39</VL>
<NO>1</NO>
<PG>14-8</PG>
<IDENTIFIERS MODIFIED="2012-09-11 12:16:19 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mettes-2010" MODIFIED="2012-09-11 12:16:32 -0400" MODIFIED_BY="[Empty name]" NAME="Mettes 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-09-11 12:16:32 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;INCstudstrat ---  CM - Comment in: Evid Based Dent. 2010;11(2):40; PMID: 20577279&lt;br&gt;Journal of dental research&lt;br&gt;ML1.8a - InclStud Strat&lt;br&gt;PMID:19966044&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 12:16:32 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Mettes TG, van der Sanden WJ, Bronkhorst E, Grol RP, Wensing M, Plasschaert AJ</AU>
<TI>Impact of guideline implementation on patient care: a cluster RCT</TI>
<SO>Journal of Dental Research</SO>
<YR>2010</YR>
<VL>89</VL>
<NO>1</NO>
<PG>71-6</PG>
<IDENTIFIERS MODIFIED="2012-09-11 12:16:32 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mockiene-2011" MODIFIED="2012-09-11 12:16:52 -0400" MODIFIED_BY="[Empty name]" NAME="Mockiene 2011" YEAR="2011">
<REFERENCE MODIFIED="2012-09-11 12:16:52 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;KW --- JC - a7p, 9111870&lt;br&gt;The Journal of the Association of Nurses in AIDS Care : JANAC&lt;br&gt;ML1.8a - KW&lt;br&gt;PMID:21123087&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 12:16:52 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Mockiene V, Suominen T, Valimaki M, Razbadauskas A, Martinkenas A, Caplinskas S</AU>
<TI>The impact of an education intervention to change nurses' HIV-related knowledge and attitudes in Lithuania: a randomized controlled trial</TI>
<SO>The Journal of the Association of Nurses in AIDS Care : JANAC.</SO>
<YR>2011</YR>
<VL>22</VL>
<NO>2</NO>
<PG>140-9</PG>
<IDENTIFIERS MODIFIED="2012-09-11 12:16:52 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mollon-2009" MODIFIED="2012-09-11 12:17:05 -0400" MODIFIED_BY="[Empty name]" NAME="Mollon 2009" YEAR="2009">
<REFERENCE MODIFIED="2012-09-11 12:17:05 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;EPOC --- JC - hwd, 0262321&lt;br&gt;Journal of continuing education in nursing&lt;br&gt;ML1.8a - EPOC&lt;br&gt;PMID:19489521&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 12:17:05 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Mollon DL, Fields WL</AU>
<TI>Is this the right patient? An educational initiative to improve compliance with two patient identifiers</TI>
<SO>Journal of Continuing Education in Nursing</SO>
<YR>2009</YR>
<VL>40</VL>
<NO>5</NO>
<PG>221-7</PG>
<IDENTIFIERS MODIFIED="2012-09-11 12:17:05 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Morse-2009" MODIFIED="2012-09-11 12:17:16 -0400" MODIFIED_BY="[Empty name]" NAME="Morse 2009" YEAR="2009">
<REFERENCE MODIFIED="2012-09-11 12:17:16 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;EPOC --- JC - id6, 8007166&lt;br&gt;The Journal of hospital infection&lt;br&gt;ML1.8a - EPOC&lt;br&gt;PMID:19464755&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 12:17:16 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Morse L, McDonald M</AU>
<TI>Failure of a poster-based educational programme to improve compliance with peripheral venous catheter care in a tertiary hospital. A clinical audit</TI>
<SO>Journal of Hospital Infections</SO>
<YR>2009</YR>
<VL>72</VL>
<NO>3</NO>
<PG>221-6</PG>
<IDENTIFIERS MODIFIED="2012-09-11 12:17:16 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ozgun-2010" MODIFIED="2012-09-11 12:17:28 -0400" MODIFIED_BY="[Empty name]" NAME="Ozgun 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-09-11 12:17:28 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;INCstudstrat ---  CP - United Kingdom&lt;br&gt;EM1.1 - InclStud Strat&lt;br&gt;EM #: 2010134447&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 12:17:28 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Ozgun H, Ertugrul BM, Soyder A, Ozturk B, Aydemir M</AU>
<TI>Peri-operative antibiotic prophylaxis: adherence to guidelines and effects of educational intervention</TI>
<SO>International Journal of Surgery</SO>
<YR>2010</YR>
<VL>8</VL>
<NO>2</NO>
<PG>159-63</PG>
<MD>EM Entry Date: 201013</MD>
<IDENTIFIERS MODIFIED="2012-09-11 12:17:28 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Perez_x002d_Jauregui-2008" MODIFIED="2012-09-11 12:17:41 -0400" MODIFIED_BY="[Empty name]" NAME="Perez-Jauregui 2008" YEAR="2008">
<REFERENCE MODIFIED="2012-09-11 12:17:41 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Perez-Jauregui, Jose&lt;br&gt;Gonzalez-Cardel, Ana Maria&lt;br&gt;Olay-Fuentes, Gabriela&lt;br&gt;Reza-Albarran, Alfredo&lt;br&gt;Mehta, Roopa&lt;br&gt;Aguilar-Salinas, Carlos A&lt;br&gt;Diabetes Care. 2008 May;31(5):882-3. Epub 2008 Feb 11.&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 12:17:41 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Perez-Jauregui J, Gonzalez-Cardel AM, Olay-Fuentes G, Reza-Albarran A, Mehta R, Aguilar-Salinas CA</AU>
<TI>Inclusion of educational messages in laboratory reports aids to complete the diagnostic workup of hyperglycemia</TI>
<SO>Diabetes Care</SO>
<YR>2008</YR>
<VL>31</VL>
<NO>5</NO>
<PG>882-3</PG>
<EN>2008/02/13</EN>
<MD>Multicenter Study</MD>
<IDENTIFIERS MODIFIED="2012-09-11 12:17:41 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Richardson-2002" MODIFIED="2012-09-11 12:17:51 -0400" MODIFIED_BY="[Empty name]" NAME="Richardson 2002" YEAR="2002">
<REFERENCE MODIFIED="2012-09-11 12:17:51 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;KW --- CM - Comment in: Age Ageing. 2002 Sep;31(5):329; PMID: 12242192&lt;br&gt;Age and ageing&lt;br&gt;ML1.8a - KW&lt;br&gt;PMID:12242194&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 12:17:51 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Richardson B, Kitchen G, Livingston G</AU>
<TI>The effect of education on knowledge and management of elder abuse: a randomized controlled trial</TI>
<SO>Age Ageing</SO>
<YR>2002</YR>
<VL>31</VL>
<NO>5</NO>
<PG>335-41</PG>
<IDENTIFIERS MODIFIED="2012-09-11 12:17:51 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schwartz-2007" MODIFIED="2012-09-11 12:18:04 -0400" MODIFIED_BY="[Empty name]" NAME="Schwartz 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-09-11 12:18:04 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;CM - Comment in: J Am Geriatr Soc. 2007 Aug;55(8):1301-2; PMID: 17661973&lt;br&gt;Journal of the American Geriatrics Society&lt;br&gt;ML1.8a - RCT&lt;br&gt;PMID:17661963&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 12:18:04 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Schwartz DN, Abiad H, DeMarais PL, Armeanu E, Trick WE, Wang Y, et al</AU>
<TI>An educational intervention to improve antimicrobial use in a hospital-based long-term care facility</TI>
<SO>Journal of the American Geriatrics Society</SO>
<YR>2007</YR>
<VL>55</VL>
<NO>8</NO>
<PG>1236-42</PG>
<IDENTIFIERS MODIFIED="2012-09-11 12:18:04 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Simon-2007" MODIFIED="2012-09-11 12:18:14 -0400" MODIFIED_BY="[Empty name]" NAME="Simon 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-09-11 12:18:14 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;CP - United States&lt;br&gt;EM1.1 - RCT&lt;br&gt;EM #: 17215654&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 12:18:14 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Simon SR, Rodriguez HP, Majumdar SR, Kleinman K, Warner C, Salem-Schatz S, et al</AU>
<TI>Economic analysis of a randomized trial of academic detailing interventions to improve use of antihypertensive medications</TI>
<SO>Journal of Clinical Hypertension (Greenwich, Conn.)</SO>
<YR>2007</YR>
<VL>9</VL>
<NO>1</NO>
<PG>15-20</PG>
<MD>EM Entry Date: 200700</MD>
<IDENTIFIERS MODIFIED="2012-09-11 12:18:14 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Steffensen-1997" MODIFIED="2012-09-11 12:19:10 -0400" MODIFIED_BY="[Empty name]" NAME="Steffensen 1997" YEAR="1997">
<REFERENCE MODIFIED="2012-09-11 12:19:10 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Steffensen FH, Sorensen HT, Olesen F</AU>
<TI>Impact of local evidence-based clinical guidelines - a Danish intervention study</TI>
<SO>Family Practice</SO>
<YR>1997</YR>
<VL>14</VL>
<NO>3</NO>
<PG>209-15</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2012-05-01 10:58:32 -0400" MODIFIED_BY="[Empty name]"/>
<ONGOING_STUDIES MODIFIED="2012-09-11 12:20:05 -0400" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Shah--2010" MODIFIED="2012-09-11 12:19:30 -0400" MODIFIED_BY="[Empty name]" NAME="Shah  2010" YEAR="2010">
<REFERENCE MODIFIED="2012-09-11 12:19:30 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Shah, Baiju R&lt;br&gt;Bhattacharyya, Onil&lt;br&gt;Yu, Catherine&lt;br&gt;Mamdani, Muhammad&lt;br&gt;Parsons, Janet A&lt;br&gt;Straus, Sharon E&lt;br&gt;Zwarenstein, Merrick&lt;br&gt;Canadian Institutes of Health Research/Canada&lt;br&gt;Randomized Controlled Trial&lt;br&gt;Research Support, Non-U.S. Gov't&lt;br&gt;England&lt;br&gt;Trials&lt;br&gt;Trials. 2010 Apr 23;11:44.&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 12:19:30 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Shah BR, Bhattacharyya O, Yu C, Mamdani M, Parsons JA, Straus SE, et al</AU>
<TI>Evaluation of a toolkit to improve cardiovascular disease screening and treatment for people with type 2 diabetes: protocol for a cluster-randomized pragmatic trial</TI>
<SO>Trials</SO>
<YR>2010</YR>
<VL>11</VL>
<PG>44</PG>
<EN>2010/04/27</EN>
<IDENTIFIERS MODIFIED="2012-09-11 12:19:30 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zwarenstein--2007" MODIFIED="2012-09-11 12:20:05 -0400" MODIFIED_BY="[Empty name]" NAME="Zwarenstein  2007" YEAR="2007">
<REFERENCE MODIFIED="2012-09-11 12:20:05 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Zwarenstein, Merrick&lt;br&gt;Hux, Janet E&lt;br&gt;Kelsall, Diane&lt;br&gt;Paterson, Michael&lt;br&gt;Grimshaw, Jeremy&lt;br&gt;Davis, Dave&lt;br&gt;Laupacis, Andreas&lt;br&gt;Evans, Michael&lt;br&gt;Austin, Peter C&lt;br&gt;Slaughter, Pamela M&lt;br&gt;Shiller, Susan K&lt;br&gt;Croxford, Ruth&lt;br&gt;Tu, Karen&lt;br&gt;England&lt;br&gt;Implementation science : IS&lt;br&gt;Implement Sci. 2007 Nov 26;2:37.&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 12:20:05 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Zwarenstein M, Hux JE, Kelsall D, Paterson M, Grimshaw J, Davis D, et al</AU>
<TI>The Ontario printed educational message (OPEM) trial to narrow the evidence-practice gap with respect to prescribing practices of general and family physicians: a cluster randomized controlled trial, targeting the care of individuals with diabetes and hypertension in Ontario, Canada</TI>
<SO>Implementation Science</SO>
<YR>2007</YR>
<VL>2</VL>
<PG>37</PG>
<IDENTIFIERS MODIFIED="2012-09-11 12:20:05 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2015-03-09 12:23:24 -0400" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2015-03-09 12:23:24 -0400" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Ancker-2007" MODIFIED="2012-09-11 12:22:45 -0400" MODIFIED_BY="[Empty name]" NAME="Ancker 2007" NOTES="&lt;p&gt;Ancker, Jessica S&lt;br&gt;Kaufman, David&lt;br&gt;5T15 LM 007079-15/LM/NLM NIH HHS/United States&lt;br&gt;Research Support, N.I.H., Extramural&lt;br&gt;Research Support, Non-U.S. Gov't&lt;br&gt;Review&lt;br&gt;United States&lt;br&gt;Journal of the American Medical Informatics Association : JAMIA&lt;br&gt;J Am Med Inform Assoc. 2007 Nov-Dec;14(6):713-21. Epub 2007 Aug 21.&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 12:22:45 -0400" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>Ancker JS, Kaufman D</AU>
<TI>Rethinking health numeracy: a multidisciplinary literature review</TI>
<SO>Journal of the American Medical Informatics Association</SO>
<YR>2007</YR>
<VL>14</VL>
<NO>6</NO>
<PG>713-21</PG>
<IDENTIFIERS MODIFIED="2012-09-11 12:22:45 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Arnold-2005" MODIFIED="2012-09-11 12:22:56 -0400" MODIFIED_BY="[Empty name]" NAME="Arnold 2005" NOTES="&lt;p&gt;Arnold, S R&lt;br&gt;Straus, S E&lt;br&gt;England&lt;br&gt;Online&lt;br&gt;Cochrane Database Syst Rev. 2005 Oct 19;(4):CD003539.&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 12:22:56 -0400" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>Arnold SR, Straus SE</AU>
<TI>Interventions to improve antibiotic prescribing practices in ambulatory care</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2005</YR>
<NO>4</NO>
<PG>CD003539</PG>
<MD>Meta-Analysis</MD>
<IDENTIFIERS MODIFIED="2012-09-11 12:22:56 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Baker-2010" MODIFIED="2012-09-11 12:23:03 -0400" MODIFIED_BY="[Empty name]" NAME="Baker 2010" NOTES="&lt;p&gt;Times Cited: 13&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 12:23:03 -0400" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>Baker R, Camosso-Stefinovic J, Gillies C, Shaw EJ, Cheater F, Flottorp S, et al</AU>
<TI>Tailored interventions to overcome identified barriers to change: effects on professional practice and health care outcomes</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2010</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2012-09-11 12:23:03 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Bero-1998" MODIFIED="2012-09-11 12:23:33 -0400" MODIFIED_BY="[Empty name]" NAME="Bero 1998" TYPE="JOURNAL_ARTICLE">
<AU>Bero L, Grilli R, Grimshaw J, Harvey E, Oxman A, Thomson MA</AU>
<TI>Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings</TI>
<SO>BMJ</SO>
<YR>1998</YR>
<VL>317</VL>
<NO>7156</NO>
<PG>465-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bull-2001" MODIFIED="2008-05-13 13:44:52 -0400" MODIFIED_BY="[Empty name]" NAME="Bull 2001" TYPE="JOURNAL_ARTICLE">
<AU>Bull F, Kreuter M, Clark E, Scharff D</AU>
<TI>Understanding the effects of printed health education material which features lead to which outcomes</TI>
<SO>Journal of Health Communication</SO>
<YR>2001</YR>
<VL>6</VL>
<NO>3</NO>
<PG>265-79</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Burgers-2003a" MODIFIED="2008-05-13 13:45:06 -0400" MODIFIED_BY="[Empty name]" NAME="Burgers 2003a" TYPE="JOURNAL_ARTICLE">
<AU>Burgers J, Grol R, Zaat J, Spies T, van der Bij A, Mokkink H</AU>
<TI>Characteristics of effective guidelines for general practice</TI>
<SO>British Journal of General Practice</SO>
<YR>2003</YR>
<VL>53</VL>
<NO>486</NO>
<PG>15-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Chastre-2003" MODIFIED="2012-09-13 08:37:01 -0400" MODIFIED_BY="Alain Mayhew" NAME="Chastre 2003" TYPE="JOURNAL_ARTICLE">
<AU>Chastre J</AU>
<TI>Antimicrobial treatment of hospital-acquired pneumonia</TI>
<SO>Infectious disease clinics of North America</SO>
<YR>2003</YR>
<VL>17</VL>
<NO>4</NO>
<PG>727-37</PG>
<IDENTIFIERS MODIFIED="2012-09-13 08:37:01 -0400" MODIFIED_BY="Alain Mayhew">
<IDENTIFIER MODIFIED="2012-09-13 08:37:01 -0400" MODIFIED_BY="Alain Mayhew" TYPE="PUBMED" VALUE=" 15008595"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Chatfield-2001" MODIFIED="2012-09-11 12:24:00 -0400" MODIFIED_BY="[Empty name]" NAME="Chatfield 2001" TYPE="BOOK">
<AU>Chatfield C</AU>
<SO>Time-series forecasting</SO>
<YR>2001</YR>
<PB>Chapman &amp; Hall/CRC Press</PB>
<CY>Florida</CY>
<IDENTIFIERS MODIFIED="2012-09-11 12:24:00 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Davis-2009" MODIFIED="2012-09-11 12:24:13 -0400" MODIFIED_BY="[Empty name]" NAME="Davis 2009" NOTES="&lt;p&gt;Davis, Dave&lt;br&gt;Galbraith, Robert&lt;br&gt;American College of Chest Physicians Health and Science Policy Committee&lt;br&gt;Review&lt;br&gt;United States&lt;br&gt;Chest&lt;br&gt;Chest. 2009 Mar;135(3 Suppl):42S-48S.&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 12:24:13 -0400" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>Davis D, Galbraith R</AU>
<TI>Continuing medical education effect on practice performance: effectiveness of continuing medical education: American College of Chest Physicians Evidence-Based Educational Guidelines</TI>
<SO>Chest</SO>
<YR>2009</YR>
<VL>135</VL>
<NO>3 Suppl</NO>
<PG>42S-8S</PG>
<EN>2009/03/20</EN>
<IDENTIFIERS MODIFIED="2012-09-11 12:24:13 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-de-Belvis-2009" MODIFIED="2012-09-11 12:24:24 -0400" MODIFIED_BY="[Empty name]" NAME="de Belvis 2009" NOTES="&lt;p&gt;de Belvis, A G&lt;br&gt;Pelone, F&lt;br&gt;Biasco, A&lt;br&gt;Ricciardi, W&lt;br&gt;Volpe, M&lt;br&gt;Ireland&lt;br&gt;Diabetes Res Clin Pract. 2009 Aug;85(2):119-31. Epub 2009 Jun 17.&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 12:24:24 -0400" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>de Belvis AG, Pelone F, Biasco A, Ricciardi W, Volpe M</AU>
<TI>Can primary care professionals' adherence to Evidence Based Medicine tools improve quality of care in type 2 diabetes mellitus? A systematic review</TI>
<SO>Diabetes Research and Clinical Practice</SO>
<YR>2009</YR>
<VL>85</VL>
<NO>2</NO>
<PG>119-31</PG>
<MD>Research Support, Non-U.S. Gov't</MD>
<IDENTIFIERS MODIFIED="2012-09-11 12:24:24 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Donner-2001" MODIFIED="2012-09-11 12:24:33 -0400" MODIFIED_BY="[Empty name]" NAME="Donner 2001" NOTES="&lt;p&gt;Donner, A&lt;br&gt;Piaggio, G&lt;br&gt;Villar, J&lt;br&gt;England&lt;br&gt;Stat Methods Med Res. 2001 Oct;10(5):325-38.&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 12:24:33 -0400" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>Donner A, Piaggio G, Villar J</AU>
<TI>Statistical methods for the meta-analysis of cluster randomization trials</TI>
<SO>Statistical Methods in Medical Research</SO>
<YR>2001</YR>
<VL>10</VL>
<NO>5</NO>
<PG>325-38</PG>
<MD>Research Support, Non-U.S. Gov't</MD>
<IDENTIFIERS MODIFIED="2012-09-11 12:24:33 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Flodgren-2011" MODIFIED="2012-09-11 13:22:58 -0400" MODIFIED_BY="[Empty name]" NAME="Flodgren 2011" NOTES="&lt;p&gt;Flodgren, Gerd&lt;br&gt;Parmelli, Elena&lt;br&gt;Doumit, Gaby&lt;br&gt;Gattellari, Melina&lt;br&gt;O'Brien, Mary Ann&lt;br&gt;Grimshaw, Jeremy&lt;br&gt;Eccles, Martin P&lt;br&gt;England&lt;br&gt;Online&lt;br&gt;Cochrane Database Syst Rev. 2011 Aug 10;(8):CD000125.&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 13:22:58 -0400" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>Flodgren G, Parmelli E, Doumit G, Gattellari M, O'Brien MA, Grimshaw J, et al</AU>
<TI>Local opinion leaders: effects on professional practice and health care outcomes</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2011</YR>
<NO>8</NO>
<PG>CD000125</PG>
<MD>Meta-Analysis</MD>
<IDENTIFIERS MODIFIED="2012-09-11 13:22:58 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Forsetlund-2009" MODIFIED="2012-09-11 13:23:19 -0400" MODIFIED_BY="[Empty name]" NAME="Forsetlund 2009" NOTES="&lt;p&gt;1469-493X (Electronic)&lt;br&gt;1469-493X (Linking)&lt;br&gt;Journal Article&lt;br&gt;Meta-Analysis&lt;br&gt;Review&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 13:23:19 -0400" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>Forsetlund L, Bjorndal A, Rashidian A, Jamtvedt G, O'Brien MA, Wolf F, et al</AU>
<TI>Continuing education meetings and workshops: effects on professional practice and health care outcomes</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2009</YR>
<NO>2</NO>
<PG>CD003030</PG>
<IDENTIFIERS MODIFIED="2012-09-11 13:23:19 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Foy-2002" MODIFIED="2008-05-13 13:48:53 -0400" MODIFIED_BY="[Empty name]" NAME="Foy 2002" TYPE="JOURNAL_ARTICLE">
<AU>Foy R, McLennan G, Grimshaw J, Penney G, Campbell M, Grol R</AU>
<TI>Attributes of clinical recommendations that influence change in practice following audit and feedback</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>2002</YR>
<VL>55</VL>
<PG>717-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Freemantle-1997" MODIFIED="2015-03-09 12:23:24 -0400" MODIFIED_BY="[Empty name]" NAME="Freemantle 1997" TYPE="COCHRANE_REVIEW">
<AU>Freemantle N, Harvey EL, Wolf F, Grimshaw JM, Grilli R, Bero LA</AU>
<TI>Printed educational materials: effects on professional practice and health care outcomes</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>1997</YR>
<NO>2</NO>
<PB>The Cochrane Collaboration</PB>
<CY>Oxford, England</CY>
<IDENTIFIERS MODIFIED="2015-03-09 12:23:24 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2015-03-09 12:23:24 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD000172"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-French-2010" MODIFIED="2012-09-11 13:24:37 -0400" MODIFIED_BY="[Empty name]" NAME="French 2010" NOTES="&lt;p&gt;French, Simon D&lt;br&gt;Green, Sally&lt;br&gt;Buchbinder, Rachelle&lt;br&gt;Barnes, Hayley&lt;br&gt;England&lt;br&gt;Online&lt;br&gt;Cochrane Database Syst Rev. 2010 Jan 20;(1):CD006094.&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 13:24:37 -0400" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>French SD, Green S, Buchbinder R, Barnes H</AU>
<TI>Interventions for improving the appropriate use of imaging in people with musculoskeletal conditions</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2010</YR>
<NO>1</NO>
<PG>CD006094</PG>
<MD>Review</MD>
<IDENTIFIERS MODIFIED="2012-09-11 13:24:37 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Graham-2006" MODIFIED="2012-09-11 13:25:14 -0400" MODIFIED_BY="[Empty name]" NAME="Graham 2006" NOTES="&lt;p&gt;10.1002/chp.47&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 13:25:14 -0400" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>Graham I, Logan J, Harrison M, Straus S, Tetroe J, Caswell W, et al</AU>
<TI>Lost in knowledge translation: time for a map?</TI>
<SO>Journal of Continuing Education in the Health Professions</SO>
<YR>2006</YR>
<VL>26</VL>
<NO>1</NO>
<PG>13-24</PG>
<IDENTIFIERS MODIFIED="2012-09-11 13:25:14 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Grandage-2002" MODIFIED="2012-09-11 13:25:26 -0400" MODIFIED_BY="[Empty name]" NAME="Grandage 2002" NOTES="&lt;p&gt;Grandage, Karen K&lt;br&gt;Slawson, David C&lt;br&gt;Shaughnessy, Allen F&lt;br&gt;Review&lt;br&gt;United States&lt;br&gt;Journal of the Medical Library Association : JMLA&lt;br&gt;J Med Libr Assoc. 2002 Jul;90(3):298-304.&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 13:25:26 -0400" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>Grandage KK, Slawson DC, Shaughnessy AF</AU>
<TI>When less is more: a practical approach to searching for evidence-based answers</TI>
<SO>Journal of the Medical Library Association</SO>
<YR>2002</YR>
<VL>90</VL>
<NO>3</NO>
<PG>298-304</PG>
<IDENTIFIERS MODIFIED="2012-09-11 13:25:26 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Grilli-2002" MODIFIED="2012-09-10 11:48:15 -0400" MODIFIED_BY="[Empty name]" NAME="Grilli 2002" NOTES="&lt;p&gt;Grilli, R&lt;br&gt;Ramsay, C&lt;br&gt;Minozzi, S&lt;br&gt;England&lt;br&gt;Online&lt;br&gt;Cochrane Database Syst Rev. 2002;(1):CD000389.&lt;/p&gt;" NOTES_MODIFIED="2012-09-10 11:48:15 -0400" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>Grilli R, Ramsay C, Minozzi S</AU>
<TI>Mass media interventions: effects on health services utilisation</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2002</YR>
<NO>1</NO>
<PG>CD000389</PG>
<MD>Review</MD>
<IDENTIFIERS MODIFIED="2012-04-18 16:13:47 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="1469-493X" TYPE="OTHER" VALUE="(Electronic)"/>
<IDENTIFIER TYPE="MEDLINE" VALUE="ITS/PEM/methods/meta analysis"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Grimshaw-2003" MODIFIED="2012-09-10 11:48:29 -0400" MODIFIED_BY="[Empty name]" NAME="Grimshaw 2003" NOTES="&lt;p&gt;Grimshaw, J&lt;br&gt;McAuley, L M&lt;br&gt;Bero, L A&lt;br&gt;Grilli, R&lt;br&gt;Oxman, A D&lt;br&gt;Ramsay, C&lt;br&gt;Vale, L&lt;br&gt;Zwarenstein, M&lt;br&gt;England&lt;br&gt;Qual Saf Health Care. 2003 Aug;12(4):298-303.&lt;/p&gt;" NOTES_MODIFIED="2012-09-10 11:48:29 -0400" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>Grimshaw J, McAuley LM, Bero LA, Grilli R, Oxman AD, Ramsay C, et al</AU>
<TI>Systematic reviews of the effectiveness of quality improvement strategies and programmes</TI>
<SO>Quality and Safety in Health Care</SO>
<YR>2003</YR>
<VL>12</VL>
<NO>4</NO>
<PG>298-303</PG>
<MD>Research Support, Non-U.S. Gov't</MD>
<IDENTIFIERS>
<IDENTIFIER OTHERTYPE="1475-3898" TYPE="OTHER" VALUE="(Print)"/>
<IDENTIFIER TYPE="MEDLINE" VALUE="methods/revue systématique"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Grimshaw-2004" MODIFIED="2008-05-13 13:51:27 -0400" MODIFIED_BY="[Empty name]" NAME="Grimshaw 2004" TYPE="JOURNAL_ARTICLE">
<AU>Grimshaw JM, Thomas RE, MacLennan G, Fraser C, Ramsay CR, Vale L, et al</AU>
<TI>Effectiveness and efficiency of guideline dissemination and implementation strategies</TI>
<SO>Health Technology Assessment</SO>
<YR>2004</YR>
<VL>8</VL>
<NO>6</NO>
<PG>iii-iv, 1-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Grimshaw-2006" MODIFIED="2012-09-11 13:27:32 -0400" MODIFIED_BY="[Empty name]" NAME="Grimshaw 2006" NOTES="&lt;p&gt;Grimshaw, Jeremy&lt;br&gt;Eccles, Martin&lt;br&gt;Thomas, Ruth&lt;br&gt;MacLennan, Graeme&lt;br&gt;Ramsay, Craig&lt;br&gt;Fraser, Cynthia&lt;br&gt;Vale, Luke&lt;br&gt;Research Support, Non-U.S. Gov't&lt;br&gt;Review&lt;br&gt;United States&lt;br&gt;Journal of general internal medicine&lt;br&gt;J Gen Intern Med. 2006 Feb;21 Suppl 2:S14-20.&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 13:27:32 -0400" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>Grimshaw J, Eccles M, Thomas R, MacLennan G, Ramsay C, Fraser C, et al</AU>
<TI>Toward evidence-based quality improvement. Evidence (and its limitations) of the effectiveness of guideline dissemination and implementation strategies 1966-1998</TI>
<SO>Journal of General Internal Medicine</SO>
<YR>2006</YR>
<VL>21 Suppl 2</VL>
<PG>S14-20</PG>
<IDENTIFIERS MODIFIED="2012-09-11 13:27:32 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Grol-1998" MODIFIED="2008-05-13 13:52:00 -0400" MODIFIED_BY="[Empty name]" NAME="Grol 1998" TYPE="JOURNAL_ARTICLE">
<AU>Grol R, Dalhuijsen J, Thomas S, Veld C, Rutten G, Mokkink H</AU>
<TI>Attributes of clinical guidelines that influence of guidelines in general practice: observational study</TI>
<SO>BMJ</SO>
<YR>1998</YR>
<VL>317</VL>
<PG>858-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Grol-2001" MODIFIED="2012-09-11 13:27:55 -0400" MODIFIED_BY="[Empty name]" NAME="Grol 2001" NOTES="&lt;p&gt;Grol, R&lt;br&gt;United States&lt;br&gt;Medical care&lt;br&gt;Med Care. 2001 Aug;39(8 Suppl 2):II46-54.&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 13:27:55 -0400" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>Grol R</AU>
<TI>Successes and failures in the implementation of evidence-based guidelines for clinical practice</TI>
<SO>Medical Care</SO>
<YR>2001</YR>
<VL>39</VL>
<NO>8 Suppl 2</NO>
<PG>II46-54</PG>
<IDENTIFIERS MODIFIED="2012-09-11 13:27:55 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Grol-2003" MODIFIED="2012-09-11 13:28:10 -0400" MODIFIED_BY="[Empty name]" NAME="Grol 2003" NOTES="&lt;p&gt;Grol, Richard&lt;br&gt;Grimshaw, Jeremy&lt;br&gt;Review&lt;br&gt;England&lt;br&gt;Lancet&lt;br&gt;Lancet. 2003 Oct 11;362(9391):1225-30.&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 13:28:10 -0400" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>Grol R, Grimshaw J</AU>
<TI>From best evidence to best practice: effective implementation of change in patients' care</TI>
<SO>Lancet</SO>
<YR>2003</YR>
<VL>362</VL>
<NO>9391</NO>
<PG>1225-30</PG>
<EN>2003/10/22</EN>
<IDENTIFIERS MODIFIED="2012-09-11 13:28:10 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Grol-2007" MODIFIED="2012-09-11 13:28:20 -0400" MODIFIED_BY="[Empty name]" NAME="Grol 2007" NOTES="&lt;p&gt;Grol, Richard P T M&lt;br&gt;Bosch, Marije C&lt;br&gt;Hulscher, Marlies E J L&lt;br&gt;Eccles, Martin P&lt;br&gt;Wensing, Michel&lt;br&gt;Milbank Q. 2007;85(1):93-138.&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 13:28:20 -0400" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>Grol RP, Bosch MC, Hulscher ME, Eccles MP, Wensing M</AU>
<TI>Planning and studying improvement in patient care: the use of theoretical perspectives</TI>
<SO>Milbank Quarterly</SO>
<YR>2007</YR>
<VL>85</VL>
<NO>1</NO>
<PG>93-138</PG>
<MD>Research Support, Non-U.S. Gov't</MD>
<IDENTIFIERS MODIFIED="2012-09-11 13:28:20 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Gross-2001" MODIFIED="2012-09-11 13:28:31 -0400" MODIFIED_BY="[Empty name]" NAME="Gross 2001" NOTES="&lt;p&gt;Gross, P A&lt;br&gt;Greenfield, S&lt;br&gt;Cretin, S&lt;br&gt;Ferguson, J&lt;br&gt;Grimshaw, J&lt;br&gt;Grol, R&lt;br&gt;Klazinga, N&lt;br&gt;Lorenz, W&lt;br&gt;Meyer, G S&lt;br&gt;Riccobono, C&lt;br&gt;Schoenbaum, S C&lt;br&gt;Schyve, P&lt;br&gt;Shaw, C&lt;br&gt;Med Care. 2001 Aug;39(8 Suppl 2):II85-92.&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 13:28:31 -0400" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>Gross PA, Greenfield S, Cretin S, Ferguson J, Grimshaw J, Grol R, et al</AU>
<TI>Optimal methods for guideline implementation: conclusions from Leeds Castle meeting</TI>
<SO>Medical Care</SO>
<YR>2001</YR>
<VL>39</VL>
<NO>8 Suppl 2</NO>
<PG>II85-92</PG>
<MD>Comparative Study</MD>
<IDENTIFIERS MODIFIED="2012-09-11 13:28:31 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Hakkennes-2008" MODIFIED="2012-09-11 13:28:38 -0400" MODIFIED_BY="[Empty name]" NAME="Hakkennes 2008" NOTES="&lt;p&gt;Times Cited: 19&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 13:28:38 -0400" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>Hakkennes S, Dodd K</AU>
<TI>Guideline implementation in allied health professions: a systematic review of the literature</TI>
<SO>Quality and Safety in Health Care</SO>
<YR>2008</YR>
<VL>17</VL>
<NO>4</NO>
<PG>296-300</PG>
<IDENTIFIERS MODIFIED="2012-09-11 13:28:38 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Haynes-2007" MODIFIED="2012-09-11 13:29:08 -0400" MODIFIED_BY="[Empty name]" NAME="Haynes 2007" NOTES="&lt;p&gt;Haynes, Brian&lt;br&gt;England&lt;br&gt;Evidence-based nursing&lt;br&gt;Evid Based Nurs. 2007 Jan;10(1):6-7.&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 13:29:08 -0400" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>Haynes B</AU>
<TI>Of studies, syntheses, synopses, summaries, and systems: the "5S" evolution of information services for evidence-based healthcare decisions</TI>
<SO>Evidence-Based Nursing</SO>
<YR>2007</YR>
<VL>10</VL>
<NO>1</NO>
<PG>6-7</PG>
<EN>2007/01/16</EN>
<IDENTIFIERS MODIFIED="2012-09-11 13:29:08 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2012-09-10 11:49:53 -0400" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins J, Green S (editors)</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>http://www.cochrane-handbook.org/</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hoffman-2004" MODIFIED="2012-09-10 11:50:07 -0400" MODIFIED_BY="[Empty name]" NAME="Hoffman 2004" TYPE="JOURNAL_ARTICLE">
<AU>Hoffman T, Worrall L</AU>
<TI>Designing effective written health education materials: considerations for health professionals</TI>
<SO>Disability and Rehabilitation</SO>
<YR>2004</YR>
<VL>26</VL>
<NO>19</NO>
<PG>1163-73</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jamtvedt-2006" MODIFIED="2012-09-11 13:29:41 -0400" MODIFIED_BY="[Empty name]" NAME="Jamtvedt 2006" NOTES="&lt;p&gt;Jamtvedt, G&lt;br&gt;Young, J M&lt;br&gt;Kristoffersen, D T&lt;br&gt;O'Brien, M A&lt;br&gt;Oxman, A D&lt;br&gt;England&lt;br&gt;Online&lt;br&gt;Cochrane Database Syst Rev. 2006 Apr 19;(2):CD000259.&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 13:29:41 -0400" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>Jamtvedt G, Young JM, Kristoffersen DT, O'Brien MA, Oxman AD</AU>
<TI>Audit and feedback: effects on professional practice and health care outcomes</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2006</YR>
<NO>2</NO>
<PG>CD000259</PG>
<EN>2006/04/21</EN>
<MD>Meta-Analysis</MD>
<IDENTIFIERS MODIFIED="2012-09-11 13:29:41 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Kanouse-1995" MODIFIED="2012-09-11 13:31:25 -0400" MODIFIED_BY="[Empty name]" NAME="Kanouse 1995" TYPE="JOURNAL_ARTICLE">
<AU>Kanouse D, Kallich J, Kahan J</AU>
<TI>Dissemination of effectiveness and outcomes research</TI>
<SO>Health Policy</SO>
<YR>1995</YR>
<VL>34</VL>
<NO>3</NO>
<PG>167-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kreuter-1996" MODIFIED="2008-05-13 13:53:19 -0400" MODIFIED_BY="[Empty name]" NAME="Kreuter 1996" TYPE="JOURNAL_ARTICLE">
<AU>Kreuter MW, Strecher VJ</AU>
<TI>Do tailored behaviour change messages enhance the effectiveness of health risk appraisals? results from a randomized controlled trial</TI>
<SO>Health Education Research</SO>
<YR>1996</YR>
<VL>11</VL>
<NO>1</NO>
<PG>97-105</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lagarde-2012" MODIFIED="2012-09-11 13:30:17 -0400" MODIFIED_BY="[Empty name]" NAME="Lagarde 2012" NOTES="&lt;p&gt;Lagarde, Mylene&lt;br&gt;England&lt;br&gt;Health Policy Plan. 2012 Jan;27(1):76-83. Epub 2011 Jan 27.&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 13:30:17 -0400" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>Lagarde M</AU>
<TI>How to do (or not to do) ... Assessing the impact of a policy change with routine longitudinal data</TI>
<SO>Health Policy Plan</SO>
<YR>2012</YR>
<VL>27</VL>
<NO>1</NO>
<PG>76-83</PG>
<EN>2011/02/01</EN>
<MD>Research Support, Non-U.S. Gov't</MD>
<IDENTIFIERS MODIFIED="2012-09-11 13:30:17 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Marriott-2000" MODIFIED="2012-09-11 13:32:09 -0400" MODIFIED_BY="[Empty name]" NAME="Marriott 2000" TYPE="JOURNAL_ARTICLE">
<AU>Marriott S, Palmer C, Lelliott P</AU>
<TI>Disseminating healthcare information: getting the message across</TI>
<SO>Quality in Health Care</SO>
<YR>2000</YR>
<VL>9</VL>
<NO>1</NO>
<PG>58-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-McGuire-1989" MODIFIED="2012-09-10 11:51:45 -0400" MODIFIED_BY="[Empty name]" NAME="McGuire 1989" TYPE="BOOK_SECTION">
<AU>McGuire WJ</AU>
<TI>Theoretical foundations of campaigns</TI>
<SO>Public Communication Campaigns</SO>
<YR>1989</YR>
<ED>Rice R, Atkins C</ED>
<PB>California: Sage Publication, Inc.</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-NHS-1999" MODIFIED="2012-04-15 13:35:21 -0400" MODIFIED_BY="[Empty name]" NAME="NHS 1999" TYPE="OTHER">
<AU>NHS CforRandD</AU>
<TI>Getting evidence into practice</TI>
<SO>Effective Health Care</SO>
<YR>1999</YR>
<VL>5</VL>
<PG>1&#8211;16</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-O_x0027_Brien-2007" MODIFIED="2012-09-11 13:32:57 -0400" MODIFIED_BY="[Empty name]" NAME="O'Brien 2007" NOTES="&lt;p&gt;O'Brien, M A&lt;br&gt;Rogers, S&lt;br&gt;Jamtvedt, G&lt;br&gt;Oxman, A D&lt;br&gt;Odgaard-Jensen, J&lt;br&gt;Kristoffersen, D T&lt;br&gt;Forsetlund, L&lt;br&gt;Bainbridge, D&lt;br&gt;Freemantle, N&lt;br&gt;Davis, D A&lt;br&gt;Haynes, R B&lt;br&gt;Harvey, E L&lt;br&gt;England&lt;br&gt;Online&lt;br&gt;Cochrane Database Syst Rev. 2007 Oct 17;(4):CD000409.&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 13:32:57 -0400" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>O'Brien MA, Rogers S, Jamtvedt G, Oxman AD, Odgaard-Jensen J, Kristoffersen DT, et al</AU>
<TI>Educational outreach visits: effects on professional practice and health care outcomes</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2007</YR>
<NO>4</NO>
<PG>CD000409</PG>
<EN>2007/10/19</EN>
<MD>Meta-Analysis</MD>
<IDENTIFIERS MODIFIED="2012-09-11 13:32:57 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Ramsay-2003" MODIFIED="2008-05-13 13:56:05 -0400" MODIFIED_BY="[Empty name]" NAME="Ramsay 2003" TYPE="JOURNAL_ARTICLE">
<AU>Ramsay CR, Matowe L, Grilli R, Grimshaw JM, Thomas RE</AU>
<TI>Interrupted time series designs in health technology assessment: lessons from two systematic reviews of behavior change strategies</TI>
<SO>International Journal of Technology Assessment in Health Care</SO>
<YR>2003</YR>
<VL>19</VL>
<NO>4</NO>
<PG>613-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Revere-2001" NAME="Revere 2001" TYPE="JOURNAL_ARTICLE">
<AU>Revere D, Dunbar P</AU>
<TI>Review of computer-generated outpatient health behavior interventions: clinical encounters in absentia</TI>
<SO>Journal of the American Medical Informatics Association</SO>
<YR>2001</YR>
<VL>8</VL>
<NO>1</NO>
<PG>62-79</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2011" MODIFIED="2012-09-10 11:51:56 -0400" MODIFIED_BY="Anne Lawson" NAME="RevMan 2011" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2011</YR>
<EN>5.1</EN>
<PB>The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rogers-1995" MODIFIED="2012-09-10 11:52:05 -0400" MODIFIED_BY="[Empty name]" NAME="Rogers 1995" TYPE="BOOK">
<AU>Rogers EM</AU>
<SO>Diffusion of innovations</SO>
<YR>1995</YR>
<PB>Free Press</PB>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rosenbaum-2010" MODIFIED="2012-09-11 13:33:59 -0400" MODIFIED_BY="[Empty name]" NAME="Rosenbaum 2010" TYPE="BOOK">
<AU>Rosenbaum ME</AU>
<SO>Improving the User Experience of Evidence: a Design Approach to Evidence-informed Healthcare [PhD thesis]</SO>
<YR>2010</YR>
<PG>170</PG>
<PB>The Oslo School of Architecture and Design</PB>
<CY>Oslo</CY>
<IDENTIFIERS MODIFIED="2012-09-11 13:33:59 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Schuster-2005" MODIFIED="2012-09-11 13:34:13 -0400" MODIFIED_BY="[Empty name]" NAME="Schuster 2005" NOTES="&lt;p&gt;Schuster, Mark A&lt;br&gt;McGlynn, Elizabeth A&lt;br&gt;Brook, Robert H&lt;br&gt;Biography&lt;br&gt;Classical Article&lt;br&gt;Historical Article&lt;br&gt;United States&lt;br&gt;The Milbank quarterly&lt;br&gt;Milbank Q. 2005;83(4):843-95.&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 13:34:13 -0400" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>Schuster MA, McGlynn EA, Brook RH</AU>
<TI>How good is the quality of health care in the United States? 1998</TI>
<SO>Milbank Quarterly</SO>
<YR>2005</YR>
<VL>83</VL>
<NO>4</NO>
<PG>843-95</PG>
<EN>2005/11/11</EN>
<IDENTIFIERS MODIFIED="2012-09-11 13:34:13 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Seitz-2011" MODIFIED="2012-09-11 13:34:28 -0400" MODIFIED_BY="[Empty name]" NAME="Seitz 2011" NOTES="&lt;p&gt;Seitz, P&lt;br&gt;Rosemann, T&lt;br&gt;Gensichen, J&lt;br&gt;Huber, C A&lt;br&gt;England&lt;br&gt;Diabetes Obes Metab. 2011 Jun;13(6):479-89. doi: 10.1111/j.1463-1326.2010.01347.x.&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 13:34:28 -0400" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>Seitz P, Rosemann T, Gensichen J, Huber CA</AU>
<TI>Interventions in primary care to improve cardiovascular risk factors and glycated haemoglobin (HbA1c) levels in patients with diabetes: a systematic review</TI>
<SO>Diabetes Obesity and Metabolism</SO>
<YR>2011</YR>
<VL>13</VL>
<NO>6</NO>
<PG>479-89</PG>
<EN>2011/01/06</EN>
<MD>Review</MD>
<IDENTIFIERS MODIFIED="2012-09-11 13:34:28 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Shojania-2010" MODIFIED="2012-09-11 13:34:59 -0400" MODIFIED_BY="[Empty name]" NAME="Shojania 2010" NOTES="&lt;p&gt;Shojania, Kaveh G&lt;br&gt;Jennings, Alison&lt;br&gt;Mayhew, Alain&lt;br&gt;Ramsay, Craig&lt;br&gt;Eccles, Martin&lt;br&gt;Grimshaw, Jeremy&lt;br&gt;Canadian Institutes of Health Research/Canada&lt;br&gt;Research Support, Non-U.S. Gov't&lt;br&gt;Review&lt;br&gt;Canada&lt;br&gt;CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne&lt;br&gt;CMAJ. 2010 Mar 23;182(5):E216-25. Epub 2010 Mar 8.&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 13:34:59 -0400" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>Shojania KG, Jennings A, Mayhew A, Ramsay C, Eccles M, Grimshaw J</AU>
<TI>Effect of point-of-care computer reminders on physician behaviour: a systematic review</TI>
<SO>CMAJ: Canadian Medical Association Journal</SO>
<YR>2010</YR>
<VL>182</VL>
<NO>5</NO>
<PG>E216-25</PG>
<EN>2010/03/10</EN>
<IDENTIFIERS MODIFIED="2012-09-11 13:34:59 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Stergiou_x002d_Kita-2010" MODIFIED="2012-09-11 13:35:26 -0400" MODIFIED_BY="[Empty name]" NAME="Stergiou-Kita 2010" NOTES="&lt;p&gt;Stergiou-Kita, Mary&lt;br&gt;Australia&lt;br&gt;Aust Occup Ther J. 2010 Apr;57(2):76-87.&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 13:35:26 -0400" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>Stergiou-Kita M</AU>
<TI>Implementing clinical practice guidelines in occupational therapy practice: recommendations from the research evidence</TI>
<SO>Australian Occupational Therapy Journal</SO>
<YR>2010</YR>
<VL>57</VL>
<NO>2</NO>
<PG>76-87</PG>
<EN>2010/09/22</EN>
<MD>Review</MD>
<IDENTIFIERS MODIFIED="2012-09-11 13:35:26 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Tseng-1999" NAME="Tseng 1999" TYPE="JOURNAL_ARTICLE">
<AU>Tseng S, Fogg B</AU>
<TI>Credibility and computing technology</TI>
<SO>Communications of the ACM</SO>
<YR>1999</YR>
<VL>42</VL>
<NO>5</NO>
<PG>39-44</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wang-2009" MODIFIED="2012-09-11 13:35:40 -0400" MODIFIED_BY="[Empty name]" NAME="Wang 2009" NOTES="&lt;p&gt;Wang, Ruiqing&lt;br&gt;Bartlett, Gillian&lt;br&gt;Grad, Roland&lt;br&gt;Pluye, Pierre&lt;br&gt;Canadian Institutes of Health Research/Canada&lt;br&gt;Research Support, Non-U.S. Gov't&lt;br&gt;England&lt;br&gt;Informatics in primary care&lt;br&gt;Inform Prim Care. 2009;17(2):79-86.&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 13:35:40 -0400" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>Wang R, Bartlett G, Grad R, Pluye P</AU>
<TI>The cognitive impact of research synopses on physicians: a prospective observational analysis of evidence-based summaries sent by email</TI>
<SO>Informatics in Primary Care</SO>
<YR>2009</YR>
<VL>17</VL>
<NO>2</NO>
<PG>79-86</PG>
<EN>2009/10/08</EN>
<IDENTIFIERS MODIFIED="2012-09-11 13:35:40 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Wathen-2002" MODIFIED="2008-05-13 13:58:08 -0400" MODIFIED_BY="[Empty name]" NAME="Wathen 2002" TYPE="JOURNAL_ARTICLE">
<AU>Wathen CN, Burkell J</AU>
<TI>Believe it or not: factors influencing credibility on the web</TI>
<SO>Journal of the American Society for Information Science and Technology</SO>
<YR>2002</YR>
<VL>53</VL>
<NO>2</NO>
<PG>134-44</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Weinmann-2007" MODIFIED="2012-09-11 13:35:51 -0400" MODIFIED_BY="[Empty name]" NAME="Weinmann 2007" NOTES="&lt;p&gt;Weinmann, S&lt;br&gt;Koesters, M&lt;br&gt;Becker, T&lt;br&gt;Denmark&lt;br&gt;Acta Psychiatr Scand. 2007 Jun;115(6):420-33.&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 13:35:51 -0400" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>Weinmann S, Koesters M, Becker T</AU>
<TI>Effects of implementation of psychiatric guidelines on provider performance and patient outcome: systematic review</TI>
<SO>Acta Psychiatrica Scandinavica</SO>
<YR>2007</YR>
<VL>115</VL>
<NO>6</NO>
<PG>420-33</PG>
<EN>2007/05/15</EN>
<MD>Research Support, Non-U.S. Gov't</MD>
<IDENTIFIERS MODIFIED="2012-09-11 13:35:51 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Wilson-2010" MODIFIED="2012-09-11 13:37:10 -0400" MODIFIED_BY="[Empty name]" NAME="Wilson 2010" NOTES="&lt;p&gt;Wilson, Paul M&lt;br&gt;Petticrew, Mark&lt;br&gt;Calnan, Mike W&lt;br&gt;Nazareth, Irwin&lt;br&gt;England&lt;br&gt;Implement Sci. 2010 Nov 22;5:91.&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 13:37:10 -0400" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>Wilson PM, Petticrew M, Calnan MW, Nazareth I</AU>
<TI>Disseminating research findings: what should researchers do? A systematic scoping review of conceptual frameworks</TI>
<SO>Implementation Science</SO>
<YR>2010</YR>
<VL>5</VL>
<PG>91</PG>
<EN>2010/11/26</EN>
<IDENTIFIERS MODIFIED="2012-09-11 13:37:10 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Wood-2008" MODIFIED="2012-09-11 13:37:23 -0400" MODIFIED_BY="[Empty name]" NAME="Wood 2008" NOTES="&lt;p&gt;Wood, Lesley&lt;br&gt;Egger, Matthias&lt;br&gt;Gluud, Lise Lotte&lt;br&gt;Schulz, Kenneth F&lt;br&gt;Juni, Peter&lt;br&gt;Altman, Douglas G&lt;br&gt;Gluud, Christian&lt;br&gt;Martin, Richard M&lt;br&gt;Wood, Anthony J G&lt;br&gt;Sterne, Jonathan A C&lt;br&gt;Medical Research Council/United Kingdom&lt;br&gt;England&lt;br&gt;Clinical research ed.&lt;br&gt;BMJ. 2008 Mar 15;336(7644):601-5. Epub 2008 Mar 3.&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 13:37:23 -0400" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>Wood L, Egger M, Gluud LL, Schulz KF, Juni P, Altman DG, et al</AU>
<TI>Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study</TI>
<SO>BMJ</SO>
<YR>2008</YR>
<VL>336</VL>
<NO>7644</NO>
<PG>601-5</PG>
<EN>2008/03/05</EN>
<MD>Research Support, Non-U.S. Gov't</MD>
<IDENTIFIERS MODIFIED="2012-09-11 13:37:23 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Woolf-1999" MODIFIED="2012-09-11 13:37:36 -0400" MODIFIED_BY="[Empty name]" NAME="Woolf 1999" NOTES="&lt;p&gt;Woolf, S H&lt;br&gt;Grol, R&lt;br&gt;Hutchinson, A&lt;br&gt;Eccles, M&lt;br&gt;Grimshaw, J&lt;br&gt;ENGLAND&lt;br&gt;Clinical research ed.&lt;br&gt;BMJ. 1999 Feb 20;318(7182):527-30.&lt;/p&gt;" NOTES_MODIFIED="2012-09-11 13:37:36 -0400" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J</AU>
<TI>Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines</TI>
<SO>BMJ</SO>
<YR>1999</YR>
<VL>318</VL>
<NO>7182</NO>
<PG>527-30</PG>
<EN>1999/02/19</EN>
<IDENTIFIERS MODIFIED="2012-09-11 13:37:36 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2012-09-12 17:03:37 -0400" MODIFIED_BY="Alain Mayhew">
<REFERENCE ID="REF-Farmer-2008" MODIFIED="2012-09-12 17:03:37 -0400" MODIFIED_BY="Alain Mayhew" NAME="Farmer 2008" NOTES="&lt;p&gt;Farmer, Anna P&lt;br&gt;Legare, France&lt;br&gt;Turcot, Lucile&lt;br&gt;Grimshaw, Jeremy&lt;br&gt;Harvey, Emma&lt;br&gt;McGowan, Jessie L&lt;br&gt;Wolf, Fredric&lt;br&gt;Review&lt;br&gt;England&lt;br&gt;Cochrane database of systematic reviews (Online)&lt;br&gt;Cochrane Database Syst Rev. 2008 Jul 16;(3):CD004398.&lt;/p&gt;" NOTES_MODIFIED="2012-09-12 17:03:37 -0400" NOTES_MODIFIED_BY="Alain Mayhew" TYPE="OTHER">
<AU>Farmer AP, Legare F, Turcot L, Grimshaw J, Harvey E, McGowan JL, et al</AU>
<TI>Printed educational materials: effects on professional practice and health care outcomes</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2008</YR>
<NO>3</NO>
<PG>CD004398</PG>
<IDENTIFIERS/>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES MODIFIED="2012-06-28 11:43:34 -0400" MODIFIED_BY="[Empty name]"/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2015-03-09 12:24:40 -0400" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2015-03-09 12:24:40 -0400" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2012-09-10 10:48:58 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Austin-2003">
<CHAR_METHODS MODIFIED="2012-09-09 10:33:32 -0400" MODIFIED_BY="[Empty name]">
<P>Study design: ITS</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-10 10:04:09 -0400" MODIFIED_BY="[Empty name]">
<P>Physicians</P>
<P>Clinical speciality: not clear</P>
<P>Level of training: fully trained</P>
<P>Setting/country: not clear/Canada</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-10 10:48:29 -0400" MODIFIED_BY="[Empty name]">
<P>2 PEMs were studied, but only 1 respected our inclusion criteria for ITS studies that more than 3 points need to be available before and after the intervention, and that PEM was the HERS. The HERS study was published in 1998 and demonstrated that the risks associated with hormone therapy outweighed the benefits for women taking continuous oestrogen and progestin regimens</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-10 10:48:27 -0400" MODIFIED_BY="[Empty name]">
<P>2 process outcomes (prescribing):</P>
<OL>
<LI>the proportion women older than 65 years who filled a prescription for ERT in Ontario (prevalence of use of ERT)</LI>
<LI>the number of prescriptions filled by women who had not filled a prescription for ERT in the previous 365 days (proportion of incident users of ERT)</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-09-10 10:48:58 -0400" MODIFIED_BY="Anne Lawson">
<P>-</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-09-10 10:49:11 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Austin-2004A">
<CHAR_METHODS MODIFIED="2012-09-10 10:04:55 -0400" MODIFIED_BY="[Empty name]">
<P>Study design: ITS</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-10 10:04:55 -0400" MODIFIED_BY="[Empty name]">
<P>Physicians;</P>
<P>Clinical specialty: Not clear;</P>
<P>Level of training: Fully trained;</P>
<P>Setting/Country: Not clear/Canada</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-10 10:04:55 -0400" MODIFIED_BY="[Empty name]">
<P>The PEM was the Women&#8217;s Health Initiative (WHI) trial, published on July 17, 2002, which concluded that overall health risks exceeded benefits from use of combined estrogen plus progestin among healthy postmenopausal women.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-10 10:49:11 -0400" MODIFIED_BY="[Empty name]">
<P>2 process outcomes (prescribing):</P>
<OL>
<LI>the total number of claims for clonidine in Ontario for person of 65 years of age and older (use of clonidine for women) and the</LI>
<LI>total number of claims for clonidine in Ontario for person of 65 years of age and older (use of clonidine for men).</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-09-10 10:49:08 -0400" MODIFIED_BY="[Empty name]">
<P>-</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-09-10 10:49:32 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Austin-2004B">
<CHAR_METHODS MODIFIED="2012-09-09 10:34:06 -0400" MODIFIED_BY="[Empty name]">
<P>Study design: ITS</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-10 10:05:31 -0400" MODIFIED_BY="[Empty name]">
<P>Physicians</P>
<P>Clinical speciality: not clear</P>
<P>Level of training: fully trained</P>
<P>Setting/country: not clear/Canada</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-10 10:05:31 -0400" MODIFIED_BY="[Empty name]">
<P>The PEM was the ALLHAT, published on 18 December 2002, which concluded that thiazide-type diuretics should be the first-step antihypertensive therapy, compared with either calcium channel blockers or ACE inhibitors</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-10 10:48:25 -0400" MODIFIED_BY="[Empty name]">
<P>4 process outcomes (prescribing):</P>
<OL>
<LI>relative market share of ACE inhibitors/angiotensin receptor blockers</LI>
<LI>relative market share of &#946;-blockers</LI>
<LI>relative market share of diuretics</LI>
<LI>relative market share of calcium channel blockers (each outcome as percentage of market share before and after publication of ALLHAT)</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-09-10 10:49:32 -0400" MODIFIED_BY="Anne Lawson">
<P>-</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-09-10 10:48:24 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Austin-2005">
<CHAR_METHODS MODIFIED="2012-09-09 10:34:27 -0400" MODIFIED_BY="[Empty name]">
<P>Study design: ITS</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-10 10:20:01 -0400" MODIFIED_BY="[Empty name]">
<P>Physicians</P>
<P>Clinical speciality: not clear</P>
<P>Level of training: fully trained</P>
<P>Setting/country: not clear/Canada</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-10 10:20:01 -0400" MODIFIED_BY="[Empty name]">
<P>2 PEMs are studied in this report: the REVERSAL trial, published on 3 March 2004, which demonstrated that for patients with CHD, intensive lipid-lowering therapy reduced progression of coronary atherosclerosis compared with moderate therapy. 1 month later, the PROVE IT&#8211;TIMI22 trial (published on 8 April 2004) demonstrated that among patients who have recently had an ACS, an intensive lipid-lowering statin regimen provided greater protection against death or major cardiovascular events than did a standard regimen. In both trials, standard therapy consisted of 40 mg/day of pravastatin, whereas intensive therapy consisted of 80 mg/day of atorvastatin. We compared the data before the 2 publications to the data after the 2 publications</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-10 10:20:01 -0400" MODIFIED_BY="[Empty name]">
<P>2 process outcomes (prescribing):</P>
<OL>
<LI>total number of prescriptions of atorvastatin 80 mg/day for residents age 65 years and older in Ontario, Canada</LI>
<LI>total number of prescriptions of pravastatin 40 mg/day for residents age 65 years and older in Ontario, Canada</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-09-10 10:48:24 -0400" MODIFIED_BY="[Empty name]">
<P>We looked at the combined effect of the 2 PEMs because of a lack of data to look at them separately. In this case, the 2 PEMs studied had similar characteristics, and we considered them as a whole (i.e. 1 PEM)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-09-10 10:56:49 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Avorn-1983">
<CHAR_METHODS MODIFIED="2012-09-10 10:50:26 -0400" MODIFIED_BY="[Empty name]">
<P>Study design: RCT </P>
<P>Unit of allocation: physicians</P>
<P>Stratification by:  geographic location</P>
<P>Type of comparison: PEM only vs. nothing:</P>
<UL>
<LI>group A: no information</LI>
<LI>group B: mailed print material</LI>
<LI>group C: face-to-face group</LI>
</UL>
<P>Groups considered in review: A and B</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-10 10:50:26 -0400" MODIFIED_BY="[Empty name]">
<P>Physicians</P>
<P>Clinical speciality: not clear</P>
<P>Level of training: fully trained</P>
<P>Setting/country: not clear/US</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-10 10:50:26 -0400" MODIFIED_BY="[Empty name]">
<P>All members of the "print-only" group received a letter announcing a pilot drug-information programme.  Half of this group then received a mailed copy of a PEM patterned after the Federal Drug Administration Drug Bulletin ("bulletin" - 3 issues, mailed twice each) describing alternatives to targeted drugs. The other half of the "print-only" group received these bulletins as well as 6 PEM ("unadvertisement") printed in colour, with illustrations and references</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-10 10:56:49 -0400" MODIFIED_BY="[Empty name]">
<P>1 process outcome: mean number of units prescribed / physician (all 3 drugs)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-09-10 10:50:25 -0400" MODIFIED_BY="[Empty name]">
<P>-</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-09-10 10:50:41 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Azocar-2003">
<CHAR_METHODS MODIFIED="2012-09-10 10:50:41 -0400" MODIFIED_BY="[Empty name]">
<P>Study design: RCT</P>
<P>Unit of allocation: physicians</P>
<P>Type of comparison: PEM only vs. nothing</P>
<UL>
<LI>group A: no dissemination</LI>
<LI>group B: target dissemination</LI>
<LI>group C: general dissemination</LI>
</UL>
<P>Groups considered in review: A and B</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-10 10:50:41 -0400" MODIFIED_BY="[Empty name]">
<P>Psychologists, psychiatrists, Master's-level therapists</P>
<P>Clinical speciality: psychiatry and psychology</P>
<P>Level of training: fully trained</P>
<P>Setting/country: not clear/US</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-10 10:50:41 -0400" MODIFIED_BY="[Empty name]">
<P>The PEM consisted of the UBH best practice guidelines for the treatment of major depression compiled from guidelines from both the American Psychiatric Association and the Agency for Health Care Policy and Research as well as current research. The UBH guidelines consist of a 1-page quick reference and an 8-page reference booklet and recommend basic steps in the assessment and treatment of major depression. The PEM was mailed to the intervention group of providers (n = 132), specifically targeting a patient recently referred with a diagnosis of major depression</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-10 10:50:41 -0400" MODIFIED_BY="[Empty name]">
<P>4 process outcomes:</P>
<OL>
<LI>guideline adherence (number of medication and psychotherapy sessions in outpatient care)</LI>
<LI>guideline adherence (continuation of treatment, i.e. more than 180 days of treatment)</LI>
<LI>guideline adherence (documentation of a mental health or substance abuse comorbidity)</LI>
<LI>guideline adherence (documentation of medical condition inducing depression)</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-09-10 10:50:41 -0400" MODIFIED_BY="[Empty name]">
<P>-<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-09-10 10:20:10 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Barbaglia-2009">
<CHAR_METHODS MODIFIED="2012-09-09 10:35:25 -0400" MODIFIED_BY="[Empty name]">
<P>Study design: ITS</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-10 10:20:10 -0400" MODIFIED_BY="[Empty name]">
<P>Physicians</P>
<P>Clinical speciality: not clear</P>
<P>Level of training: fully trained</P>
<P>Setting/country: outpatient (e.g. ambulatory care provided by hospitals/specialists)/Spain</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-10 10:20:10 -0400" MODIFIED_BY="[Empty name]">
<P>The PEM was the WHI trial, published on 17 July 2002, which concluded that overall health risks exceeded benefits from use of combined oestrogen plus progestin among healthy postmenopausal women</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-10 10:20:10 -0400" MODIFIED_BY="[Empty name]">
<P>4 process outcomes:</P>
<OL>
<LI>prevalence of HRT use in women aged 50 to 54 years (%)</LI>
<LI>prevalence HRT use in women aged 55 to 59 years (%)</LI>
<LI>prevalence HRT use in women aged 60 to 64 years (%)</LI>
<LI>prevalence HRT use in women aged 65 to 69 years (%)</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-09-10 10:20:10 -0400" MODIFIED_BY="Anne Lawson">
<P>-</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-09-10 10:21:51 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bearcroft-1994">
<CHAR_METHODS MODIFIED="2012-09-10 10:21:51 -0400" MODIFIED_BY="[Empty name]">
<P>Study design: C-RCT</P>
<P>Unit of allocation: GP practices</P>
<P>Type of comparison: PEM only vs. nothing</P>
<UL>
<LI>group A: no mailing</LI>
<LI>group B: mailing of guidelines + background information</LI>
</UL>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-10 10:21:51 -0400" MODIFIED_BY="[Empty name]">
<P>Physicians</P>
<P>Clinical speciality: general practice/family medicine</P>
<P>Level of training: fully trained</P>
<P>Setting/country: general practice/UK</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-10 10:21:51 -0400" MODIFIED_BY="[Empty name]">
<P>The PEM consisted of a mailed package including: guidelines for referrals for chest radiography that were advisory only and relevant background information.  Guidelines for referrals for chest radiography were developed after a previous study involving the prospective analysis of 2017 consecutive chest radiograph referrals. The presenting indications were compared with the subsequent radiological findings and those indications with a particularly low yield were identified. These guidelines, therefore, were specifically relevant to local practice and they highlighted those groups of patients in whom, based on the previous study, significant abnormalities were uncommon. They were advisory only and included a general reminder that a good clinical history, together with a presumptive diagnosis, would allow a more helpful, accurate and patient-specific report</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-10 10:21:51 -0400" MODIFIED_BY="[Empty name]">
<P>4 process outcomes:</P>
<OL>
<LI>x-ray requests not meeting guideline requirements</LI>
<LI>x-ray requests with inadequate patient history</LI>
<LI>recorded clinical diagnosis</LI>
<LI>reported smoking history</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-09-10 10:21:51 -0400" MODIFIED_BY="[Empty name]">
<P>-<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-09-10 10:21:50 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Beaulieu-2004">
<CHAR_METHODS MODIFIED="2012-09-10 10:21:50 -0400" MODIFIED_BY="[Empty name]">
<P>Study design: RCT</P>
<P>Unit of allocation: physicians</P>
<P>Type of comparison: PEM only vs. nothing</P>
<UL>
<LI>group A: control</LI>
<LI>group B: guideline</LI>
<LI>group C: guideline + recall</LI>
</UL>
<P>Groups considered in review: A and B</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-10 10:21:50 -0400" MODIFIED_BY="[Empty name]">
<P>Physicians</P>
<P>Clinical speciality: general practice/family medicine, internal medicine, cardiology</P>
<P>Level of training: fully trained</P>
<P>Setting/country: mixed/Canada</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-10 10:21:50 -0400" MODIFIED_BY="[Empty name]">
<P>The PEM consisted of a 1-page summary (developed by the College des Medecins du Quebec) of existing provincial guidelines for anti-anginal therapy. This summary incorporated 3 key messages targeting the most problematic prescribing practices identified in our earlier cross-sectional study, namely low prescribing rates for antiplatelet and hypolipaemic drugs and for &#946;-blockers in patients without apparent major contraindications. The key recommendations in the summary were: (i) to write a prescription for acetylsalicylic acid (aspirin) for patients with stable angina; (ii) to control serum cholesterol, with a target value for LDL cholesterol &lt; 2.6 mmol/L; and (iii) to favour &#946;-blockers as the first choice for anti-angina medication. Data on prescribing rates for the 3 targeted medication classes by physicians practicing in the same regions as the participating physicians were also included in the 1-page summary</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-10 10:21:50 -0400" MODIFIED_BY="[Empty name]">
<P>2 process outcomes:</P>
<OL>
<LI>prescription for &#946;-blockers</LI>
<LI>prescription for antiplatelets</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-09-10 10:21:50 -0400" MODIFIED_BY="Anne Lawson">
<P>-</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-09-10 10:21:49 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bjornson-1990">
<CHAR_METHODS MODIFIED="2012-09-10 10:21:49 -0400" MODIFIED_BY="[Empty name]">
<P>Study design: RCT</P>
<P>Unit of allocation: physicians</P>
<P>Type of comparison: PEM only vs. nothing</P>
<UL>
<LI>group A: no mailing</LI>
<LI>group B: mailing of an information packet: NEJM + questionnaire + patient drug history profile</LI>
</UL>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-10 10:21:49 -0400" MODIFIED_BY="[Empty name]">
<P>Physicians</P>
<P>Clinical speciality: general practice/family medicine, internal medicine, cardiology</P>
<P>Level of training: fully trained</P>
<P>Setting/country: mixed/US</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-10 10:21:49 -0400" MODIFIED_BY="[Empty name]">
<P>The PEM consisted of a mailed package that contained (1) a covering letter and questionnaire from the Drug-Use Review coordinator, (2) the <I>New England Journal of Medicine</I> article (12 June 1976), which showed that patients who had the vasodilators hydralazine hydrochloride and isosorbide dinitrate added to their drug therapy had a lower mortality than those who had digoxin and diuretics; and (3) a drug history profile of a congestive heart failure patient based on a computer match of heart failure and the less effective therapy described in the VA study. The primary objective was to evaluate the Drug-Use Review programme as an agent of change in physician prescribing practices after results of an RCT were published</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-10 10:21:49 -0400" MODIFIED_BY="[Empty name]">
<P>2 process outcomes:</P>
<OL>
<LI>complete change of therapy (switch of therapy to hydralazine and isosorbide)</LI>
<LI>partial change of therapy (switch of therapy to at least 1 of hydralazine or isosorbide or discontinued prazosin)</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-09-10 10:21:49 -0400" MODIFIED_BY="Anne Lawson">
<P>-</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-09-10 10:57:44 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Black-2002">
<CHAR_METHODS MODIFIED="2012-09-09 10:38:06 -0400" MODIFIED_BY="[Empty name]">
<P>Study design: ITS</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-10 10:21:48 -0400" MODIFIED_BY="[Empty name]">
<P>Not clear</P>
<P>Clinical speciality: not clear</P>
<P>Level of training: fully trained</P>
<P>Setting/country: not clear/UK</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-10 10:21:48 -0400" MODIFIED_BY="[Empty name]">
<P>The PEM consisted of an NHS Effective Health Care bulletin (November 1992) on the treatment of glue ear in children (EHC-OM bulletin). The bulletin reviewed the research evidence available at the time and recognised the benefits of surgery for children with severe glue ear (otitis media with effusion), but cautioned against overuse of surgery in children with milder forms of the condition that might resolve without any intervention. The stated primary aim of this paper was to ascertain whether or not the passive dissemination of national guidelines to typical service providers (district general hospitals as well as teaching hospitals) had any impact on clinical practice</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-10 10:57:41 -0400" MODIFIED_BY="[Empty name]">
<P>1 process outcome: surgery rate for glue ear (mean number of surgery per 10,000 children aged under 10 years for 13 health districts)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-09-10 10:57:44 -0400" MODIFIED_BY="[Empty name]">
<P>-</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-09-10 10:57:58 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Buyle-2010">
<CHAR_METHODS MODIFIED="2012-09-09 10:38:19 -0400" MODIFIED_BY="[Empty name]">
<P>Study design: ITS</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-10 10:21:48 -0400" MODIFIED_BY="[Empty name]">
<P>Physicians</P>
<P>Clinical speciality: not clear</P>
<P>Level of training: fully trained</P>
<P>Setting/country: hospital/inpatient/Belgium</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-10 10:21:48 -0400" MODIFIED_BY="[Empty name]">
<P>The PEM consisted of guidelines for sequential antibiotic therapy (IV to PO with fluoroquinolones) published and disseminated in the local drug letter (October 2003), the official letter of the Pharmacotherapeutic Committee. This intervention was oriented towards all physicians (approximately 650) in the hospital</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-10 10:57:55 -0400" MODIFIED_BY="[Empty name]">
<P>1 process outcome: usage of IV versus total fluoroquinolone</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-09-10 10:57:58 -0400" MODIFIED_BY="Alain Mayhew">
<P>-</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-09-10 10:58:12 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Coopersmith-2002">
<CHAR_METHODS MODIFIED="2012-09-09 10:38:32 -0400" MODIFIED_BY="[Empty name]">
<P>Study design: ITS</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-10 10:21:47 -0400" MODIFIED_BY="[Empty name]">
<P>Physicians, nurses, critical care fellows</P>
<P>Clinical speciality: not clear</P>
<P>Level of training: fully trained</P>
<P>Setting/country: hospital/inpatient/US</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-10 10:21:47 -0400" MODIFIED_BY="[Empty name]">
<P>The PEM consisted of a 10-page self-study module on risk factors and practice modifications involved in catheter-related infections. The intervention was primarily targeted at registered nurses and provided actions to address specific risk factors. The stated purpose of the study was to determine whether an education initiative aimed at improving central venous catheter insertion and care could decrease the rate of primary bloodstream infections</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-10 10:58:12 -0400" MODIFIED_BY="[Empty name]">
<P>1 process outcome: monthly rate per 1000 central venous catheter days of catheter-related bloodstream infections</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-09-10 10:21:47 -0400" MODIFIED_BY="Anne Lawson">
<P>-</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-09-10 10:21:47 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Denig-1990">
<CHAR_METHODS MODIFIED="2012-09-10 10:21:47 -0400" MODIFIED_BY="[Empty name]">
<P>Study design: RCT</P>
<P>Unit of allocation: physicians</P>
<P>Stratification by: village or town</P>
<P>Type of comparison: PEM only vs. nothing</P>
<UL>
<LI>group A: bulletin as usual</LI>
<LI>group B: bulletin as usual plus 1 extra bulletin on antispasmodics</LI>
</UL>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-10 10:21:47 -0400" MODIFIED_BY="[Empty name]">
<P>Physicians</P>
<P>Clinical speciality: general practice/family medicine</P>
<P>Level of training: fully trained</P>
<P>Setting/country: general practice/The Netherlands</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-10 10:21:46 -0400" MODIFIED_BY="[Empty name]">
<P>The PEM consisted of a 'bulletin' that looked like a regular issue of the monthly <I>Geneesmiddelenbulletin</I> distributed by the Dutch government to all physicians and pharmacists. The bulletin used for the evaluation concerned the use of antispasmodic drugs for 2 kinds of spasms commonly seen in general practice, IBS and renal colic. The bulletin advised against (a) fixed combinations of antispasmodics with chlordiazepoxide, (b) PO/rectal butylscopolamine, and (c) fixed combinations of antispasmodics with metamizole. Recommended for renal colic were (d) diclofenac preparations. The objective was to evaluate the effects of a direct mailed drug bulletin on drug choice and prescribing practice in physicians</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-10 10:21:46 -0400" MODIFIED_BY="[Empty name]">
<P>2 process outcomes: </P>
<OL>
<LI>prescription - undesirable antispasmodics (IBS)</LI>
<LI>antispasmodic prescription - all antispasmodics (IBS)</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-09-10 10:21:46 -0400" MODIFIED_BY="Anne Lawson">
<P>-</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-09-10 10:21:46 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dormuth-2004">
<CHAR_METHODS MODIFIED="2012-09-10 10:21:46 -0400" MODIFIED_BY="[Empty name]">
<P>Study design: C-RCT</P>
<P>Unit of allocation: health areas</P>
<P>Stratification by: number of physicians per area</P>
<P>Type of comparison: PEM only vs. nothing</P>
<UL>
<LI>group A: control: delayed intervention</LI>
<LI>group B: mailing of therapeutic letters</LI>
</UL>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-10 10:21:46 -0400" MODIFIED_BY="[Empty name]">
<P>Physicians</P>
<P>Clinical speciality: general practice/family medicine</P>
<P>Level of training: fully trained</P>
<P>Setting/country: not clear/Canada</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-10 10:21:46 -0400" MODIFIED_BY="[Empty name]">
<P>The PEM consisted of 12 issues of the '<I>Therapeutics Letter</I>' distributed between October 1994 and December 1997. Therapeutics Letter was a 2- to 4-page colour-printed bulletin mailed to most practicing physicians in British Columbia. <I>Therapeutics Letter</I> is a publication issued by the Therapeutics Initiative of the University of British Columbia. The letters included were those that had a clear message which could be predicted to result in a change to prescribing behaviour</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-10 10:21:46 -0400" MODIFIED_BY="[Empty name]">
<P>12 process outcomes:<BR/>
</P>
<OL>
<LI>proportion of newly treated patients receiving the analysis drug (cimetidine)</LI>
<LI>proportion of newly treated patients receiving the analysis drug (metronidazole/amoxicillin or tetracycline)</LI>
<LI>proportion of newly treated patients receiving the analysis drug  (ASA/ibuprofen/naproxen)</LI>
<LI>proportion of newly treated patients receiving the analysis drug (isosorbide dinitrate)</LI>
<LI>proportion of newly treated patients receiving the analysis drug (thiazide diuretics)</LI>
<LI>proportion of newly treated patients receiving the analysis drug (inhaled corticosteroids)</LI>
<LI>proportion of newly treated patients receiving the analysis drug (calcium-channel blockers)</LI>
<LI>proportion of newly treated patients receiving the analysis drug (long-acting benzodiazepines)</LI>
<LI>proportion of newly treated patients receiving the analysis drug (hormones)</LI>
<LI>proportion of newly treated patients receiving the analysis drug (calcium-channel blockers)</LI>
<LI>proportion of newly treated patients receiving the analysis drug (clonazepam/alprazolam/diazepam)</LI>
<LI>proportion of newly treated patients receiving the analysis drug (finasteride)</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-09-10 10:21:45 -0400" MODIFIED_BY="[Empty name]">
<P>ES not computable<BR/>No intervention: increase of 10% in the number of patients with prescriptions<BR/>PEM: decrease of 15% in the number of patients with prescriptions</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-09-10 10:58:39 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fijn-2000">
<CHAR_METHODS MODIFIED="2012-09-09 10:42:57 -0400" MODIFIED_BY="[Empty name]">
<P>Study design: ITS</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-10 10:21:45 -0400" MODIFIED_BY="[Empty name]">
<P>Physicians</P>
<P>Clinical speciality: general practice/family medicine</P>
<P>Level of training: fully trained</P>
<P>Setting/country: not clear/The Netherlands</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-10 10:21:45 -0400" MODIFIED_BY="[Empty name]">
<P>The PEM consisted of revised independent Dutch national recommendations on antithrombotic prophylaxis of IHD were introduced in 1996. 2 peer-reviewed clinical practice guidelines were issued: 1 by the Dutch Institute for Healthcare Improvement, a national scientific authority representing hospital specialists, and 1 by the Dutch Scientific Society of General Practitioners. At the same time, identical recommendations were presented by the Dutch Drug Bulletin Institute and the Health Insurance Fund Council. All of these recommend additional prophylactic antithrombotic therapy, preferably thrombocyte aggregation inhibitors, to existing rescue or maintenance therapy, or both, for acute and chronic IHD</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-10 10:58:37 -0400" MODIFIED_BY="[Empty name]">
<P>1 process outcome: number of patient who were prescribed antithrombotic therapy after having a diagnosis of IHD</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-09-10 10:58:39 -0400" MODIFIED_BY="Alain Mayhew">
<P>-</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-09-10 10:21:44 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fonarow-2009">
<CHAR_METHODS MODIFIED="2012-09-09 10:43:17 -0400" MODIFIED_BY="[Empty name]">
<P>Study design: ITS</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-10 10:21:44 -0400" MODIFIED_BY="[Empty name]">
<P>Physicians</P>
<P>Clinical speciality: not clear</P>
<P>Level of training: fully trained</P>
<P>Setting/country: hospital/inpatient/US</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-10 10:21:44 -0400" MODIFIED_BY="[Empty name]">
<P>The 4 PEMs were 2 published studies and 2 guidelines: 1. 4 April 2001, publication that statins produce early event reduction in ACS (MIRACL); 2. 22 March 2002, AHA/ACC Unstable Angina/Non-STEMI guidelines recommending lipid-lowering therapy before discharge in UA/non-STEMI patients (ACC-AHA-NS); 3. 8 March 2004, publication that high-dose statins superior in ACS to standard-dose statins (PROVE IT-TIMI 22); and 4. 4 August 2004, AHA/ACC STEMI guidelines recommending lipid-lowering therapy before discharge in patients with STEMI (ACC-AHA-STEMI)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-10 10:21:44 -0400" MODIFIED_BY="[Empty name]">
<P>3 process outcomes:</P>
<OL>
<LI>use of lipid-lowering medications at discharge for all patients</LI>
<LI>initiation of lipid-lowering medication</LI>
<LI>continuation of lipid-lowering medication</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-09-10 10:21:44 -0400" MODIFIED_BY="Anne Lawson">
<P>-</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-09-10 10:21:44 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fukuda-2009">
<CHAR_METHODS MODIFIED="2012-09-09 10:43:46 -0400" MODIFIED_BY="[Empty name]">
<P>Study design: ITS</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-10 10:21:44 -0400" MODIFIED_BY="[Empty name]">
<P>Physicians</P>
<P>Clinical speciality: surgery</P>
<P>Level of training: fully trained</P>
<P>Setting/country: hospital/inpatient/Japan</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-10 10:21:44 -0400" MODIFIED_BY="[Empty name]">
<P>The PEM consisted of evidence-based clinical practice guidelines for treatment of early-stage breast cancer in Japanese women published in July 1999. The guidelines recommended breast-conserving surgery followed by radiotherapy for the majority of women with Stage I or II breast cancer</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-10 10:21:44 -0400" MODIFIED_BY="[Empty name]">
<P>1 process outcome:</P>
<OL>
<LI>rate of use of breast-conserving surgery (adjusted odds ratios of receiving breast-conserving surgery in patients with breast cancer)</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-09-10 10:21:44 -0400" MODIFIED_BY="Anne Lawson">
<P>-</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-09-10 10:59:28 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Guay-2007">
<CHAR_METHODS MODIFIED="2012-09-09 10:43:59 -0400" MODIFIED_BY="[Empty name]">
<P>Study design: ITS</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-10 10:21:43 -0400" MODIFIED_BY="[Empty name]">
<P>Physicians</P>
<P>Clinical speciality: not clear</P>
<P>Level of training: fully trained</P>
<P>Setting/country: outpatient (e.g., ambulatory care provided by hospitals/specialists)/Canada</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-10 10:21:43 -0400" MODIFIED_BY="[Empty name]">
<P>The PEM was the WHI trial, published on 17 July 2002, which concluded that overall health risks exceeded benefits from use of combined oestrogen plus progestin among healthy postmenopausal women</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-10 10:59:28 -0400" MODIFIED_BY="[Empty name]">
<P>1 process outcome: total number of HRT prescriptions dispensed per month</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-09-10 10:21:43 -0400" MODIFIED_BY="Anne Lawson">
<P>-</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-09-10 10:21:42 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Haas-2004">
<CHAR_METHODS MODIFIED="2012-09-09 10:44:12 -0400" MODIFIED_BY="[Empty name]">
<P>Study design: ITS</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-10 10:21:42 -0400" MODIFIED_BY="[Empty name]">
<P>Physicians</P>
<P>Clinical speciality: not clear</P>
<P>Level of training: fully trained</P>
<P>Setting/country: outpatient (e.g. ambulatory care provided by hospitals/specialists)/US</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-10 10:21:42 -0400" MODIFIED_BY="[Empty name]">
<P>2 PEMs are studied in this report: 1. The HERS published in 1998 and 2. The WHI, published on 17 July 2002. These clinical trials demonstrated that the risks associated with hormone therapy outweighed the benefits for women taking continuous oestrogen and progestin regimens</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-10 10:21:42 -0400" MODIFIED_BY="[Empty name]">
<P>2 process outcomes:</P>
<OL>
<LI>use of hormone therapy among postmenopausal women (before and after the publication of HERS)</LI>
<LI>use of hormone therapy among postmenopausal women (before and after the publication of WHI)</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-09-10 10:21:42 -0400" MODIFIED_BY="Anne Lawson">
<P>-</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-09-10 10:59:45 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hersh-2004">
<CHAR_METHODS MODIFIED="2012-09-09 10:44:27 -0400" MODIFIED_BY="[Empty name]">
<P>Study design: ITS</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-10 10:21:42 -0400" MODIFIED_BY="[Empty name]">
<P>Physicians</P>
<P>Clinical speciality: not clear</P>
<P>Level of training: fully trained</P>
<P>Setting/country: not clear/US</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-10 10:21:42 -0400" MODIFIED_BY="[Empty name]">
<P>3 PEMs were studied in this report: 1. The HERS (August 1998), 2. HERS follow-up (HERS II - July 2002), and 3. The WHI (17 July 2002). HERS and HERS II concluded that postmenopausal hormone therapy with combination PO oestrogen/progestin offered no cardiovascular disease benefit among women with established disease. The oestrogen plus progestin trial of the WHI demonstrated that hormone therapy with an oestrogen/progestin combination caused increased risk of breast cancer and cardiovascular disease in postmenopausal women</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-10 10:59:45 -0400" MODIFIED_BY="[Empty name]">
<P>1 process outcome: total number of prescriptions per year (before and after the publication of HERS - August 1998)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-09-10 10:21:42 -0400" MODIFIED_BY="[Empty name]">
<P>We looked at the combined effect of the 3 PEMs because of a lack of data to look at them separately. In this case, the 2 PEMs studied had similar characteristics, and we considered them as a whole (i.e. 1 PEM)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-09-10 10:59:53 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jackevicius-2001">
<CHAR_METHODS MODIFIED="2012-09-09 10:44:42 -0400" MODIFIED_BY="[Empty name]">
<P>Study design: ITS</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-10 10:21:41 -0400" MODIFIED_BY="[Empty name]">
<P>Physicians</P>
<P>Clinical speciality: internal medicine, cardiology, not specified</P>
<P>Level of training: fully trained</P>
<P>Setting/country: hospital/inpatient/Canada</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-10 10:21:41 -0400" MODIFIED_BY="[Empty name]">
<P>The PEM consisted of the 4S, published in 1994, which demonstrated that lipid lowering with simvastatin resulted in a clear and substantial decrease in total mortality and in fewer CHD events and less cardiovascular mortality when used in patients with CHD (history of angina or myocardial infarction) who also had high LDL-cholesterol levels</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-10 10:59:53 -0400" MODIFIED_BY="[Empty name]">
<P>1 process outcome: prescription for statin (all statins)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-09-10 10:21:41 -0400" MODIFIED_BY="Anne Lawson">
<P>-</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-09-10 11:00:06 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jameson-2010">
<CHAR_METHODS MODIFIED="2012-09-09 10:44:54 -0400" MODIFIED_BY="[Empty name]">
<P>Study design: ITS</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-10 10:21:40 -0400" MODIFIED_BY="[Empty name]">
<P>Surgeons</P>
<P>Clinical speciality: orthopaedic surgery</P>
<P>Level of training: fully trained</P>
<P>Setting/country: hospital/inpatient/UK</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-10 10:21:40 -0400" MODIFIED_BY="[Empty name]">
<P>The PEM consisted of a guideline on prophylaxis against venous thromboembolism produced by NICE in April 2007. The recommendations were that all orthopaedic inpatients be offered an LMWH for the duration of their stay in hospital, while high-risk patients including all patients aged over 60 years should continue treatment for 4 weeks after discharge</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-10 11:00:06 -0400" MODIFIED_BY="[Empty name]">
<P>1 process outcome: use of LMWH following a lower limb arthroplasty</P>
<P>2 patient outcomes:</P>
<OL>
<LI>complications from hip or knee replacement surgeries (venous thromboembolic events)</LI>
<LI>complications from hip or knee replacement surgeries (thrombocytopenia)</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-09-10 10:21:40 -0400" MODIFIED_BY="Anne Lawson">
<P>-</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-09-10 10:21:40 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jousimaa-2002">
<CHAR_METHODS MODIFIED="2012-09-10 10:21:40 -0400" MODIFIED_BY="[Empty name]">
<P>Study design: C-RCT</P>
<P>Unit of allocation: physician</P>
<P>Type of comparison: paper-based PEM vs. CD-Rom PEM</P>
<UL>
<LI>group A: computerised guidelines</LI>
<LI>group B: paper-based guidelines</LI>
</UL>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-10 10:21:40 -0400" MODIFIED_BY="[Empty name]">
<P>Physicians</P>
<P>Clinical speciality: general practice/family medicine</P>
<P>Level of training: newly qualified physicians in their last 2-year training period (during which they work independently and are responsible for their own clinical decisions)</P>
<P>Setting/country: general practice/Finland</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-10 10:21:40 -0400" MODIFIED_BY="[Empty name]">
<P>The PEM studied in this report was the Physician's Desk Reference and Database (now re-named Evidence-Based Medicine Guidelines), a collection of Finnish clinical practice guidelines. The over 1100 guidelines were written by GPs in cooperation with experts from other specialities</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-10 10:21:40 -0400" MODIFIED_BY="[Empty name]">
<P>9 process outcomes:</P>
<OL>
<LI>proportion of consultation decision compliant with guidelines (laboratory examinations)</LI>
<LI>proportion of consultation decision compliant with guidelines (radiological examinations)</LI>
<LI>proportion of consultation decision compliant with guidelines (physical examinations)</LI>
<LI>proportion of consultation decision compliant with guidelines (other examinations)</LI>
<LI>proportion of consultation decision compliant with guidelines (procedures)</LI>
<LI>proportion of consultation decision compliant with guidelines (physiotherapy)</LI>
<LI>proportion of consultation decision compliant with guidelines (non-pharmacological treatments)</LI>
<LI>proportion of consultation decision compliant with guidelines (pharmacological treatment)</LI>
<LI>proportion of consultation decision compliant with guidelines (referrals)</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-09-10 10:21:40 -0400" MODIFIED_BY="Anne Lawson">
<P>-</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-09-10 11:00:20 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Juurlink-2004">
<CHAR_METHODS MODIFIED="2012-09-09 10:45:32 -0400" MODIFIED_BY="[Empty name]">
<P>Study design: ITS</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-10 10:21:39 -0400" MODIFIED_BY="[Empty name]">
<P>Physicians</P>
<P>Clinical speciality: not clear</P>
<P>Level of training: fully trained</P>
<P>Setting/country: mixed/Canada</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-10 10:21:39 -0400" MODIFIED_BY="[Empty name]">
<P>The PEM consisted of the RALES published in September 1999, which demonstrated that treatment with spironolactone substantially reduced morbidity and mortality in patients with severe heart failure</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-10 11:00:20 -0400" MODIFIED_BY="[Empty name]">
<P>1 process outcome: rate of spironolactone prescription for patients with heart failure</P>
<P>2 patient outcomes:</P>
<OL>
<LI>rate of hospital admission for hyperkalaemia for patients with heart failure</LI>
<LI>rate of in-hospital death owing to hyperkalaemia for heart failure patients</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-09-10 10:21:39 -0400" MODIFIED_BY="Anne Lawson">
<P>-</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-09-10 10:21:38 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kabir-2007">
<CHAR_METHODS MODIFIED="2012-09-09 10:46:04 -0400" MODIFIED_BY="[Empty name]">
<P>Study design: ITS</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-10 10:21:38 -0400" MODIFIED_BY="[Empty name]">
<P>Physicians</P>
<P>Clinical speciality: not clear</P>
<P>Level of training: fully trained</P>
<P>Setting/country: not clear/Ireland</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-10 10:21:38 -0400" MODIFIED_BY="[Empty name]">
<P>3 PEMs were studied in this report: 1. the LIFE (2002), 2. the ALLHAT (18 December 2002), and 3. the VALUE (2004). The LIFE study showed that for a similar level of BP reduction losartan reduced events more than atenolol, a &#946;-adrenoceptor blocker. The ALLHAT trial confirmed that thiazides (chlorthalidone) controlled systolic BP as well as, and in elected subgroups better than both ACE inhibitors (lisinopril) and calcium channel blockers (amlodipine). However, the VALUE trial showed that the amlodipine-based regimen significantly reduced BP further than valsartan, especially in the early period. Another feature common to all studies was a demonstration of the need for polypharmacy to achieve BP control</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-10 10:21:38 -0400" MODIFIED_BY="[Empty name]">
<P>7 process outcomes:</P>
<OL>
<LI>prescription for atenolol  (monthly rate of new prescriptions for atenolol before and after LIFE</LI>
<LI>prescription for losartan (monthly rate of new prescriptions for losartan before and after LIFE)</LI>
<LI>prescription for ACE inhibitors (monthly rate of new prescriptions for ACE inhibitors before and after ALLHAT)</LI>
<LI>prescription for amlodopine (monthly rate of new prescriptions for amlodopine before and after ALLHAT)</LI>
<LI>prescription for thiazide-type diuretic (monthly rate of new prescriptions for thiazide-type diuretics  before and after ALLHAT)</LI>
<LI>prescription for valsartan (monthly rate of new prescriptions for valsartan before and after VALUE)</LI>
<LI>prescription for calcium channel blockers (monthly rate of new prescriptions for calcium channel blockers before and after VALUE)</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-09-10 10:21:38 -0400" MODIFIED_BY="Anne Lawson">
<P>-</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-09-10 11:00:41 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kajita-2010">
<CHAR_METHODS MODIFIED="2012-09-10 10:21:38 -0400" MODIFIED_BY="[Empty name]">
<P>Study design: C-RCT</P>
<P>Unit of allocation: municipal health centres</P>
<P>Type of comparison: PEM only vs. nothing</P>
<UL>
<LI>group A: no intervention</LI>
<LI>group B: Mmiled information packet</LI>
</UL>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-10 10:21:38 -0400" MODIFIED_BY="[Empty name]">
<P>Nurses, public health nurses, and allied health professionals in the field of community health</P>
<P>Clinical speciality: community health</P>
<P>Level of training: fully trained</P>
<P>Setting/country: community-based (e.g. community health centre, public health department)/Japan</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-10 10:21:37 -0400" MODIFIED_BY="[Empty name]">
<P>The intervention was the distribution of an evidence-based guideline. The guideline was entitled "Evidence-based guideline for the prevention of osteoporosis and osteoporotic fractures in community health", a purely evidence-based practice guideline written in Japanese for the prevention of osteoporosis published in October 2004. This guideline was developed and formatted in accordance with recommendations for evidence-based guidelines, according to formal assessment procedures specified in the Japanese version of the AGREE instrument</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-10 11:00:41 -0400" MODIFIED_BY="[Empty name]">
<P>46 process outcomes, including implementation rate of evidence-based health education items for osteoporosis prevention (see <LINK REF="TBL-04" TYPE="TABLE">Table 4</LINK> for a complete list)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-09-10 10:21:37 -0400" MODIFIED_BY="Anne Lawson">
<P>-</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-09-10 10:21:37 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kottke-1989">
<CHAR_METHODS MODIFIED="2012-09-10 10:21:37 -0400" MODIFIED_BY="[Empty name]">
<P>Study design: RCT</P>
<P>Unit of allocation: physicians</P>
<P>Type of comparison: PEM only vs. nothing</P>
<UL>
<LI>group A: no intervention</LI>
<LI>group B: reception of educational patient material</LI>
<LI>group C: workshop + patient education materials</LI>
</UL>
<P>Groups considered in review: A and B</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-10 10:21:37 -0400" MODIFIED_BY="[Empty name]">
<P>Physicians</P>
<P>Clinical speciality: general practice/family medicine</P>
<P>Level of training: fully trained</P>
<P>Setting/country: general practice/US</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-10 10:21:37 -0400" MODIFIED_BY="[Empty name]">
<P>The PEM studied in this report was a smoking cessation manual entitled 'Quit-and-Win' that could be used as an instructor's manual, as a self-help guide, or as 1 part of a comprehensive intervention. The physicians were advised to give a copy to any patient who smoked. They were told that their supply of Quit-and-Win booklets would be replenished when required</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-10 10:21:37 -0400" MODIFIED_BY="[Empty name]">
<P>5 process outcomes:</P>
<OL>
<LI>patients have been asked by physician if he/she smokes</LI>
<LI>smoking patients who reported being asked by physician to quit smoking</LI>
<LI>smoking patients who were asked to set a quit date</LI>
<LI>smoking patients who were given a follow up appointment</LI>
<LI>smoking patients who received supportive materials</LI>
</OL>
<P>5 patient outcomes:</P>
<OL>
<LI>PEM only vs. % of patients who reported an attempt to quit smoking (more than 24 hours without smoking)</LI>
<LI>duration of smoking cessation (in days)</LI>
<LI>month of quit attempt</LI>
<LI>% of patients who reported not smoking at the time of interview</LI>
<LI>smoking patients who agreed to quit smoking</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-09-10 10:21:37 -0400" MODIFIED_BY="[Empty name]">
<P>2 separate PEM analysis for all 10 points:</P>
<OL>
<LI>PEM only vs. no intervention</LI>
<LI>PEM only vs. workshop</LI>
</OL>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-09-10 11:01:07 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lam-2009">
<CHAR_METHODS MODIFIED="2012-09-09 10:47:09 -0400" MODIFIED_BY="[Empty name]">
<P>Study design: ITS</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-10 10:21:36 -0400" MODIFIED_BY="[Empty name]">
<P>Physicians</P>
<P>Clinical speciality: not clear</P>
<P>Level of training: fully trained</P>
<P>Setting/country: not clear/Canada</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-10 10:21:36 -0400" MODIFIED_BY="[Empty name]">
<P>The PEM studied in this report was "4D" (published 21 July 2005). The results showed that atorvastatin did not significantly reduce the primary end point of cardiovascular death, non-fatal myocardial infarction, or stroke. In a secondary analysis, there was an unexpected increase in fatal strokes in the atorvastatin group compared with those receiving placebo. The trial investigators concluded that "in persons with type II diabetes mellitus who are receiving maintenance hemodialysis and have low-density lipoprotein cholesterol values between 80 and 190 mg per deciliter (2.07 and 4.92 mmol/l), routine treatment with a statin to reduce the primary end point of death from cardiac causes, myocardial infarction, and stroke is not warranted"</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-10 11:01:07 -0400" MODIFIED_BY="[Empty name]">
<P>1 process outcome: rate of statin use (age and sex standardised rate of statin use per 1000 diabetic haemodialysis patients)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-09-10 10:21:36 -0400" MODIFIED_BY="Anne Lawson">
<P>-</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-09-10 10:21:35 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Majumdar-2003">
<CHAR_METHODS MODIFIED="2012-09-09 10:47:25 -0400" MODIFIED_BY="[Empty name]">
<P>Study design: ITS</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-10 10:21:35 -0400" MODIFIED_BY="[Empty name]">
<P>Physicians</P>
<P>Clinical speciality: not clear</P>
<P>Level of training: fully trained</P>
<P>Setting/country: not clear/US and Canada</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-10 10:21:35 -0400" MODIFIED_BY="[Empty name]">
<P>2 PEMs were studied in this report. The HOPE study demonstrated a 22% reduction in cardiovascular morbidity and mortality, and provided a new indication for ramipril. RALES compared spironolactone with placebo in patients with heart failure and demonstrated a 30% reduction in mortality<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-10 10:21:35 -0400" MODIFIED_BY="[Empty name]">
<P>4 process outcomes:</P>
<OL>
<LI>prescribing patterns of ramipril (in Canada) before and after publication of HOPE</LI>
<LI>prescribing patterns of ramipril (in US) before and after publication of HOPE</LI>
<LI>prescribing patterns of spironolactone (in Canada) before and after publication of RALES</LI>
<LI>prescribing patterns of spironolactone (in US) before and after publication of RALES</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-09-10 10:21:35 -0400" MODIFIED_BY="[Empty name]">
<P>-</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-09-10 10:21:35 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Majumdar-2004">
<CHAR_METHODS MODIFIED="2012-09-09 10:47:44 -0400" MODIFIED_BY="[Empty name]">
<P>Study design: ITS</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-10 10:21:35 -0400" MODIFIED_BY="[Empty name]">
<P>Physicians</P>
<P>Clinical speciality: not clear</P>
<P>Level of training: fully trained</P>
<P>Setting/country: not clear/US</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-10 10:21:34 -0400" MODIFIED_BY="[Empty name]">
<P>The PEM was the WHI trial, published on 17 July 2002, which concluded that overall health risks exceeded benefits from use of combined oestrogen plus progestin among healthy postmenopausal women</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-10 10:21:34 -0400" MODIFIED_BY="[Empty name]">
<P>5 process outcomes:</P>
<OL>
<LI>prescription of HRT</LI>
<LI>prescription for premarin as a postmenopausal HT</LI>
<LI>prescription for prempro as a postmenopausal HT</LI>
<LI>prescription for lower dose premarin and prempro as a postmenopausal HT</LI>
<LI>prescription for all other formulations as a postmenopausal HT</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-09-10 10:21:34 -0400" MODIFIED_BY="[Empty name]">
<P>-</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-09-10 10:21:34 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mason-1998_x002f_99">
<CHAR_METHODS MODIFIED="2012-09-09 10:47:59 -0400" MODIFIED_BY="[Empty name]">
<P>Study design: ITS</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-10 10:21:34 -0400" MODIFIED_BY="[Empty name]">
<P>Physicians</P>
<P>Clinical speciality: general practice/family medicine</P>
<P>Level of training: fully trained</P>
<P>Setting/country: general practice/UK</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-10 10:21:34 -0400" MODIFIED_BY="[Empty name]">
<P>The PEM studied in this report was an "Effective Health Care" bulletin questioning the cost effectiveness of prescribing SSRIs was distributed to all GPs by the chief medical officer. Original distribution of the bulletin to all GPs occurred in March 1993. We examined the effect of this intervention on prescribing in English primary care using time-series analysis</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-10 10:21:34 -0400" MODIFIED_BY="[Empty name]">
<P>2 process outcomes:</P>
<OL>
<LI>prescription of SSRIs</LI>
<LI>prescription of tricyclic antidepressants</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-09-10 10:21:34 -0400" MODIFIED_BY="[Empty name]">
<P>-</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-09-10 11:01:35 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mason-2001">
<CHAR_METHODS MODIFIED="2012-09-09 10:48:15 -0400" MODIFIED_BY="[Empty name]">
<P>Study design: ITS</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-10 10:21:33 -0400" MODIFIED_BY="[Empty name]">
<P>Physicians</P>
<P>Clinical speciality: not clear</P>
<P>Level of training: fully trained</P>
<P>Setting/country: not clear/UK</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-10 10:21:33 -0400" MODIFIED_BY="[Empty name]">
<P>An NHS Effective Health Care bulletin (November 1992) on the treatment of glue ear in children (EHC-OM bulletin) was distributed nationally to NHS decision makers in 1992. Based on systematic review, the bulletin concluded that surgery should be restricted to children with an extended period of substantial hearing impairment, with persistence and severity established by watchful waiting</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-10 11:01:35 -0400" MODIFIED_BY="[Empty name]">
<P>1 process outcome: use of surgery for glue ear (mean number of procedures per 1000 habitants under 15 years old  for 14 regions)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-09-10 10:21:33 -0400" MODIFIED_BY="[Empty name]">
<P>-</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-09-10 11:01:47 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Matowe-2002">
<CHAR_METHODS MODIFIED="2012-09-09 10:48:32 -0400" MODIFIED_BY="[Empty name]">
<P>Study design: ITS</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-10 10:21:33 -0400" MODIFIED_BY="[Empty name]">
<P>Physicians</P>
<P>Clinical speciality: radiology</P>
<P>Level of training: fully trained</P>
<P>Setting/country: general practice/UK</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-10 10:21:33 -0400" MODIFIED_BY="[Empty name]">
<P>To evaluate the effect of postal dissemination of the third edition of the RCR guidelines on GP referral for radiography. The RCR guidelines were introduced to encourage appropriate use of diagnostic radiology and reduce the use of clinically unhelpful examinations. Between 1989 and 1998 4 editions of these guidelines were produced and a large number of copies distributed by mail to primary care. The current edition of the guideline includes 285 individual recommendations</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-10 11:01:47 -0400" MODIFIED_BY="[Empty name]">
<P>1 process outcome: total number of x-ray referrals</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-02-27 08:25:45 -0500" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-03-09 12:24:40 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Meyer-2007">
<CHAR_METHODS MODIFIED="2012-09-09 10:48:49 -0400" MODIFIED_BY="[Empty name]">
<P>Study design: ITS</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-10 10:21:32 -0400" MODIFIED_BY="[Empty name]">
<P>Physicians</P>
<P>Clinical speciality: general practice/family medicine</P>
<P>Level of training: fully trained</P>
<P>Setting/country: outpatient (e.g. ambulatory care provided by hospitals/specialists)/Germany</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-03-09 12:24:40 -0400" MODIFIED_BY="[Empty name]">
<P>Revised guidelines on empirical antibiotic treatment in the ICU: the written guidelines on empirical antibiotic treatment in the ICU were revised in December 2003 upon publication of the study by Chastre et al (<LINK REF="REF-Chastre-2003" TYPE="REFERENCE">Chastre 2003</LINK>). and with respect to the local resistance situation. This change of empirical therapy was performed by a multidisciplinary team consisting of the intensive care specialist responsible for the ward and an infection control physician, and occasionally included also a microbiologist and a pharmacist</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-10 11:01:56 -0400" MODIFIED_BY="[Empty name]">
<P>1 process outcome: antibiotic use density (AD; expressed as defined daily doses per 1000 patient-days)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-09-10 10:21:32 -0400" MODIFIED_BY="Anne Lawson">
<P>-</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-09-10 11:02:05 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Oakeshott-1994">
<CHAR_METHODS MODIFIED="2012-09-10 10:21:32 -0400" MODIFIED_BY="[Empty name]">
<P>Study design: C-RCT</P>
<P>Unit of allocation: practices</P>
<P>Stratification by: number of partners and number of radiographic examinations requested</P>
<P>Type of comparison: PEM only vs. nothing</P>
<UL>
<LI>group A: control</LI>
<LI>group B: guideline + distribution letter </LI>
</UL>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-10 10:21:31 -0400" MODIFIED_BY="[Empty name]">
<P>Physicians</P>
<P>Clinical speciality: general practice/family medicine</P>
<P>Level of training: fully trained (e.g., consultant)</P>
<P>Setting/country: general practice/UK</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-10 10:21:31 -0400" MODIFIED_BY="[Empty name]">
<P>The PEM studied in this report consisted of the guidelines for examinations of the chest, limbs and joints, and spine taken from the RCR guidelines. The RCR guidelines aimed to encourage more appropriate use of diagnostic radiology and so reduce the use of clinically unhelpful x-rays. The guidelines were printed verbatim on 2 sides of a sheet of A4 paper, which was then plasticised</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-10 10:21:31 -0400" MODIFIED_BY="[Empty name]">
<P>3 process outcomes:</P>
<OL>
<LI>relevant positive findings at radiology</LI>
<LI>radiological request forms giving physical findings</LI>
<LI>proportion of radiology requests conforming to the guidelines</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-09-10 11:02:05 -0400" MODIFIED_BY="Alain Mayhew">
<P>-</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-09-10 10:21:31 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Perria-2007">
<CHAR_METHODS MODIFIED="2012-09-10 10:21:31 -0400" MODIFIED_BY="[Empty name]">
<P>Study design: C-RCT</P>
<P>Unit of allocation: GPs</P>
<P>Type of comparison: PEM only vs. nothing</P>
<UL>
<LI>group A: control</LI>
<LI>group B: guideline administration</LI>
<LI>group C: guideline administration + training module</LI>
</UL>
<P>Groups considered in review: A and B</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-10 10:21:31 -0400" MODIFIED_BY="[Empty name]">
<P>Physicians</P>
<P>Clinical speciality: general practice/family medicine</P>
<P>Level of training: fully trained (e.g., consultant)</P>
<P>Setting/country: general practice/Italy</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-10 10:21:31 -0400" MODIFIED_BY="[Empty name]">
<P>The PEM studied in this report was an evidence-based guideline for the management of non-complicated type 2 diabetes mellitus. The source guideline was a French guideline entitled "Stratégie de prise en charge du patient diabétique de type 2 à l'exclusion de la prise en charge des complications" published by ANAES, which was then translated, updated, and adapted for Italian GPs</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-10 10:21:31 -0400" MODIFIED_BY="[Empty name]">
<P>3 process outcomes:</P>
<OL>
<LI>proportion of patients who were prescribed 3 measurements of glycosilated haemoglobin with at least 2 months' interval per year (metabolic control)</LI>
<LI>proportion of patients who were prescribed all macrovascular complications assessment tests per year (macrovascular control)</LI>
<LI>proportion of patients who were prescribed all microvascular complications assessment tests per year (microvascular control)</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-09-10 10:21:31 -0400" MODIFIED_BY="Anne Lawson">
<P>-</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-09-10 10:21:30 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Roberts-2007">
<CHAR_METHODS MODIFIED="2012-09-09 10:49:51 -0400" MODIFIED_BY="[Empty name]">
<P>Study design: ITS</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-10 10:21:30 -0400" MODIFIED_BY="[Empty name]">
<P>Physicians</P>
<P>Clinical speciality: prosthetic care</P>
<P>Level of training: fully trained</P>
<P>Setting/country: outpatient (e.g. ambulatory care provided by hospitals/specialists)/UK</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-10 10:21:30 -0400" MODIFIED_BY="[Empty name]">
<P>The PEM studied in this report was the Technology Appraisal Guidance No. 2 - Guidance on the selection of protheses for primary total hip replacements (April 2000). TAG No. 2 contained a recommendation that cemented protheses be used</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-10 10:21:30 -0400" MODIFIED_BY="[Empty name]">
<P>2 process outcomes:</P>
<OL>
<LI>percentage use of uncemented prostheses</LI>
<LI>percentage use of hybrid prostheses of all hips implanted</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-09-10 10:21:30 -0400" MODIFIED_BY="Anne Lawson">
<P>-</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-09-10 11:02:33 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Santerre-1996">
<CHAR_METHODS MODIFIED="2012-09-09 10:50:34 -0400" MODIFIED_BY="[Empty name]">
<P>Study design: ITS</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-10 10:21:29 -0400" MODIFIED_BY="[Empty name]">
<P>Physicians</P>
<P>Clinical speciality: obstetrics and gynaecology</P>
<P>Level of training: fully trained</P>
<P>Setting/country: not clear/US</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-10 10:21:29 -0400" MODIFIED_BY="[Empty name]">
<P>In October 1988, the ACOG issued a physician practice guideline stating that a prior caesarean section was no longer a reason for performing a repeat section</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-10 11:02:33 -0400" MODIFIED_BY="[Empty name]">
<P>1 process outcome: vaginal birth after previous caesarean section</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-09-10 10:21:29 -0400" MODIFIED_BY="[Empty name]">
<P>-</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-09-10 11:02:46 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Shah-2008">
<CHAR_METHODS MODIFIED="2012-09-09 10:50:48 -0400" MODIFIED_BY="[Empty name]">
<P>Study design: ITS</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-10 10:39:12 -0400" MODIFIED_BY="[Empty name]">
<P>Physicians</P>
<P>Clinical speciality: not clear</P>
<P>Level of training: fully trained</P>
<P>Setting/country: outpatient (e.g. ambulatory care provided by hospitals/specialists)/Canada</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-10 10:39:12 -0400" MODIFIED_BY="[Empty name]">
<P>The PEM studied in this report was the publication "Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes." <I>New England Journal of Medicine</I>, May 21, 2007.  This meta-analysis suggested an increased risk of myocardial infarction associated with rosiglitazone compared with active comparator or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-10 11:02:46 -0400" MODIFIED_BY="[Empty name]">
<P>1 process outcome: number of new users of thiazolidinedione (rosiglitazone or pioglitazone)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-09-10 10:39:12 -0400" MODIFIED_BY="Anne Lawson">
<P>-</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-09-10 11:02:53 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Stafford-2004">
<CHAR_METHODS MODIFIED="2012-09-09 10:51:03 -0400" MODIFIED_BY="[Empty name]">
<P>Study design: ITS</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-10 10:39:11 -0400" MODIFIED_BY="[Empty name]">
<P>Physicians</P>
<P>Clinical speciality: not clear</P>
<P>Level of training: fully trained</P>
<P>Setting/country: outpatient (e.g. ambulatory care provided by hospitals/specialists)/US</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-10 10:39:11 -0400" MODIFIED_BY="[Empty name]">
<P>The PEM studied in this report was the ALLHAT, published on 18 December 2002. In April 2000, the  results that  involved the study's doxazosin mesylate arm led to early termination of this arm owing to results that indicated an increased risk associated with use of the &#945;-blocker doxazosin mesylate compared with diuretics</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-10 11:02:53 -0400" MODIFIED_BY="[Empty name]">
<P>1 process outcome: number of &#945;-blockers prescriptions dispensed (in millions) - all &#945;-blockers, (both newly dispensed and refills)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-09-10 10:39:11 -0400" MODIFIED_BY="Anne Lawson">
<P>-</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-09-10 11:03:30 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tsuji-2009">
<CHAR_METHODS MODIFIED="2012-09-10 10:39:11 -0400" MODIFIED_BY="[Empty name]">
<P>Study design: C-RCT</P>
<P>Unit of allocation: physician</P>
<P>Stratification by: healthcare unit size and geographic location</P>
<P>Type of comparison: PEM only vs. nothing</P>
<UL>
<LI>group A: patient depression diagnosis and severity transmitted to doctor</LI>
<LI>group B: patient depression diagnosis and severity transmitted to doctor + depression-specific guide</LI>
</UL>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-10 10:39:10 -0400" MODIFIED_BY="[Empty name]">
<P>Physicians</P>
<P>Clinical speciality: general practice/family medicine</P>
<P>Level of training: fully trained</P>
<P>Setting/country: general practice/Brazil</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-10 10:39:10 -0400" MODIFIED_BY="[Empty name]">
<P>The PEM studied in this report was a depression-specific guide, adapted from rigorous previously published guidelines, which provided brief and objective educational information regarding the effects of depression on patient daily living, strategies for improving adherence to treatment, and guidelines for the therapeutic management planning using standardised antidepressants in primary care</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-10 11:03:30 -0400" MODIFIED_BY="[Empty name]">
<P>1 process outcome: preccscription of an antidepressant at the first appointment with the clinician</P>
<P>1 patient outcome: clinical remission (proportion of patients with depression severity of less than 8 points on Hamilton Rating Scale for Depression Severity)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-09-10 10:40:00 -0400" MODIFIED_BY="Anne Lawson"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-09-10 10:39:10 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-2005">
<CHAR_METHODS MODIFIED="2012-09-09 10:51:43 -0400" MODIFIED_BY="[Empty name]">
<P>Study design: ITS</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-10 10:39:10 -0400" MODIFIED_BY="[Empty name]">
<P>Physicians</P>
<P>Clinical speciality: general practice/family medicine</P>
<P>Level of training: fully trained</P>
<P>Setting/country: outpatient (e.g. ambulatory care provided by hospitals/specialists)/US</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-10 10:39:10 -0400" MODIFIED_BY="[Empty name]">
<P>2- PEMs were studied in this report. The ADA guidelines published in January 1998 advocated an LDL cholesterol goal under 100 mg/dL for patients with diabetes.  The second PEM was the third report entitled ATP III published by the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (May 2001) that designated diabetes as a CHD risk equivalent, with the same LDL cholesterol goal of under 100 mg/dL</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-10 10:39:10 -0400" MODIFIED_BY="[Empty name]">
<P>2 process outcomes:</P>
<OL>
<LI>LDL cholesterol reporting for diabetes visits relative to CHD visits (per cent of diabetes visits with LDL cholesterol reported) minus (per cent of CHD visits with LDL cholesterol reported)</LI>
<LI>LDL cholesterol control for diabetes visits relative to CHD visits (per cent of LDL cholesterol reported during diabetes visits) minus (per cent of LDL cholesterol reported during CHD visits)</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-09-10 10:39:09 -0400" MODIFIED_BY="[Empty name]">
<P>We looked at the combined effect of the 2 PEMs because of a lack of data to look at them separately. In this case, the 2 PEMs studied were very similar, and we characterised them as a whole (i.e. 1 PEM)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-09-10 10:39:47 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Watson-2001">
<CHAR_METHODS MODIFIED="2012-09-10 10:39:09 -0400" MODIFIED_BY="[Empty name]">
<P>Study design: C-RCT</P>
<P>Unit of allocation: practices</P>
<P>Stratification by: size (number of GPs) and fund holding status</P>
<P>Type of comparison: PEM only vs. nothing</P>
<UL>
<LI>group A: control</LI>
<LI>group B: mailed guidelines</LI>
<LI>group C: mailed guidelines + educational outreach visit</LI>
</UL>
<P>Groups considered in review: A and B</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-10 10:39:09 -0400" MODIFIED_BY="[Empty name]">
<P>Physicians</P>
<P>Clinical speciality: general practice/family medicine</P>
<P>Level of training: fully trained</P>
<P>Setting/country: general practice/UK</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-10 10:39:09 -0400" MODIFIED_BY="[Empty name]">
<P>The PEM studied in this report was a locally developed guideline for the use of PO NSAIDs in the management of musculoskeletal disorders. NSAIDs were selected as the subject of the guidelines because they are associated with high volume and cost prescribing, significant morbidity and mortality, and considerable variation in practice. The guidelines were developed to promote awareness of NSAID prescribing issues and were informed by literature reviews of their relative effectiveness and safety</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-10 10:39:47 -0400" MODIFIED_BY="[Empty name]">
<P>1 process outcome: prescription of 3 recommended NSAIDS relative to total NSAID prescribing (mean in all practices) (%)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-09-10 10:39:42 -0400" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-09-10 10:39:33 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Weiss-2011">
<CHAR_METHODS MODIFIED="2012-09-09 10:52:28 -0400" MODIFIED_BY="[Empty name]">
<P>Study design: ITS</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-10 10:39:08 -0400" MODIFIED_BY="[Empty name]">
<P>Physicians, pharmacists</P>
<P>Clinical speciality: general practice/family medicine</P>
<P>Level of training: guidelines were distributed both to physicians and to residents in training, but prescribing data collected could only be from fully trained physicians</P>
<P>Setting/country: outpatient (e.g. ambulatory care provided by hospitals/specialists)/Canada</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-10 10:39:08 -0400" MODIFIED_BY="[Empty name]">
<P>In 2004, the Quebec Medication Council (Conseil du Medicament du Quebec, Quebec City), with the help of designated physicians and pharmacists, issued a first series of guidelines targeting the most common infectious conditions in the outpatient setting. Eleven 2-page highly graphic guidelines providing clinical information (diagnosis, investigation) and antibiotic recommendations were published and sent to all physicians (including medical residents), and pharmacists in January 2005. Emphasis was placed not only on proper antibiotic regimens but also on not using antibiotics when viral infections were suspected and on prescribing the shortest possible duration of treatment. A letter signed by all key stakeholders in Quebec (Minister of Health, College of Physicians, College of Pharmacists, and Medical associations) accompanied the initial mailing explaining the reasons supporting the process and the importance of prescribing antibiotics appropriately. The main objective of this study was to assess the impact of a multipronged, mostly Web-based education strategy on the per capita number and cost of antibiotic prescriptions in the province of Quebec and to compare the trends with those the other 9 Canadian provinces</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-10 10:39:33 -0400" MODIFIED_BY="[Empty name]">
<P>1 process outcome: monthly prescribing rates (number of prescriptions/1000 inhabitants) for all antibiotics in Quebec relative to the rest of Canada</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-09-10 10:39:26 -0400" MODIFIED_BY="Anne Lawson"/>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>4D: Der Deutsche Diabetes Dialyse Studie; 4S: Scandinavian Simvastatin Survival Study; ACC: American College of Cardiology; ACE: angiotensin-converting enzyme; ACOG: American College of Obstetricians and Gynecologists; ACS: acute coronary syndrome; ADA: American Diabetes Association; AGREE: Appraisal of Guidelines for Research and Evaluation; AHA: American Heart Association; ALLHAT: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial; ANAES: Agence Nationale d'Accréditation et d'Evaluation en Santé; ASA: aspirin; ATP: Adult Treatment Panel; BP: blood pressure; CHD: coronary heart disease; CME: continuing medical education; C-RCT: cluster randomised controlled trial; ERT: oestrogen replacement therapy; ES: effect size; GP: general practitioner; HERS: Heart and Estrogen/progestin Replacement Study; HOPE: Heart Outcomes and Prevention Evaluation; HRT: hormone replacement therapy; HT: hormone therapy; IBS: irritable bowel syndrome; ICU: intensive care unit; IHD: ischaemic heart disease; ITS: interrupted time series; IV: intravenous; LDL: low-density lipoprotein; LIFE: Losartan Intervention for Endpoint; LMWH: low molecular weight heparin; MIRACL: Myocardial Ischemia Reduction with Acute Cholesterol Lowering; NDTI: National Disease and Therapeutic Index; NEJM: New England Journal of Medicine; NHS: National Health Service (UK); NICE: National Institute for Health and Clinical Excellence; NPA: National Prescription Audit Plus; NSAID: non-steroidal anti-inflammatory drug; ODB: Ontario's universal Drug Benefit program; PEM: printed educational material; PO: oral; PROVE IT-TIMI22: Pravastatin or Atorvastatin Evaluation and Infection Therapy&#8211; Thrombolysis In Myocardial Infarction 22; RALES: Randomized Aldactone Evaluation Study; RCR: Royal College of Radiologists; RCT: randomised controlled trial; REVERSAL: Reversal of Atherosclerosis With Aggressive Lipid Lowering; SSRI: selective serotonin reuptake inhibitor; STEMI: ST-elevation myocardial infarction; THR: total hip replacement; TKR: total knee replacement; UBH: United Behavioral Health; VA: Veterans Administration; VALUE: Valsartan Anti-hypertensive Long-term Use Evaluation; VBAC: vaginal births after caesarean; WHI: Women's Health Initiative.</P>
<P>                                  </P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2012-09-10 10:53:25 -0400" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2012-09-10 10:53:01 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bishop-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-09-10 10:53:01 -0400" MODIFIED_BY="[Empty name]">
<P>The comparison studied is not included: multifaceted intervention comprising PEM + reminder vs. usual care</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-09-10 10:53:03 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Croudace--2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-09-10 10:53:03 -0400" MODIFIED_BY="[Empty name]">
<P>The comparison studied is not included: multifaceted intervention comprising PEM + educational meeting vs. usual care</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-09-10 10:53:04 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Emslie-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-09-10 10:53:04 -0400" MODIFIED_BY="[Empty name]">
<P>The comparison studied is not included: PEM + reminder vs. usual care</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-09-10 10:53:05 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Engers-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-09-10 10:53:05 -0400" MODIFIED_BY="[Empty name]">
<P>The comparison studied is not included: multifaceted intervention comprising PEM + workshop vs. no intervention</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-09-10 10:53:05 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Evans-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-09-10 10:53:05 -0400" MODIFIED_BY="[Empty name]">
<P>Outcomes are not objective (knowledge test)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-09-10 10:53:06 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ferrari-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-09-10 10:53:06 -0400" MODIFIED_BY="[Empty name]">
<P>PEM only vs. usual care + information sheet</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-09-10 10:53:08 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fontaine-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-09-10 10:53:08 -0400" MODIFIED_BY="[Empty name]">
<P>The intervention was a reminder</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-09-10 10:53:11 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hazard--1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-09-10 10:53:11 -0400" MODIFIED_BY="[Empty name]">
<P>The comparison studied is not included: multifaceted intervention comprising PEM + patient-mediated reminder vs. usual care</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-09-10 10:53:14 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hunskaar-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-09-10 10:53:14 -0400" MODIFIED_BY="[Empty name]">
<P>Outcomes were not objective</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-09-10 10:53:15 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jackevicius-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-09-10 10:53:15 -0400" MODIFIED_BY="[Empty name]">
<P>Outcomes were not objective</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-09-10 10:53:18 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jain-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-09-10 10:53:18 -0400" MODIFIED_BY="[Empty name]">
<P>The comparison studied was not included (PEM was used as control): PEM as part of a multifaceted intervention vs. PEM</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-04-19 14:47:00 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Janmeja-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-04-19 14:47:00 -0400" MODIFIED_BY="[Empty name]">
<P>The intervention was addressed at patients and not at healthcare professionals</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-09-10 10:53:19 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kocher-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-09-10 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>This study aimed to evaluate the validity of the guideline, and not its effectiveness to change professional practice</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-04-16 13:36:08 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kulkarni-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-04-16 13:36:08 -0400" MODIFIED_BY="[Empty name]">
<P>Study design</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-09-10 10:53:19 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Maiman--1988">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-09-10 10:53:19 -0400" MODIFIED_BY="[Empty name]">
<P>The comparison studied is not included (PEM is used as control): PEM + tutorial vs. PEM</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-09-10 10:53:20 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Majumdar-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-09-10 10:53:20 -0400" MODIFIED_BY="[Empty name]">
<P>The comparison studied was not included: PEM + reminder vs. usual care</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-04-16 13:36:06 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Martino-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-04-16 13:36:06 -0400" MODIFIED_BY="[Empty name]">
<P>Study design</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-09-10 10:53:21 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mettes-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-09-10 10:53:21 -0400" MODIFIED_BY="[Empty name]">
<P>The comparison studied was not included (PEM is used as control): PEM + multifaceted intervention vs. PEM</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-09-10 10:53:22 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mockiene-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-09-10 10:53:22 -0400" MODIFIED_BY="[Empty name]">
<P>The outcome was not objective</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-04-16 13:36:04 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mollon-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-04-16 13:36:04 -0400" MODIFIED_BY="[Empty name]">
<P>Study design</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-04-16 13:36:03 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Morse-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-04-16 13:36:03 -0400" MODIFIED_BY="[Empty name]">
<P>Study design</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-04-16 13:36:00 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ozgun-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-04-16 13:36:00 -0400" MODIFIED_BY="[Empty name]">
<P>Study design</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-04-19 14:47:01 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Perez_x002d_Jauregui-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-04-19 14:47:01 -0400" MODIFIED_BY="[Empty name]">
<P>The intervention is a reminder.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-09-10 10:53:23 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Richardson-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-09-10 10:53:23 -0400" MODIFIED_BY="[Empty name]">
<P>Outcomes were not objective</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-08-13 16:19:19 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Schwartz-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-08-13 16:19:19 -0400" MODIFIED_BY="[Empty name]">
<P>The comparison is not included: PEM + conference vs. usual care</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-09-10 10:53:24 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Simon-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-09-10 10:53:24 -0400" MODIFIED_BY="[Empty name]">
<P>The comparison was not included: PEM + academic detailing vs. no intervention</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-09-10 10:53:24 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Steffensen-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-09-10 10:53:24 -0400" MODIFIED_BY="[Empty name]">
<P>The report of this study did not provide pre-intervention data</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>PEM: printed educational material.</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2012-05-01 10:58:32 -0400" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2012-09-10 10:53:59 -0400" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2012-09-10 10:53:38 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Shah--2010">
<CHAR_STUDY_NAME MODIFIED="2012-02-24 12:36:29 -0500" MODIFIED_BY="[Empty name]">
<P>Evaluation of a toolkit to improve cardiovascular disease screening and treatment for people with type 2 diabetes: protocol for a cluster-randomized pragmatic trial </P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2012-09-10 10:53:31 -0400" MODIFIED_BY="[Empty name]">
<P>Study design: C-RCT</P>
<P>Unit of allocation: practice</P>
<P>Stratification by: health region</P>
<P>Type of comparison:  PEM only vs. nothing</P>
<UL>
<LI>group A: toolkit received in spring 2010</LI>
<LI>group B: toolkit received in Spring 2009</LI>
</UL>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-10 10:53:32 -0400" MODIFIED_BY="[Empty name]">
<P>Physicians</P>
<P>Clinical speciality: general practice/family medicine;</P>
<P>Level of training: not clear</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-10 10:53:35 -0400" MODIFIED_BY="[Empty name]">
<P>The cardiovascular disease toolkit was packaged in a brightly coloured box with CDA branding. The contents included an introductory letter from the Chair of the practice guidelines' Dissemination and Implementation Committee; an 8-page summary of selected sections of the practice guidelines targeted towards primary care physicians; a 4-page synopsis of the key guideline elements pertaining to cardiovascular disease risk; a small double-sided laminated card with a simplified algorithm for cardiovascular risk assessment, vascular protection strategies and screening for cardiovascular disease; and a pad of tear-off sheets for patients with a cardiovascular risk self-assessment tool and a list of recommended risk reduction strategies. In the intervention group, the Toolkit was mailed with the Spring 2009 edition of Canadian Diabetes, a newsletter from the CDA which provides practical information on diagnosis and treatment issues associated with diabetes that is sent quarterly to all primary care physicians in Canada. The content of this edition of the newsletter did not pertain to cardiovascular risk screening or treatment. Both the Toolkit and Canadian Diabetes were packaged together in a large mailing envelope. The control group received Canadian Diabetes alone in its usual shrink wrap packaging, and will receive the Toolkit with the Spring 2010 edition of the newsletter</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-10 10:53:37 -0400" MODIFIED_BY="[Empty name]">
<P>The primary outcome will be that the patient is receiving a statin. Secondary outcomes will include 1) the receipt of an angiotensin converting enzyme inhibitor or angiotensin receptor blocker, 2) various intermediate measures (A1c, BP, LDL-cholesterol, total-/HDL-cholesterol ratio, body mass index, and waist circumference), and 3) clinical inertia (the failure to change therapy in response to an abnormal A1c, BP, or cholesterol reading)</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2012-02-24 12:38:38 -0500" MODIFIED_BY="[Empty name]">
<P>Spring 2010</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2012-02-24 12:40:36 -0500" MODIFIED_BY="[Empty name]">
<P>Baiju Shah University of Toronto, Toronto, Ontario, Canada Email: baiju.shah@ices.on.ca</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2012-09-10 10:53:38 -0400" MODIFIED_BY="Anne Lawson">
<P>-</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2012-09-10 10:53:50 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zwarenstein--2007">
<CHAR_STUDY_NAME MODIFIED="2012-09-10 10:53:39 -0400" MODIFIED_BY="[Empty name]">
<P>The OPEM trial to narrow the evidence-practice gap with respect to prescribing practices of general and family physicians: a C-RCT, targeting the care of individuals with diabetes and hypertension in Ontario, Canada</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2012-09-10 10:53:44 -0400" MODIFIED_BY="[Empty name]">
<P>Study design: C-RCT</P>
<P>Unit of allocation: practices</P>
<P>Type of comparison:  PEM only vs. nothing</P>
<UL>
<LI>group A: control: quarterly evidence-based synopsis of current clinical information</LI>
<LI>group B: quarterly evidence-based synopsis of current clinical information + outsert</LI>
<LI>group C: quarterly evidence-based synopsis of current clinical information + insert</LI>
<LI>group D: quarterly evidence-based synopsis of current clinical information + outsert + insert</LI>
</UL>
<P>Groups considered in review: A and D</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-10 10:53:45 -0400" MODIFIED_BY="[Empty name]">
<P>Physicians</P>
<P>Clinical speciality: general practice/family medicine</P>
<P>Level of training: not clear</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-10 10:53:48 -0400" MODIFIED_BY="[Empty name]">
<P>The authors aim to conduct 3 replicates of the trial to cover the 3 evidence-practice gaps over a 9-month period (3 successive mail outs of informed). They plan to test the effects of short (directive) and long (discursive) PEMs compared with no PEM on the clinical practices of primary care physicians, and on related patient outcomes. In the first replicate (ACE inhibitors, hypertension treatment, and cholesterol-lowering agents for diabetes), the first intervention group will receive a copy of informed with both the short, directive, evidence-based outsert stapled to the lower-left quarter of the front page, and the longer 2-page insert focusing on the same topic as the outsert. The second intervention group will receive the identical informed, with only the above-mentioned outsert. The third intervention group will receive the identical copy of informed with the above-mentioned insert. The control group will receive the identical informed only, without the insert or the outsert. The healthcare topic shared by the insert and outsert will not be covered elsewhere in that issue of informed. For the second replicate (retinal screening in patients with diabetes), in addition to the short, directive outsert and the longer, explanatory insert, a reminder note will be added that physicians could give to their patients to supplement the verbal reminder that physicians are encouraged to give. Because it is not clear whether this patient-held reminder to make an appointment with their eye-care provider is any more effective than the verbal reminder that physicians will be encouraged to give, those physicians receiving an outsert to receive a pad of the patient-aimed reminder slips will be randomised. For the third replicate (using thiazides as first-line treatment for hypertension), 2 different short directive outsert messages will be used (in addition to the long, explanatory insert message). The OPEM team will develop the first outsert message, whereas a team of psychologists with experience in knowledge implementation and the use of psychological theories will develop the second outsert message. With the addition of a theory-based outsert, it will be possible to determine whether a message that is based on psychological theory, specifically on the Theory of Planned Behaviour, will be more effective in changing clinical behaviour towards more evidence-based practice than a message that is based on 'standard' methods, which are uninformed by an explicit theoretical basis</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-10 10:53:50 -0400" MODIFIED_BY="[Empty name]">
<OL>
<LI>% of target patients receiving an ACE inhibitor, % receiving 2 or more antihypertensive, and % receiving lipid-lowering drug</LI>
<LI>% of target patients receiving complete eye examination from optometrist or ophthalmologist</LI>
<LI>% of target patients receiving a diuretic</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE/>
<CHAR_CONTACT_INFORMATION MODIFIED="2012-02-24 12:46:54 -0500" MODIFIED_BY="[Empty name]">
<P>Merrick Zwarenstein Institute for Clinical Evaluative Sciences, Toronto, Canada Email: merrick.zwarenstein@ices.on.ca</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES/>
</ONGOING_CHAR>
<FOOTNOTES>
<P>ACE: angiotensin-converting enzyme; ALLHAT: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial; C-RCT: cluster randomised controlled trial; HDL: high-density lipoprotein; ITS: interrupted time series; LDL: low-density lipoprotein; ODB: Ontario's universal Drug Benefit; OPEM: Ontario Printed Educational Message; PEM: printed educational material.</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2012-09-10 10:50:41 -0400" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2012-09-10 10:50:41 -0400" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:04:40 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Austin-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:05:24 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Austin-2004A">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:19:54 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Austin-2004B">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:48:23 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Austin-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:50:25 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Avorn-1983">
<DESCRIPTION>
<P>Quote, pg. 1460: "control and experimental interventions (described above) were then allocated randomly within each block"</P>
<P>COMMENT: method of randomisation is not specified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:50:41 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Azocar-2003">
<DESCRIPTION>
<P>Quote (2001 article), pg. 1015: "simple randomization was used"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:20:21 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Barbaglia-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-08 10:24:44 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bearcroft-1994">
<DESCRIPTION>
<P>Quote, pg. 56: "GP practices were allocated using a random number table into either the study or control group"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:50 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Beaulieu-2004">
<DESCRIPTION>
<P>Quote, pg. 22: "the physicians identified in our previous study were randomly assigned, using computer-generated random numbers, to one of three groups"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:49 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bjornson-1990">
<DESCRIPTION>
<P>No information was provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:30:59 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Black-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:32:36 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Buyle-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:33:48 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Coopersmith-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:46 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Denig-1990">
<DESCRIPTION>
<P>Quote from correspondence with author: "The allocation was conducted by using envelopes drawn by a person who was not involved in the research project</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:45 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dormuth-2004">
<DESCRIPTION>
<P>Quote, pg. 1058: "one local health area in each pair was randomly selected and assigned (blindly by M.M. using the RAND function on Excel) to be in the control group"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:35:10 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fijn-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:37:17 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fonarow-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:38:13 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fukuda-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:39:47 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Guay-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:42:50 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Haas-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:43:47 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hersh-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:44:39 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jackevicius-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:46:46 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jameson-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:39 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jousimaa-2002">
<DESCRIPTION>
<P>Quote, pg. 588: "students agreeing to participate in the study were randomized centrally using computer-generated numbers to receive either computerized or textbook-based guidelines"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:48:12 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Juurlink-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:49:41 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kabir-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:37 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kajita-2010">
<DESCRIPTION>
<P>Quote, pg. 2: "after the pre-intervention assessment, the 100 centers were randomly allocated in a 1:1 ratio to the intervention and control group by a minimization method that defined region and city/town as stratification factors"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:36 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kottke-1989">
<DESCRIPTION>
<P>Quote from correspondence with the author: "believe that we assigned the physicians using a computer random generator"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:50:38 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lam-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:52:07 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Majumdar-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:53:28 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Majumdar-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:54:42 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mason-1998_x002f_99">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:07:35 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mason-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:09:20 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Matowe-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:10:30 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Meyer-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:31 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Oakeshott-1994">
<DESCRIPTION>
<P>Author could not confirm the method to generate the sequence (P. Oakeshott, personal communication)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:30 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Perria-2007">
<DESCRIPTION>
<P>Quote, pg. 4: "our randomization sequences was computer-generated"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:12:11 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Roberts-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:13:20 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Santerre-1996">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:15:16 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shah-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:19:21 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Stafford-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:39:10 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tsuji-2009">
<DESCRIPTION>
<P>No information was provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:21:09 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:39:09 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Watson-2001">
<DESCRIPTION>
<P>Quote (MC Watson, PhD Thesis), pg. 89-90: "randomization commenced with the blinded selection of one of these cards. The practice undergoing randomization was then allocated to the study group corresponding to the number on the card. The second practice was then randomized to the group on the second selected card (without replacement of the first card), and so on"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:22:08 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Weiss-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2012-09-10 10:50:40 -0400" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:04:40 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Austin-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:05:24 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Austin-2004A">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:19:54 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Austin-2004B">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:48:23 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Austin-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:50:25 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Avorn-1983">
<DESCRIPTION>
<P>Quote, pg. 1460: "control and experimental interventions (described above) were then allocated randomly within each block"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:50:40 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Azocar-2003">
<DESCRIPTION>
<P>Quote (2001 article), pg. 1015: "simple randomization was used"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:20:22 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Barbaglia-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:50 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bearcroft-1994">
<DESCRIPTION>
<P>COMMENT: the unit of allocation is by GP practice and allocation is performed on all units at the start of the study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:50 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Beaulieu-2004">
<DESCRIPTION>
<P>COMMENT: the unit of allocation is by physician and allocation is performed on all units at the start of the study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:49 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bjornson-1990">
<DESCRIPTION>
<P>No information was provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:30:59 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Black-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:32:36 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Buyle-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:33:48 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Coopersmith-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:46 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Denig-1990">
<DESCRIPTION>
<P>No information is provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:45 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dormuth-2004">
<DESCRIPTION>
<P>Quote, pg. 1058: "one local health area in each pair was randomly selected and assigned (blindly by M.M. using the RAND function in Excel) to be in the control group"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:35:10 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fijn-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:37:17 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fonarow-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:38:13 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fukuda-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:39:47 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Guay-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:42:50 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Haas-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:43:47 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hersh-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:44:39 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jackevicius-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:46:46 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jameson-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:39 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jousimaa-2002">
<DESCRIPTION>
<P>COMMENT: the unit of allocation is by physician and allocation is performed on all units at the start of the study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:48:12 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Juurlink-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:49:41 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kabir-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:37 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kajita-2010">
<DESCRIPTION>
<P>Quote, pg. 2: "the allocation was performed by the controller of the trial (M. I.), who was not involved in the assessment as an evaluator"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:36 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kottke-1989">
<DESCRIPTION>
<P>No information was provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:50:38 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lam-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:52:07 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Majumdar-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:53:28 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Majumdar-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:54:42 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mason-1998_x002f_99">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:07:35 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mason-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:09:20 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Matowe-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:10:30 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Meyer-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:31 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Oakeshott-1994">
<DESCRIPTION>
<P>COMMENT: the unit of allocation is by physician and allocation was performed on all units at the start of the study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:30 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Perria-2007">
<DESCRIPTION>
<P>Quote, pg. 4: "randomization was performed by a researcher not involved in the study and who was blind to the identity of the practices"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:12:11 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Roberts-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:13:20 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Santerre-1996">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:15:16 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shah-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:19:21 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Stafford-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:39:10 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tsuji-2009">
<DESCRIPTION>
<P>COMMENT: the unit of allocation was by physician and allocation was performed on all units at the start of the study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:21:09 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:39:09 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Watson-2001">
<DESCRIPTION>
<P>COMMENT: the unit of allocation is by practice and allocation is performed on all units at the start of the study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:22:08 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Weiss-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-09" LEVEL="STUDY" MODIFIED="2012-09-10 10:50:40 -0400" MODIFIED_BY="[Empty name]" NO="9">
<NAME>Baseline characteristics similar (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias due to the lack of similarity in baseline characteristics</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:04:40 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Austin-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:05:47 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Austin-2004A">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:19:54 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Austin-2004B">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:48:23 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Austin-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:50:25 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Avorn-1983">
<DESCRIPTION>
<P>Quote, pg. 1460: "the physicians in each of the study groups were comparable before the intervention in terms of the amount of the target drugs they prescribed through Medicaid, their type of specialty and their board certification"</P>
<P>COMMENT: there are no data tables provided, neither is raw data provided in the text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:50:40 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Azocar-2003">
<DESCRIPTION>
<P>Quote (2001 article), pg. 1015: "the type of license was controlled for in all group comparisons because it was somewhat confounded by group assignment"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:20:22 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Barbaglia-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:50 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bearcroft-1994">
<DESCRIPTION>
<P>No baseline characteristics were reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:50 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Beaulieu-2004">
<DESCRIPTION>
<P>TABLE 1, pg. 24: "there was no significant difference in the distribution of the sexes and medical training amongst the study groups. There was a significant difference in the distribution of professional experience and mean number of patients in the database according to the physician's training amongst the groups"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:49 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bjornson-1990">
<DESCRIPTION>
<P>Quote, pg. 1543: "the physicians in the two groups were similar in terms of board certification, medical specialty, type and location of practice, sex ratio, medical school attended, and number of years of practice. The CHF patients represented by the two groups were well balanced in terms of age, sex ratio, and nursing home residency"</P>
<P>COMMENT: there were no data tables provided, and raw data is not provided in the text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:30:59 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Black-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:32:36 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Buyle-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:33:48 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Coopersmith-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:46 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Denig-1990">
<DESCRIPTION>
<P>Quote, pg. 6: "the physicians participating in this study were similar to their colleagues in The Netherlands with regard to years in practice, size of practice, percentage of elderly patients, and sex distribution of patients (table 5.1). Moreover, there were no significant differences in these characteristics between the control and intervention groups of the study (t-tests; P &gt; 0.05)"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:45 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dormuth-2004">
<DESCRIPTION>
<P>Quote, pg. 1059: "characteristics of the intervention and control physicians in 1991 are displayed in Table 2. The physicians and their patient populations were well balanced for these characteristics." TABLE 2, pg. 1058: "shows physician characteristics in 1994. Characteristics measured are percentage of general practitioners, mean age in years, percentage of men, mean number of visits from patients aged 66 years or more, mean age in years of patients aged 66 years or more and percentage of men/women/sex unknown of patients aged 66 years or more"</P>
<P>COMMENT: the baseline characteristics of the intervention and control groups were reported and similar</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:35:10 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fijn-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:37:17 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fonarow-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:38:14 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fukuda-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:39:47 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Guay-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:42:50 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Haas-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:43:47 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hersh-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:44:39 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jackevicius-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:46:46 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jameson-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:39 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jousimaa-2002">
<DESCRIPTION>
<P>Quote, pg. 589: "the baseline characteristics of both study groups were similar (Table 1)"</P>
<P>COMMENT: the baseline characteristics of the intervention and control groups were reported and similar</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:48:12 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Juurlink-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:49:41 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kabir-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:37 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kajita-2010">
<DESCRIPTION>
<P>Quote, pg. 4: "there were no significant differences between the intervention and control groups in municipality type, population, population aging rate, number of permanent health center staff, or the qualifications of the staff (physicians, public health nurses, nurses, dieticians, physical therapists, and clerks). There was no significant difference between the intervention and control groups in the implementation rate for osteoporosis screening or any type of health education or counseling before the intervention"</P>
<P>COMMENT: numerical data to support this was not provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:36 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kottke-1989">
<DESCRIPTION>
<P>TABLE 1 and quote, pg. 2103: "neither the mean age of the physicians, the size of the clinics nor the patient load&#8230;differed significantly among the three groups"</P>
<P>COMMENT: even if professionals were well balanced, patients did not have all baseline characteristics similar</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:50:38 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lam-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:52:07 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Majumdar-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:53:28 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Majumdar-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:54:42 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mason-1998_x002f_99">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:07:35 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mason-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:09:20 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Matowe-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:10:30 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Meyer-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:31 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Oakeshott-1994">
<DESCRIPTION>
<P>No report in text or tables of provider characteristics</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:30 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Perria-2007">
<DESCRIPTION>
<P>Baseline information is provided in Table 1 and there are no important differences between study groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:12:12 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Roberts-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:13:20 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Santerre-1996">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:15:16 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shah-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:19:21 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Stafford-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:39:10 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tsuji-2009">
<DESCRIPTION>
<P>Quote, pg. 223: "clinician and patient baseline characteristics were comparable in the experimental and control groups (Tables 1 and 2)"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:21:09 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:39:09 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Watson-2001">
<DESCRIPTION>
<P>Quote, pg. 210: "the 20 participating practices did not differ appreciably from other practices in Avon in terms of size or dispensing status, although fewer had fund holding status (Table 1)"</P>
<P>COMMENT: the baseline characteristics of the intervention and control groups were reported and similar</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:22:08 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Weiss-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-10" LEVEL="STUDY" MODIFIED="2012-09-10 10:50:40 -0400" MODIFIED_BY="[Empty name]" NO="10">
<NAME>Baseline outcome measurements similar (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias due to the lack of baseline outcome measurements, or lack of similarity in baseline outcome similarity</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:04:40 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Austin-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Austin-2004A">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:19:54 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Austin-2004B">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:48:23 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Austin-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:50:25 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Avorn-1983">
<DESCRIPTION>
<P>Quote, pg. 1460: "the model thus controlled for differences in preintervention prescribing levels among individual physicians as well as for prescribing trends within the control group"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:50:40 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Azocar-2003">
<DESCRIPTION>
<P>No information was provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:20:22 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Barbaglia-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-08 10:24:52 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bearcroft-1994">
<DESCRIPTION>
<P>No information is provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:50 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Beaulieu-2004">
<DESCRIPTION>
<P>No information was provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:49 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bjornson-1990">
<DESCRIPTION>
<P>No information was provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:30:59 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Black-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:32:36 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Buyle-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:33:48 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Coopersmith-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:46 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Denig-1990">
<DESCRIPTION>
<P>Quote, pg. 7: "...before the intervention, the study groups did not differ significantly in terms of knowledge, perceived drug utility, or stated prescription.  Nor did a significant difference occur in actual prescribing between the intervention and control groups (Tables 5.2-5.5). The physicians in both study groups who were interviewed, however, prescribed fewer antispasmodics in general as well as fewer undesirable antispasmodics than the physicians who did not agree to be interviewed but permitted the use of their prescribing data"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:45 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dormuth-2004">
<DESCRIPTION>
<P>Based on the large total number of prescriptions, baseline outcomes for the number of newly treated patients are similar across groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:35:10 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fijn-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:37:17 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fonarow-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:38:14 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fukuda-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:39:47 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Guay-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:42:50 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Haas-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:43:48 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hersh-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:44:39 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jackevicius-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:46:47 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jameson-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:39 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jousimaa-2002">
<DESCRIPTION>
<P>No information was provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:48:12 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Juurlink-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:49:41 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kabir-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:37 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kajita-2010">
<DESCRIPTION>
<P>Quote, pg. 4: "there was no significant difference in the overall score for the implementation status of evidence-based health education items, as recommended by the guideline, between the intervention (median, 10; first and third quartiles: 3, 17) and control (median, 9; first and third quartiles: 1.5, 18.5) groups in the pre-intervention assessment. The Table shows the implementation status of each health education item in these groups"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:36 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kottke-1989">
<DESCRIPTION>
<P>Outcomes were not collected at baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:50:38 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lam-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:52:08 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Majumdar-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:53:28 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Majumdar-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:54:42 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mason-1998_x002f_99">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:07:35 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mason-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:09:20 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Matowe-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:10:30 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Meyer-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:31 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Oakeshott-1994">
<DESCRIPTION>
<P>COMMENT: we judge that no important difference is present across the study groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:30 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Perria-2007">
<DESCRIPTION>
<P>The generalised estimating equation model was to used account for baseline differences</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:12:12 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Roberts-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:13:20 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Santerre-1996">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:15:16 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shah-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:19:21 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Stafford-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:39:10 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tsuji-2009">
<DESCRIPTION>
<P>Baseline outcomes were not reported for this RCT</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:21:10 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:39:09 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Watson-2001">
<DESCRIPTION>
<P>Quote, pg. 209: "analysis of covariance adjusting for baseline was performed using Stata"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:22:08 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Weiss-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2012-09-10 10:50:40 -0400" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-09-10 10:04:40 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Austin-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-02-28 11:05:47 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Austin-2004A">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-09-10 10:19:54 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Austin-2004B">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-09-10 10:48:23 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Austin-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-09-10 10:50:25 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Avorn-1983">
<DESCRIPTION>
<P>While the authors do not give specific group-by-group drop-out information, quote pg. 1460: "the dropout rates for each cause were found to be approximately equally divided among the three groups", total drop-out was 5% overall (see drop-out rates: pg. 1460, right column, first paragraph)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-09-10 10:50:40 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Azocar-2003">
<DESCRIPTION>
<P>Quote (2003 article), pg. 115: "in addition, patient noncompliance with treatment recommendations and patient dropout was not measured, yet they are factors that can significantly influence treatment length and efficiency. Furthermore, services provided but not billed to UBH such as medication management by primary care physicians could not be accounted for"</P>
<P>COMMENT: Not enough information is provided on drop-out rates in each group and on reasons for dropping out</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-09-10 10:20:22 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Barbaglia-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-09-10 10:21:50 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bearcroft-1994">
<DESCRIPTION>
<P>This is not specified: while it is implied by it being a prospective analysis of all GP requests for chest radiography, it is not specified whether any of the records were missing after baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-09-10 10:21:49 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Beaulieu-2004">
<DESCRIPTION>
<P>Quote, pg. 23: "of the 3293 physicians in our initial study, 967 (29.4%) were not in the database in 1999, hence were considered lost to follow-up. Thus 2326 (70.6%) were available for the current study (Figure 1). Since our database was anonymous, it was impossible to track down what happened to those physicians"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-09-10 10:21:49 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bjornson-1990">
<DESCRIPTION>
<P>Incomplete outcome data was only provided for the intervention group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-02-28 11:30:59 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Black-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-02-28 11:32:36 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Buyle-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-02-28 11:33:48 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Coopersmith-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-09-10 10:21:46 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Denig-1990">
<DESCRIPTION>
<P>Reasons are provided for the 25 withdrawal/ineligible participants who agreed to join, but did not form part of the group analysed, but no indication of the distribution between control and intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-09-10 10:21:45 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dormuth-2004">
<DESCRIPTION>
<P>Quote, pg. 1058: "no requests to be excluded were received"</P>
<P>COMMENT: the study does not specifically report on all physicians randomized by area at the beginning of the study remaining in the prescribing database throughout the study. Perhaps physicians retired, moved to a new area, or died</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-02-28 11:35:10 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fijn-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-02-28 11:37:17 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fonarow-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-02-28 11:38:14 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fukuda-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-02-28 11:39:47 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Guay-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-02-28 11:42:50 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Haas-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-02-28 11:43:48 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hersh-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-02-28 11:44:39 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jackevicius-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-02-28 11:46:47 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jameson-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-09-10 10:21:39 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jousimaa-2002">
<DESCRIPTION>
<P>The reasons for loss to study were similar and the proportions were similar, 6/72 = 8.3% in intervention and 3/67 = 4.5% in control group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-02-28 11:48:12 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Juurlink-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-02-28 11:49:42 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kabir-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-09-10 10:21:37 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kajita-2010">
<DESCRIPTION>
<P>Quote, pg. 4: "all 100 municipal health centers completed the preintervention assessment. Of these, 3 centers declined to participate in the trial and 1 center was absorbed into another municipality (Figure 1). We performed the post-intervention assessments for the remaining 96 centers (48 in the intervention group and 48 in the control group; 96% follow-up rate)"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-09-10 10:21:36 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kottke-1989">
<DESCRIPTION>
<P>The proportion of patient-smokers was similar between groups, and the percentage reached at 1 year for follow-up was similar. Quote, pg. 2103:  "patients who either could not be contacted or refused to be interviewed were assumed to be continuing to smoke and were assumed not to have made any cessation attempts"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-02-28 11:50:38 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lam-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-02-28 11:52:08 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Majumdar-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-02-28 11:53:28 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Majumdar-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-02-28 11:54:42 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mason-1998_x002f_99">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-02-28 12:07:35 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mason-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-02-28 12:09:21 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Matowe-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-02-28 12:10:31 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Meyer-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-09-10 10:21:31 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Oakeshott-1994">
<DESCRIPTION>
<P>No information was provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-09-10 10:21:30 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Perria-2007">
<DESCRIPTION>
<P>COMMENT: intervention arm 2 (passive dissemination) and the control group had similar numbers of missing data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-02-28 12:12:12 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Roberts-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-02-28 12:13:20 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Santerre-1996">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-02-28 12:15:16 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shah-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-02-28 12:19:21 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Stafford-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-09-10 10:39:10 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tsuji-2009">
<DESCRIPTION>
<P>Quote, pg. 223: "dichotomous end points (withdrawals, appropriate treatment and 16-week clinical remission) were analyzed using the adjusted chi-square approach."  Withdrawals were quantified by group and reason, quote. pg. 223: "There were a total of 36 study withdrawals, 13 (10.8%) in the intervention arm and 23 (20.2%) in the usual care arm (intracluster coefficient correlation = 0.032, P = 0.153). Nine subjects (7.5%) in the intervention arm and 19 (16.7%) in the usual care arm withdrew (P = 0.122). Eight subjects, four (3.3%) in the intervention arm and four (3.5%) in the usual care arm, worsened and were withdrawn (P =  .949)"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-02-28 12:21:10 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-09-10 10:39:08 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Watson-2001">
<DESCRIPTION>
<P>COMMENT: missing outcome measures were unlikely to bias the results because a registry was used in its entirety</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-02-28 12:22:08 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Weiss-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2012-09-10 10:50:40 -0400" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-09-10 10:04:40 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Austin-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-02-28 11:05:48 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Austin-2004A">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-09-10 10:19:54 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Austin-2004B">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-09-10 10:48:23 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Austin-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-09-10 10:50:25 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Avorn-1983">
<DESCRIPTION>
<P>The outcome was objective</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-09-10 10:50:40 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Azocar-2003">
<DESCRIPTION>
<P>Quote (2003 article), pg. 113: "guideline adherence was measured objectively using submitted claims and treatment plans provided by the clinicians"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-09-10 10:20:22 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Barbaglia-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-09-10 10:21:50 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bearcroft-1994">
<DESCRIPTION>
<P>While an attempt was made to blind the outcome assessors, quote, pg. 56: "the reporter was unaware from which group of GPs the request originated", this was not complete, quote, pg. 56: "the majority of the examinations performed were then reported by one of two radiologists (PWPB and JS)", and no quantification of this "majority" was provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-09-10 10:21:49 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Beaulieu-2004">
<DESCRIPTION>
<P>The outcome was objective</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-09-10 10:21:49 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bjornson-1990">
<DESCRIPTION>
<P>The outcome was objective</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-02-28 11:30:59 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Black-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-02-28 11:32:36 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Buyle-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-02-28 11:33:48 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Coopersmith-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-09-10 10:21:46 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Denig-1990">
<DESCRIPTION>
<P>The outcome was objective</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-09-10 10:21:45 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dormuth-2004">
<DESCRIPTION>
<P>The outcome was objective</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-02-28 11:35:11 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fijn-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-02-28 11:37:18 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fonarow-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-02-28 11:38:14 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fukuda-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-02-28 11:39:47 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Guay-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-02-28 11:42:50 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Haas-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-02-28 11:43:48 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hersh-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-02-28 11:44:39 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jackevicius-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-02-28 11:46:47 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jameson-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-09-10 10:21:39 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jousimaa-2002">
<DESCRIPTION>
<P>Quote, pg. 589: "the anonymous patient records were then evaluated by one author (JJ, experienced primary care physician) blinded to the study group (computer or textbook, information searching or non-information searching consultation)"</P>
<P>COMMENT: the authors state explicitly that the primary outcome variables were assessed blindly</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-02-28 11:48:12 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Juurlink-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-02-28 11:49:42 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kabir-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-09-10 10:21:37 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kajita-2010">
<DESCRIPTION>
<P>Quote, pg. 3: "the post-intervention assessment was performed 1 year after the distribution of the guideline under blinded conditions in which the evaluators were unaware of the allocation"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-09-10 10:21:36 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kottke-1989">
<DESCRIPTION>
<P>This is a self-report assessment by patients who were not blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-02-28 11:50:38 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lam-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-02-28 11:52:08 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Majumdar-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-02-28 11:53:28 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Majumdar-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-02-28 11:54:42 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mason-1998_x002f_99">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-02-28 12:07:35 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mason-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-02-28 12:09:21 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Matowe-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-02-28 12:10:31 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Meyer-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-09-10 10:21:31 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Oakeshott-1994">
<DESCRIPTION>
<P>Quote, pg. 197: "conformity was assessed by P 0 and J W who were unaware which practices had been sent the guidelines"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-09-10 10:21:30 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Perria-2007">
<DESCRIPTION>
<P>The outcome was objective</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-02-28 12:12:12 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Roberts-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-02-28 12:13:20 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Santerre-1996">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-02-28 12:15:16 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shah-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-02-28 12:19:21 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Stafford-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-09-10 10:39:10 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tsuji-2009">
<DESCRIPTION>
<P>Quote, pg. 222: "investigators were blind to the treatment assignment of the clinicians and to which clinician the patient was assigned" and, "at 16-week  depression severity, as measured by the HAM-D scale, was evaluated at a mental health facility by two independent evaluators who were blind to treatment allocation"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-02-28 12:21:10 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-09-10 10:39:08 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Watson-2001">
<DESCRIPTION>
<P>The outcome was objective</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-02-28 12:22:08 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Weiss-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-11" LEVEL="STUDY" MODIFIED="2012-09-10 10:50:40 -0400" MODIFIED_BY="[Empty name]" NO="11">
<NAME>Contamination protection (contamination bias)</NAME>
<DESCRIPTION>
<P>Contamination bias due to inadequate protection against contamination.</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:04:40 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Austin-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:05:48 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Austin-2004A">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:19:54 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Austin-2004B">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:48:23 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Austin-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:50:25 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Avorn-1983">
<DESCRIPTION>
<P>Quote, pg. 1460: "If a small town contained more than one physician from our sample, all physicians in that town were randomized as a cluster to prevent cross-contamination of information"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:50:40 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Azocar-2003">
<DESCRIPTION>
<P>Quote (2003 article), pg. 1015: "simple randomization was used to give each clinician an equal chance of being assigned to each of the three groups&#8230;"</P>
<P>COMMENT: professionals may have been allocated within a clinic or practice and it is possible that communication between intervention and control professionals could have occurred</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:20:22 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Barbaglia-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:50 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bearcroft-1994">
<DESCRIPTION>
<P>Quote, pg. 58: "in addition, there may have been crossfertilization between study and control groups as GPs meet professionally and socially. Such an effect would be conservative, leading to a reduction in the overall difference"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:49 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Beaulieu-2004">
<DESCRIPTION>
<P>Quote, pg. 30: "contamination might have occurred between the study groups, either directly (physicians in the intervention groups sharing information with physicians in the control groups) or indirectly (uptake of the guideline messages through the communication channels of various stakeholders and CME activities). Such contamination is indicated by our survey of a subsample of the physicians.24 In this study, 90% of respondents, including physicians in the control group, were aware of the guidelines, and 75% had participated in at least one CME activity on the topic during the previous 6 months"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:49 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bjornson-1990">
<DESCRIPTION>
<P>Quote, pg. 1543: "ninety-five (67.4%) respondents in the intervention group indicated they were already aware of the VA study with 77 (54.6%) citing the <I>New England Journal of Medicine</I> article as the principal source of their knowledge (Table 1)"</P>
<P>COMMENT: thus, perhaps the control group physicians were also aware of the study. Additionally, since the randomisation was not clustered by practice, physicians in the intervention group could have shared information with their colleagues in the control group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:30:59 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Black-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:32:36 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Buyle-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:33:48 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Coopersmith-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:46 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Denig-1990">
<DESCRIPTION>
<P>Quote, pg. 3: "physicians living in the same village or town were stratified into the control or intervention groups." From this quote it is UNCLEAR if a clustered approach was used to randomise participants</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:45 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dormuth-2004">
<DESCRIPTION>
<P>Quote, pg. 1058: "the intervention and control groups were created by grouping an approximate 10% sample of prescribing physicians in 24 local health areas in a paired, cluster randomized design into 12 pairs based on the number of physicians in each area." such that all physicians within 1 local health area would be clustered</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:35:11 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fijn-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:37:18 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fonarow-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:38:14 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fukuda-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:39:47 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Guay-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:42:50 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Haas-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:43:48 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hersh-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:44:40 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jackevicius-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:46:47 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jameson-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:39 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jousimaa-2002">
<DESCRIPTION>
<P>COMMENT: professionals were possibly allocated within a clinic or practice and it is possible that communication between intervention and control professionals could have occurred</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:48:12 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Juurlink-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:49:42 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kabir-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:37 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kajita-2010">
<DESCRIPTION>
<P>COMMENT: the unit of allocation was by institution (health centre)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:36 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kottke-1989">
<DESCRIPTION>
<P>Quote, pg. 2102: "to prevent contamination from having physicians of the same practice in different trial groups, all physicians in the same practice were either moved to the most intense level of intervention to which any of them had been originally randomized or, if not yet randomized at the time this problem was discovered, added to the group to which their partner(s) had been randomized"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:50:38 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lam-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:52:08 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Majumdar-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:53:28 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Majumdar-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:54:42 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mason-1998_x002f_99">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:07:35 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mason-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:09:21 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Matowe-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:10:31 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Meyer-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:31 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Oakeshott-1994">
<DESCRIPTION>
<P>Quote, pg. 197: "practices were stratified by number of partners and number of radiographic examinations requested, and randomized into two groups"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:30 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Perria-2007">
<DESCRIPTION>
<P>Quote, pg. 4: "GPs who accepted to take part in the study, were assigned by simple random allocation by the REXSCO [21] software, which assigns to same-practice partners a nil probability of being randomized, thus minimizing the chances of participant contamination"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:12:12 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Roberts-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:13:20 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Santerre-1996">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:15:16 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shah-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:19:21 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Stafford-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:39:10 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tsuji-2009">
<DESCRIPTION>
<P>Quote, pg. 222: "to avoid cross-contamination of clinicians, sensitization of patients and for administrative reasons eight clinicians were stratified by basic healthcare unit size and geographical area and randomized to use either usual care or a treatment guide in treating depression"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:21:10 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-19 14:46:55 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Watson-2001">
<DESCRIPTION>
<P>Quote, pg. 208: "practices in Avon, England, that used the Egton Medical Information Systems Ltd (EMIS) computer system (n=51) were invited to participate. Of these, 20 (39%) were randomized"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:22:08 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Weiss-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2012-09-10 10:50:40 -0400" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:04:40 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Austin-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:05:48 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Austin-2004A">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:19:54 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Austin-2004B">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:48:23 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Austin-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:50:25 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Avorn-1983">
<DESCRIPTION>
<P>All relevant outcomes in the methods section were reported in the results section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:50:40 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Azocar-2003">
<DESCRIPTION>
<P>All relevant outcomes in the methods section were reported in the results section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:29:39 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Barbaglia-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:50 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bearcroft-1994">
<DESCRIPTION>
<P>All relevant outcomes in the methods section were reported in the results section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:49 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Beaulieu-2004">
<DESCRIPTION>
<P>All relevant outcomes in the methods section were reported in the results section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:49 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bjornson-1990">
<DESCRIPTION>
<P>All relevant outcomes in the methods section were reported in the results section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:30:59 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Black-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:32:36 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Buyle-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:33:49 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Coopersmith-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:46 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Denig-1990">
<DESCRIPTION>
<P>All relevant outcomes in the methods section were reported in the results section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:45 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dormuth-2004">
<DESCRIPTION>
<P>All relevant outcomes in the methods section were reported in the results section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:35:11 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fijn-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:37:18 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fonarow-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:38:14 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fukuda-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:39:47 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Guay-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:42:50 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Haas-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:43:48 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hersh-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:44:40 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jackevicius-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:46:47 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jameson-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:39 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jousimaa-2002">
<DESCRIPTION>
<P>All relevant outcomes in the methods section were reported in the results section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:48:12 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Juurlink-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:49:42 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kabir-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:37 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kajita-2010">
<DESCRIPTION>
<P>All relevant outcomes in the methods section were reported in the results section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:36 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kottke-1989">
<DESCRIPTION>
<P>All relevant outcomes in the methods section were reported in the results section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:50:38 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lam-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:52:08 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Majumdar-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:53:28 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Majumdar-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:54:42 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mason-1998_x002f_99">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:07:35 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mason-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:09:21 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Matowe-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:10:31 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Meyer-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:31 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Oakeshott-1994">
<DESCRIPTION>
<P>All relevant outcomes in the methods section were reported in the results section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:30 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Perria-2007">
<DESCRIPTION>
<P>Quote, pg. 7: "as results showed the non-effectiveness of the intervention strategy, we did not perform any economic evaluation or carry out analysis on  participant sub-clusters"</P>
<P>COMMENT: all relevant primary outcomes were reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:12:12 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Roberts-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:13:20 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Santerre-1996">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:15:16 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shah-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:19:21 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Stafford-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:39:10 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tsuji-2009">
<DESCRIPTION>
<P>All relevant outcomes in the methods section were reported in the results section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:21:10 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:39:08 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Watson-2001">
<DESCRIPTION>
<P>All relevant outcomes in the methods section were reported in the results section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:22:08 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Weiss-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2012-09-10 10:50:40 -0400" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:04:40 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Austin-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:05:48 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Austin-2004A">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:24:07 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Austin-2004B">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:26:17 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Austin-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:50:25 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Avorn-1983">
<DESCRIPTION>
<P>There was no evidence of other risks of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:50:40 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Azocar-2003">
<DESCRIPTION>
<P>Quote (2003 article), pg. 115: "the small number of sessions delivered by study clinicians could have been due to the overrepresentation of psychiatrists in the sample and their delivering primarily monthly medication management services, rather than weekly psychotherapy", and "Furthermore, services provided but not billed to UBH such as medication management by primary care physicians could not be accounted for"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:29:39 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Barbaglia-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:50 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bearcroft-1994">
<DESCRIPTION>
<P>There is evidence of potential unit of analysis error</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:49 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Beaulieu-2004">
<DESCRIPTION>
<P>There was no evidence of other risks of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:48 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bjornson-1990">
<DESCRIPTION>
<P>COMMENT: there was no information provided regarding from where the outcome data was being recorded. It may have come from Medicaid, a similar computer-based record, or physician surveys</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:30:59 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Black-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:32:36 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Buyle-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:33:49 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Coopersmith-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:46 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Denig-1990">
<DESCRIPTION>
<P>There was no evidence of other risks of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:45 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dormuth-2004">
<DESCRIPTION>
<P>There was no evidence of other risks of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:35:11 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fijn-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:37:18 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fonarow-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:38:14 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fukuda-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:39:47 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Guay-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:42:51 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Haas-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:43:48 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hersh-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:44:40 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jackevicius-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:46:47 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jameson-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:39 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jousimaa-2002">
<DESCRIPTION>
<P>No evidence of other risks of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:48:12 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Juurlink-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:49:42 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kabir-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:37 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kajita-2010">
<DESCRIPTION>
<P>Quote, pg. 9: "the study did not use a double-blind design because it was not possible to use a placebo guideline. Instead, we offered to reimburse the control centers for the cost for materials needed to revise their health education programs. Although only 3 centers claimed reimbursement, our offer may have increased the use of information other than the guideline in the control group and may have improved the evidence-based status of the programs of the control centers, thereby decreasing the magnitude of differences in the outcome measures between the groups"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:36 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kottke-1989">
<DESCRIPTION>
<P>COMMENT: the primary outcome measure was 102 question questionnaire for patients, making this outcome measure susceptible to LOW validity</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:50:38 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lam-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:52:08 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Majumdar-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:53:28 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Majumdar-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:54:42 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mason-1998_x002f_99">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:07:35 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mason-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:09:21 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Matowe-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:10:31 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Meyer-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:31 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Oakeshott-1994">
<DESCRIPTION>
<P>There was no evidence of other risks of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:30 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Perria-2007">
<DESCRIPTION>
<P>No evidence of other risks of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:12:12 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Roberts-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:13:20 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Santerre-1996">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:15:16 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shah-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:19:22 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Stafford-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:39:10 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tsuji-2009">
<DESCRIPTION>
<P>There was no evidence of other risks of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:21:10 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:39:08 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Watson-2001">
<DESCRIPTION>
<P>Quote, pg. 210: "ceiling effects will therefore have limited the magnitude of change possible"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 12:22:08 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Weiss-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-12" LEVEL="STUDY" MODIFIED="2012-09-10 10:50:12 -0400" MODIFIED_BY="[Empty name]" NO="12">
<NAME>Intervention independent of other changes - ITS</NAME>
<DESCRIPTION>
<P>Bias due to the intervention not being independent of other changes over time, or the outcome being influenced by other confounding variables/historic events during study period.</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:04:40 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Austin-2003">
<DESCRIPTION>
<P>No information is provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:05:24 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Austin-2004A">
<DESCRIPTION>
<P>Quote, pg. 193: "our study demonstrated a significant increase in incident clonidine use exceeding secular trends among elderly postmenopausal women"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:19:54 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Austin-2004B">
<DESCRIPTION>
<P>No information was provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:50:12 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Austin-2005">
<DESCRIPTION>
<P>Quote, pg. 1300: "we were unable to account for temporal influences beyond the publication of the results of the trials. In particular, we were unable to account for changes in drug company promotion patterns." Quote, pg. 1300: "because of  the study design and the relatively low monthly number of incident statin users, we were unable to definitively determine whether the trends that we observed were a result of an increase in the number of incident statin users who were being placed on high-dose atorvastatin or whether they were because of prevalent statin users&#8217; changing therapy"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-07 15:36:08 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Avorn-1983">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Azocar-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:20:22 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Barbaglia-2009">
<DESCRIPTION>
<P>No information was provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:29:12 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bearcroft-1994">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:30:51 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Beaulieu-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:33:30 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bjornson-1990">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:48 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Black-2002">
<DESCRIPTION>
<P>COMMENT: the authors present 5 possible alternative reasons that could contribute to the observed outcome and provide compelling arguments that these factors may have contributed, but that the intervention was effective. Reasons considered: statistical artefact, supply factors, demand factors, organisational changes in the NHS and broadly publicised adverse publicity</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:48 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Buyle-2010">
<DESCRIPTION>
<P>No information was provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 11:33:49 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Coopersmith-2002">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:36:26 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Denig-1990">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:38:58 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dormuth-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:45 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fijn-2000">
<DESCRIPTION>
<P>No information was provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:44 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fonarow-2009">
<DESCRIPTION>
<P>No information is provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:43 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fukuda-2009">
<DESCRIPTION>
<P>Quote, pg. 373: "because of language barriers, several large clinical trials published in Western countries seemed to have less impact on knowledge of the effectiveness of BCS in Japan compared with the impact in English-speaking countries. Before the publication of the Japanese guideline, therefore, it was possible that Japanese women might be unaware of this treatment choice" </P>
<P>COMMENT: the authors make an argument that a language barrier (Japanese/English) may have limited passive dissemination from other countries</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:43 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Guay-2007">
<DESCRIPTION>
<P>No information was provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:42 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Haas-2004">
<DESCRIPTION>
<P>No information was provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:41 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hersh-2004">
<DESCRIPTION>
<P>No information was provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:41 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Jackevicius-2001">
<DESCRIPTION>
<P>Quote, pg. 187: "it is impossible to separate the effects of the publication of 4S, the subsequent continuing education efforts, and the effects of marketing by the pharmaceutical industry. Therefore, the results of this study show the effects of the combined efforts among many different parties to promote appropriate medication prescribing with lipid-lowering therapy in patients after AMI"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:40 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jameson-2010">
<DESCRIPTION>
<P>No information was provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:45:09 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jousimaa-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:39 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Juurlink-2004">
<DESCRIPTION>
<P>No information was provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:38 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kabir-2007">
<DESCRIPTION>
<P>No information was provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:48:00 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kajita-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:50:10 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kottke-1989">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:36 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lam-2009">
<DESCRIPTION>
<P>Quote, pg. 1174: "it was not possible to evaluate the extent to which other potential factors, such as pharmaceutical marketing, influenced prescribing patterns"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:35 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Majumdar-2003">
<DESCRIPTION>
<P>Quote, pg. 468: "To adjust for potential differences between Canadian and United States physicians in the adoption of published evidence, we examined the effect of the Randomized Aldactone Evaluation Study (RALES) on prescribing trends for spironolactone. This study compared spironolactone with placebo in patients with heart failure and demonstrated a 30% reduction in mortality. RALES was prereleased and published in the same year and the same journal as the HOPE study. Because spironolactone was not promoted by the pharmaceutical industry in either country, any observed differences in prescribing trends should be attributable mostly to a publication effect"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:34 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Majumdar-2004">
<DESCRIPTION>
<P>No information was provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:34 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mason-1998_x002f_99">
<DESCRIPTION>
<P>Quote, pg. 122: "the Effective Health Care Bulletin, and related article in the BMJ published at the same time, were the first scientific reports to question the widespread switch to SSRIs.  These sparked considerable interest in the media, and also considerable activity from medical and pharmaceutical advisors in the NHS"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:33 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Mason-2001">
<DESCRIPTION>
<P>Quote, pg. 1097: "the change cannot be attributed to the bulletin alone, which was commissioned because of pre­existing concerns about appropriate use of the procedure. Its publication received coverage in the medical and academic press,4 possibly encouraging doctors to examine their own practices and bring about behavioural change"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:33 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Matowe-2002">
<DESCRIPTION>
<P>No information was provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:32 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Meyer-2007">
<DESCRIPTION>
<P>No information was provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:53:20 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Oakeshott-1994">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:58:49 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Perria-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:30 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Roberts-2007">
<DESCRIPTION>
<P>No information was provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:39:12 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Santerre-1996">
<DESCRIPTION>
<P>No information was provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:39:12 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Shah-2008">
<DESCRIPTION>
<P>Quote, pg. 873: "several other studies of cardiovascular risk with thiazolidinediones were reported throughout 2007, which may have contributed to the overall decline in their use"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:39:11 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Stafford-2004">
<DESCRIPTION>
<P>Quote, pg. 61: "because there are multiple simultaneous influences, it is difficult to establish a primary influencing factor on the significant decline in physician prescribing of &#945;-blockers. Nevertheless, our findings are clearly consistent with ALLHAT early termination results having a significant impact on &#945;-blocker use. Declining pharmaceutical industry promotion also may have contributed further to decreased &#945;-blocker use. The lack of an abrupt and more pronounced decline in prescribing shortly after the ALLHAT results, however, suggests slow and potentially incomplete diffusion of information from this clinical trial"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 09:07:02 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tsuji-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:39:09 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2005">
<DESCRIPTION>
<P>No information was provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 09:26:31 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Watson-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:39:08 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Weiss-2011">
<DESCRIPTION>
<P>Quote, pg. 6: "this study has a number of limitations; we did not take into account samples given to physicians, but they represent a very small percentage of the total amount of antibiotics, and filling an antibiotic prescription at a community pharmacy does not guarantee that the patient will finish the entire treatment.  The Quebec antibiotic guidelines were produced in a period when health care professionals, government authorities, and perhaps the population as a whole were highly aware of the risks associated with antibiotic overuse (C. difficile infections). Thus, external factors besides the guidelines themselves may have influenced antibiotic prescribing practices"  </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-13" LEVEL="STUDY" MODIFIED="2012-09-10 10:50:12 -0400" MODIFIED_BY="[Empty name]" NO="13">
<NAME>Shape of Intervention effect pre-specified - ITS</NAME>
<DESCRIPTION>
<P>Bias due to point of analysis not being the point of intervention.</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:04:40 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Austin-2003">
<DESCRIPTION>
<P>Quote, pg. 3241: "we examined patterns of prescriptions for estrogen replacement therapy (ERT) before and after publication of the Women's Health Initiative (WHI) study on July 17, 2002. We also examined trends around the publication of the Heart and Estrogen/progestin Replacement Study (HERS) in 1998"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:05:24 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Austin-2004A">
<DESCRIPTION>
<P>Quote, pg. 193: "as women abandoned ERT, some may have initiated treatment with medications such as clonidine, for the treatment of menopausal hot flashes. There are limitations of our study. First, we were unable to determine the exact reason for initiating clonidine. Although clonidine is classified as an antihypertensive medication, it is not commonly used for hypertension"</P>
<P>COMMENT: a rational explanation for the shape of intervention effect was not provided by the authors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:19:55 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Austin-2004B">
<DESCRIPTION>
<P>Quote, pg. 44: "The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT), published on December 18, 2002, concluded that thiazide-type diuretics should be the first-step antihypertensive therapy, compared with either calcium channel blockers (CCBs) or angiotensin converting enzyme (ACE) inhibitors. We examined trends in incident use of antihypertensive agents following publication of the ALLHAT trial"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:50:12 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Austin-2005">
<DESCRIPTION>
<P>Quote, pg. 1297: "the objective of the present study was to examine the impact of the publication of these 2 trials on trends in intensive versus moderate statin therapy in the province of Ontario"</P>
<P>COMMENT: the authors do not specify what the expected impact of the intervention is</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Avorn-1983">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Azocar-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:20:22 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Barbaglia-2009">
<DESCRIPTION>
<P>COMMENT: the authors describe how previous studies have shown decreases in HT use based on pharmacy data. They propose a study with direct report of HT use and a longer follow-up period to better assess this trend</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:29:12 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bearcroft-1994">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:30:51 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Beaulieu-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:33:30 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bjornson-1990">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:48 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Black-2002">
<DESCRIPTION>
<P>COMMENT: the authors state that prior to the PEM, the rate of the surgery (primary outcome) was already declining, and that to demonstrate that the guidelines were effective: quote, pg. 121: "it would be necessary to show an acceleration in the decline. The primary aim of this paper is to ascertain whether or not the passive dissemination of national guidelines to typical service providers (district general hospitals as well as teaching hospitals) had any impact on clinical practice. Studies of such interventions in other areas have reported either no clinically significant effect or only a modest impact. If the guidelines were shown to have had an effect on this occasion, our secondary aim was to establish why this was so"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:48 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Buyle-2010">
<DESCRIPTION>
<P>COMMENT: the authors describe the suitability of fluoroquinolones for IV to PO antibiotic switches and suggest that sequential therapy (which would be reflected by a decrease in the proportion of IV antibiotic out of total antibiotic use (IV + PO))</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:47 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Coopersmith-2002">
<DESCRIPTION>
<P>Quote, pg. 59: "to determine whether a focused education initiative in a surgical/burn/trauma ICU could decrease the primary bloodstream infection rate"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:36:26 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Denig-1990">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:38:58 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dormuth-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:45 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fijn-2000">
<DESCRIPTION>
<P>Quote, pg. 740: "All of these recommend additional prophylactic antithrombotic therapy, preferably thrombocyte aggregation inhibitors, to existing rescue and/or maintenance therapy for acute and chronic IHD." "this research will evaluate antithrombotic prescribing in newly diagnosed IHD patients in general practice"  </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:44 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fonarow-2009">
<DESCRIPTION>
<P>Quote, pg. 186: "it has not been well studied to what extent utilization of lipid lowering medications in patients with AMI has changed in response to more recent published clinical trial evidence and updates to national guidelines. In this study, the National Registry for Myocardial Infarction (NRMI) 3, 4, and 5 was used to examine national trends in the use of lipid-lowering medications at discharge in patients hospitalized for AMI from 1998 to 2006"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:43 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fukuda-2009">
<DESCRIPTION>
<P>Quote, pg. 373: "the aim of this study was to evaluate whether publication of clinical guidelines was associated with a change of treatment practices for breast cancer patients through the use of secondary administrative data from Japanese hospitals"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:43 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Guay-2007">
<DESCRIPTION>
<P>Quote, pg. 18: "from this perspective, the aim of our study is to evaluate the impact of the publication of the WHI study in the Quebecers population, and to estimate if the use of HRT did indeed change in accordance with the new guidelines"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:42 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Haas-2004">
<DESCRIPTION>
<P>Quote, pg. 184: "we designed our analysis to examine whether the use of hormone therapy has changed among postmenopausal women as a result of the publication of the results from HERS and the WHI. We were also interested in examining whether patterns of use differ by patient characteristics. Because HERS examined the outcomes of older women, we hypothesized that there would be earlier and more substantial declines in hormone therapy use among this group. We also expected that there would be variation in use by race or ethnicity because white women may have better access to new information. Finally, because the WHI study results were specific to women taking continuous estrogen plus progestin, we hypothesized that hormone use would be more stable among women who had had hysterectomies because such women typically take only estrogen and may believe that the findings do not apply to them"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:41 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hersh-2004">
<DESCRIPTION>
<P>Quote, pg. 48: "national trends in hormone therapy use since 1995 have not been reported, and the impact of recent evidence on hormone therapy prescriptions in subsequent months is unknown. Our objective was to describe these trends using national data on hormone therapy prescriptions and patient visits to  physicians during which hormone therapy was prescribed"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:41 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jackevicius-2001">
<DESCRIPTION>
<P>Quote, pg. 183: "the use of statins in patients after AMI represents a proven innovation that is not complex to use, that has been endorsed by professional societies and practice guidelines, and that has been aggressively marketed by drug manufacturers. Analysis of the use of statins may provide us with information on the extent to which it is possible to change prescribing behaviour in a large population when strong clinical evidence and practice guidelines are combined with aggressive marketing"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:40 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jameson-2010">
<DESCRIPTION>
<P>Quote, pg. 124: "the early effect of the NICE guidelines has yet to be reported. This paper aims to examine their impact on the use of LMWH in patients  undergoing arthroplasty of the lower limb in England and Wales, and to analyze the effect on the national rates of complications relating to venous thromboembolic prophylaxis"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:45:09 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jousimaa-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:39 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Juurlink-2004">
<DESCRIPTION>
<P>Quote, pg. 543: "the Randomized Aldactone Evaluation Study (RALES) demonstrated that spironolactone significantly improves outcomes in patients with severe heart failure. Use of angiotensin-converting&#8211;enzyme (ACE) inhibitors is also indicated in these patients. However, life-threatening hyperkalemia can occur when these drugs are used together..."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:38 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kabir-2007">
<DESCRIPTION>
<P>Quote, pg. 382: "studies in Canada and the US have shown that such publications have influenced prescribing patterns. This study assesses such prescribing patterns in Ireland from January 2001 to July 2005, 12 months before and after the publication of the three major hypertension trials: LIFE, ALLHAT and VALUE"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:48:00 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kajita-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:50:10 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kottke-1989">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:36 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lam-2009">
<DESCRIPTION>
<P>Quote, pg. 1172: "one of the largest randomized controlled trials ever published in nephrology is Der Deutsche Diabetes Dialyse Studie (4D), which showed no beneficial effect of statins in diabetic patients receiving hemodialysis. We sought to determine whether there was a change in statin use among diabetic patients on dialysis after the publication of 4D"</P>
<P>Quote, pg. 1177: "in this study, we specified the publication date of 4D (21 July 2005) as the primary time point to assess whether there was a change in prescribing practice"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:35 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Majumdar-2003">
<DESCRIPTION>
<P>Quote, pg. 468: "Therefore, we compared the prescribing trends for ramipril in Canada and the United States to test the hypotheses that publication of the HOPE study would increase the use of ramipril in both countries (publication effect), and that this increase would be greater in Canada (promotion effect)"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:34 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Majumdar-2004">
<DESCRIPTION>
<P>Quote, pg. 1983: "to examine pharmaceutical industry response to the WHI E+P [oestrogen plus progestin] results by analyzing promotional expenditures for hormone therapy before and after July 2002"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:34 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mason-1998_x002f_99">
<DESCRIPTION>
<P>A specific null hypothesis is not provided. Quote pg. 120: "we examined the effect of this intervention on prescribing in English primary care using time series analysis"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:33 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mason-2001">
<DESCRIPTION>
<P>Quote, pg. 1096: "based on systematic review, the bulletin concluded that surgery should be restricted to children with an extended period of substantial hearing impairment, with persistence and severity established by watchful waiting. We evaluated surgery rates before and after distribution of the bulletin"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:33 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Matowe-2002">
<DESCRIPTION>
<P>COMMENT: the authors specifically refer to reductions in x-ray requests found by other studies and propose an ITS study of longer duration to improve the detection of the effect. They verified if other guidelines were disseminated independent of this study, and they also evaluated the effect of guidelines for 18 radiology examinations</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:32 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Meyer-2007">
<DESCRIPTION>
<P>Quote, pg. 1148: "to evaluate the impact of an intervention to reduce the duration of antibiotic treatment for pneumonia in a neurosurgical intensive care unit (ICU). The usage of antibiotics and the resultant costs were examined using interrupted time series analysis while resistance and device-associated infection rates are also described"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:53:20 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Oakeshott-1994">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:58:49 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Perria-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:30 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Roberts-2007">
<DESCRIPTION>
<P>Quote, pg. 864: "in April 2000, NICE published the Technology Appraisal Guidance (TAG) No. 2 - &#8216;Guidance on the selection of prostheses for Primary Total Hip Replacements. [&#8230;] As more than five years have passed since the publication of these guidelines, we decided to review the effect it has had, and the extent to which the guidelines have influenced clinical practice and contracting"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:39:12 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Santerre-1996">
<DESCRIPTION>
<P>Quote, pg. 317: "the ACOG guideline essentially states that a previous birth by cesarean is no longer a good reason for doing one again in the future.  Consequently, if guidelines are effective at altering practice patterns, a noticeable increase in the VBAC rate should be detected after 1988 when the ACOG guideline was established"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:39:11 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shah-2008">
<DESCRIPTION>
<P>Quote, pg. 871: "we sought to determine whether physicians&#8217; choices of glucose-lowering medications changed in the immediate aftermath of the publication of the meta-analysis"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:39:11 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Stafford-2004">
<DESCRIPTION>
<P>Quote, pg. 55: "our analytic goals were 2-fold: to describe patterns of &#945;-blocker use before and after the April 2000 publication of the early ALLHAT results and to examine whether these clinical trial results or alternative influences were associated with changes in &#945;-blocker prescribing that occurred in this time frame"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 09:07:02 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tsuji-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:39:09 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2005">
<DESCRIPTION>
<P>Quote, pg. 2942: "The publication of the ADA and ATP III guidelines provides an opportunity to assess the effect of guideline changes on LDL cholesterol reporting and control for diabetes visits"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 09:26:31 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Watson-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:39:08 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Weiss-2011">
<DESCRIPTION>
<P>Quote, pg. 2: "the main objective of this study was to assess the impact of a multipronged, mostly Web-based education strategy on the per capita number and  cost of antibiotic prescriptions in the province of Quebec and to compare the trends with those the other 9 Canadian provinces"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-14" LEVEL="STUDY" MODIFIED="2012-09-10 10:50:12 -0400" MODIFIED_BY="[Empty name]" NO="14">
<NAME>Intervention unlikely to affect data collection - ITS</NAME>
<DESCRIPTION>
<P>Bias due to the intervention changing the source or method of data collection</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:04:40 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Austin-2003">
<DESCRIPTION>
<P>COMMENT: the intervention (publication of the WHI study in 2002) did not affect either the source or method of data collection</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:05:24 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Austin-2004A">
<DESCRIPTION>
<P>Quote, pg. 191: "Retrospective, population-based administrative database design"</P>
<P>COMMENT: the intervention itself is unlikely to affect data collection</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:19:55 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Austin-2004B">
<DESCRIPTION>
<P>The intervention (publication of the ALLHAT study in 2002) did not affect either the source or method of data collection</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:50:12 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Austin-2005">
<DESCRIPTION>
<P>Quote pg. 1297: "we studied claims for statins to Ontario's universal Drug Benefit program for seniors (ODB) between June 1, 1997 (the month atorvastatin was added to the ODB formulary), and September 30, 2004. The ODB tracks medication use by all 1.4 million residents of Ontario older than 65 years" </P>
<P>COMMENT: data source and method of collection unchanged throughout study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Avorn-1983">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Azocar-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:20:22 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Barbaglia-2009">
<DESCRIPTION>
<P>Data were collected during a breast screening programme that was not affected by the release of the trial</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:29:12 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bearcroft-1994">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:30:51 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Beaulieu-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:33:30 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bjornson-1990">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:48 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Black-2002">
<DESCRIPTION>
<P>The intervention (publication of the Effective Health Care bulletin on childhood surgery for glue ear - 1992) did not affect either the source or method of data collection</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:47 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Buyle-2010">
<DESCRIPTION>
<P>The intervention (publication/dissemination of guideline in the local drug letter in October 2003) did not affect either the source or method of data collection</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:47 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Coopersmith-2002">
<DESCRIPTION>
<P>The intervention (10-page self-study module about catheter-related bloodstream infections) did not affect either the source or method of data collection</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:36:26 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Denig-1990">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:38:58 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dormuth-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:45 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fijn-2000">
<DESCRIPTION>
<P>The intervention did not affect the source (community pharmacies in the InterAction working group) or the method of data collection</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:44 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fonarow-2009">
<DESCRIPTION>
<P>The interventions (MIRACL, ACC/AHA NSTEMI Guideline, PROVE IT-TIMI 22, ACC/AHA STEMI Guideline) did not affect either the source or method of data collection</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:43 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fukuda-2009">
<DESCRIPTION>
<P>The intervention (evidence-based clinical practice guidelines) did not affect either the source or method of data collection</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:43 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Guay-2007">
<DESCRIPTION>
<P>The intervention (WHI study) did not affect either the source or method of data collection</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:42 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Haas-2004">
<DESCRIPTION>
<P>The interventions (HERS study; WHI Study) did not affect either the source or method of data collection</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:41 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hersh-2004">
<DESCRIPTION>
<P>The interventions (HERS study; HERS II;  WHI Study) did not affect either the source or method of data collection</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:41 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jackevicius-2001">
<DESCRIPTION>
<P>The intervention (4S) did not affect either the source or method of data collection</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:40 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jameson-2010">
<DESCRIPTION>
<P>The intervention (NICE guidelines on prophylaxis against venous thromboembolism)  did not affect either the source or method of data collection</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:45:09 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jousimaa-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:39 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Juurlink-2004">
<DESCRIPTION>
<P>The intervention (RALES)  did not affect either the source or method of data collection</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:38 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kabir-2007">
<DESCRIPTION>
<P>The interventions (LIFE, ALLHAT, and VALUE studies)  did not affect either the source or method of data collection</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:48:00 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kajita-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:50:10 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kottke-1989">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:36 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lam-2009">
<DESCRIPTION>
<P>The intervention (4D) did not affect either the source or the method of data collection</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:35 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Majumdar-2003">
<DESCRIPTION>
<P>The interventions studied (HOPE; RALES) did not affect either the source or the method of data collection</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:34 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Majumdar-2004">
<DESCRIPTION>
<P>The intervention (WHI study) did not affect either source or method of data collection</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:34 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mason-1998_x002f_99">
<DESCRIPTION>
<P>The Effective Health Care Bulletin (the intervention) did not affect the data source (Prescriptions Pricing Authority) or the method of data collection</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:33 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mason-2001">
<DESCRIPTION>
<P>The intervention (Effective Health Care bulletin) did not affect either the source or the method of data collection</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:32 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Matowe-2002">
<DESCRIPTION>
<P>The intervention did not affect the data source (hospital radiology department records), and sources and methods of data collection were the same before and after the intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:32 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Meyer-2007">
<DESCRIPTION>
<P>The intervention (written guidelines) did not affect the source or method of data collection</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:53:20 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Oakeshott-1994">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:58:50 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Perria-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:30 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Roberts-2007">
<DESCRIPTION>
<P>The intervention (NICE Technology Appraisal Guideline 2) did not affect either the source or method of data collection</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:39:12 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Santerre-1996">
<DESCRIPTION>
<P>The intervention (ACOG guidelines) did not affect either the source or method of data collection</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:39:11 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Shah-2008">
<DESCRIPTION>
<P>The intervention (publication of report on rosiglitazone) did not affect either the source or the method of data collection</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:39:11 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stafford-2004">
<DESCRIPTION>
<P>The intervention (publication of ALLHAT) did not affect either the source or the method of data collection</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 09:07:02 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tsuji-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:39:09 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2005">
<DESCRIPTION>
<P>The interventions (ADA guidelines and ATP III  guidelines) did not affect either the source or the method of data collection</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 09:26:32 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Watson-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:39:08 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Weiss-2011">
<DESCRIPTION>
<P>The intervention (education guidelines) did not affect either the source or the method of data collection</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-15" LEVEL="GROUP" MODIFIED="2012-09-10 10:50:12 -0400" MODIFIED_BY="[Empty name]" NO="15">
<NAME>Blinding of outcome assessors (detection bias) - ITS</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors.</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-15.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" MODIFIED="2012-09-10 10:04:40 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Austin-2003">
<DESCRIPTION>
<P>The outcome was objective</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" MODIFIED="2012-09-10 10:05:24 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Austin-2004A">
<DESCRIPTION>
<P>The outcome was objective</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" MODIFIED="2012-09-10 10:19:55 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Austin-2004B">
<DESCRIPTION>
<P>The outcome was objective</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" MODIFIED="2012-09-10 10:50:12 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Austin-2005">
<DESCRIPTION>
<P>The outcome was objective</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" RESULT="UNKNOWN" STUDY_ID="STD-Avorn-1983">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" RESULT="UNKNOWN" STUDY_ID="STD-Azocar-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" MODIFIED="2012-09-10 10:20:22 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Barbaglia-2009">
<DESCRIPTION>
<P>COMMENT: patients included in the study were interviewed at a breast cancer screening programme. The highly publicised nature of the WHI study suggests the possibility that the outcome assessor (patient) would be aware of the intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" RESULT="UNKNOWN" STUDY_ID="STD-Bearcroft-1994">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" RESULT="UNKNOWN" STUDY_ID="STD-Beaulieu-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" RESULT="UNKNOWN" STUDY_ID="STD-Bjornson-1990">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" MODIFIED="2012-09-10 10:21:48 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Black-2002">
<DESCRIPTION>
<P>The outcome was objective</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" MODIFIED="2012-09-10 10:21:47 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Buyle-2010">
<DESCRIPTION>
<P>The outcome was objective</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" MODIFIED="2012-09-10 10:21:47 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Coopersmith-2002">
<DESCRIPTION>
<P>The outcome was objective</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" RESULT="UNKNOWN" STUDY_ID="STD-Denig-1990">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" RESULT="UNKNOWN" STUDY_ID="STD-Dormuth-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" MODIFIED="2012-09-10 10:21:45 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fijn-2000">
<DESCRIPTION>
<P>The outcome was objective</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" MODIFIED="2012-09-10 10:21:44 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fonarow-2009">
<DESCRIPTION>
<P>Outcome was objective</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" MODIFIED="2012-09-10 10:21:43 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fukuda-2009">
<DESCRIPTION>
<P>The outcome was objective</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" MODIFIED="2012-09-10 10:21:43 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Guay-2007">
<DESCRIPTION>
<P>The outcome was objective</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" MODIFIED="2012-09-10 10:21:42 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Haas-2004">
<DESCRIPTION>
<P>The outcome was objective</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" MODIFIED="2012-09-10 10:21:41 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hersh-2004">
<DESCRIPTION>
<P>The outcome was objective</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" MODIFIED="2012-09-10 10:21:41 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jackevicius-2001">
<DESCRIPTION>
<P>The outcome was objective.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" MODIFIED="2012-09-10 10:21:40 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jameson-2010">
<DESCRIPTION>
<P>The outcome was objective</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" RESULT="UNKNOWN" STUDY_ID="STD-Jousimaa-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" MODIFIED="2012-09-10 10:21:39 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Juurlink-2004">
<DESCRIPTION>
<P>The outcome was objective</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" MODIFIED="2012-09-10 10:21:38 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kabir-2007">
<DESCRIPTION>
<P>The outcome was objective</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" RESULT="UNKNOWN" STUDY_ID="STD-Kajita-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" RESULT="UNKNOWN" STUDY_ID="STD-Kottke-1989">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" MODIFIED="2012-09-10 10:21:35 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lam-2009">
<DESCRIPTION>
<P>The outcome was objective</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" MODIFIED="2012-09-10 10:21:35 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Majumdar-2003">
<DESCRIPTION>
<P>The outcome was objective</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" MODIFIED="2012-09-10 10:21:34 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Majumdar-2004">
<DESCRIPTION>
<P>The outcome was objective</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" MODIFIED="2012-09-10 10:21:34 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mason-1998_x002f_99">
<DESCRIPTION>
<P>The outcome was objective</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" MODIFIED="2012-09-10 10:21:33 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mason-2001">
<DESCRIPTION>
<P>The outcome was objective</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" MODIFIED="2012-09-10 10:21:32 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Matowe-2002">
<DESCRIPTION>
<P>The outcome was objective</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" MODIFIED="2012-09-10 10:21:32 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Meyer-2007">
<DESCRIPTION>
<P>The outcome was objective</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" RESULT="UNKNOWN" STUDY_ID="STD-Oakeshott-1994">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" RESULT="UNKNOWN" STUDY_ID="STD-Perria-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" MODIFIED="2012-09-10 10:21:30 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Roberts-2007">
<DESCRIPTION>
<P>The outcome was objective</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" MODIFIED="2012-09-10 10:39:12 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Santerre-1996">
<DESCRIPTION>
<P>The outcome was objective</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" MODIFIED="2012-09-10 10:39:11 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Shah-2008">
<DESCRIPTION>
<P>The outcome was objective</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" MODIFIED="2012-09-10 10:39:11 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stafford-2004">
<DESCRIPTION>
<P>The outcome was objective</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" RESULT="UNKNOWN" STUDY_ID="STD-Tsuji-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" MODIFIED="2012-09-10 10:39:09 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2005">
<DESCRIPTION>
<P>The outcome was objective</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" RESULT="UNKNOWN" STUDY_ID="STD-Watson-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" MODIFIED="2012-09-10 10:39:08 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Weiss-2011">
<DESCRIPTION>
<P>The outcome was objective</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-16" LEVEL="GROUP" MODIFIED="2012-09-10 10:50:12 -0400" MODIFIED_BY="[Empty name]" NO="16">
<NAME>Incomplete outcome data (attrition bias) - ITS</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data.</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-16.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-16.01" MODIFIED="2012-09-10 10:04:40 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Austin-2003">
<DESCRIPTION>
<P>Quote, pg. 3241: "we studied claims for ERT to Ontario's universal Drug Benefit program for seniors (ODB), which tracks medication use by all 1.3 million residents of Ontario older than 65 years"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-16.01" MODIFIED="2012-09-10 10:05:24 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Austin-2004A">
<DESCRIPTION>
<P>Quote, pg. 192: "we studied incident claims for clonidine to Ontario's universal Drug Benefit program for seniors (ODB), which tracks medication use by all 1.3 million residents of Ontario 65 years of age and older"  </P>
<P>COMMENT: data is collected pre- and post-intervention from same province wide data base</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-16.01" MODIFIED="2012-09-10 10:19:55 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Austin-2004B">
<DESCRIPTION>
<P>Quote, pg. 44: "we studied claims for antihypertensive agents that were submitted to the Ontario Drug Benefit (ODB) program between January 1, 1992, and April 30, 2003. The ODB program tracks prescriptions dispensed to all 1.3 million residents of Ontario older than 65 years.antihypertensive agents following publication of the ALLHAT trial"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-16.01" MODIFIED="2012-09-10 10:50:12 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Austin-2005">
<DESCRIPTION>
<P>The authors used the complete database of all prescription on Ontario, so there is no missing data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-16.01" RESULT="UNKNOWN" STUDY_ID="STD-Avorn-1983">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-16.01" RESULT="UNKNOWN" STUDY_ID="STD-Azocar-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-16.01" MODIFIED="2012-09-10 10:20:22 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Barbaglia-2009">
<DESCRIPTION>
<P>COMMENT: specific data on loss to follow-up was not given for pre-post-intervention or by age group. However, a very small percentage was lost. Quote, pg. 1062: "we excluded 1,467 women (2.8%) from the analysis because of their inconsistencies in successive answers about HT use as well as 42 women (0.1%) who refused to complete the questionnaire"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-16.01" RESULT="UNKNOWN" STUDY_ID="STD-Bearcroft-1994">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-16.01" RESULT="UNKNOWN" STUDY_ID="STD-Beaulieu-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-16.01" RESULT="UNKNOWN" STUDY_ID="STD-Bjornson-1990">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-16.01" MODIFIED="2012-09-10 10:21:48 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Black-2002">
<DESCRIPTION>
<P>Quote, pg. 121-122: "adjustments were made for shortfalls in the clinical coding in otolaryngology, which never exceeded a few percent in any year. It was assumed that failure to code procedures was not influenced by the procedure carried out. Intervention rates for surgery for OME were therefore adjusted according to the overall shortfall for the specialty" </P>
<P>COMMENT: the authors do not provide numbers to support "a few percent"; however, it seems reasonable to infer that it is less than 10%</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-16.01" MODIFIED="2012-09-10 10:21:47 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Buyle-2010">
<DESCRIPTION>
<P>COMMENT: the reasons for loss to follow-up were similar. The number lost was low and similarly distributed between groups (2/36 from control group; 5/45 in total from the 2 intervention groups)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-16.01" MODIFIED="2012-09-10 10:21:47 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Coopersmith-2002">
<DESCRIPTION>
<P>Quote, pg. 60: "all patients admitted to the ICU between January 1, 1998, and June 30, 1999, were followed prospectively by an infection control team and surveyed for bloodstream infections"</P>
<P>COMMENT: while this implies complete data follow-up, this is not specified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-16.01" RESULT="UNKNOWN" STUDY_ID="STD-Denig-1990">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-16.01" RESULT="UNKNOWN" STUDY_ID="STD-Dormuth-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-16.01" MODIFIED="2012-09-10 10:21:44 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fijn-2000">
<DESCRIPTION>
<P>The complete databases from 10 pharmacies were used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-16.01" MODIFIED="2012-09-10 10:21:44 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fonarow-2009">
<DESCRIPTION>
<P>National registries were used all along the study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-16.01" MODIFIED="2012-09-10 10:21:43 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fukuda-2009">
<DESCRIPTION>
<P>The complete database of 10 teaching hospital in Japan was used for the study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-16.01" MODIFIED="2012-09-10 10:21:43 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Guay-2007">
<DESCRIPTION>
<P>The authors provide a thorough description of the proportions of patients removed from analysis by inclusion and exclusion criteria. There was a 10% difference between loss to follow-up in pre-WHI cohort (39% loss) and the post-WHI cohort (49%), and the reasons for loss were similar. The cohorts were considerably different in absolute size, but this was attributable to the large difference in the time-frame (16,560 patients, 3 years in pre-WHI vs. 2067 women in 9 months post-WHI)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-16.01" MODIFIED="2012-09-10 10:21:42 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Haas-2004">
<DESCRIPTION>
<P>The San Francisco mammography registry was used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-16.01" MODIFIED="2012-09-10 10:21:41 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hersh-2004">
<DESCRIPTION>
<P>Data come from 2 nationally representative databases</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-16.01" MODIFIED="2012-09-10 10:21:41 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jackevicius-2001">
<DESCRIPTION>
<P>Quote, pg. 184: "all Ontario residents 65 years or older are covered under a comprehensive drug benefit plan. Each time a prescription is filled, a claim is submitted to the provincial government that contains the patient health insurance number and a unique drug identifier. The Ontario Myocardial Infarction Database provides data on all elderly patients treated for AMI in any Ontario hospital and records any prescriptions filled after hospital discharge"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-16.01" MODIFIED="2012-09-10 10:21:40 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jameson-2010">
<DESCRIPTION>
<P>COMMENT: an exclusion criterion was described as "missing date of operation" in patient records and while the number and distribution between pre- and post-guideline periods is not given, it is likely to be small and evenly distributed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-16.01" RESULT="UNKNOWN" STUDY_ID="STD-Jousimaa-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-16.01" MODIFIED="2012-09-10 10:21:38 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Juurlink-2004">
<DESCRIPTION>
<P>Quote, pg. 544: "we examined the computerized prescription records of the Ontario Drug Benefit Program, which records prescription drugs dispensed to all Ontario residents 65 years of age or older. The overall error rate in this database is less than 1 percent. Hospitalization records were obtained from the Canadian Institute for Health Information Discharge Abstract Database, which contains a record of all hospitalizations, including up to 16 diagnoses for each admission. Although the accuracy of coding in this database has not been established for all diagnoses, one recent study showed a positive predictive value of 90 to 96 percent for the diagnosis of heart failure."</P>
<P>COMMENT: the authors establish that the databases used as sources are accurate and complete</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-16.01" MODIFIED="2012-09-10 10:21:38 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kabir-2007">
<DESCRIPTION>
<P>Data were collected from a regional database</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-16.01" RESULT="UNKNOWN" STUDY_ID="STD-Kajita-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-16.01" RESULT="UNKNOWN" STUDY_ID="STD-Kottke-1989">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-16.01" MODIFIED="2012-09-10 10:21:35 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lam-2009">
<DESCRIPTION>
<P>Quote, pg. 1177: "we used database codes with proven validity as detailed in Supplementary Appendix B. All of these data source have been successfully used in previous studies to examine prescribing rates of statins and a number of other medications in Ontario" </P>
<P>COMMENT: 4 databases were used as sources in this report, all of which are comprehensive. Missing data were likely to be very low</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-16.01" MODIFIED="2012-09-10 10:21:35 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Majumdar-2003">
<DESCRIPTION>
<P>Quote, pg. 468: "We used nationally representative drug dispensing information collected by IMS Health (IMS Health-Canada and IMS Health-America), which conducts research on prescribing patterns. Methods for data collection are identical in Canada and the United States. The IMS "CompuScript" database collects monthly dispensing records from a representative sample of retail pharmacies. The sample is drawn from 4800 pharmacies in Canada and 51,355 pharmacies in the United States, about two thirds of retail pharmacies" </P>
<P>COMMENT: missing data, if any, were likely to be similar pre- and post-intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-16.01" MODIFIED="2012-09-10 10:21:34 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Majumdar-2004">
<DESCRIPTION>
<P>Quote, pg. 1984: "we used nationally representative databases published by IMS Health (Plymouth Meeting, Pa), an independent pharmaceutical research company, to describe national trends in hormone therapy prescription and promotion. Information on prescriptions was obtained from the NPA, which we have described in detail elsewhere"</P>
<P>COMMENT: missing data, if any, is likely to be similar pre- and post-intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-16.01" MODIFIED="2012-09-10 10:21:34 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mason-1998_x002f_99">
<DESCRIPTION>
<P>Quote, pg. 120: "these data reflect the total number of prescriptions reimbursed for antidepressants on a quarterly basis" </P>
<P>COMMENT: if a patient does not seek or receive reimbursement, this data could be missed, but this is unlikely to be affected by the publication of the PEMs</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-16.01" MODIFIED="2012-09-10 10:21:33 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mason-2001">
<DESCRIPTION>
<P>Quote, pg. 1096: "quarterly numbers of D151 procedures&#8212;insertion of a ventilation tube through the tympanic membrane &#8212; performed in children aged under 15 in England from 1989 to 1996 were obtained from the hospital episodes system. We calculated per capita regional and national rates for this procedure" </P>
<P>COMMENT: missing data, if any, were likely to be similar pre- and post-intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-16.01" MODIFIED="2012-09-10 10:21:32 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Matowe-2002">
<DESCRIPTION>
<P>Quote, pg. 576: "data were abstracted from the computerized administrative systems of two radiology departments serving over 90% of general practices in the region" </P>
<P>COMMENT: missing data from GPs not using these radiology departments is not considered but it is not a high proportion (10%)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-16.01" MODIFIED="2012-09-10 10:21:32 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Meyer-2007">
<DESCRIPTION>
<P>Quote, pg. 1149: "monthly data on antimicrobial usage and costs of antibiotics were obtained from the computerized pharmacy database" </P>
<P>COMMENT: missing data, if any, is likely similar pre- and post-intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-16.01" RESULT="UNKNOWN" STUDY_ID="STD-Oakeshott-1994">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-16.01" RESULT="UNKNOWN" STUDY_ID="STD-Perria-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-16.01" MODIFIED="2012-09-10 10:21:29 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Roberts-2007">
<DESCRIPTION>
<P>Quote, pg. 865: "since the beginning of 1990, and with the agreement of all consultant orthopaedic surgeons in the region, all primary total hip and knee replacements (THR, TKR) performed throughout the Trent region were recorded prospectively"</P>
<P>COMMENT: it is unlikely that there would be a difference in missing data before and after implementation of the intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-16.01" MODIFIED="2012-09-10 10:39:12 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Santerre-1996">
<DESCRIPTION>
<P>The data set came from 55 Massachusetts hospitals from 1987 to 1991</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-16.01" MODIFIED="2012-09-10 10:39:11 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Shah-2008">
<DESCRIPTION>
<P>Quote, pg. 871: "we examined prescription claims in the Ontario Drug Benefits (ODB) programme database, which contains records of all prescription medications dispensed to Ontario residents aged &#8805; 65 years. We restricted our analysis to people aged &#8805; 66 years (approximate n = 1.5 million), purposefully excluding the first year of eligibility to avoid incomplete medication records"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-16.01" MODIFIED="2012-09-10 10:39:11 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stafford-2004">
<DESCRIPTION>
<P>2 databases were used as sources of prescribing information pre- and post-intervention. Missing data, if any, were likely to be similar  pre- and post-intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-16.01" RESULT="UNKNOWN" STUDY_ID="STD-Tsuji-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-16.01" MODIFIED="2012-09-10 10:39:09 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2005">
<DESCRIPTION>
<P>Quote, pg. 2942: "we used the National Disease and Therapeutic Index (NDTI) (3), an ongoing survey of U.S. office-based physicians conducted by IMS Health providing nationally representative diagnostic and treatment data, to analyze the national trends of LDL cholesterol reporting and control for diabetes and CHD visits by year between 1995 and 2004"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-16.01" RESULT="UNKNOWN" STUDY_ID="STD-Watson-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-16.01" MODIFIED="2012-09-10 10:39:08 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Weiss-2011">
<DESCRIPTION>
<P>Quote, pg. 2: "the province of Quebec, Canada (2009 population, 7.8 million) has a universal health care insurance program in which medical visits, required investigations, and treatments (whether outpatient or inpatient) are provided free of charge to all citizens. In 1997, the Quebec government instituted a  universal drug plan in which everybody has to be covered by either private insurance obtained through his or her employer (57% of the population) or by the  public plan (43% of the population). Other provinces have similar drug plans, but not as extensive as that in Quebec"  COMMENT:  data for Quebec were likely to be complete, but no information was specified for the other provinces</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-17" LEVEL="STUDY" MODIFIED="2012-09-10 10:50:12 -0400" MODIFIED_BY="[Empty name]" NO="17">
<NAME>Selective reporting (reporting bias) - ITS</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:04:40 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Austin-2003">
<DESCRIPTION>
<P>All relevant outcomes in the methods section were reported in the results section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:05:24 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Austin-2004A">
<DESCRIPTION>
<P> All relevant outcomes in the methods section were reported in the results section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:19:55 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Austin-2004B">
<DESCRIPTION>
<P>All relevant outcomes in the methods section were reported in the results section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:50:12 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Austin-2005">
<DESCRIPTION>
<P> All relevant outcomes in the methods section were reported in the results section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Avorn-1983">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Azocar-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:20:22 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Barbaglia-2009">
<DESCRIPTION>
<P>All relevant outcomes in the methods section were reported in results section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:29:12 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bearcroft-1994">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:30:52 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Beaulieu-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:33:30 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bjornson-1990">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:48 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Black-2002">
<DESCRIPTION>
<P>All relevant outcomes in the methods section were reported in results section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:47 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Buyle-2010">
<DESCRIPTION>
<P>All relevant outcomes in the methods section were reported in results section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:47 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Coopersmith-2002">
<DESCRIPTION>
<P>All relevant outcomes in the methods section were reported in results section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:36:26 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Denig-1990">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:38:58 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dormuth-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:44 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fijn-2000">
<DESCRIPTION>
<P>All relevant outcomes in the methods section were reported in results section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:44 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fonarow-2009">
<DESCRIPTION>
<P>All relevant outcomes in the methods section were reported in results section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:43 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fukuda-2009">
<DESCRIPTION>
<P>All relevant outcomes in the methods section were reported in results section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:43 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Guay-2007">
<DESCRIPTION>
<P>All relevant outcomes in the methods section were reported in results section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:42 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Haas-2004">
<DESCRIPTION>
<P>All relevant outcomes in the methods section were reported in results section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:41 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hersh-2004">
<DESCRIPTION>
<P>All relevant outcomes in the methods section were reported in results section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:41 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jackevicius-2001">
<DESCRIPTION>
<P>All relevant outcomes in the methods section were reported in results section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:40 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jameson-2010">
<DESCRIPTION>
<P>All relevant outcomes in the methods section were reported in results section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:45:10 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jousimaa-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:38 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Juurlink-2004">
<DESCRIPTION>
<P>All relevant outcomes in the methods section were reported in results section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:38 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kabir-2007">
<DESCRIPTION>
<P>All relevant outcomes in the methods section were reported in results section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:48:00 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kajita-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:50:10 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kottke-1989">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:35 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lam-2009">
<DESCRIPTION>
<P>All relevant outcomes in the methods section were reported in results section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:35 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Majumdar-2003">
<DESCRIPTION>
<P>All relevant outcomes in the methods section were reported in results section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:34 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Majumdar-2004">
<DESCRIPTION>
<P>All relevant outcomes in the methods section were reported in results section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:34 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mason-1998_x002f_99">
<DESCRIPTION>
<P>All relevant outcomes in the methods section were reported in the results section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:33 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mason-2001">
<DESCRIPTION>
<P>All relevant outcomes in the methods section were reported in the results section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:32 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Matowe-2002">
<DESCRIPTION>
<P>All relevant outcomes in the methods section were reported in the results section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:32 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Meyer-2007">
<DESCRIPTION>
<P>All relevant outcomes in the methods section were reported in the results section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:53:20 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Oakeshott-1994">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:58:50 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Perria-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:29 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Roberts-2007">
<DESCRIPTION>
<P>All relevant outcomes in the methods section were reported in the results section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:39:12 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Santerre-1996">
<DESCRIPTION>
<P>All relevant outcomes in the methods section were reported in the results section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:39:11 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Shah-2008">
<DESCRIPTION>
<P>All relevant outcomes in the methods section were reported in the results section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:39:11 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stafford-2004">
<DESCRIPTION>
<P>All relevant outcomes in the methods section were reported in the results section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 09:07:02 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tsuji-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:39:09 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2005">
<DESCRIPTION>
<P>All relevant outcomes in the methods section were reported in the results section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 09:26:32 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Watson-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:39:08 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Weiss-2011">
<DESCRIPTION>
<P>All relevant outcomes in the methods section were reported in the results section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-18" LEVEL="STUDY" MODIFIED="2012-09-10 10:50:12 -0400" MODIFIED_BY="[Empty name]" NO="18">
<NAME>Other bias - ITS</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:04:40 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Austin-2003">
<DESCRIPTION>
<P>There was no evidence of other risks of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:05:24 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Austin-2004A">
<DESCRIPTION>
<P>There was no evidence of other risks of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:19:55 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Austin-2004B">
<DESCRIPTION>
<P>There was no evidence of other risks of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:50:12 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Austin-2005">
<DESCRIPTION>
<P>There was no evidence of other risks of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Avorn-1983">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Azocar-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:20:22 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Barbaglia-2009">
<DESCRIPTION>
<P>The primary outcome is not objective (self report)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:29:12 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bearcroft-1994">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:30:52 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Beaulieu-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:33:30 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bjornson-1990">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:48 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Black-2002">
<DESCRIPTION>
<P>There was no evidence of other risks of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:47 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Buyle-2010">
<DESCRIPTION>
<P>Quote, pg. 408-409: "the IV/PO ratio may be an indicator for implementing sequential therapy but could be biased by confounding factors. An example of a possible confounding factor is the length of stay of the patients. Patients who are switched to an oral therapy could be discharged earlier as the oral therapy can easily be continued at home. In this case the IV/PO ratio will increase as we only look at the consumption in the hospital"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:47 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Coopersmith-2002">
<DESCRIPTION>
<P>Quote, pg. 63: "in a pre- and post observational, non randomized study, the ICU staff is not blinded to either the presence of or the recipients of the intervention. This raises the possibility of staff behaviour changes based upon the widespread knowledge of the measured outcome"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:36:26 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Denig-1990">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:38:58 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dormuth-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:44 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fijn-2000">
<DESCRIPTION>
<P>There was no evidence of other risks of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:44 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fonarow-2009">
<DESCRIPTION>
<P>There was no evidence of other risks of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:43 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fukuda-2009">
<DESCRIPTION>
<P>There was no evidence of other risks of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:42 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Guay-2007">
<DESCRIPTION>
<P>There was no evidence of other risks of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:42 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Haas-2004">
<DESCRIPTION>
<P>There was no evidence of other risks of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:41 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hersh-2004">
<DESCRIPTION>
<P>There was no evidence of other risks of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:40 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jackevicius-2001">
<DESCRIPTION>
<P>There was no evidence of other risks of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:40 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jameson-2010">
<DESCRIPTION>
<P>There was no evidence of other risks of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:45:23 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jousimaa-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:38 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Juurlink-2004">
<DESCRIPTION>
<P>Quote, pg. 550: "indeed, many of the patients hospitalized for hyperkalemia may have died of another illness. The diagnostic coding for hyperkalemia has not been validated; moreover, many patients hospitalized for hyperkalemia may have also had volume contraction or renal insufficiency related to spironolactone therapy. In addition, we were unable to identify adverse outcomes that occurred before admission" </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:38 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kabir-2007">
<DESCRIPTION>
<P>There was no evidence of other risks of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:48:00 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kajita-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:50:10 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kottke-1989">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:35 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lam-2009">
<DESCRIPTION>
<P>There was no evidence of other risks of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:35 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Majumdar-2003">
<DESCRIPTION>
<P>There was no evidence of other risks of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:34 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Majumdar-2004">
<DESCRIPTION>
<P>There was no evidence of other risks of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:34 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mason-1998_x002f_99">
<DESCRIPTION>
<P>There was no evidence of other risks of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:33 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mason-2001">
<DESCRIPTION>
<P>There was no evidence of other risks of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:32 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Matowe-2002">
<DESCRIPTION>
<P>There was no evidence of other risks of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:32 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Meyer-2007">
<DESCRIPTION>
<P>There was no evidence of other risks of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:53:20 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Oakeshott-1994">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 08:58:50 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Perria-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:21:29 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Roberts-2007">
<DESCRIPTION>
<P>There was no evidence of other risks of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:39:12 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Santerre-1996">
<DESCRIPTION>
<P>There was no evidence of other risks of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:39:11 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Shah-2008">
<DESCRIPTION>
<P>There was no evidence of other risks of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:39:11 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stafford-2004">
<DESCRIPTION>
<P>There was no evidence of other risks of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 09:07:02 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tsuji-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:39:09 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2005">
<DESCRIPTION>
<P>There was no evidence of other risks of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-28 09:26:32 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Watson-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-10 10:39:08 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Weiss-2011">
<DESCRIPTION>
<P>There was no evidence of other risks of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2012-02-27 11:52:45 -0500" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2012-02-27 11:52:45 -0500" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-07.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2015-03-06 09:24:14 -0500" MODIFIED_BY="[Empty name]">
<SOF_TABLE ID="SOF-01" MODIFIED="2015-03-06 09:24:14 -0500" MODIFIED_BY="[Empty name]" NO="1" READONLY="YES">
<TITLE MODIFIED="2012-09-10 11:05:46 -0400" MODIFIED_BY="Grade Profiler">Printed educational material vs. no intervention</TITLE>
<TABLE COLS="4" ROWS="7">
<TR>
<TD COLSPAN="4">
<P>
<B>Printed educational material vs. no intervention</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="4">
<P>
<B>Patient or population:</B> healthcare professionals (physicians in 9/10 studies)<BR/>
<B>Settings: </B>multiple settings<BR/>
<B>Intervention:</B> printed educational material<BR/>
<B>Comparison: n</B>o intervention</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Outcomes*</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Standard median effect size</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>No of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
</TR>
<TR>
<TD>
<P>
<B>Categorical measure of professional practice</B>
<BR/>Absolute risk difference across various outcomes<BR/>Mean follow-up: 6 months</P>
</TD>
<TD>
<P>
<B>0.02 higher</B> (range from 0.00 to +0.11)</P>
</TD>
<TD>
<P>294,937<BR/>(7 studies)</P>
</TD>
<TD>
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>1, 2, 3</SUP>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Continuous measure of professional practice</B>
<BR/>Standardised mean difference across various outcomes<BR/>Mean follow-up: 9 months</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>0.13 higher </B>(range from -0.16 to +0.36)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>297<BR/>(3 studies)</P>
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP> 3,4,5</SUP>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="4">
<P>* Where studies reported more than one measure of each endpoint, the primary measure (as defined by the authors of the study) or the median measure was abstracted. For <B>categorical measures</B>, we calculated the odds ratio between the intervention of interest and the control intervention. For <B>continuous endpoints</B>, we calculated standardised mean difference by dividing the mean score difference of the intervention and comparison groups in each study by the pooled estimate standard deviation for the two groups</P>
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="4">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP> Unclear sequence generation.</P>
<P>
<SUP>2 </SUP>Unclear addressing of incomplete outcome data.</P>
<P>
<SUP>3</SUP> Imprecision of the observed effect - the analyses used do not allow computing confidence intervals to support an evaluation of the precision of the estimate. However, most of the median effect sizes of the individual studies included were imprecise.</P>
<P>
<SUP>4 </SUP>Inadequate allocation concealment.<BR/>5 Inconsistency: one study measured a deterioration in outcomes whereas the other two showed improvements.</P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES MODIFIED="2012-09-10 11:19:11 -0400" MODIFIED_BY="[Empty name]">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2012-09-10 11:07:27 -0400" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2012-09-10 11:06:13 -0400" MODIFIED_BY="[Empty name]">Characteristics of the included interventions: source and channel of information</TITLE>
<TABLE COLS="7" ROWS="53">
<TR>
<TD>
<P/>
<P>
<B>Study (PEM)</B>
</P>
<P/>
</TD>
<TD>
<P>
<B>Source of information *</B>
</P>
</TD>
<TD>
<P>
<B>Endorsement</B>
</P>
</TD>
<TD>
<P>
<B>Tailoring <SUP>¶</SUP>
</B>
</P>
</TD>
<TD>
<P>
<B>Mode of delivery </B>
<SUP>¥</SUP>
</P>
</TD>
<TD>
<P>
<B>Frequency of delivery</B>
</P>
</TD>
<TD>
<P>
<B>Duration of delivery</B>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Austin 2003 (HERS trial report)</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
</TR>
<TR>
<TD>
<P>Austin 2004-A (WHI trial report)</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
</TR>
<TR>
<TD>
<P>Austin 2004-B (ALLHAT trial report)</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
</TR>
<TR>
<TD>
<P>Austin 2005</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
</TR>
<TR>
<TD>
<P>Avorn 1983</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>unclear</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>4 times</P>
</TD>
<TD>
<P>4-6 months</P>
</TD>
</TR>
<TR>
<TD>
<P>Azocar 2003</P>
</TD>
<TD>
<P>1; 3</P>
</TD>
<TD>
<P>unclear</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>once</P>
</TD>
<TD>
<P>once</P>
</TD>
</TR>
<TR>
<TD>
<P>Barbaglia 2009 (WHI trial report)</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
</TR>
<TR>
<TD>
<P>Bearcroft 1994</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>unclear</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>once</P>
</TD>
<TD>
<P>once</P>
</TD>
</TR>
<TR>
<TD>
<P>Beaulieu 2004</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>twice</P>
</TD>
<TD>
<P>1-3 months</P>
</TD>
</TR>
<TR>
<TD>
<P>Bjornson 1990</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>unclear</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>once</P>
</TD>
<TD>
<P>once</P>
</TD>
</TR>
<TR>
<TD>
<P>Black 2002 (EHC-OM bulletin)</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
</TR>
<TR>
<TD>
<P>Buyle 2010</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
</TR>
<TR>
<TD>
<P>Coopersmith 2002</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>unclear</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>7</P>
</TD>
<TD>
<P>once</P>
</TD>
<TD>
<P>once</P>
</TD>
</TR>
<TR>
<TD>
<P>Denig 1990</P>
</TD>
<TD>
<P>5</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>once</P>
</TD>
<TD>
<P>once</P>
</TD>
</TR>
<TR>
<TD>
<P>Dormuth 2004</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>4 times</P>
</TD>
<TD>
<P>&gt; 6 months</P>
</TD>
</TR>
<TR>
<TD>
<P>Fijn 2000</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
</TR>
<TR>
<TD>
<P>Fonarow 2009 (MIRACL trial report)</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
</TR>
<TR>
<TD>
<P>Fonarow 2009 (PROVE-IT TIMI 22 trial report)</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
</TR>
<TR>
<TD>
<P>Fonarow 2009 (ACC-AHA-STEMI guidelines)</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
</TR>
<TR>
<TD>
<P>Fonarow 2009 (AHA-AHA-NS guidelines)</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
</TR>
<TR>
<TD>
<P>Fukuda 2009</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
</TR>
<TR>
<TD>
<P>Guay 2007 (WHI publication)</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
</TR>
<TR>
<TD>
<P>Haas 2004 (HERS publication)</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
</TR>
<TR>
<TD>
<P>Haas 2004 (WHI publication)</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
</TR>
<TR>
<TD>
<P>Hersh 2004 (WHI; HERS; HERSIII publications)</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
</TR>
<TR>
<TD>
<P>Jackevicius 2001</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
</TR>
<TR>
<TD>
<P>Jameson 2010</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
</TR>
<TR>
<TD>
<P>Jousimaa 2002</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>unclear</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>once</P>
</TD>
<TD>
<P>once</P>
</TD>
</TR>
<TR>
<TD>
<P>Juurlink 2004</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
</TR>
<TR>
<TD>
<P>Kabir 2007 (LIFE publication)</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
</TR>
<TR>
<TD>
<P>Kabir 2007 (ALLHAT publication)</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
</TR>
<TR>
<TD>
<P>Kabir 2007 (VALUE trial report)</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
</TR>
<TR>
<TD>
<P>Kajita 2012</P>
</TD>
<TD>
<P>9</P>
</TD>
<TD>
<P>unclear</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>once</P>
</TD>
<TD>
<P>once</P>
</TD>
</TR>
<TR>
<TD>
<P>Kottke 1989</P>
</TD>
<TD>
<P>9</P>
</TD>
<TD>
<P>unclear</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>7</P>
</TD>
<TD>
<P>once</P>
</TD>
<TD>
<P>once</P>
</TD>
</TR>
<TR>
<TD>
<P>Lam 2009</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
</TR>
<TR>
<TD>
<P>Majumdar 2003 (HOPE trial report)</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
</TR>
<TR>
<TD>
<P>Majumdar 2003 (RALES trial report)</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
</TR>
<TR>
<TD>
<P>Majumdar 2004 (WHI trial report)</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
</TR>
<TR>
<TD>
<P>Mason 1998</P>
</TD>
<TD>
<P>9</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>once</P>
</TD>
<TD>
<P>once</P>
</TD>
</TR>
<TR>
<TD>
<P>Mason 2001 (EHC-OM bulletin)</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>once</P>
</TD>
<TD>
<P>once</P>
</TD>
</TR>
<TR>
<TD>
<P>Matowe 2002</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>once</P>
</TD>
<TD>
<P>once</P>
</TD>
</TR>
<TR>
<TD>
<P>Meyer 2007</P>
</TD>
<TD>
<P>1; 3</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>7</P>
</TD>
<TD>
<P>once</P>
</TD>
<TD>
<P>once</P>
</TD>
</TR>
<TR>
<TD>
<P>Oakeshott 1994</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>once</P>
</TD>
<TD>
<P>once</P>
</TD>
</TR>
<TR>
<TD>
<P>Perria 2007</P>
</TD>
<TD>
<P>1; 3</P>
</TD>
<TD>
<P>unclear</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>once</P>
</TD>
<TD>
<P>once</P>
</TD>
</TR>
<TR>
<TD>
<P>Roberts 2007</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>unclear</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
</TR>
<TR>
<TD>
<P>Santerre 1996</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
</TR>
<TR>
<TD>
<P>Shah 2008</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
</TR>
<TR>
<TD>
<P>Stafford 2004 (ALLHAT trial report)</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
</TR>
<TR>
<TD>
<P>Tsuji  2009</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>no</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>7</P>
</TD>
<TD>
<P>once</P>
</TD>
<TD>
<P>once</P>
</TD>
</TR>
<TR>
<TD>
<P>Wang 2005 (ADA guidelines; ATP III trial report)</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
<TD>
<P>indeterminate</P>
</TD>
</TR>
<TR>
<TD>
<P>Watson 2001</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>no</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>once</P>
</TD>
<TD>
<P>once</P>
</TD>
</TR>
<TR>
<TD>
<P>Weiss 2011</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>once</P>
</TD>
<TD>
<P>once</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>* Source of information: 1 = researchers / clinicians; 2 = university; 3 = local expert body; 4 = national professional expert body; 5 = national government expert body; 6 = local clinicians; 7 = international professional expert body; 8 = international government expert body; 9 = unclear.</P>
<P>
<SUP>¶</SUP> Tailoring: 1 = tailored to individuals based on diagnostic, behavioural, or motivational characteristics; 2 = tailored to groups of individuals; 3 = personalised, but not tailored (person's name on the information); 4 = generic; 5 = unclear.</P>
<P>
<SUP>¥</SUP> Mode of delivery: 1 = publication in peer-reviewed journal; 2 = passive dissemination; 3 = direct mailing; 4 = mass mailing; 5 = media; 6 = hand delivery; 7 = unclear.</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-02" MODIFIED="2012-09-10 11:08:33 -0400" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2012-09-10 11:07:03 -0400" MODIFIED_BY="[Empty name]">Characteristics of the included interventions: message</TITLE>
<TABLE COLS="6" ROWS="53">
<TR>
<TD>
<P>
<B>Study (PEM)</B>
</P>
</TD>
<TD>
<P>
<B>Clinical area</B>
</P>
</TD>
<TD>
<P>
<B>Type of targeted behaviour*</B>
</P>
</TD>
<TD>
<P>
<B>Purpose</B>
<SUP>¥</SUP>
</P>
</TD>
<TD>
<P>
<B>Level of evidence </B>
<SUP>&#8661;</SUP>
</P>
</TD>
<TD>
<P>
<B>Educational component <SUP>&#8710;</SUP>
</B>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Austin 2003 (HERS trial report)</P>
</TD>
<TD>
<P>Oestrogen replacement therapy for menopausal women</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>5</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Austin 2004-A (WHI trial report)</P>
</TD>
<TD>
<P>Oestrogen replacement therapy for menopausal women</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>5</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Austin 2004-B (ALLHAT trial report)</P>
</TD>
<TD>
<P>Hypertension</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Austin 2005</P>
</TD>
<TD>
<P>Cardiovascular disease</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Avorn 1983</P>
</TD>
<TD>
<P>No specific clinical area</P>
</TD>
<TD>
<P>1; 2</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>3</P>
</TD>
</TR>
<TR>
<TD>
<P>Azocar 2003</P>
</TD>
<TD>
<P>Depression</P>
</TD>
<TD>
<P>1; 3; 4; 5</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>3</P>
</TD>
</TR>
<TR>
<TD>
<P>Barbaglia 2009 (WHI trial report)</P>
</TD>
<TD>
<P>Oestrogen replacement therapy for menopausal women</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>5</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Bearcroft 1994</P>
</TD>
<TD>
<P>Chest radiography</P>
</TD>
<TD>
<P>5; 6; 7</P>
</TD>
<TD>
<P>5</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Beaulieu 2004</P>
</TD>
<TD>
<P>Stable angina</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>3</P>
</TD>
</TR>
<TR>
<TD>
<P>Bjornson 1990</P>
</TD>
<TD>
<P>Cardiovascular disease</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Black 2002 (EHC-OM bulletin)</P>
</TD>
<TD>
<P>Glue ear surgery</P>
</TD>
<TD>
<P>5; 8</P>
</TD>
<TD>
<P>5</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Buyle 2010</P>
</TD>
<TD>
<P>Antibiotic treatment</P>
</TD>
<TD>
<P>1; 2</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Coopersmith 2002</P>
</TD>
<TD>
<P>Central venous catheter insertion</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>9</P>
</TD>
<TD>
<P>3</P>
</TD>
</TR>
<TR>
<TD>
<P>Denig 1990</P>
</TD>
<TD>
<P>Antispasmodic drugs for Irritable bowel syndrome and renal colic spasms</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>9</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Dormuth 2004</P>
</TD>
<TD>
<P>No specific clinical area</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Fijn 2000</P>
</TD>
<TD>
<P>Antithrombotic therapy </P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Fonarow 2009 (MIRACL trial report)</P>
</TD>
<TD>
<P>Cardiovascular disease</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Fonarow 2009 (PROVE-IT TIMI 22 trial report)</P>
</TD>
<TD>
<P>Cardiovascular disease</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Fonarow 2009 (ACC-AHA-STEMI guidelines)</P>
</TD>
<TD>
<P>Cardiovascular disease</P>
</TD>
<TD>
<P>1; 3; 4; 5; 6; 7; 8; 9; 10; 11; 15</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Fonarow 2009 (AHA-AHA-NS guidelines)</P>
</TD>
<TD>
<P>Cardiovascular disease</P>
</TD>
<TD>
<P>1; 3; 4; 5; 6; 7; 8; 9; 10; 11; 15</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Fukuda 2009</P>
</TD>
<TD>
<P>Breast-conserving surgery</P>
</TD>
<TD>
<P>1; 8</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Guay 2007 (WHI publication)</P>
</TD>
<TD>
<P>Oestrogen replacement therapy for menopausal women</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>5</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Haas 2004 (HERS publication)</P>
</TD>
<TD>
<P>Oestrogen replacement therapy for menopausal women</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>5</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Haas 2004 (WHI publication)</P>
</TD>
<TD>
<P>Oestrogen replacement therapy for menopausal women</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>5</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Hersh 2004 (WHI; HERS; HERSIII publications)</P>
</TD>
<TD>
<P>Oestrogen replacement therapy for menopausal women</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>5</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Jackevicius 2001</P>
</TD>
<TD>
<P>Cardiovascular disease</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Jameson 2010</P>
</TD>
<TD>
<P>Orthopaedic surgery</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Jousimaa 2002</P>
</TD>
<TD>
<P>Unclear</P>
</TD>
<TD>
<P>16</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Juurlink 2004</P>
</TD>
<TD>
<P>Cardiovascular disease</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Kabir 2007 (LIFE publication)</P>
</TD>
<TD>
<P>Hypertension</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Kabir 2007 (ALLHAT publication)</P>
</TD>
<TD>
<P>Hypertension</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Kabir 2007 (VALUE trial report)</P>
</TD>
<TD>
<P>Hypertension</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Kajita 2012</P>
</TD>
<TD>
<P>Osteoporosis prevention</P>
</TD>
<TD>
<P>3; 9; 10</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>9</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Kottke 1989</P>
</TD>
<TD>
<P>Smoking cessation</P>
</TD>
<TD>
<P>9</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>9</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Lam 2009</P>
</TD>
<TD>
<P>Diabetes</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>5</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Majumdar 2003 (HOPE trial report)</P>
</TD>
<TD>
<P>Cardiovascular disease</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Majumdar 2003 (RALES trial report)</P>
</TD>
<TD>
<P>Cardiovascular disease</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Majumdar 2004 (WHI trial report)</P>
</TD>
<TD>
<P>Oestrogen replacement therapy for menopausal women</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>5</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Mason 1998</P>
</TD>
<TD>
<P>Depression</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Mason 2001 (EHC-OM bulletin)</P>
</TD>
<TD>
<P>Glue ear surgery</P>
</TD>
<TD>
<P>5; 8</P>
</TD>
<TD>
<P>5</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Matowe 2002</P>
</TD>
<TD>
<P>X-rays examination</P>
</TD>
<TD>
<P>7</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Meyer 2007</P>
</TD>
<TD>
<P>Pneumonia</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>5</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Oakeshott 1994</P>
</TD>
<TD>
<P>X-rays examination</P>
</TD>
<TD>
<P>6; 7</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Perria 2007</P>
</TD>
<TD>
<P>Diabetes</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Roberts 2007</P>
</TD>
<TD>
<P>Protheses</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Santerre 1996</P>
</TD>
<TD>
<P>Caesarean section</P>
</TD>
<TD>
<P>5</P>
</TD>
<TD>
<P>5</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Shah 2008</P>
</TD>
<TD>
<P>Diabetes</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Stafford 2004 (ALLHAT trial report)</P>
</TD>
<TD>
<P>Hypertension</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Tsuji  2009</P>
</TD>
<TD>
<P>Depression</P>
</TD>
<TD>
<P>1; 4</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>3</P>
</TD>
</TR>
<TR>
<TD>
<P>Wang 2005 (ADA guidelines; ATP III trial report)</P>
</TD>
<TD>
<P>Diabetes</P>
</TD>
<TD>
<P>3; 12</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Watson 2001</P>
</TD>
<TD>
<P>Inflammation</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Weiss 2011</P>
</TD>
<TD>
<P>Antibiotic treatment</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>5</P>
</TD>
<TD>
<P>8</P>
</TD>
<TD>
<P>3</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>* Type of targeted behaviour: 1 = prescribing/treatment; 2 = financial (resource use); 3 = general management of a problem; 4 = diagnosis; 5 = procedures; 6 = referrals; 7 = test ordering; 8 = surgery; 9 = patient education/advice; 10 = clinical prevention service; 11 = screening; 12 = reporting; 13 = professional-patient communication; 14 = record keeping; 15 = discharge planning; 16 = unclear.</P>
<P>
<SUP>&#8737;</SUP> Purpose: 1 = initiation of management (e.g. introduction of new technology); 2 = stopping introduction of new management; 3 = increase of established management; 4 = cessation of established management; 5 = reduction of established management; 6 = modification of management (e.g. increased management in one activity, reduction in another).</P>
<P>
<SUP>&#8661;</SUP> Level of evidence: 1 = system (computerised decision support services); 2 = summary (evidence-based textbooks); 3 = systematic review of RCTs; 4 = clinical practice guidelines developed through formal consensus process; 5 = other synthesis; 6 = original RCT; 7 = original study not RCT; 8 = expert opinion; 9 = unclear.</P>
<P>
<SUP>&#8710;</SUP> Educational component: 1 = continuing professional development (CPD) credits to recipients of PEMs; 2 = PEM delivered within a formal education programme; 3 = clear statement in in the study that the PEM is intended for education; 4 = no clear educational component.</P>
<P>
<SUP>¶</SUP> Tailoring: 1 = tailored to individuals based on diagnostic, behavioural, or motivational characteristics; 2 = tailored to groups of individuals; 3 = personalised, but not tailored (person's name on the information); 4 = generic; 5 = unclear.</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-03" MODIFIED="2012-09-10 11:09:02 -0400" MODIFIED_BY="[Empty name]" NO="3">
<TITLE MODIFIED="2012-09-10 11:08:49 -0400" MODIFIED_BY="[Empty name]">Characteristics of the included interventions: format</TITLE>
<TABLE COLS="4" ROWS="53">
<TR>
<TD>
<P/>
<P>
<B>Study (PEM)</B>
</P>
<P/>
</TD>
<TD>
<P>
<B>Format*</B>
</P>
</TD>
<TD>
<P>
<B>Appearance<SUP>§</SUP>
</B>
</P>
</TD>
<TD>
<P>
<B>Length<SUP>¥</SUP>
</B>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Austin 2003 (HERS trial report)</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Austin 2004-A (WHI trial report)</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Austin 2004-B (ALLHAT trial report)</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Austin 2005</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Avorn 1983</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>3</P>
</TD>
</TR>
<TR>
<TD>
<P>Azocar 2003</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>2</P>
</TD>
</TR>
<TR>
<TD>
<P>Barbaglia 2009 (WHI trial report)</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Bearcroft 1994</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>3</P>
</TD>
</TR>
<TR>
<TD>
<P>Beaulieu 2004</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>2</P>
</TD>
</TR>
<TR>
<TD>
<P>Bjornson 1990</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Black 2002 (EHC-OM bulletin)</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Buyle 2010</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>3</P>
</TD>
</TR>
<TR>
<TD>
<P>Coopersmith 2002</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Denig 1990</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>3</P>
</TD>
</TR>
<TR>
<TD>
<P>Dormuth 2004</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Fijn 2000</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>3</P>
</TD>
</TR>
<TR>
<TD>
<P>Fonarow 2009 (MIRACL trial report)</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Fonarow 2009 (PROVE-IT TIMI 22 trial report)</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Fonarow 2009 (ACC-AHA-STEMI guidelines)</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Fonarow 2009 (AHA-AHA-NS guidelines)</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Fukuda 2009</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>3</P>
</TD>
</TR>
<TR>
<TD>
<P>Guay 2007 (WHI publication)</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Haas 2004 (HERS publication)</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Haas 2004 (WHI publication)</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Hersh 2004 (WHI; HERS; HERSIII publications)</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Jackevicius 2001</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Jameson 2010</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>3</P>
</TD>
</TR>
<TR>
<TD>
<P>Jousimaa 2002</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Juurlink 2004</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Kabir 2007 (LIFE publication)</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Kabir 2007 (ALLHAT publication)</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Kabir 2007 (VALUE trial report)</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Kajita 2012</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>3</P>
</TD>
</TR>
<TR>
<TD>
<P>Kottke 1989</P>
</TD>
<TD>
<P>5</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Lam 2009</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Majumdar 2003 (HOPE trial report)</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Majumdar 2003 (RALES trial report)</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Majumdar 2004 (WHI trial report)</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Mason 1998</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Mason 2001 (EHC-OM bulletin)</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Matowe 2002</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>3</P>
</TD>
</TR>
<TR>
<TD>
<P>Meyer 2007</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>3</P>
</TD>
</TR>
<TR>
<TD>
<P>Oakeshott 1994</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>2</P>
</TD>
</TR>
<TR>
<TD>
<P>Perria 2007</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>3</P>
</TD>
</TR>
<TR>
<TD>
<P>Roberts 2007</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Santerre 1996</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>3</P>
</TD>
</TR>
<TR>
<TD>
<P>Shah 2008</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Stafford 2004 (ALLHAT trial report)</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Tsuji  2009</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>3</P>
</TD>
</TR>
<TR>
<TD>
<P>Wang 2005 (ADA guidelines; ATP III trial report)</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Watson 2001</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>3</P>
</TD>
</TR>
<TR>
<TD>
<P>Weiss 2011</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>* Format: 1 = publication of RCT in peer-reviewed journal; 2 = quick reference of clinical guidelines; 3 = full clinical guidelines; 4 = newsletter/bulletin; 5 = manual of peer-reviewed clinical article reprints; 6 = other.</P>
<P>
<SUP>§</SUP> Appearance: 1 = black and white, with a few figures/tables; 2 = enhanced communication format (colour, picture, or figure); 3 = unclear.</P>
<P>
<SUP>¥</SUP> Length: 1 = more than two pages; 2 = two pages or less; 3 = unclear.</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-04" MODIFIED="2012-09-10 11:19:11 -0400" MODIFIED_BY="[Empty name]" NO="4">
<TITLE MODIFIED="2012-09-10 11:09:20 -0400" MODIFIED_BY="[Empty name]">Comparison group #1, RCT design - categorical, professional practice outcomes. Standard median effect size across all studies in this table = 0.02</TITLE>
<TABLE COLS="8" ROWS="75">
<TR>
<TH ROWSPAN="2">
<P>Study</P>
</TH>
<TH ROWSPAN="2">
<P>Outcome</P>
</TH>
<TH COLSPAN="2">
<P>Control (n/N)</P>
</TH>
<TH COLSPAN="2">
<P>Experimental (n/N)</P>
</TH>
<TH ROWSPAN="2">
<P>Absolute risk difference (95% CI)*</P>
</TH>
<TH ROWSPAN="2">
<P>Standard median effect size</P>
</TH>
</TR>
<TR>
<TH>
<P>Pre</P>
</TH>
<TH>
<P>Post</P>
</TH>
<TH>
<P>Pre</P>
</TH>
<TH>
<P>Post</P>
</TH>
</TR>
<TR>
<TD>
<P>Tsuji 2009</P>
</TD>
<TD>
<P>Prescription of an antidepressant at the first appointment with the clinician</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>100/114</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>119/120</P>
</TD>
<TD>
<P>0.11 (0.05 to 0.18)</P>
</TD>
<TD>
<P>0.11</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="3">
<P>Oakeshott 1994</P>
</TD>
<TD>
<P>Relevant positive findings at radiology</P>
</TD>
<TD>
<P>9/21</P>
</TD>
<TD>
<P>10/21</P>
</TD>
<TD>
<P>9/22</P>
</TD>
<TD>
<P>10/22</P>
</TD>
<TD>
<P>-0.02 (-0.32 to 0.28)</P>
</TD>
<TD ROWSPAN="3">
<P>0.02</P>
</TD>
</TR>
<TR>
<TD>
<P>Radiological request forms giving physical findings</P>
</TD>
<TD>
<P>14/21</P>
</TD>
<TD>
<P>12/21</P>
</TD>
<TD>
<P>13/22</P>
</TD>
<TD>
<P>13/22</P>
</TD>
<TD>
<P>0.02 (-0.28 to 0.31)</P>
</TD>
</TR>
<TR>
<TD>
<P>Proportion of radiology requests conforming to the guidelines</P>
</TD>
<TD>
<P>16/21</P>
</TD>
<TD>
<P>15/21</P>
</TD>
<TD>
<P>16/22</P>
</TD>
<TD>
<P>18/22</P>
</TD>
<TD>
<P>0.1 (-0.15 to 0.36)</P>
</TD>
</TR>
<TR>
<TD>
<P>Bjornsson 1990</P>
</TD>
<TD>
<P>Complete change of therapy</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>1/288</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>4/288</P>
</TD>
<TD>
<P>0.01 (-0.00 to 0.03)</P>
</TD>
<TD>
<P>0.01</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="4">
<P>Bearcroft 1994</P>
</TD>
<TD>
<P>X-ray requests not meeting guideline requirements<SUP>&#8737;</SUP>
</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>87/1059</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>78/1362</P>
</TD>
<TD>
<P>0.02</P>
</TD>
<TD ROWSPAN="4">
<P>0.045</P>
</TD>
</TR>
<TR>
<TD>
<P>X-ray requests with inadequate patient history<SUP>&#8737;</SUP>
</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>164/1059</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>148/1362</P>
</TD>
<TD>
<P>0.05</P>
</TD>
</TR>
<TR>
<TD>
<P>Recorded clinical diagnosis</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>454/1059</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>668/1362</P>
</TD>
<TD>
<P>0.06</P>
</TD>
</TR>
<TR>
<TD>
<P>Reported smoking history</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>258/1059</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>382/1362</P>
</TD>
<TD>
<P>0.04</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="11">
<P>Dormuth 2004</P>
</TD>
<TD>
<P>Newly treated patients<BR/>receiving the analysis drugs (metronidazole/amoxicillin or tetracycline)</P>
</TD>
<TD>
<P>20/134,245</P>
</TD>
<TD>
<P>10/137,742</P>
</TD>
<TD>
<P>7/153,561</P>
</TD>
<TD>
<P>9/157,743</P>
</TD>
<TD>
<P>0 (-0.00 to 0.00)</P>
</TD>
<TD ROWSPAN="11">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Newly treated patients<BR/>receiving the analysis drugs (ASA/ibuprofen/naproxen)</P>
</TD>
<TD>
<P>116/136,589</P>
</TD>
<TD>
<P>121/142,610</P>
</TD>
<TD>
<P>100/156,390</P>
</TD>
<TD>
<P>131/161,168</P>
</TD>
<TD>
<P>0 (-0.00 to 0.00)</P>
</TD>
</TR>
<TR>
<TD>
<P>Newly treated patients receiving the analysis drug (isosorbide dinitrate)</P>
</TD>
<TD>
<P>7/142,091</P>
</TD>
<TD>
<P>4/131,571</P>
</TD>
<TD>
<P>7/160,368</P>
</TD>
<TD>
<P>7/144,926</P>
</TD>
<TD>
<P>0 (-0.00 to 0.00)</P>
</TD>
</TR>
<TR>
<TD>
<P>Newly treated patients receiving the analysis drug (thiazide diuretics)</P>
</TD>
<TD>
<P>114/141,176</P>
</TD>
<TD>
<P>50/131,588</P>
</TD>
<TD>
<P>104/156,544</P>
</TD>
<TD>
<P>69/148,488</P>
</TD>
<TD>
<P>0 (-0.00 to 0.00)</P>
</TD>
</TR>
<TR>
<TD>
<P>Newly treated patients receiving the analysis drug (inhaled corticosteroids)</P>
</TD>
<TD>
<P>13/138,165</P>
</TD>
<TD>
<P>4/140,163</P>
</TD>
<TD>
<P>15/150,533</P>
</TD>
<TD>
<P>11/154,274</P>
</TD>
<TD>
<P>0 (-0.00 to 0.00)</P>
</TD>
</TR>
<TR>
<TD>
<P>Newly treated patients receiving the analysis drug (calcium-channel blockers)*</P>
</TD>
<TD>
<P>141,107/141,176</P>
</TD>
<TD>
<P>131,541/131,588</P>
</TD>
<TD>
<P>156,457/156,544</P>
</TD>
<TD>
<P>148,450/148,488</P>
</TD>
<TD>
<P>0 (-0.00 to 0.00)</P>
</TD>
</TR>
<TR>
<TD>
<P>Newly treated patients receiving the analysis drug (long-acting benzodiazepines)*</P>
</TD>
<TD>
<P>141,806/141,967</P>
</TD>
<TD>
<P>133,804/133,995</P>
</TD>
<TD>
<P>154,554/154,719</P>
</TD>
<TD>
<P>147,960/148,121</P>
</TD>
<TD>
<P>0 (-0.00 to 0.00)</P>
</TD>
</TR>
<TR>
<TD>
<P>Newly treated patients receiving the analysis drug (hormones)*</P>
</TD>
<TD>
<P>133,333/133,403</P>
</TD>
<TD>
<P>134,904/134,991</P>
</TD>
<TD>
<P>147,656/147,745</P>
</TD>
<TD>
<P>147,381/147,487</P>
</TD>
<TD>
<P>0 (-0.00 to 0.00)</P>
</TD>
</TR>
<TR>
<TD>
<P>Newly treated patients receiving the analysis drug (calcium-channel blockers)*</P>
</TD>
<TD>
<P>132,461/132,512</P>
</TD>
<TD>
<P>139,870/139,935</P>
</TD>
<TD>
<P>150,298/150,358</P>
</TD>
<TD>
<P>152,025/152,082</P>
</TD>
<TD>
<P>0 (-0.00 to 0.00)</P>
</TD>
</TR>
<TR>
<TD>
<P>Newly treated patients receiving the analysis drug (clonazepam/alprazolam/diazepam)*</P>
</TD>
<TD>
<P>129,906/129,951</P>
</TD>
<TD>
<P>139,796/139,836</P>
</TD>
<TD>
<P>148,318/148,381</P>
</TD>
<TD>
<P>152,844/152,891</P>
</TD>
<TD>
<P>0 (-0.00 to 0.00)</P>
</TD>
</TR>
<TR>
<TD>
<P>Newly treated patients receiving the analysis drug (finasteride)*</P>
</TD>
<TD>
<P>136,681/136,691</P>
</TD>
<TD>
<P>129,769/129,775</P>
</TD>
<TD>
<P>152,183/152,195</P>
</TD>
<TD>
<P>142,379/142,392</P>
</TD>
<TD>
<P>0 (-0.00 to 0.00)</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="3">
<P>Perria 2007</P>
</TD>
<TD>
<P>Metabolic control</P>
</TD>
<TD>
<P>196/2232</P>
</TD>
<TD>
<P>230/2232</P>
</TD>
<TD>
<P>169/2190</P>
</TD>
<TD>
<P>222/2190</P>
</TD>
<TD>
<P>0 (-0.02 to 0.02)</P>
</TD>
<TD ROWSPAN="3">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Macrovascular complications</P>
</TD>
<TD>
<P>244/2232</P>
</TD>
<TD>
<P>277/2232</P>
</TD>
<TD>
<P>235/2190</P>
</TD>
<TD>
<P>257/2190</P>
</TD>
<TD>
<P>-0.01 (-0.03 to 0.01)</P>
</TD>
</TR>
<TR>
<TD>
<P>Microvascular complications</P>
</TD>
<TD>
<P>112/2232</P>
</TD>
<TD>
<P>105/2232</P>
</TD>
<TD>
<P>98/2190</P>
</TD>
<TD>
<P>108/2190</P>
</TD>
<TD>
<P>0 (-0.01 to 0.01)</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="46">
<P>Kajita 2010</P>
</TD>
<TD>
<P>Education on milk and dairy product - young</P>
</TD>
<TD>
<P>4/49</P>
</TD>
<TD>
<P>6/49</P>
</TD>
<TD>
<P>4/51</P>
</TD>
<TD>
<P>8/51</P>
</TD>
<TD>
<P>0.03 (-0.10 to 0.17)</P>
</TD>
<TD ROWSPAN="46">
<P>0.04</P>
</TD>
</TR>
<TR>
<TD>
<P>Education on milk and dairy product - post</P>
</TD>
<TD>
<P>19/49</P>
</TD>
<TD>
<P>20/49</P>
</TD>
<TD>
<P>16/51</P>
</TD>
<TD>
<P>26/51</P>
</TD>
<TD>
<P>0.1 (-0.09 to 0.30)</P>
</TD>
</TR>
<TR>
<TD>
<P>Education on milk and dairy product - elderly</P>
</TD>
<TD>
<P>18/49</P>
</TD>
<TD>
<P>20/49</P>
</TD>
<TD>
<P>16/51</P>
</TD>
<TD>
<P>23/51</P>
</TD>
<TD>
<P>0.04 (-0.15 to 0.24)</P>
</TD>
</TR>
<TR>
<TD>
<P>Education on soy product - young</P>
</TD>
<TD>
<P>14/49</P>
</TD>
<TD>
<P>20/49</P>
</TD>
<TD>
<P>19/51</P>
</TD>
<TD>
<P>27/51</P>
</TD>
<TD>
<P>0.12 (-0.07 to 0.32)</P>
</TD>
</TR>
<TR>
<TD>
<P>Education on soy product - post</P>
</TD>
<TD>
<P>16/49</P>
</TD>
<TD>
<P>20/49</P>
</TD>
<TD>
<P>20/51</P>
</TD>
<TD>
<P>28/51</P>
</TD>
<TD>
<P>0.14 (-0.05 to 0.33)</P>
</TD>
</TR>
<TR>
<TD>
<P>Education on soy product - elderly</P>
</TD>
<TD>
<P>16/49</P>
</TD>
<TD>
<P>20/49</P>
</TD>
<TD>
<P>19/51</P>
</TD>
<TD>
<P>26/51</P>
</TD>
<TD>
<P>0.1 (-0.09 to 0.30)</P>
</TD>
</TR>
<TR>
<TD>
<P>Education on calcium Intake - young</P>
</TD>
<TD>
<P>25/49</P>
</TD>
<TD>
<P>22/49</P>
</TD>
<TD>
<P>22/51</P>
</TD>
<TD>
<P>29/51</P>
</TD>
<TD>
<P>0.12 (-0.07 to 0.31)</P>
</TD>
</TR>
<TR>
<TD>
<P>Education on calcium intake - post</P>
</TD>
<TD>
<P>26/49</P>
</TD>
<TD>
<P>23/49</P>
</TD>
<TD>
<P>23/51</P>
</TD>
<TD>
<P>33/51</P>
</TD>
<TD>
<P>0.18 (-0.01 to 0.37)</P>
</TD>
</TR>
<TR>
<TD>
<P>Education on calcium Intake - Elderly</P>
</TD>
<TD>
<P>23/49</P>
</TD>
<TD>
<P>21/49</P>
</TD>
<TD>
<P>22/51</P>
</TD>
<TD>
<P>29/51</P>
</TD>
<TD>
<P>0.14 (-0.05 to 0.33)</P>
</TD>
</TR>
<TR>
<TD>
<P>Education on calcium supplement - young</P>
</TD>
<TD>
<P>0/49</P>
</TD>
<TD>
<P>0/49</P>
</TD>
<TD>
<P>0/51</P>
</TD>
<TD>
<P>1/51</P>
</TD>
<TD>
<P>0.02 (-0.03 to 0.07)</P>
</TD>
</TR>
<TR>
<TD>
<P>Education on calcium supplement - post</P>
</TD>
<TD>
<P>0/49</P>
</TD>
<TD>
<P>0/49</P>
</TD>
<TD>
<P>0/51</P>
</TD>
<TD>
<P>2/51</P>
</TD>
<TD>
<P>0.04 (-0.03 to 0.10)</P>
</TD>
</TR>
<TR>
<TD>
<P>Education on calcium supplement - elderly</P>
</TD>
<TD>
<P>0/49</P>
</TD>
<TD>
<P>0/49</P>
</TD>
<TD>
<P>0/51</P>
</TD>
<TD>
<P>2/51</P>
</TD>
<TD>
<P>0.04 (-0.03 to 0.10)</P>
</TD>
</TR>
<TR>
<TD>
<P>Education on vitamin D intake - young</P>
</TD>
<TD>
<P>0/49</P>
</TD>
<TD>
<P>0/49</P>
</TD>
<TD>
<P>1/51</P>
</TD>
<TD>
<P>2/51</P>
</TD>
<TD>
<P>0.04 (-0.03 to 0.10)</P>
</TD>
</TR>
<TR>
<TD>
<P>Education on vitamin D intake - post</P>
</TD>
<TD>
<P>0/49</P>
</TD>
<TD>
<P>0/49</P>
</TD>
<TD>
<P>1/51</P>
</TD>
<TD>
<P>2/51</P>
</TD>
<TD>
<P>0.04 (-0.03 to 0.10)</P>
</TD>
</TR>
<TR>
<TD>
<P>Education on vitamin D intake - elderly</P>
</TD>
<TD>
<P>0/49</P>
</TD>
<TD>
<P>0/49</P>
</TD>
<TD>
<P>0/51</P>
</TD>
<TD>
<P>1/51</P>
</TD>
<TD>
<P>0.02 (-0.03 to 0.07)</P>
</TD>
</TR>
<TR>
<TD>
<P>Education on magnesium intake - young</P>
</TD>
<TD>
<P>1/49</P>
</TD>
<TD>
<P>0/49</P>
</TD>
<TD>
<P>1/51</P>
</TD>
<TD>
<P>2/51</P>
</TD>
<TD>
<P>0.04 (-0.03 to 0.10)</P>
</TD>
</TR>
<TR>
<TD>
<P>Education on magnesium intake - post</P>
</TD>
<TD>
<P>0/49</P>
</TD>
<TD>
<P>0/49</P>
</TD>
<TD>
<P>1/51</P>
</TD>
<TD>
<P>2/51</P>
</TD>
<TD>
<P>0.04 (-0.03 to 0.10)</P>
</TD>
</TR>
<TR>
<TD>
<P>Education on magnesium intake - elderly</P>
</TD>
<TD>
<P>0/49</P>
</TD>
<TD>
<P>0/49</P>
</TD>
<TD>
<P>0/51</P>
</TD>
<TD>
<P>1/51</P>
</TD>
<TD>
<P>0.02 (-0.03 to 0.07)</P>
</TD>
</TR>
<TR>
<TD>
<P>Education on isoflavone intake - young</P>
</TD>
<TD>
<P>2/49</P>
</TD>
<TD>
<P>4/49</P>
</TD>
<TD>
<P>3/51</P>
</TD>
<TD>
<P>5/51</P>
</TD>
<TD>
<P>0.02 (-0.10 to 0.13)</P>
</TD>
</TR>
<TR>
<TD>
<P>Education on isoflavone intake - post</P>
</TD>
<TD>
<P>2/49</P>
</TD>
<TD>
<P>5/49</P>
</TD>
<TD>
<P>3/51</P>
</TD>
<TD>
<P>8/51</P>
</TD>
<TD>
<P>0.05 (-0.08 to 0.19)</P>
</TD>
</TR>
<TR>
<TD>
<P>Education on brisk walking - elderly</P>
</TD>
<TD>
<P>14/49</P>
</TD>
<TD>
<P>10/49</P>
</TD>
<TD>
<P>19/51</P>
</TD>
<TD>
<P>25/51</P>
</TD>
<TD>
<P>0.29 (0.11 to 0.46)</P>
</TD>
</TR>
<TR>
<TD>
<P>Education on high-impact training - young</P>
</TD>
<TD>
<P>2/49</P>
</TD>
<TD>
<P>4/49</P>
</TD>
<TD>
<P>2/51</P>
</TD>
<TD>
<P>10/51</P>
</TD>
<TD>
<P>0.11 (-0.02 to 0.25)</P>
</TD>
</TR>
<TR>
<TD>
<P>Education on high-impact training - post</P>
</TD>
<TD>
<P>2/49</P>
</TD>
<TD>
<P>5/49</P>
</TD>
<TD>
<P>2/51</P>
</TD>
<TD>
<P>9/51</P>
</TD>
<TD>
<P>0.07 (-0.06 to 0.21)</P>
</TD>
</TR>
<TR>
<TD>
<P>Education on high-impact training - elderly</P>
</TD>
<TD>
<P>2/49</P>
</TD>
<TD>
<P>5/49</P>
</TD>
<TD>
<P>2/51</P>
</TD>
<TD>
<P>11/51</P>
</TD>
<TD>
<P>0.11 (-0.03 to 0.25)</P>
</TD>
</TR>
<TR>
<TD>
<P>Education on low-impact training - elderly</P>
</TD>
<TD>
<P>4/49</P>
</TD>
<TD>
<P>2/49</P>
</TD>
<TD>
<P>8/51</P>
</TD>
<TD>
<P>12/51</P>
</TD>
<TD>
<P>0.19 (0.07 to 0.32)</P>
</TD>
</TR>
<TR>
<TD>
<P>Education on being active in everyday life - elderly</P>
</TD>
<TD>
<P>0/49</P>
</TD>
<TD>
<P>2/49</P>
</TD>
<TD>
<P>1/51</P>
</TD>
<TD>
<P>2/51</P>
</TD>
<TD>
<P>0 (-0.08 to 0.08)</P>
</TD>
</TR>
<TR>
<TD>
<P>Education on strengthening of back muscles - elderly</P>
</TD>
<TD>
<P>0/49</P>
</TD>
<TD>
<P>1/49</P>
</TD>
<TD>
<P>2/51</P>
</TD>
<TD>
<P>3/51</P>
</TD>
<TD>
<P>0.04 (-0.04 to 0.11)</P>
</TD>
</TR>
<TR>
<TD>
<P>Education on exposure to sunlight - young</P>
</TD>
<TD>
<P>6/49</P>
</TD>
<TD>
<P>5/49</P>
</TD>
<TD>
<P>4/51</P>
</TD>
<TD>
<P>2/51</P>
</TD>
<TD>
<P>-0.06 (-0.16 to 0.04)</P>
</TD>
</TR>
<TR>
<TD>
<P>Education on exposure to sunlight - post</P>
</TD>
<TD>
<P>6/49</P>
</TD>
<TD>
<P>4/49</P>
</TD>
<TD>
<P>4/51</P>
</TD>
<TD>
<P>2/51</P>
</TD>
<TD>
<P>-0.04 (-0.14 to 0.05)</P>
</TD>
</TR>
<TR>
<TD>
<P>Education on exposure to sunlight - elderly</P>
</TD>
<TD>
<P>5/49</P>
</TD>
<TD>
<P>4/49</P>
</TD>
<TD>
<P>4/51</P>
</TD>
<TD>
<P>2/51</P>
</TD>
<TD>
<P>-0.04 (-0.14 to 0.05)</P>
</TD>
</TR>
<TR>
<TD>
<P>Education on maintenance of appropriate weight - young</P>
</TD>
<TD>
<P>8/49</P>
</TD>
<TD>
<P>12/49</P>
</TD>
<TD>
<P>15/51</P>
</TD>
<TD>
<P>12/51</P>
</TD>
<TD>
<P>-0.01 (-0.18 to 0.16)</P>
</TD>
</TR>
<TR>
<TD>
<P>Education on maintenance of appropriate weight - post</P>
</TD>
<TD>
<P>8/49</P>
</TD>
<TD>
<P>12/49</P>
</TD>
<TD>
<P>14/51</P>
</TD>
<TD>
<P>12/51</P>
</TD>
<TD>
<P>-0.01 (-0.18 to 0.16)</P>
</TD>
</TR>
<TR>
<TD>
<P>Education on maintenance of appropriate weight - elderly</P>
</TD>
<TD>
<P>7/49</P>
</TD>
<TD>
<P>11/49</P>
</TD>
<TD>
<P>13/51</P>
</TD>
<TD>
<P>10/51</P>
</TD>
<TD>
<P>-0.03 (-0.19 to 0.13)</P>
</TD>
</TR>
<TR>
<TD>
<P>Education on do not start smoking - young</P>
</TD>
<TD>
<P>8/49</P>
</TD>
<TD>
<P>6/49</P>
</TD>
<TD>
<P>9/51</P>
</TD>
<TD>
<P>3/51</P>
</TD>
<TD>
<P>-0.06 (-0.18 to 0.05)</P>
</TD>
</TR>
<TR>
<TD>
<P>Education on do not start smoking - post</P>
</TD>
<TD>
<P>8/49</P>
</TD>
<TD>
<P>6/49</P>
</TD>
<TD>
<P>8/51</P>
</TD>
<TD>
<P>4/51</P>
</TD>
<TD>
<P>-0.04 (-0.16 to 0.07)</P>
</TD>
</TR>
<TR>
<TD>
<P>Education on stop smoking - young</P>
</TD>
<TD>
<P>5/49</P>
</TD>
<TD>
<P>2/49</P>
</TD>
<TD>
<P>6/51</P>
</TD>
<TD>
<P>4/51</P>
</TD>
<TD>
<P>0.04 (-0.05 to 0.13)</P>
</TD>
</TR>
<TR>
<TD>
<P>Education on stop smoking - post</P>
</TD>
<TD>
<P>5/49</P>
</TD>
<TD>
<P>1/49</P>
</TD>
<TD>
<P>5/51</P>
</TD>
<TD>
<P>3/51</P>
</TD>
<TD>
<P>0.04 (-0.04 to 0.11)</P>
</TD>
</TR>
<TR>
<TD>
<P>Education on stop smoking - elderly</P>
</TD>
<TD>
<P>5/49</P>
</TD>
<TD>
<P>1/49</P>
</TD>
<TD>
<P>5/51</P>
</TD>
<TD>
<P>3/51</P>
</TD>
<TD>
<P>0.04 (-0.04 to 0.11)</P>
</TD>
</TR>
<TR>
<TD>
<P>Education on alcohol drinking - elderly</P>
</TD>
<TD>
<P>7/49</P>
</TD>
<TD>
<P>8/49</P>
</TD>
<TD>
<P>11/51</P>
</TD>
<TD>
<P>10/51</P>
</TD>
<TD>
<P>0.03 (-0.12 to 0.18)</P>
</TD>
</TR>
<TR>
<TD>
<P>Education for elderly subjects with a history of falls - elderly</P>
</TD>
<TD>
<P>30/49</P>
</TD>
<TD>
<P>23/49</P>
</TD>
<TD>
<P>24/51</P>
</TD>
<TD>
<P>23/51</P>
</TD>
<TD>
<P>0.06 (-0.13 to 0.26)</P>
</TD>
</TR>
<TR>
<TD>
<P>Education on total body exercise including balance - post</P>
</TD>
<TD>
<P>10/49</P>
</TD>
<TD>
<P>8/49</P>
</TD>
<TD>
<P>8/51</P>
</TD>
<TD>
<P>8/51</P>
</TD>
<TD>
<P>0.05 (-0.08 to 0.19)</P>
</TD>
</TR>
<TR>
<TD>
<P>Education on total body exercise including balance - elderly</P>
</TD>
<TD>
<P>15/49</P>
</TD>
<TD>
<P>13/49</P>
</TD>
<TD>
<P>11/51</P>
</TD>
<TD>
<P>13/51</P>
</TD>
<TD>
<P>0.09 (-0.07 to 0.25)</P>
</TD>
</TR>
<TR>
<TD>
<P>Education on modification of behaviour after examination of risk factors - post</P>
</TD>
<TD>
<P>15/49</P>
</TD>
<TD>
<P>10/49</P>
</TD>
<TD>
<P>15/51</P>
</TD>
<TD>
<P>10/51</P>
</TD>
<TD>
<P>0.03 (-0.12 to 0.18)</P>
</TD>
</TR>
<TR>
<TD>
<P>Education on modification of behaviour after examination of risk factors - elderly</P>
</TD>
<TD>
<P>20/49</P>
</TD>
<TD>
<P>18/49</P>
</TD>
<TD>
<P>22/51</P>
</TD>
<TD>
<P>18/51</P>
</TD>
<TD>
<P>0.09 (-0.09 to 0.27)</P>
</TD>
</TR>
<TR>
<TD>
<P>Education on environmental Improvement - post</P>
</TD>
<TD>
<P>14/49</P>
</TD>
<TD>
<P>10/49</P>
</TD>
<TD>
<P>17/51</P>
</TD>
<TD>
<P>10/51</P>
</TD>
<TD>
<P>0.03 (-0.12 to 0.18)</P>
</TD>
</TR>
<TR>
<TD>
<P>Education on environmental Improvement - elderly</P>
</TD>
<TD>
<P>20/49</P>
</TD>
<TD>
<P>19/49</P>
</TD>
<TD>
<P>26/51</P>
</TD>
<TD>
<P>19/51</P>
</TD>
<TD>
<P>0.09 (-0.10 to 0.27)</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="2">
<P>Beaulieu 2004</P>
</TD>
<TD>
<P>Antiplatelets prescription </P>
</TD>
<TD COLSPAN="6" ROWSPAN="2">
<P>Quote: "we observed an overall increase of 10% in the prescribing rates for antiplatelet agents and beta blockers from 1997 to 1999, and a smaller overall increase in the prescribing rates for hypolipaemic drugs. However, for hypolipaemic drugs these increases were not distributed equally among patient age groups: greater increases were seen for patients aged  greater than or equal to 70 years (Figure 2b)" (improvement)</P>
</TD>
</TR>
<TR>
<TD>
<P>Hypolipaemics prescription (&#946;-blockers)</P>
</TD>
</TR>
<TR>
<TD>
<P>Bjornsson 1990</P>
</TD>
<TD>
<P>Partial change of therapy</P>
</TD>
<TD COLSPAN="6">
<P>Quote: "a total of five (0.9%) of the physicians in the two groups switched their patients to both hydralazine and isosorbide (full change); another 23 (4.05) switched them to at least one of the drugs or discontinued prazosin (partial change)" (indeterminate)</P>
</TD>
</TR>
<TR>
<TD>
<P>Dormuth 2004<SUP>¥</SUP>
</P>
</TD>
<TD>
<P>Newly treated patients receiving the analysis drug (cimetidine)</P>
</TD>
<TD COLSPAN="6">
<P>Quote: "a significant change was observed in the proportion of newly treated patients receiving the analysis drugs as first-line therapy. The preference for the analysis drugs was 1.3 times more in the predicted direction in the intervention group of physicians than in the control group (95% confidence interval [CI] 1.13 - 1.52)" (improvement)</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>* Results were transformed so that a positive difference in outcomes between groups could be interpreted as an improvement in outcome.</P>
<P>
<SUP>¥</SUP> Baseline measures not comparable.</P>
<P>
<SUP>&#8737; </SUP>Confidence intervals are not included due to a unit of analysis error.</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-05" MODIFIED="2012-09-10 11:19:06 -0400" MODIFIED_BY="[Empty name]" NO="5">
<TITLE MODIFIED="2012-09-10 11:10:09 -0400" MODIFIED_BY="[Empty name]">Comparison group #1, RCT design - continuous, professional practice outcomes. Standard median effect size across all studies in this table = 0.13</TITLE>
<TABLE COLS="10" ROWS="16">
<TR>
<TH ROWSPAN="2" VALIGN="TOP">
<P>Study</P>
</TH>
<TH ROWSPAN="2" VALIGN="TOP">
<P>Outcome</P>
</TH>
<TH COLSPAN="3" VALIGN="TOP">
<P>Control</P>
</TH>
<TH COLSPAN="3" VALIGN="TOP">
<P>Experimental</P>
</TH>
<TH ROWSPAN="2" VALIGN="TOP">
<P>Standard effect size (95% CI)*</P>
</TH>
<TH ROWSPAN="2" VALIGN="TOP">
<P>Standard median effect size</P>
</TH>
</TR>
<TR>
<TH VALIGN="TOP">
<P>N</P>
</TH>
<TH VALIGN="TOP">
<P>Pre mean (SD)</P>
</TH>
<TH VALIGN="TOP">
<P>Post mean (SD)</P>
</TH>
<TH VALIGN="TOP">
<P>N</P>
</TH>
<TH VALIGN="TOP">
<P>Pre mean (SD)</P>
</TH>
<TH VALIGN="TOP">
<P>Post mean (SD)</P>
</TH>
</TR>
<TR>
<TD ROWSPAN="2" VALIGN="MIDDLE">
<P>Denig 1990</P>
</TD>
<TD VALIGN="TOP">
<P>Antispasmodic prescription - undesirable antispasmodics (IBS)*</P>
</TD>
<TD VALIGN="TOP">
<P>90</P>
</TD>
<TD VALIGN="TOP">
<P>28.2 (31.6)</P>
</TD>
<TD VALIGN="TOP">
<P>29 (28.3)</P>
</TD>
<TD VALIGN="TOP">
<P>96</P>
</TD>
<TD VALIGN="TOP">
<P>27.2 (38.2)</P>
</TD>
<TD VALIGN="TOP">
<P>25.6 (33.6)</P>
</TD>
<TD VALIGN="TOP">
<P>0.11 (-0.18; 0.40)</P>
</TD>
<TD ROWSPAN="2" VALIGN="MIDDLE">
<P>0.13</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Antispasmodic prescription - all antispasmodics (IBS)*</P>
</TD>
<TD VALIGN="TOP">
<P>90</P>
</TD>
<TD VALIGN="TOP">
<P>124.9 (88.2)</P>
</TD>
<TD VALIGN="TOP">
<P>130.4 (101.2)</P>
</TD>
<TD VALIGN="TOP">
<P>96</P>
</TD>
<TD VALIGN="TOP">
<P>116.5 (92.7)</P>
</TD>
<TD VALIGN="TOP">
<P>115.7 (97.5)</P>
</TD>
<TD VALIGN="TOP">
<P>0.15 (-0.14; 0.44)</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="5" VALIGN="MIDDLE">
<P>Kottke 1989</P>
</TD>
<TD>
<P>Average proportion patients asked by physicians if they smoke</P>
</TD>
<TD>
<P>17</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>51.4 (24.9)</P>
</TD>
<TD>
<P>22</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>61 (29)</P>
</TD>
<TD>
<P>-0.34 (-0.29; 0.98)</P>
</TD>
<TD ROWSPAN="5" VALIGN="MIDDLE">
<P>0.36</P>
</TD>
</TR>
<TR>
<TD>
<P>Proportion of patients asked by physicians to quit smoking for each physician</P>
</TD>
<TD>
<P>17</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>39.7 (14.2)</P>
</TD>
<TD>
<P>22</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>54.9 (20)</P>
</TD>
<TD>
<P>0.84 (0.18; 1.50)</P>
</TD>
</TR>
<TR>
<TD>
<P>Proportion of smoking patients who were asked to set a quit date for each physician</P>
</TD>
<TD>
<P>17</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>5.4 (17.3)</P>
</TD>
<TD>
<P>22</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>9.6 (19.5)</P>
</TD>
<TD>
<P>0.22 (-0.41; 0.86)</P>
</TD>
</TR>
<TR>
<TD>
<P>Proportion of smoking patients who were given a follow-up appointment for each physician</P>
</TD>
<TD>
<P>17</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>3.8 (5.5)</P>
</TD>
<TD>
<P>22</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>6.9 (10.1)</P>
</TD>
<TD>
<P>0.36 (-0.28; 1.00)</P>
</TD>
</TR>
<TR>
<TD>
<P>Smoking patients who received supportive materials</P>
</TD>
<TD>
<P>17</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>10.6 (7.7)</P>
</TD>
<TD>
<P>22</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>36.4 (15.7)</P>
</TD>
<TD>
<P>1.96 (1.18; 2.75)</P>
</TD>
</TR>
<TR>
<TD>
<P>Watson 2001</P>
</TD>
<TD>
<P>Prescription of 3 recommended NSAIDS relative to total NSAID prescribing (mean in all practices) (%)</P>
</TD>
<TD>
<P>36</P>
</TD>
<TD>
<P>79 (4.9)</P>
</TD>
<TD>
<P>81.2 (3.7)</P>
</TD>
<TD>
<P>36</P>
</TD>
<TD>
<P>77 (7.6)</P>
</TD>
<TD>
<P>80.3 (7.2)</P>
</TD>
<TD>
<P>-0.16 (-0.32; 0.26)</P>
</TD>
<TD>
<P>-0.16</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="2" VALIGN="MIDDLE">
<P>Avorn 1983</P>
</TD>
<TD ROWSPAN="2">
<P>Mean number of units prescribed / physician (All three drugs)</P>
</TD>
<TD>
<P>140</P>
</TD>
<TD>
<P>5415 (NA)</P>
</TD>
<TD>
<P>4921 (NA)</P>
</TD>
<TD>
<P>132</P>
</TD>
<TD>
<P>5875 (NA)</P>
</TD>
<TD>
<P>5071 (NA)</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD VALIGN="MIDDLE">
<P>NA</P>
</TD>
</TR>
<TR>
<TD COLSPAN="8">
<P>Quote: "a significant difference was found in the postintervention prescribing pattern of the face-to-face group as compared with those of the other physicians in the study in terms of units of medication (number of tablets or capsules) prescribed for the three target-drugs groups" (improvement)</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="4" VALIGN="MIDDLE">
<P>Azocar 2003</P>
</TD>
<TD VALIGN="TOP">
<P>Guidelines adherence (Combined outpatient)</P>
</TD>
<TD COLSPAN="8">
<P>Quote: "there were no group differences in the probability of receiving medication (overall adjusted probability = 0.61), psychotherapy (overall adjusted probability = 0.49), or combined treatment (overall adjusted probability = 0.50). Given the possibility that patients received services from clinicians outside of the study, either concurrently or subsequently within the index episode, further analyses assessed the effect that guideline dissemination had on the receipt of any mental health service type. This analysis also showed no dissemination effects, indicating an equal likelihood of receiving psychotherapy, medication management, or combined outpatient care, intermediate care (eg. day treatment or residential treatment) and inpatient care within the index episode" (no effect)</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Guideline adherence (continuation of treatment. i.e. more than 180 days of treatment)</P>
</TD>
<TD COLSPAN="8">
<P>Quote: "finally, there were no differences in the delivery of continuation treatment across dissemination group despite the fact that this practice is heavily emphasized in UBH, AHCPR, and APA treatment guidelines. Only 19% of study patients received continuation care" (no effect)</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Guideline adherence (documentation of a mental health or substance abuse comorbidity)</P>
</TD>
<TD COLSPAN="8">
<P>Quote: "detection of comorbid substance use disorders by study clinicians was low, with only 0.6% documenting the detection of substance abuse or dependence where actual rates are to be approximately 15%" (no effect)</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Guideline adherence (documentation of medical condition inducing depression)</P>
</TD>
<TD COLSPAN="8">
<P>Quote: "detection of depression due to medical problems by clinicians, using Mood Disorder Due to a Medical Condition of the Diagnostic and Statistical Manual Fourth Edition (DSM IV) diagnosis code as a proxy, also was remarkably low at 0.4%" (no effect)</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>* Results were transformed so that a positive difference in outcomes between group could be interpreted as an improvement in outcome.</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-06" MODIFIED="2012-09-10 11:11:14 -0400" MODIFIED_BY="[Empty name]" NO="6">
<TITLE MODIFIED="2012-09-10 11:10:51 -0400" MODIFIED_BY="[Empty name]">Comparison group #1, ITS design, professional practice outcomes. Data were re-analysed with segmented regression statistical model. P value &lt; 0.0001:***, &lt; 0.001: **, &#8804; 0.05: *, &gt; 0.05: NS. Standardardised median change in level across all studies in this table = 1.69</TITLE>
<TABLE COLS="6" ROWS="64">
<TR>
<TH ROWSPAN="2">
<P>ID</P>
</TH>
<TH ROWSPAN="2">
<P>Outcome</P>
</TH>
<TH ROWSPAN="2">
<P>Change in slope (SE)</P>
</TH>
<TH ALIGN="CENTER" COLSPAN="3">
<P>Level</P>
</TH>
</TR>
<TR>
<TH>
<P>Change in level of outcome (SE)</P>
</TH>
<TH>
<P>Standardised change in level of outcome (change/SE)</P>
</TH>
<TH>
<P>
<B>Median change in level</B>
</P>
</TH>
</TR>
<TR>
<TD>
<P>Austin 2003</P>
</TD>
<TD>
<P>Per cent of female patients over 65 receiving ERT Rx before and after HERS study<SUP>&#8737;</SUP>
</P>
</TD>
<TD>
<P>0.18 (0.03)***</P>
</TD>
<TD>
<P>-0.81 (0.27)*</P>
</TD>
<TD>
<P>-2.98*</P>
</TD>
<TD ROWSPAN="2">
<P>0.45</P>
</TD>
</TR>
<TR>
<TD>
<P>Austin 2003</P>
</TD>
<TD>
<P>Incidence of female patients over 65 receiving ERT Rx before and after HERS study<SUP>&#8737;</SUP>
</P>
</TD>
<TD>
<P>228 (24)***</P>
</TD>
<TD>
<P>726.92 (188)**</P>
</TD>
<TD>
<P>3.88**</P>
</TD>
</TR>
<TR>
<TD>
<P>Austin 2004A</P>
</TD>
<TD>
<P>Total number of claims for clonidine in Ontario for women 65 years of age and older</P>
</TD>
<TD>
<P>6.3 (11) (NS)</P>
</TD>
<TD>
<P>102.39 (31)*</P>
</TD>
<TD>
<P>3.28*</P>
</TD>
<TD ROWSPAN="2">
<P>1.57</P>
</TD>
</TR>
<TR>
<TD>
<P>Austin 2004A</P>
</TD>
<TD>
<P>Total number of claims for clonidine in Ontario for men 65 years of age and older</P>
</TD>
<TD>
<P>5.2 (3.3) (NS)</P>
</TD>
<TD>
<P>-1.41 (10) (NS)</P>
</TD>
<TD>
<P>-0.14 (NS)</P>
</TD>
</TR>
<TR>
<TD>
<P>Austin 2004B</P>
</TD>
<TD>
<P>Relative market share of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers<SUP>&#8737;</SUP>
</P>
</TD>
<TD>
<P>-0.81 (0.74) (NS)</P>
</TD>
<TD>
<P>8.89 (1.92)***</P>
</TD>
<TD>
<P>4.62***</P>
</TD>
<TD ROWSPAN="4">
<P>3.23</P>
</TD>
</TR>
<TR>
<TD>
<P>Austin 2004B</P>
</TD>
<TD>
<P>Relative market share of &#946;-blockers<SUP>&#8737;</SUP>
</P>
</TD>
<TD>
<P>-0.34 (0.57) (NS)</P>
</TD>
<TD>
<P>-0.66 (1.65) (NS)</P>
</TD>
<TD>
<P>0.40 (NS)</P>
</TD>
</TR>
<TR>
<TD>
<P>Austin 2004B</P>
</TD>
<TD>
<P>Relative market share of thiazide-type diuretics</P>
</TD>
<TD>
<P>-0.32 (0.39) (NS)</P>
</TD>
<TD>
<P>10.45 (1)***</P>
</TD>
<TD>
<P>9.99***</P>
</TD>
</TR>
<TR>
<TD>
<P>Austin 2004B</P>
</TD>
<TD>
<P>Relative market share of calcium channel blockers<SUP>&#8737;</SUP>
</P>
</TD>
<TD>
<P>-0.10 (0.44) (NS)</P>
</TD>
<TD>
<P>2.14 (1.2) (NS)</P>
</TD>
<TD>
<P>1.84 (NS)</P>
</TD>
</TR>
<TR>
<TD>
<P>Austin 2005</P>
</TD>
<TD>
<P>Statin prescribing (atorvastatin 80 mg/day)</P>
</TD>
<TD>
<P>73 (9.6)***</P>
</TD>
<TD>
<P>366.28 (3) ***</P>
</TD>
<TD>
<P>10.59***</P>
</TD>
<TD ROWSPAN="2">
<P/>
<P>5.36</P>
</TD>
</TR>
<TR>
<TD>
<P>Austin 2005</P>
</TD>
<TD>
<P>Statin prescribing (pravastatin 40 mg/day)<SUP>&#8737;</SUP>
</P>
</TD>
<TD>
<P>-87 (73) (NS)</P>
</TD>
<TD>
<P>-41.14 (31) (NS)</P>
</TD>
<TD>
<P>0.14 (NS)</P>
</TD>
</TR>
<TR>
<TD>
<P>Black 2002</P>
</TD>
<TD>
<P>Mean number of surgery per 10,000 children aged under 10 years for 13 health districts<SUP>&#8737;</SUP>
</P>
</TD>
<TD>
<P>13.9 (4.0)*</P>
</TD>
<TD>
<P>9.89 (11.6) (NS)</P>
</TD>
<TD>
<P>0.85 (NS)</P>
</TD>
<TD>
<P>0.85</P>
</TD>
</TR>
<TR>
<TD>
<P>Buyle 2010</P>
</TD>
<TD>
<P>Monthly ratio of intravenous versus total fluoroquinolone consumption, in daily defined doses per 1000 bed days</P>
</TD>
<TD>
<P>-0.10 (0.19) (NS)</P>
</TD>
<TD>
<P>-4.95 (2.4) *</P>
</TD>
<TD>
<P>-2.07*</P>
</TD>
<TD>
<P>-2.07</P>
</TD>
</TR>
<TR>
<TD>
<P>Coopersmith 2002</P>
</TD>
<TD>
<P>Monthly rate per 1000 central venous catheter days of catheter-related bloodstream infections (BSI)<SUP>&#8737;</SUP>
</P>
</TD>
<TD>
<P>-0.01 (0.02) (NS)</P>
</TD>
<TD>
<P>0.52 (0.24) *</P>
</TD>
<TD>
<P>2.13*</P>
</TD>
<TD>
<P>2.13</P>
</TD>
</TR>
<TR>
<TD>
<P>Fonarow 2009 - MIRACL</P>
</TD>
<TD>
<P>Rates (%) of lipid-lowering agent use for all patients</P>
</TD>
<TD>
<P>-0.50 (0.10)***</P>
</TD>
<TD>
<P>3.49 (0.85)**</P>
</TD>
<TD>
<P>4.13**</P>
</TD>
<TD ROWSPAN="3">
<P>0.91</P>
</TD>
</TR>
<TR>
<TD>
<P>Fonarow 2009 - MIRACL</P>
</TD>
<TD>
<P>Rates (%) of lipid-lowering agent use for patients initiating treatment</P>
</TD>
<TD>
<P>-0.04 (0.14) (NS)</P>
</TD>
<TD>
<P>0.69 (0.76) (NS)</P>
</TD>
<TD>
<P>0.91 (NS)</P>
</TD>
</TR>
<TR>
<TD>
<P>Fonarow 2009 - MIRACL</P>
</TD>
<TD>
<P>Rate (%) of lipid-lowering agent use for patent continuing treatment</P>
</TD>
<TD>
<P>0.14 (0.15) (NS)</P>
</TD>
<TD>
<P>-4.02 (0.79) **</P>
</TD>
<TD>
<P>-5.06**</P>
</TD>
</TR>
<TR>
<TD>
<P>Fonarow 2009 - ACC-AHA NS</P>
</TD>
<TD>
<P>Rates (%) of lipid-lowering agent use for all patients</P>
</TD>
<TD>
<P>0.34 (0.08)**</P>
</TD>
<TD>
<P>0.02 (0.52) (NS)</P>
</TD>
<TD>
<P>0.04 (NS)</P>
</TD>
<TD ROWSPAN="2">
<P>-1.57</P>
</TD>
</TR>
<TR>
<TD>
<P>Fonarow 2009 - ACC AHA NS</P>
</TD>
<TD>
<P>Rates (%) of lipid-lowering agent use for patients initiating treatment</P>
</TD>
<TD>
<P>0.23 (0.10)*</P>
</TD>
<TD>
<P>-1.93 (0.61)*</P>
</TD>
<TD>
<P>-3.18*</P>
</TD>
</TR>
<TR>
<TD>
<P>Fonarow 2009 - PROVE-IT TIMI 22</P>
</TD>
<TD>
<P>Rates (%) of lipid-lowering agent use for all patients</P>
</TD>
<TD>
<P>0.43 (0.32) (NS)</P>
</TD>
<TD>
<P>6.24 (0.95)***</P>
</TD>
<TD>
<P>6.55***</P>
</TD>
<TD ROWSPAN="3">
<P>4.63</P>
</TD>
</TR>
<TR>
<TD>
<P>Fonarow 2009 - PROVE-IT TIMI 22</P>
</TD>
<TD>
<P>Rate (%) of lipid-lowering agent use for patent continuing treatment</P>
</TD>
<TD>
<P>-0.14 (0.37) (NS)</P>
</TD>
<TD>
<P>5.35 (1.2)**</P>
</TD>
<TD>
<P>4.63**</P>
</TD>
</TR>
<TR>
<TD>
<P>Fonarow 2009 - PROVE-IT TIMI 22</P>
</TD>
<TD>
<P>Rates (%) of lipid-lowering agent use for patients initiating treatment</P>
</TD>
<TD>
<P>-0.14 (0.37) (NS)</P>
</TD>
<TD>
<P>5.35 (1.2)**</P>
</TD>
<TD>
<P>4.63**</P>
</TD>
</TR>
<TR>
<TD>
<P>Fonarow 2009 - ACC-AHA STEMI Guideline</P>
</TD>
<TD>
<P>Rate (%) of lipid-lowering agent use for patent continuing treatment</P>
</TD>
<TD>
<P>0.23 (0.10)*</P>
</TD>
<TD>
<P>-1.93 (0.61)*</P>
</TD>
<TD>
<P>-3.18*</P>
</TD>
<TD>
<P>-3.18</P>
</TD>
</TR>
<TR>
<TD>
<P>Guay 2007</P>
</TD>
<TD>
<P>Total number of HRT prescriptions dispensed per month<SUP>&#8737;</SUP>
</P>
</TD>
<TD>
<P>-30 (89) (NS)</P>
</TD>
<TD>
<P>-695.38 (193)**</P>
</TD>
<TD>
<P>3.61**</P>
</TD>
<TD>
<P>3.61</P>
</TD>
</TR>
<TR>
<TD>
<P>Haas 2004 - HERS study</P>
</TD>
<TD>
<P>Percentage of women reporting hormone use<SUP>&#8737;</SUP>
</P>
</TD>
<TD>
<P>0.58 (0.17)*</P>
</TD>
<TD>
<P>-3.95 (2.09) (NS)</P>
</TD>
<TD>
<P>-1.89 (NS)</P>
</TD>
<TD>
<P>-1.89</P>
</TD>
</TR>
<TR>
<TD>
<P>Haas 2004 - WHI study</P>
</TD>
<TD>
<P>Percentage of women reporting hormone use<SUP>&#8737;</SUP>
</P>
</TD>
<TD>
<P>1.5 (0.24)***</P>
</TD>
<TD>
<P>4.16 (2.0) *</P>
</TD>
<TD>
<P>2.08*</P>
</TD>
<TD>
<P>2.08</P>
</TD>
</TR>
<TR>
<TD>
<P>Jackevicius 2001</P>
</TD>
<TD>
<P>All statin prescriptions</P>
</TD>
<TD>
<P>0.52 (0.04)***</P>
</TD>
<TD>
<P>2.39 (0.52) ***</P>
</TD>
<TD>
<P>4.58***</P>
</TD>
<TD>
<P>4.58</P>
</TD>
</TR>
<TR>
<TD>
<P>Jameson 2010</P>
</TD>
<TD>
<P>Use of low-molecular-weight-heparin (LMWH)</P>
</TD>
<TD>
<P>0.63 (0.17)*</P>
</TD>
<TD>
<P>1.92 (1.2) (NS)</P>
</TD>
<TD>
<P>1.64 (NS)</P>
</TD>
<TD>
<P/>
<P>1.64</P>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Juurlink 2004</P>
</TD>
<TD>
<P>Rate of spironolactone Rx</P>
</TD>
<TD>
<P>12 (0.92)***</P>
</TD>
<TD>
<P>62.43 (4.4) (NS)</P>
</TD>
<TD>
<P>14.26***</P>
</TD>
<TD>
<P>14.26</P>
</TD>
</TR>
<TR>
<TD>
<P>Kabir 2007 - LIFE trial</P>
</TD>
<TD>
<P>New prescriptions of atenolol </P>
</TD>
<TD>
<P>0.07 (0.07) (NS)</P>
</TD>
<TD>
<P>-0.39 (0.5) (NS)</P>
</TD>
<TD>
<P>-0.82 (NS)</P>
</TD>
<TD ROWSPAN="2">
<P>1.60</P>
</TD>
</TR>
<TR>
<TD>
<P>Kabir 2007 - LIFE trial</P>
</TD>
<TD>
<P>New prescriptions of losartan</P>
</TD>
<TD>
<P>-0.04 (0.05) (NS)</P>
</TD>
<TD>
<P>0.71 (0.2) *</P>
</TD>
<TD>
<P>4.01*</P>
</TD>
</TR>
<TR>
<TD>
<P>Kabir 2007 - ALLHAT</P>
</TD>
<TD>
<P>New prescription of angiotensin converting enzyme (ACE) inhibitors</P>
</TD>
<TD>
<P>0.33 (0.11)*</P>
</TD>
<TD>
<P>0.91 (0.82) (NS)</P>
</TD>
<TD>
<P>1.12 (NS)</P>
</TD>
<TD ROWSPAN="2">
<P>0.41</P>
</TD>
</TR>
<TR>
<TD>
<P>Kabir 2007 - ALLHAT</P>
</TD>
<TD>
<P>New prescriptions of thiazide-type diuretics</P>
</TD>
<TD>
<P>-0.05 (0.11) (NS)</P>
</TD>
<TD>
<P>-0.22 (0.73) (NS)</P>
</TD>
<TD>
<P>-0.31 (NS)</P>
</TD>
</TR>
<TR>
<TD>
<P>Kabir 2007 - VALUE trial</P>
</TD>
<TD>
<P>New prescription of valsartan<SUP>&#8737;</SUP>
</P>
</TD>
<TD>
<P>0.0014 (0.05) (NS)</P>
</TD>
<TD>
<P>-0.01 (0.34) (NS)</P>
</TD>
<TD>
<P>-0.03 (NS)</P>
</TD>
<TD ROWSPAN="2">
<P>-0.41</P>
</TD>
</TR>
<TR>
<TD>
<P>Kabir 2007 - VALUE trial</P>
</TD>
<TD>
<P>New prescriptions of calcium channel blockers</P>
</TD>
<TD>
<P>0.14 (0.07) (NS)</P>
</TD>
<TD>
<P>-0.42 (0.54) (NS)</P>
</TD>
<TD>
<P>-0.78 (NS)</P>
</TD>
</TR>
<TR>
<TD>
<P>Lam 2009</P>
</TD>
<TD>
<P>Rate of statin use  per 1000 diabetic haemodialysis patients</P>
</TD>
<TD>
<P>-8.2 (4.6) (NS)</P>
</TD>
<TD>
<P>39.52 (22.5) (NS)</P>
</TD>
<TD>
<P>-1.76 (NS)</P>
</TD>
<TD>
<P>-1.76</P>
</TD>
</TR>
<TR>
<TD>
<P>Majumdar 2003- HOPE</P>
</TD>
<TD>
<P>Number of prescriptions of ramipril in Canada</P>
</TD>
<TD>
<P>37 (1.9)***</P>
</TD>
<TD>
<P>-37.45 (6.82)*</P>
</TD>
<TD>
<P>-5.49*</P>
</TD>
<TD ROWSPAN="2">
<P>-4.21</P>
</TD>
</TR>
<TR>
<TD>
<P>Majumdar 2003- HOPE</P>
</TD>
<TD>
<P>Number of prescriptions of ramipril in the US</P>
</TD>
<TD>
<P>18 (3.1)**</P>
</TD>
<TD>
<P>-29.25 (10)*</P>
</TD>
<TD>
<P>-2.92*</P>
</TD>
</TR>
<TR>
<TD>
<P>Majumdar 2003- RALES</P>
</TD>
<TD>
<P>Number of prescriptions of Spironolactone in Canada</P>
</TD>
<TD>
<P>7.83 (1.7)*</P>
</TD>
<TD>
<P>8.16 (5.4) (NS)</P>
</TD>
<TD>
<P>1.53 (NS)</P>
</TD>
<TD ROWSPAN="2">
<P>1.73</P>
</TD>
</TR>
<TR>
<TD>
<P>Majumdar 2003- RALES</P>
</TD>
<TD>
<P>Number of prescriptions of spironolactone in the US</P>
</TD>
<TD>
<P>5.3 (2.4)*</P>
</TD>
<TD>
<P>14.12 (7.3) (NS)</P>
</TD>
<TD>
<P>1.93 (NS)</P>
</TD>
</TR>
<TR>
<TD>
<P>Majumdar 2004</P>
</TD>
<TD>
<P>Number of prescriptions for postmenopausal hormone therapy<SUP>&#8737;</SUP>
</P>
</TD>
<TD>
<P>1.2 (2.8) (NS)</P>
</TD>
<TD>
<P>9.87 (8.63) (NS)</P>
</TD>
<TD>
<P>1.14 (NS)</P>
</TD>
<TD ROWSPAN="5">
<P>3.70</P>
</TD>
</TR>
<TR>
<TD>
<P>Majumdar 2004</P>
</TD>
<TD>
<P>Number of prescriptions for postmenopausal hormone therapy (Premarin)<SUP>&#8737;</SUP>
</P>
</TD>
<TD>
<P>0.37 (0.06)**</P>
</TD>
<TD>
<P>0.86 (0.19)*</P>
</TD>
<TD>
<P>4.54*</P>
</TD>
</TR>
<TR>
<TD>
<P>Majumdar 2004</P>
</TD>
<TD>
<P>Number of prescriptions for postmenopausal hormone therapy (Pempro)<SUP>&#8737;</SUP>
</P>
</TD>
<TD>
<P>0.33 (0.08)*</P>
</TD>
<TD>
<P>1.40 (0.25)**</P>
</TD>
<TD>
<P>5.53**</P>
</TD>
</TR>
<TR>
<TD>
<P>Majumdar 2004</P>
</TD>
<TD>
<P>Number of prescriptions for postmenopausal hormone therapy (lower dose Premarin and Pempro)<SUP>&#8737;</SUP>
</P>
</TD>
<TD>
<P>-0.05 (0.05) (NS)</P>
</TD>
<TD>
<P>0.15 (0.12) (NS)</P>
</TD>
<TD>
<P>1.24 (NS)</P>
</TD>
</TR>
<TR>
<TD>
<P>Majumdar 2004</P>
</TD>
<TD>
<P>Number of prescription for postmenopausal hormone therapy (all other formulations)<SUP>&#8737;</SUP>
</P>
</TD>
<TD>
<P>0.44 (0.05)***</P>
</TD>
<TD>
<P>0.52 (0.14)*</P>
</TD>
<TD>
<P>3.70*</P>
</TD>
</TR>
<TR>
<TD>
<P>Mason 1998-99</P>
</TD>
<TD>
<P>Prescription of antidepressants (selective serotonin reuptake inhibitors, SSRIs)<SUP>&#8737;</SUP>
</P>
</TD>
<TD>
<P>-3584 (683)***</P>
</TD>
<TD>
<P>4092 (3318) (NS)</P>
</TD>
<TD>
<P/>
<P>1.23 (NS)</P>
</TD>
<TD ROWSPAN="2">
<P>2.17</P>
</TD>
</TR>
<TR>
<TD>
<P>Mason 1998-99</P>
</TD>
<TD>
<P>Prescription of antidepressants (tricyclic)</P>
</TD>
<TD>
<P>-984 (414)*</P>
</TD>
<TD>
<P>5901 (1897) *</P>
</TD>
<TD>
<P>3.11*</P>
</TD>
</TR>
<TR>
<TD>
<P>Mason 2001</P>
</TD>
<TD>
<P>Use of surgery for glue ear<SUP>&#8737;</SUP>
</P>
</TD>
<TD>
<P>0.05 (0.01)*</P>
</TD>
<TD>
<P>0.39 (0.08) ***</P>
</TD>
<TD>
<P>4.83***</P>
</TD>
<TD>
<P>4.83</P>
</TD>
</TR>
<TR>
<TD>
<P>Matowe 2002</P>
</TD>
<TD>
<P>Total number of imaging requests from general practice<SUP>&#8737;</SUP>
</P>
</TD>
<TD>
<P>11 (18) (NS)</P>
</TD>
<TD>
<P>-71.70 (162) (NS)</P>
</TD>
<TD>
<P>-0.44 (NS)</P>
</TD>
<TD>
<P>-0.44</P>
</TD>
</TR>
<TR>
<TD>
<P>Meyer 2007</P>
</TD>
<TD>
<P>Antimicrobial use density<SUP>&#8737;</SUP>
</P>
</TD>
<TD>
<P>-2.15 (0.81) (NS)</P>
</TD>
<TD>
<P>386 (123)*</P>
</TD>
<TD>
<P>3.14*</P>
</TD>
<TD>
<P>3.14</P>
</TD>
</TR>
<TR>
<TD>
<P>Roberts 2007</P>
</TD>
<TD>
<P>Rate (%) of use of uncemented prostheses<SUP>&#8737;</SUP>
</P>
</TD>
<TD>
<P>-1.6 (0.51)*</P>
</TD>
<TD>
<P>-5.47 (1.8)*</P>
</TD>
<TD>
<P>-3.01*</P>
</TD>
<TD ROWSPAN="2">
<P>-1.89</P>
</TD>
</TR>
<TR>
<TD>
<P>Roberts 2007</P>
</TD>
<TD>
<P>Rate (%) of use of hybrid prostheses of all hips implanted</P>
</TD>
<TD>
<P>2.8 (0.77)*</P>
</TD>
<TD>
<P>-1.87 (2.6) (NS)</P>
</TD>
<TD>
<P>-0.74 (NS)</P>
</TD>
</TR>
<TR>
<TD>
<P>Shah 2008</P>
</TD>
<TD>
<P>Number of new users of thiazolidinedione (rosiglitazone or pioglitazone)</P>
</TD>
<TD>
<P>28 (1.81)***</P>
</TD>
<TD>
<P>-218.07 (31)***</P>
</TD>
<TD>
<P>6.96***</P>
</TD>
<TD>
<P>6.96</P>
</TD>
</TR>
<TR>
<TD>
<P>Stafford 2004</P>
</TD>
<TD>
<P>Number of &#945;-blockers prescriptions dispensed - all &#945;-blockers (both newly dispensed and refills)<SUP>&#8737;</SUP>
</P>
</TD>
<TD>
<P>0.14 (0.01)***</P>
</TD>
<TD>
<P>0.06 (0.07) (NS)</P>
</TD>
<TD>
<P>0.87 (NS)</P>
</TD>
<TD>
<P>0.87</P>
</TD>
</TR>
<TR>
<TD>
<P>Weiss 2011</P>
</TD>
<TD>
<P>Monthly prescribing rates (no. of prescriptions/1000 inhabitants) for all antibiotics in Quebec relative to the rest of Canada<SUP>&#8737;</SUP>
</P>
</TD>
<TD>
<P>-0.16 (0.10) (NS)</P>
</TD>
<TD>
<P>2.98 (1.5) (NS)</P>
</TD>
<TD>
<P>2.00 (NS)</P>
</TD>
<TD>
<P>2.00</P>
</TD>
</TR>
<TR>
<TD>
<P>Barbaglia 2009</P>
</TD>
<TD>
<P>Prevalence of HRT use in women</P>
</TD>
<TD COLSPAN="4">
<P>Quote: "annual increases in the prevalence of HT use in all age group (Fig. 1) were found from 1998 up to 2002 when prevalence levels peaked, especially in the youngest age group (11.0%) and in the group aged 55 to 59 years (10.1%). A sudden reversal and similar progressive decrease were observed in all age groups and for all educational levels. Five years after publication of the WHI results, the prevalence of HT users was 1.2% in 50- to 54-year-old women (a decrease of 89.1% with respect to 2002; 57% within the subsequent 2 y), 1.4% (overall 87.5%; 61% in the first 2 y) in 55- to 59-year-old women, 0.6% (-84.6%) in 60- to 64-year-old women, and 0.3% (-66.0%) in 64- to 69-year-old women" (improvement)</P>
</TD>
</TR>
<TR>
<TD>
<P>Fijn 2000</P>
</TD>
<TD>
<P>Proportion of patients newly prescribed antithrombotic therapy after having a diagnosis of ischaemic heart disease</P>
</TD>
<TD COLSPAN="4">
<P>Quote: "the introduction of national guidelines increased the chance of antithrombotic prescribing by a factor of 1.4. The present findings indicate that for about 65% of all newly diagnosed IHD patients, antithrombotics are initiated within 6 months after diagnosis" (improvement)</P>
</TD>
</TR>
<TR>
<TD>
<P>Fonarow 2009 - ACC-AHA STEMI Guideline</P>
</TD>
<TD>
<P>Rates (%) of lipid-lowering agent use for all patients</P>
</TD>
<TD COLSPAN="4">
<P>Quote: "although each successive quarter and year showed an increase in lipid-lowering medication treatment rates from 1998 to 2006, the rate of increase was larger in the earlier periods of the study (Figure 2). Although the slope differences of monthly discharge rates before and after each publication date of interest showed decreases, the greatest jump in lipid-lowering medication use was observed in month 72, corresponding to the publication on the PROVE IT-TIMI 22. Each publication time point of interest before month 72 showed no significant upward jumps in treatment. However, beginning with month 72, each of the 2 remaining time points demonstrated a significantly greater absolute increase in the use of lipid-lowering agents at discharge (month 72, 6.0%, P b .0001, and month 77, 5.7%, P b .0001) than otherwise would have been expected. Multivariate logistic modeling qualitatively confirmed that the upward change in the level of medication use (or jump) at each time point was independent of other variables predictive of lipid-lowering medication use" (improvement)</P>
</TD>
</TR>
<TR>
<TD>
<P>Fonarow 2009 - ACC-AHA STEMI Guideline</P>
</TD>
<TD>
<P>Rates (%) of lipid-lowering agent use for patients initiating treatment</P>
</TD>
<TD COLSPAN="4">
<P>Quote: "most patients being prescribed lipid lowering medications at hospital discharge were newly initiated on therapy during hospitalization for AMI, and the large increase in use of lipid-lowering medications at discharge is not merely resulting from a substantial increase in preadmission use of lipid-lowering medications over time" (improvement)</P>
</TD>
</TR>
<TR>
<TD>
<P>Fukuda 2009</P>
</TD>
<TD>
<P>Use of breast-conserving surgery</P>
</TD>
<TD COLSPAN="4">
<P>Quote: "the proportion of BCS use increased from 26.4% before guideline publication to 59.9% after guideline publication in Japan. The percentage of patients receiving BCS almost doubled between the two time periods (P&lt;0.001)" (improvement)</P>
</TD>
</TR>
<TR>
<TD>
<P>Hersh 2004</P>
</TD>
<TD>
<P>Prescriptions of all forms of hormone therapy per year</P>
</TD>
<TD COLSPAN="4">
<P>Quote: "following the release of WHI and HERS II in July 2002, hormone therapy prescriptions declined in successive months through July 2003 (Figure 1 and FIGURE 2). Based on data from July 2003, hormone therapy prescriptions declined by 38% (95% CI, 37%-39%) overall relative to months prior to July 2002, with a decline of 74% (95%CI, 73%-75%) for Prempro. The percentage of women aged 50 to 74 years taking hormone therapy increased from 33% to 42% between 1995 and 2001. By July 2003, this exposure had declined to 28% of women in this age group" (improvement)</P>
</TD>
</TR>
<TR>
<TD>
<P>Santerre 1996</P>
</TD>
<TD>
<P>Proportion of vaginal birth after C-section in 55 hospitals</P>
</TD>
<TD COLSPAN="4">
<P>Quote: "the parameter estimates on the guideline binary variable in the regression models indicate that the ACOG guideline resulted in a 31% increase in the VBAC rate at the typical hospital in Massachusetts. That percentage increase amounts to a permanent 5.6 percentage point increase in the VBAC rate when evaluated at the mean VBAC rate of 17.92% for the sample" (improvement)</P>
</TD>
</TR>
<TR>
<TD>
<P>Wang 2005</P>
</TD>
<TD>
<P>LDL cholesterol control for diabetes visits relative to CHD visits</P>
</TD>
<TD COLSPAN="4">
<P>Quote: "in 1995, the rate of LDL cholesterol control was 4% higher for diabetes visits than for CHD (Fig. 1B). LDL cholesterol control increased for both diseases over time (but at a slower speed for diabetes) to 44% of diabetes visits and 55% of CHD visits in 2004, with an absolute difference of 11%. Despite the publication of new guidelines in 1998 and 2001, diabetes lagged behind CHD visits in LDL cholesterol control after 1998" (no effect)</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>&#8737; </SUP>Results were transformed so that a positive difference in outcomes between groups could be interpreted as an improvement in outcome.</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-07" MODIFIED="2012-09-10 11:11:19 -0400" MODIFIED_BY="[Empty name]" NO="7">
<TITLE MODIFIED="2012-04-11 14:26:41 -0400" MODIFIED_BY="[Empty name]">Comparison group #1, RCT design - categorical, patient outcomes</TITLE>
<TABLE COLS="7" ROWS="3">
<TR>
<TH ROWSPAN="2">
<P>Study</P>
</TH>
<TH ROWSPAN="2">
<P>Outcome</P>
</TH>
<TH COLSPAN="2">
<P>Control (n/N)</P>
</TH>
<TH COLSPAN="2">
<P>Experimental (n/N)</P>
</TH>
<TH ROWSPAN="2">
<P>Absolute risk difference (95% CI)</P>
</TH>
</TR>
<TR>
<TH>
<P>Pre</P>
</TH>
<TH>
<P>Post</P>
</TH>
<TH>
<P>Pre</P>
</TH>
<TH>
<P>Post</P>
</TH>
</TR>
<TR>
<TD>
<P>Tsugi 2009</P>
</TD>
<TD>
<P>Clinical remission</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>65/114</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>84/120</P>
</TD>
<TD>
<P>0.13 (0.01 to 0.25)</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-08" MODIFIED="2012-09-10 11:12:47 -0400" MODIFIED_BY="[Empty name]" NO="8">
<TITLE MODIFIED="2012-09-10 11:12:47 -0400" MODIFIED_BY="[Empty name]">Comparison group #1, RCT design - continuous, patient outcome</TITLE>
<TABLE COLS="10" ROWS="7">
<TR>
<TH>
<P>Study</P>
</TH>
<TH>
<P>Outcome</P>
</TH>
<TH COLSPAN="3">
<P>Control</P>
</TH>
<TH COLSPAN="3">
<P>Experimental</P>
</TH>
<TH>
<P>Standard effect size (95% CI)</P>
</TH>
<TH>
<P>Standard median effect size</P>
</TH>
</TR>
<TR>
<TH>
<P/>
</TH>
<TH>
<P/>
</TH>
<TH>
<P>N</P>
</TH>
<TH>
<P>Pre mean (SD)</P>
</TH>
<TH>
<P>Post mean (SD)</P>
</TH>
<TH>
<P>N</P>
</TH>
<TH>
<P>Pre mean (SD)</P>
</TH>
<TH>
<P>Post mean (SD)</P>
</TH>
<TH>
<P/>
</TH>
<TH>
<P/>
</TH>
</TR>
<TR>
<TD ROWSPAN="5">
<P>Kottke 1989</P>
</TD>
<TD>
<P>Proportion of patients who agreed to quit smoking for each physician</P>
</TD>
<TD>
<P>17</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>17.1 (8.1)</P>
</TD>
<TD>
<P>22</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>25.5 (12.9)</P>
</TD>
<TD>
<P>0.74 (0.09; 1.40)</P>
</TD>
<TD ROWSPAN="5">
<P>-0.14</P>
</TD>
</TR>
<TR>
<TD>
<P>Proportion of patients who reported an attempt to quit smoking (more than 24 hours without smoking)</P>
</TD>
<TD>
<P>17</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>44.4 (12.6)</P>
</TD>
<TD>
<P>22</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>44 (9.6)</P>
</TD>
<TD>
<P>-0.04 (-0.67; 0.60)</P>
</TD>
</TR>
<TR>
<TD>
<P>Duration of smoking cessation (in days)</P>
</TD>
<TD>
<P>17</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>74.2 (35.8)</P>
</TD>
<TD>
<P>22</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>66.7 (63.1)</P>
</TD>
<TD>
<P>-0.14 (-0.77; 0.50)</P>
</TD>
</TR>
<TR>
<TD>
<P>Number of months patients have attempted to quit (patient report)</P>
</TD>
<TD>
<P>17</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>8.2 (2.0)</P>
</TD>
<TD>
<P>22</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>7.8 (1.2)</P>
</TD>
<TD>
<P>-0.25 (-0.88; 0.39)</P>
</TD>
</TR>
<TR>
<TD>
<P>Proportion patients who reported not smoking at the time of interview for each physician</P>
</TD>
<TD>
<P>17</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>14.3 (6.5)</P>
</TD>
<TD>
<P>22</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>12 (7.4)</P>
</TD>
<TD>
<P>-0.32 (-0.96; 0.32)</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-09" MODIFIED="2012-09-10 11:12:27 -0400" MODIFIED_BY="[Empty name]" NO="9">
<TITLE MODIFIED="2012-09-10 11:12:27 -0400" MODIFIED_BY="[Empty name]">Comparison group #1, ITS design, patient outcomes. Data were re-analysed with segmented regression statistical model. P value &lt; 0.0001:***, &lt; 0.001: **, &#8804; 0.05: *, &gt; 0.05: NS. Standard median change in level across all studies in this table = 3.79</TITLE>
<TABLE COLS="6" ROWS="6">
<TR>
<TH ROWSPAN="2">
<P>
<B>ID</B>
</P>
</TH>
<TH ROWSPAN="2">
<P>
<B>Outcome</B>
</P>
</TH>
<TH ROWSPAN="2">
<P>Change in slope (SE)</P>
</TH>
<TH ALIGN="CENTER" COLSPAN="3">
<P>Level</P>
</TH>
</TR>
<TR>
<TH>
<P>Change in level of outcome (SE)</P>
</TH>
<TH>
<P>
<B>Standardised change in level of outcome (change/SE)</B>
</P>
</TH>
<TH>
<P>
<B>Median change in level</B>
</P>
</TH>
</TR>
<TR>
<TD>
<P>Jameson 2010</P>
</TD>
<TD>
<P>Complications from hip or knee replacement surgeries (venous thromboembolic events; VTE)<SUP>&#8737;</SUP>
</P>
</TD>
<TD>
<P>-0.01 (0.02)</P>
<P>(NS)</P>
</TD>
<TD>
<P>-0.30 (0.16) (NS)</P>
</TD>
<TD>
<P>-1.91 (NS)</P>
</TD>
<TD ROWSPAN="2">
<P>-1.82</P>
</TD>
</TR>
<TR>
<TD>
<P>Jameson 2010</P>
</TD>
<TD>
<P>Complications from hip or knee replacement surgeries (thrombocytopenia; TCP)<SUP>&#8737;</SUP>
</P>
</TD>
<TD>
<P>0.01 (0.01) (NS)</P>
</TD>
<TD>
<P>-0.07 (0.04) (NS)</P>
</TD>
<TD>
<P>-1.73 (NS)</P>
</TD>
</TR>
<TR>
<TD>
<P>Juurlink 2004</P>
</TD>
<TD>
<P>Rate of hospital admission for hyperkalaemia for patients with heart failure</P>
</TD>
<TD>
<P>0.53 (0.08)***</P>
</TD>
<TD>
<P>3.63  (0.37)***</P>
</TD>
<TD>
<P>9.94***</P>
</TD>
<TD ROWSPAN="2">
<P>9.41</P>
</TD>
</TR>
<TR>
<TD>
<P>Juurlink 2004</P>
</TD>
<TD>
<P>Rate of in-hospital death owing to hyperkalaemia for heart failure patients</P>
</TD>
<TD>
<P>0.05 (0.03) (NS)</P>
</TD>
<TD>
<P>0.64 (0.07)***</P>
</TD>
<TD>
<P>8.87***</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>&#8737;</SUP> Results were transformed so that a positive difference in outcomes between groups could be interpreted as an improvement in outcome.</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-10" MODIFIED="2012-09-10 11:13:26 -0400" MODIFIED_BY="[Empty name]" NO="10">
<TITLE MODIFIED="2012-09-10 11:12:10 -0400" MODIFIED_BY="[Empty name]">Comparison group #2, RCT design - categorical, professional practice outcomes</TITLE>
<TABLE COLS="8" ROWS="11">
<TR>
<TH ROWSPAN="2">
<P>Study</P>
</TH>
<TH ROWSPAN="2">
<P>Outcome</P>
</TH>
<TH COLSPAN="2">
<P>Control (n/N)</P>
</TH>
<TH COLSPAN="2">
<P>Experimental (n/N)</P>
</TH>
<TH ROWSPAN="2">
<P>Absolute risk difference (95% CI)</P>
</TH>
<TH ROWSPAN="2">
<P>Standard median effect size</P>
</TH>
</TR>
<TR>
<TH>
<P>Pre</P>
</TH>
<TH>
<P>Post</P>
</TH>
<TH>
<P>Pre</P>
</TH>
<TH>
<P>Post</P>
</TH>
</TR>
<TR>
<TD ROWSPAN="9">
<P>Jousimaa 2002</P>
</TD>
<TD>
<P>Proportion of consultation decision compliant with guidelines (laboratory examinations)</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>1372/1529</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>1481/1640</P>
</TD>
<TD>
<P>0.01 (-0.02 to 0.03)</P>
</TD>
<TD ROWSPAN="9">
<P>-0.02</P>
</TD>
</TR>
<TR>
<TD>
<P>Proportion of consultation decision compliant with guidelines (radiological examinations)</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>1416/1518</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>1504/1604</P>
</TD>
<TD>
<P>0 (-0.01 to 0.02)</P>
</TD>
</TR>
<TR>
<TD>
<P>Proportion of consultation decision compliant with guidelines (physical examinations)</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>1461/1545</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>1494/1610</P>
</TD>
<TD>
<P>-0.02 (-0.03 to -0.00)</P>
</TD>
</TR>
<TR>
<TD>
<P>Proportion of consultation decision compliant with guidelines (other examinations)</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>248/307</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>235/314</P>
</TD>
<TD>
<P>-0.06 (-0.12 to 0.01)</P>
</TD>
</TR>
<TR>
<TD>
<P>Proportion of consultation decision compliant with guidelines (procedures)</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>140/171</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>152/196</P>
</TD>
<TD>
<P>-0.04 (-0.13 to 0.04)</P>
</TD>
</TR>
<TR>
<TD>
<P>Proportion of consultation decision compliant with guidelines (physiotherapy)</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>83/103</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>77/98</P>
</TD>
<TD>
<P>-0.02 (-0.13 to 0.09)</P>
</TD>
</TR>
<TR>
<TD>
<P>Proportion of consultation decision compliant with guidelines (non-pharmacological treatments)</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>110/122</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>80/92</P>
</TD>
<TD>
<P>-0.03 (-0.12 to 0.05)</P>
</TD>
</TR>
<TR>
<TD>
<P>Proportion of consultation decision compliant with guidelines (pharmacological treatment)</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>1350/1568</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>1391/1654</P>
</TD>
<TD>
<P>-0.02 (-0.04 to 0.00)</P>
</TD>
</TR>
<TR>
<TD>
<P>Proportion of consultation decision compliant with guidelines (referrals)</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>1508/1578</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>1619/1684</P>
</TD>
<TD>
<P>0.01 (-0.01 to 0.02)</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES"/>
<FIGURES MODIFIED="2012-09-13 08:56:16 -0400" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="RCT.Rob.Fig.#3.jpg" FILE_TYPE="JPG" ID="FIG-01" MODIFIED="2012-09-13 08:52:03 -0400" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Risk of bias summary: review authors' judgements about each risk of bias item for each included RCT study.</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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</FILE>
</FIGURE>
<FIGURE FILENAME="ITS.Rob.Fig.jpg" FILE_TYPE="JPG" ID="FIG-02" MODIFIED="2012-09-13 08:52:36 -0400" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Risk of bias summary: review authors' judgements about each risk of bias item for each included ITS study.</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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</FILE>
</FIGURE>
<FIGURE FILENAME="source infromation.JPG" FILE_TYPE="JPG" ID="FIG-03" MODIFIED="2012-09-10 13:08:14 -0400" MODIFIED_BY="Alain Mayhew" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Potential effect modifier - source of information. Legend: 1 = researchers/clinicians; 2 = university; 3 local expert body; 4 = national professional expert body; 5 = national government expert body; 6 = local clinicians; 7 = international expert body; 8 = international government expert body; 9 = unclear.</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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</FILE>
</FIGURE>
<FIGURE FILENAME="endorsement.JPG" FILE_TYPE="JPG" ID="FIG-04" MODIFIED="2012-09-10 13:55:35 -0400" MODIFIED_BY="Alain Mayhew" NO="4" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Potential effect modifier - endorsement (yes, no, unclear).</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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</FILE>
</FIGURE>
<FIGURE FILENAME="tailoring.JPG" FILE_TYPE="JPG" ID="FIG-05" MODIFIED="2012-09-10 13:57:52 -0400" MODIFIED_BY="Alain Mayhew" NO="5" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Potential effect modifier - tailoring. Legend: 1 = tailored to individuals based on diagnostic, behavioural, or motivational characteristics; 2 = tailored to groups of individuals; 3 = personalised, but not tailored (person's name on the information); 4 = generic; 5 = unclear.</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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</FILE>
</FIGURE>
<FIGURE FILENAME="mode delivery.JPG" FILE_TYPE="JPG" ID="FIG-06" MODIFIED="2012-09-10 13:59:10 -0400" MODIFIED_BY="Alain Mayhew" NO="6" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Potential effect modifier - Mode of delivery. Legend: 1 = publication in peer-reviewed journal; 2 = passive dissemination; 3 = direct mailing; 4 = mass mailing; 5 = media; 6 = hand delivery; 7 = unclear</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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</FILE>
</FIGURE>
<FIGURE FILENAME="frequency delivery.JPG" FILE_TYPE="JPG" ID="FIG-07" MODIFIED="2012-09-10 14:01:07 -0400" MODIFIED_BY="Alain Mayhew" NO="7" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Potential effect modifier - frequency of delivery (once, twice, 3 times, more than 3 times, indeterminate).</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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</FILE>
</FIGURE>
<FIGURE FILENAME="duration delivery.JPG" FILE_TYPE="JPG" ID="FIG-08" MODIFIED="2012-09-10 14:02:17 -0400" MODIFIED_BY="Alain Mayhew" NO="8" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Potential effect modifier - duration of delivery (once, 1-3 months, 4-6 months, over 6 months, indeterminate).</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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</FILE>
</FIGURE>
<FIGURE FILENAME="clinical area.JPG" FILE_TYPE="JPG" ID="FIG-09" MODIFIED="2012-09-10 14:04:20 -0400" MODIFIED_BY="Alain Mayhew" NO="9" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Potential effect modifier - clinical area. Legend: ERT = Oestrogen-replacement therapy.</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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</FILE>
</FIGURE>
<FIGURE FILENAME="tageted behaviour.JPG" FILE_TYPE="JPG" ID="FIG-10" MODIFIED="2012-09-10 14:05:28 -0400" MODIFIED_BY="Alain Mayhew" NO="10" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Potential effect modifier - type of targeted behaviour. Legend: 1 = prescribing/treatment; 2 = financial (resource use); 3 = general management of a problem; 4 = diagnosis; 5 = procedures; 6 = referrals; 7 = test ordering; 8 = surgery; 9 = patient education/advice; 10 = clinical prevention service; 11 = screening; 12 = reporting; 13 = professional-patient communication; 14 = record keeping; 15 = discharge planning; 16 = unclear.</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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=
</FILE>
</FIGURE>
<FIGURE FILENAME="purpose.JPG" FILE_TYPE="JPG" ID="FIG-11" MODIFIED="2012-09-10 14:07:13 -0400" MODIFIED_BY="Alain Mayhew" NO="11" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Potential effect modifier - purpose. Legend: 1 = initiation of management (e.g. introduction of new technology); 2 = stopping introduction of new management; 3 = increase of established management; 4 = cessation of established management; 5 = reduction of established management; 6 = modification of management (e.g. increased management in one activity, reduction in another).</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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</FILE>
</FIGURE>
<FIGURE FILENAME="level evidence.JPG" FILE_TYPE="JPG" ID="FIG-12" MODIFIED="2012-09-10 14:10:59 -0400" MODIFIED_BY="Alain Mayhew" NO="12" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Potential effect modifier - Level of evidence. Legend: 1 = system (computerised decision support); 2 = summaries (evidence-based textbook); 3 = systematic review of RCTs; 4 = clinical practice guidelines developed through formal consensus process; 5 = other synthesis; 6 = original RCT; 7 = original studies not RCT; 8 = expert opinion; 9 = unclear.</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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</FILE>
</FIGURE>
<FIGURE FILENAME="educational component.JPG" FILE_TYPE="JPG" ID="FIG-13" MODIFIED="2012-09-10 14:13:09 -0400" MODIFIED_BY="Alain Mayhew" NO="13" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Potential effect modifier - educational component. Legend: 1 = continuing professional development (CPD) credits to recipients of PEMs; 2 = PEM delivered within a formal education programme; 3 = clear statement in the study that the PEM is intended for education; 4 = no clear educational component.</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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</FILE>
</FIGURE>
<FIGURE FILENAME="format.JPG" FILE_TYPE="JPG" ID="FIG-14" MODIFIED="2012-09-10 14:16:31 -0400" MODIFIED_BY="Alain Mayhew" NO="14" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Potential effect modifier - format. Legend: 1 = publication of RCT results in peer-reviewed journal; 2 = quick reference of clinical guidelines; 3 = full clinical guidelines; 4 = newsletter or bulletin; 5 = manual of peer-reviewed clinical article reprints; 6 = other.</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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</FILE>
</FIGURE>
<FIGURE FILENAME="appearance.JPG" FILE_TYPE="JPG" ID="FIG-15" MODIFIED="2012-09-10 14:19:01 -0400" MODIFIED_BY="Alain Mayhew" NO="15" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Potential effect modifier - appearance. Legend: 1 = black and white, with a few figures or tables; 2 = enhanced communication format (colour, picture, or figure); 3 = unclear.</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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</FILE>
</FIGURE>
<FIGURE FILENAME="endorsement2.JPG" FILE_TYPE="JPG" ID="FIG-16" MODIFIED="2012-09-10 14:25:09 -0400" MODIFIED_BY="Alain Mayhew" NO="16" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Potential effect modifier - endorsement (yes, no, unclear).</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2012-09-13 12:38:11 -0400" MODIFIED_BY="Anik Giguere">
<APPENDIX ID="APP-01" MODIFIED="2012-09-10 11:19:25 -0400" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2012-04-04 10:45:10 -0400" MODIFIED_BY="[Empty name]">Search strategies 2011</TITLE>
<APPENDIX_BODY MODIFIED="2012-09-10 11:19:25 -0400" MODIFIED_BY="[Empty name]">
<P>
<BR/>
</P>
<P>
<B>MEDLINE(R) &lt;1948 to present&gt;</B>
<BR/>
<BR/>1 (guideline? and (impact or influence)).ti. (638)<BR/>
<BR/>2 (impact and guideline?).ti. (532)<BR/>
<BR/>3 (effect$ and guideline?).ti. (886)<BR/>
<BR/>4 (impact and bulletin?).ti. (7)<BR/>
<BR/>5 (impact and publication?).ti. (97)<BR/>
<BR/>6 (impact and disseminat$).ti. (75)<BR/>
<BR/>7 (guideline and (notification or notify$)).ti. (2)<BR/>
<BR/>8 (publication and evidence).ti. (48)<BR/>
<BR/>9 (guideline? and disseminat$).ti. (109)<BR/>
<BR/>10 drug utilization/ and publication.ti,ab. (93)<BR/>
<BR/>11 education, dental, continuing/ or education, medical, continuing/ or education, nursing, continuing/ or education, pharmacy, continuing/ (41329)<BR/>
<BR/>12 11 and patient education as topic/ (940)<BR/>
<BR/>13 *Physician's practice patterns/ and *practice guidelines as topic/ (1011)<BR/>
<BR/>14 *Family practice/ and *practice guidelines as topic/ (456)<BR/>
<BR/>15 *primary health care/ and *practice guidelines as topic/ (345)<BR/>
<BR/>16 publication.ti. and physician's practice patterns/ (34)<BR/>
<BR/>17 (publication and (influenc$ or impact or chang$ or prescribing or physician? behavio?r?)).ti. (141)<BR/>
<BR/>18 publication.ti. and practice guidelines as topic/ (60)<BR/>
<BR/>19 or/1-10,12-18 (4514)<BR/>
<BR/>20 19 not "publication bias".ti. [Strategy A ] (4492)<BR/>
<BR/>21 print$ education$.ti,ab. (86)<BR/>
<BR/>22 ((print or printed) adj2 intervention?).ti,ab. (60)<BR/>
<BR/>23 ((allied health$ or counsel?or? or doctor? or nurse or nurses or physician? or physiotherapist? or therapist? or dentist? or pharmacist? or health$ worker? or health$ staff) adj2 (pamphlet? or booklet? or poster? or brochure? or written material? or printed or print)).ti,ab. (93)<BR/>
<BR/>24 paper-based education$.ti,ab. (4)<BR/>
<BR/>25 (postal adj4 guideline?).ti,ab. (19)<BR/>
<BR/>26 (spiral bound or bound copy or bound copies).ti,ab. (10)<BR/>
<BR/>27 or/21-26 [Strategy B: Keyword--screen without filters] (265)<BR/>
<BR/>28 education, dental, continuing/ or education, medical, continuing/ or education, nursing, continuing/ or education, pharmacy, continuing/ (41329)<BR/>
<BR/>29 (continuing adj (medical or nursing or pharma$ or dental$ or physician? or doctor? or surg$) adj2 education$).ti,ab. (3981)<BR/>
<BR/>30 (continuing education$ adj2 (medical or nursing or pharma$ or dental$ or physician? or doctor? or surg$)).ti,ab. (743)<BR/>
<BR/>31 CME.ti,ab. (3055)<BR/>
<BR/>32 or/28-31 [Continuing Medical Education CME] (44488)<BR/>
<BR/>33 education, professional/ or education, continuing/ or education, professional, retraining/ (9345)<BR/>
<BR/>34 ((train$ or educat$) adj2 (clinical competenc$ or practitioner? or practice? or general practi$ or family doctor?)).ti,ab. (9123)<BR/>
<BR/>35 Education Department, Hospital/ (209)<BR/>
<BR/>36 (continuing adj2 education$).ti,ab. (13514)<BR/>
<BR/>37 (professional adj2 (development$ or education$ or retrain$ or skill? enhanc$ or (skill? adj2 improv$) or training or upgrade? or upgrading)).ti,ab. (8465)<BR/>
<BR/>38 (professional adj2 (education$ or training)).ti,ab. (4836)<BR/>
<BR/>39 or/33-38 [Cont Education General/Professional Dev General] (37565)<BR/>
<BR/>40 exp Physicians/ or exp Nurses/ or "Internship and Residency"/ or Preceptorship/ or Clinical Competence/ (205019)<BR/>
<BR/>41 (exp Allied Health Personnel/ not Animal Technicians/) or (exp Health Occupations/ not exp Veterinary Medicine/) (1174652)<BR/>
<BR/>42 exp Medical Staff/ or exp Nursing Staff/ or Pharmacists/ or Laboratory Personnel/ or exp Dentists/ or exp Dental Staff/ (93842)<BR/>
<BR/>43 exp Health Facility Administrators/ (9604)<BR/>
<BR/>44 (counsel?or? or dental aide or dental aides or dental hygienist? or dentist? or dietetic? or dietician? or doctor? or general practitioner? or health$ professional? or hospitalist? or medical aide? or medical aides or medical technician? or nurse or nurses or nutritionist? or orthodontist? or pediatric$ or paediatric$ or pharmacist? or physician? or physiotherapist? or psychiatrist? or psychiatric? aide or psychiatric aides or psychologist? or practitioner? or rheumatologist? or surgeon? or therapist?).ti. (330556)<BR/>
<BR/>45 (internship? or intern? or resident? or residency or residencies).ti. (25238)<BR/>
<BR/>46 or/40-45 [Health Professionals] (1516683)<BR/>
<BR/>47 ((print or printed or paper) adj2 (display? or document? or education$ material? or format? or portfolio or material? or media or medium? or workshop? material?)).ti,ab. (2704)<BR/>
<BR/>48 ((print or printed) adj5 (format or formats)).ti,ab. (128)<BR/>
<BR/>49 (printed adj4 (diagram? or text)).ti,ab. (117)<BR/>
<BR/>50 (paper adj5 format?).ti,ab. (298)<BR/>
<BR/>51 (book? or booklet? or brochure? or bulletin? or handout? or hand-out? or "hard copy" or hardcopy or "hard copies" or hardcopies or monograph$ or paper-based or "paper copy" or "paper copies" or print-based or pamphlet? or poster?).ti,ab. (31033)<BR/>
<BR/>52 (written material? or written teaching or written learning).ti,ab. (669)<BR/>
<BR/>53 (mail$ adj2 (information or guideline? or publication? or protocol? or practice guideline or therap$ guideline? or prescrib$ guideline or article or articles or research or result? or study or studies or journal? or copy or copies)).ti,ab. (716)<BR/>
<BR/>54 exp books/ or manuals as topic/ or reference books/ or textbooks as topic/ or broadsides as topic/ or pamphlets/ (21585)<BR/>
<BR/>55 posters as topic/ (33)<BR/>
<BR/>56 or/47-55 [Print Materials ] (53646)<BR/>
<BR/>57 Guideline adherence/ (14605)<BR/>
<BR/>58 ((guideline? or best practice? or evidence or EBM) adj2 (adher$ or apply$ or application or disseminat$ or implement$ or introduc$ or publication or release or uptake)).ti,ab. (9552)<BR/>
<BR/>59 ((publication or published) adj2 (guideline? or protocol?)).ti,ab. (4002)<BR/>
<BR/>60 or/57-58 [GL Adherence] (22663)<BR/>
<BR/>61 Guidelines as Topic/ or Practice guidelines as Topic/ (87965)<BR/>
<BR/>62 exp Evidence-based practice/ (45475)<BR/>
<BR/>63 (evidence based adj2 (practice? or practitioner? or medicine or medical or treatment? or therap$ or nurse or nurses or nursing or dentist$ or healthcare or care)).ti,ab. (16859)<BR/>
<BR/>64 (applied learning or knowledge transfer$ or knowledge translation).ti,ab. (928)<BR/>
<BR/>65 or/62-64 [Evidence Based Medicine/Knowledge transfer-translation--EBM/KT] (53167)<BR/>
<BR/>66 exp patient care management/ or comprehensive health care/ or critical pathways/ or "delivery of health care"/ or "delivery of health care, integrated"/ or health care reform/ or dentist's practice patterns/ or disease management/ or medication reconciliation/ or medication therapy management/ or nurse's practice patterns/ or patient care team/ or nursing, team/ or patient-centered care/ or "quality of health care"/ (467245) [Patient Care]<BR/>
<BR/>67 (randomized controlled trial or controlled clinical trial).pt. or randomized.ab. or clinical trials as topic.sh. or randomly.ab. or trial.ti. (713091)<BR/>
<BR/>68 exp animals/ not humans.sh. (3598690)<BR/>
<BR/>69 "comment on".cm. or systematic review.ti. or literature review.ti. or editorial.pt. or meta-analysis.pt. or news.pt. or review.pt. [This line is not found in Cochrane Handbook; added by TSC to exclude irrelevant publication types] (2404378)<BR/>
<BR/>70 67 not (or/68-69) [Cochrane RCT Filter 6.4.d Sens/Precision Maximizing] (560727)<BR/>
<BR/>71 intervention?.ti. or (intervention? adj6 (clinician? or collaborat$ or community or complex or DESIGN$ or doctor? or educational or family doctor? or family physician? or family practitioner? or financial or GP or general practice? or hospital? or impact? or improv$ or individuali?e? or individuali?ing or interdisciplin$ or multicomponent or multi-component or multidisciplin$ or multi-disciplin$ or multifacet$ or multi-facet$ or multimodal$ or multi-modal$ or personali?e? or personali?ing or pharmacies or pharmacist? or pharmacy or physician? or practitioner? or prescrib$ or prescription? or primary care or professional$ or provider? or regulatory or regulatory or tailor$ or target$ or team$ or usual care)).ab. (114937)<BR/>
<BR/>72 (hospital$ or patient?).hw. and (study or studies or care or health$ or practitioner? or provider? or physician? or nurse? or nursing or doctor?).ti,hw. (614765)<BR/>
<BR/>73 demonstration project?.ti,ab. (1704)<BR/>
<BR/>74 (pre-post or "pre test$" or pretest$ or posttest$ or "post test$" or (pre adj5 post)).ti,ab. (47930)<BR/>
<BR/>75 (pre-workshop or post-workshop or (before adj3 workshop) or (after adj3 workshop)).ti,ab. (434)<BR/>
<BR/>76 trial.ti. or ((study adj3 aim?) or "our study").ab. (447008)<BR/>
<BR/>77 (before adj10 (after or during)).ti,ab. (299382)<BR/>
<BR/>78 ("quasi-experiment$" or quasiexperiment$ or "quasi random$" or quasirandom$ or "quasi control$" or quasicontrol$ or ((quasi$ or experimental) adj3 (method$ or study or trial or design$))).ti,ab,hw. [ML] (82551)<BR/>
<BR/>79 ("time series" adj2 interrupt$).ti,ab,hw. [ML] (598)<BR/>
<BR/>80 (time points adj3 (over or multiple or three or four or five or six or seven or eight or nine or ten or eleven or twelve or month$ or hour? or day? or "more than")).ab. (6197)<BR/>
<BR/>81 pilot.ti. (29268)<BR/>
<BR/>82 Pilot projects/ [ML] (65924)<BR/>
<BR/>83 (clinical trial or controlled clinical trial or multicenter study).pt. [ML] (560102)<BR/>
<BR/>84 (multicentre or multicenter or multi-centre or multi-center).ti. (22040)<BR/>
<BR/>85 random$.ti,ab. or controlled.ti. (590536)<BR/>
<BR/>86 (control adj3 (area or cohort? or compare? or condition or design or group? or intervention? or participant? or study)).ab. not (controlled clinical trial or randomized controlled trial).pt. [ML] (322561)<BR/>
<BR/>87 "comment on".cm. or review.ti,pt. or randomized controlled trial.pt. [ML] (2454941)<BR/>
<BR/>88 (rat or rats or cow or cows or chicken? or horse or horses or mice or mouse or bovine or animal?).ti. (1215743)<BR/>
<BR/>89 exp animals/ not humans.sh. [ML] (3598690)<BR/>
<BR/>90 *experimental design/ or *pilot study/ or quasi experimental study/ [EM] (16605)<BR/>
<BR/>91 ("quasi-experiment$" or quasiexperiment$ or "quasi random$" or quasirandom$ or "quasi control$" or quasicontrol$ or ((quasi$ or experimental) adj3 (method$ or study or trial or design$))).ti,ab. [EM] (82551)<BR/>
<BR/>92 ("time series" adj2 interrupt$).ti,ab. [EM] (598)<BR/>
<BR/>93 (or/71-86) not (or/87-89) [EPOC Methods Filter ML 1.9] (1714043)<BR/>
<BR/>94 or/71-77,80-81,84-85,88,90-92 [EPOC Methods Filter EM 1.9-2.3] (3103200)<BR/>
<BR/>
<BR/>Combinations<BR/>
<BR/>95 32 and 56 [CME &amp; Print] (750)<BR/>
<BR/>96 (39 and 46 and 56) not 95 [Print &amp; CE &amp; Health Professionals] (248)<BR/>
<BR/>97 (56 and 60) not (or/95-96) [Print &amp; GL Adherence] (383)<BR/>
<BR/>98 (56 and 61) not (or/95-97) [Print &amp; GL as Topic] (933)<BR/>
<BR/>99 (56 and 65) not (or/95-98) [Print and EBM/KT] (476)<BR/>
<BR/>100 (56 and 66 and 46) not (or/95-99) [Print &amp; Patient Care &amp; Health Professionals] (1598)<BR/>
<BR/>101 (or/95-100) not 27 [Strategy C] (4337)<BR/>
<BR/>
<BR/>Results<BR/>
<BR/>102 (20 or 101) and 70 [RCT results Strategies A, C] (727)<BR/>
<BR/>103 (101 and 93) not (or/69,102) [EPOC results Strategies A, C] (1265)<BR/>
<BR/>104 or/21-26 [Strategy B: Keyword--screen without filters] (265)<BR/>
</P>
<P>
<B>Ovid HealthStar &lt;1999 to May 2011&gt;</B>
<BR/>Strategy was identical to that for OVID MEDLINE; number of results are below.<BR/>
<BR/>95 32 and 56 [CME &amp; print] (359)<BR/>
<BR/>96 (39 and 46 and 56) not 95 [CE &amp; health pro &amp; print] (145)<BR/>
<BR/>97 (56 and 60) not (or/95-96) [print &amp; GL adherence] (307)<BR/>
<BR/>98 (56 and 61) not (or/95-97) [print &amp; GL as topic] (159)<BR/>
<BR/>99 (56 and 65) not (or/95-98) [print and EBM/KT] (176)<BR/>
<BR/>100 (56 and 66 and 46) not (or/95-99) [print &amp; pt care &amp; health pro] (1053)<BR/>
<BR/>101 (or/95-100) not 27 [results before filters] (2166)<BR/>
<BR/>102 ((20 or 101) and 70) [RCT results, Strategies A, C ] (353)<BR/>
<BR/>103 (101 and 93) not (or/69,102) [EPOC results, Strategies A, C] (711)<BR/>
<BR/>104 or/21-26 [KW screen without filters] (161)</P>
<P>
<B>EMBASE Classic + EMBASE (OVID) &lt;1947 to 2011 June 10&gt;</B>
<BR/>
<BR/>1 print$ education$.ti,ab. (97)<BR/>
<BR/>2 ((print or printed) adj2 intervention?).ti,ab. (62)<BR/>
<BR/>3 ((allied health$ or counsel?or? or doctor? or nurse or nurses or physician? or physiotherapist? or therapist? or dentist? or pharmacist? or health$ worker? or health$ staff) adj2 (pamphlet? or booklet? or poster? or brochure? or written material? or printed or print)).ti,ab. (115)<BR/>
<BR/>4 paper-based education$.ti,ab. (2)<BR/>
<BR/>5 (postal adj4 guideline?).ti,ab. (46)<BR/>
<BR/>6 or/1-5 [KW screen without filters] (313)<BR/>
<BR/>7 (continuing adj (medical or nursing or pharma$ or dental$ or physician? or doctor? or surg$) adj2 education$).ti,ab. (5103)<BR/>
<BR/>8 (continuing education$ adj2 (medical or nursing or pharma$ or dental$ or physician? or doctor? or surg$)).ti,ab. (873)<BR/>
<BR/>9 CME.ti,ab. (5190)<BR/>
<BR/>10 or/7-9 [CME] (10058)<BR/>
<BR/>11 *vocational education/ (4170)<BR/>
<BR/>12 continuing education/ (24423)<BR/>
<BR/>13 ((train$ or educat$) adj2 (clinical competenc$ or practitioner? or practice? or general practi$ or family doctor?)).ti,ab. (10677)<BR/>
<BR/>14 (continuing adj2 education$).ti,ab. (16727)<BR/>
<BR/>15 (professional adj2 (development$ or education$ or retrain$ or skill? enhanc$ or (skill? adj2 improv$) or training or upgrade? or upgrading)).ti,ab. (10595)<BR/>
<BR/>16 (professional adj2 (education$ or training)).ti,ab. (6130)<BR/>
<BR/>17 or/11-16 [CE general] (59211)<BR/>
<BR/>18 *residency education/ or *clinical competence/ (20700)<BR/>
<BR/>19 exp *physician/ or exp *paramedical personnel/ or exp *dentistry/ or exp *preventive dentistry/ or *dental surgery/ or *medical staff/ (313208)<BR/>
<BR/>20 exp *nursing discipline/ or *nursing/ or exp *nurse/ (157423)<BR/>
<BR/>21 *optometry/ or *podiatry/ or *medical psychology/ or *serology/ (11643)<BR/>
<BR/>22 *psychiatry/ or *child psychiatry/ (41816)<BR/>
<BR/>23 (counsel?or? or dental aide or dental aides or dental hygienist? or dentist? or dietetic? or dietician? or doctor? or general practitioner? or health$ professional? or hospitalist? or medical aide? or medical aides or medical technician? or nurse or nurses or nutritionist? or orthodontist? or pediatric$ or paediatric$ or pharmacist? or physician? or physiotherapist? or psychiatrist? or psychiatric? aide or psychiatric aides or psychologist? or practitioner? or rheumatologist? or surgeon? or therapist?).ti. (387185)<BR/>
<BR/>24 (internship? or intern? or resident? or residency or residencies).ti. (28985)<BR/>
<BR/>25 or/18-24 [health professionals] (766023)<BR/>
<BR/>26 ((print or printed or paper) adj2 (display? or document? or education$ material? or format? or portfolio or material? or media or medium? or workshop? material?)).ti,ab. (3403)<BR/>
<BR/>27 ((print or printed) adj5 (format or formats)).ti,ab. (163)<BR/>
<BR/>28 (printed adj4 (diagram? or text)).ti,ab. (124)<BR/>
<BR/>29 (paper adj5 format?).ti,ab. (377)<BR/>
<BR/>30 (book? or booklet? or brochure? or bulletin? or handout? or hand-out? or "hard copy" or hardcopy or "hard copies" or hardcopies or monograph$ or paper-based or "paper copy" or "paper copies" or print-based or pamphlet? or poster?).ti,ab. (46075)<BR/>
<BR/>31 (written material? or written teaching or written learning).ti,ab. (810)<BR/>
<BR/>32 (mail$ adj2 (information or guideline? or publication? or protocol? or practice guideline or therap$ guideline? or prescrib$ guideline or article or articles or research or result? or study or studies or journal? or copy or copies)).ti,ab. (1275)<BR/>
<BR/>33 *medical illustration/ (1657)<BR/>
<BR/>34 *book/ (4738)<BR/>
<BR/>35 or/26-34 [Print material KW &amp; SH] (56537)<BR/>
<BR/>36 ((guideline? or best practice? or evidence or EBM) adj2 (adher$ or apply$ or application or disseminat$ or implement$ or introduc$ or publication or release or uptake)).ti,ab. (12014)<BR/>
<BR/>37 ((publication or published) adj2 (guideline? or protocol?)).ti,ab. (5244)<BR/>
<BR/>38 or/36-37 [GL adherence] (16761)<BR/>
<BR/>39 exp *evidence based practice/ (27747)<BR/>
<BR/>40 (evidence based adj2 (practice? or practitioner? or medicine or medical or treatment? or therap$ or nurse or nurses or nursing or dentist$ or healthcare or care)).ti,ab. (20366)<BR/>
<BR/>41 (applied learning or knowledge transfer$ or knowledge translation).ti,ab. (1026)<BR/>
<BR/>42 or/39-41 [EBM/KT] (41720)<BR/>
<BR/>43 *patient care/ (35908)<BR/>
<BR/>44 exp *nursing assessment/ (10475)<BR/>
<BR/>45 *patient care planning/ or *primary health care/ or *progressive patient care/ or *health care delivery/ or *integrated health care system/ or *health care policy/ or *disease management/ or *managed care/ or *medication therapy management/ or *patient selection/ or *health care quality/ or *rapid response team/ or *clinical pathways/ (173413)<BR/>
<BR/>46 or/43-45 [patient care] (214605)<BR/>
<BR/>47 intervention?.ti. or (intervention? adj6 (clinician? or collaborat$ or community or complex or DESIGN$ or doctor? or educational or family doctor? or family physician? or family practitioner? or financial or GP or general practice? or hospital? or impact? or improv$ or individuali?e? or individuali?ing or interdisciplin$ or multicomponent or multi-component or multidisciplin$ or multi-disciplin$ or multifacet$ or multi-facet$ or multimodal$ or multi-modal$ or personali?e? or personali?ing or pharmacies or pharmacist? or pharmacy or physician? or practitioner? or prescrib$ or prescription? or primary care or professional$ or provider? or regulatory or regulatory or tailor$ or target$ or team$ or usual care)).ab. (140986)<BR/>
<BR/>48 (hospital$ or patient?).hw. and (study or studies or care or health$ or practitioner? or provider? or physician? or nurse? or nursing or doctor?).ti,hw. (1201558)<BR/>
<BR/>49 demonstration project?.ti,ab. (2043)<BR/>
<BR/>50 (pre-post or "pre test$" or pretest$ or posttest$ or "post test$" or (pre adj5 post)).ti,ab. (63052)<BR/>
<BR/>51 (pre-workshop or post-workshop or (before adj3 workshop) or (after adj3 workshop)).ti,ab. (533)<BR/>
<BR/>52 trial.ti. or ((study adj3 aim?) or "our study").ab. (570480)<BR/>
<BR/>53 (before adj10 (after or during)).ti,ab. (385889)<BR/>
<BR/>54 ("quasi-experiment$" or quasiexperiment$ or "quasi random$" or quasirandom$ or "quasi control$" or quasicontrol$ or ((quasi$ or experimental) adj3 (method$ or study or trial or design$))).ti,ab,hw. [ML] (123459)<BR/>
<BR/>55 ("time series" adj2 interrupt$).ti,ab,hw. [ML] (680)<BR/>
<BR/>56 (time points adj3 (over or multiple or three or four or five or six or seven or eight or nine or ten or eleven or twelve or month$ or hour? or day? or "more than")).ab. (7492)<BR/>
<BR/>57 pilot.ti. (36582)<BR/>
<BR/>58 Pilot projects/ [ML] (46805)<BR/>
<BR/>59 (clinical trial or controlled clinical trial or multicenter study).pt. [ML] (0)<BR/>
<BR/>60 (multicentre or multicenter or multi-centre or multi-center).ti. (28288)<BR/>
<BR/>61 random$.ti,ab. or controlled.ti. (710884)<BR/>
<BR/>62 (control adj3 (area or cohort? or compare? or condition or design or group? or intervention? or participant? or study)).ab. not (controlled clinical trial or randomized controlled trial).pt. [ML] (467730)<BR/>
<BR/>63 "comment on".cm. or review.ti,pt. or randomized controlled trial.pt. [ML] (1865950)<BR/>
<BR/>64 (rat or rats or cow or cows or chicken? or horse or horses or mice or mouse or bovine or animal?).ti. (1487767)<BR/>
<BR/>65 exp animals/ not humans.sh. [ML] (1668982)<BR/>
<BR/>66 *experimental design/ or *pilot study/ or quasi experimental study/ [EM] (3285)<BR/>
<BR/>67 ("quasi-experiment$" or quasiexperiment$ or "quasi random$" or quasirandom$ or "quasi control$" or quasicontrol$ or ((quasi$ or experimental) adj3 (method$ or study or trial or design$))).ti,ab. [EM] (106818)<BR/>
<BR/>68 ("time series" adj2 interrupt$).ti,ab. [EM] (680)<BR/>
<BR/>69 (or/47-62) not (or/63-65) [EPOC Methods Filter ML 1.9] (2652569)<BR/>
<BR/>70 or/47-53,56-57,60-61,64,66-68 [EPOC Methods Filter EM 1.9-2.3] (4156041)<BR/>
<BR/>71 controlled clinical trial/ or controlled study/ or randomized controlled trial/ [EM] (3590624)<BR/>
<BR/>72 (book or conference paper or editorial or letter or review).pt. not randomized controlled trial/ [Per BMJ Clinical Evidence filter] (3504869)<BR/>
<BR/>73 (random sampl$ or random digit$ or random effect$ or random survey or random regression).ti,ab. not randomized controlled trial/ [Per BMJ Clinical Evidence filter] (38712)<BR/>
<BR/>74 (animal$ not human$).sh,hw. (3563374)<BR/>
<BR/>75 71 not (or/72-74) [Trial filter per BMJ CLinical Evidence] (2332014)<BR/>
<BR/>76 10 and 35 [CME &amp; print] (177)<BR/>
<BR/>77 (17 and 25 and 35) not 76 [CE &amp; health pro &amp; print] (205)<BR/>
<BR/>78 (35 and 38) not (or/76-77) [print &amp; guideline adherence] (264)<BR/>
<BR/>79 (35 and 42) not (or/76-78) [print &amp; EBM] (413)<BR/>
<BR/>80 (35 and 46 and 25) not (or/76-79) [print &amp; patient care &amp; health pro] (191)<BR/>
<BR/>81 (or/76-80) not 6 [results excluding Keyword results] (1227)<BR/>
<BR/>82 guideline? and (impact or influence)).ti. (770)<BR/>
<BR/>83 (impact and guideline?).ti. (639)<BR/>
<BR/>84 (effect$ and guideline?).ti. (1033)<BR/>
<BR/>85 (impact and bulletin?).ti. (11)<BR/>
<BR/>86 (impact and publication?).ti. (116)<BR/>
<BR/>87 (impact and disseminat$).ti. (91)<BR/>
<BR/>88 (guideline and (notification or notify$)).ti. (2)<BR/>
<BR/>89 (publication and evidence).ti. (51)<BR/>
<BR/>90 (guideline? and disseminat$).ti. (123)<BR/>
<BR/>91 (publication and (influenc$ or impact or chang$ or prescribing or physician? behavio?r?)).ti. (177)<BR/>
<BR/>92 *drug utilization/ and publication.ti,ab. (22)<BR/>
<BR/>93 *clinical practice/ and *practice guidelines/ (892)<BR/>
<BR/>94 publication.ti. and *clinical practice/ (15)<BR/>
<BR/>95 publication.ti. and *practice guidelines/ (100)<BR/>
<BR/>96 *general practice/ and *practice guidelines/ (328)<BR/>
<BR/>97 *primary health care/ and *practice guidelines/ (221)<BR/>
<BR/>98 or/82-97 [] (3675)<BR/>
<BR/>99 ((81 or 98) and 75) [RCT results] (685)<BR/>
<BR/>100 (81 and 70) not 102 [EPOC Filter results] (485)<BR/>
<BR/>101 or/1-5 [Keyword Results] (313)<BR/>
</P>
<P>
<I>
<B>The Cochrane Library</B>
</I>
<B> (Wiley)</B>
<BR/>
<BR/>Search Date: 10 June 2011#1 (print* education*):ti or (print* education*):ab<BR/>
<BR/>#2 ((print or printed) NEAR/2 intervention):ti,ab<BR/>
<BR/>#3 ((allied health* or counsellor or counselor or doctor or nurse or nurses or physician or physiotherapist or therapist or dentist or pharmacist or health* worker or health* staff) NEAR/2 (pamphlet or booklet or poster or brochure or written material or printed or print)):ti,ab<BR/>
<BR/>#4 paper-based education*:ti,ab<BR/>
<BR/>#5 (postal near/4 guideline):ti,ab<BR/>
<BR/>#6 (#1 OR #2 OR #3 OR #4 OR #5)<BR/>
<BR/>#7 MeSH descriptor Education, Dental, Continuing, this term only<BR/>
<BR/>#8 MeSH descriptor Education, Medical, Continuing, this term only<BR/>
<BR/>#9 MeSH descriptor Education, Nursing, Continuing, this term only<BR/>
<BR/>#10 MeSH descriptor Education, Pharmacy, Continuing, this term only<BR/>
<BR/>#11 (continuing NEXT (medical or nursing or pharma* or dental* or physician or doctor or surg*) NEAR/2 education*):ti,ab<BR/>
<BR/>#12 (continuing education* NEAR/2 (medical or nursing or pharma* or dental* or physician or doctor or surg*)):ti,ab<BR/>
<BR/>#13 CME:ti,ab.<BR/>
<BR/>#14 (#7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13)<BR/>
<BR/>#15 MeSH descriptor Education, Professional, this term only<BR/>
<BR/>#16 MeSH descriptor Education, Continuing, this term only<BR/>
<BR/>#17 MeSH descriptor Education, Professional, Retraining, this term only<BR/>
<BR/>#18 ((train* or educat*) near/2 (clinical competenc* or practitioner or practice or general practi* or family doctor)):ti,ab<BR/>
<BR/>#19 MeSH descriptor Education Department, Hospital, this term only<BR/>
<BR/>#20 (continuing near/2 education*):ti,ab<BR/>
<BR/>#21 (professional NEAR/2 (development* or education* or retrain* or skill enhanc* or (skill near/2 improv*) or training or upgrade or upgrading)):ti,ab<BR/>
<BR/>#22 (professional near/2 (education* or training)):ti,ab<BR/>
<BR/>#23 (#15 OR #16 OR #17 OR #18 OR #19 OR #20 OR #21 OR #22)<BR/>
<BR/>#24 MeSH descriptor Physicians explode all trees<BR/>
<BR/>#25 MeSH descriptor Nurses explode all trees<BR/>
<BR/>#26 MeSH descriptor Internship and Residency, this term only<BR/>
<BR/>#27 MeSH descriptor Preceptorship, this term only<BR/>
<BR/>#28 MeSH descriptor Clinical Competence, this term only<BR/>
<BR/>#29 MeSH descriptor Allied Health Personnel explode all trees<BR/>
<BR/>#30 MeSH descriptor Animal Technicians explode all trees<BR/>
<BR/>#31 (#29 AND NOT #30)<BR/>
<BR/>#32 MeSH descriptor Health Occupations explode all trees<BR/>
<BR/>#33 MeSH descriptor Veterinary Medicine explode all trees<BR/>
<BR/>#34 (#32 AND NOT #33)<BR/>
<BR/>#35 MeSH descriptor Medical Staff explode all trees<BR/>
<BR/>#36 MeSH descriptor Nursing Staff explode all trees<BR/>
<BR/>#37 MeSH descriptor Pharmacists, this term only<BR/>
<BR/>#38 MeSH descriptor Laboratory Personnel, this term only<BR/>
<BR/>#39 MeSH descriptor Dentists explode all trees<BR/>
<BR/>#40 MeSH descriptor Dental Staff explode all trees<BR/>
<BR/>#41 MeSH descriptor Health Facility Administrators explode all trees<BR/>
<BR/>#42 (counsellor or counselor or dental aide or dental aides or dental hygienist or dentist or dietetic or dietician or doctor or general practitioner or health* professional or hospitalist or medical aide or medical aides or medical technician or nurse or nurses or nutritionist or orthodontist or pediatric* or paediatric* or pharmacist or physician or physiotherapist or psychiatrist or psychiatric aide or psychiatric aides or psychologist or practitioner or rheumatologist or surgeon or therapist):ti<BR/>
<BR/>#43 (internship or intern or resident or residency or residencies):ti<BR/>
<BR/>#44 (#24 OR #25 OR #26 OR #27 OR #28 OR #31 OR #34 OR #35 OR #36 OR #37 OR #38 OR #39 OR #40 OR #41 OR #42 OR #43)<BR/>
<BR/>#45 ((print or printed or paper) near/2 (display or document or education* material or format or portfolio or material or media or medium or workshop material)):ti,ab<BR/>
<BR/>#46 ((print or printed) near/5 (format or formats)):ti,ab<BR/>
<BR/>#47 (printed near/4 (diagram or text)):ti,ab<BR/>
<BR/>#48 (paper near/5 format):ti,ab<BR/>
<BR/>#49 (book or booklet or brochure or bulletin or handout or hand-out or "hard copy" or hardcopy or "hard copies" or hardcopies or monograph* or paper-based or "paper copy" or "paper copies" or print-based or pamphlet or poster):ti,ab<BR/>
<BR/>#50 (written material or written teaching or written learning):ti,ab<BR/>
<BR/>#51 (mail* near/2 (information or guideline or publication or protocol or practice guideline or therap* guideline or prescrib* guideline or article or articles or research or result or study or studies or journal or copy or copies)):ti,ab<BR/>
<BR/>#52 MeSH descriptor Books explode all trees<BR/>
<BR/>#53 MeSH descriptor Manuals as Topic, this term only<BR/>
<BR/>#54 MeSH descriptor Reference Books, this term only<BR/>
<BR/>#55 MeSH descriptor Textbooks as Topic, this term only<BR/>
<BR/>#56 MeSH descriptor Broadsides as Topic, this term only<BR/>
<BR/>#57 MeSH descriptor Pamphlets, this term only<BR/>
<BR/>#58 MeSH descriptor Posters as Topic, this term only<BR/>
<BR/>#59 (#45 OR #46 OR #47 OR #48 OR #49 OR #50 OR #51 OR #52 OR #53 OR #54 OR #55 OR #56 OR #57 OR #58)<BR/>
<BR/>#60 MeSH descriptor Guideline Adherence, this term only<BR/>
<BR/>#61 ((guideline or best practice or evidence or EBM) near/2 (adher* or apply* or application or disseminat* or implement* or introduc* or publication or release or uptake)):ti,ab<BR/>
<BR/>#62 ((publication or published) near/2 (guideline or protocol)):ti,ab<BR/>
<BR/>#63 (#60 OR #61 OR #62)<BR/>
<BR/>#64 MeSH descriptor Guidelines as Topic, this term only<BR/>
<BR/>#65 MeSH descriptor Practice Guidelines as Topic, this term only<BR/>
<BR/>#66 (#64 OR #65)<BR/>
<BR/>#67 MeSH descriptor Evidence-Based Practice explode all trees<BR/>
<BR/>#68 (evidence based near/2 (practice or practitioner or medicine or medical or treatment or therap* or nurse or nurses or nursing or dentist* or healthcare or care)):ti,ab<BR/>
<BR/>#69 (applied learning or knowledge transfer* or knowledge translation):ti,ab<BR/>
<BR/>#70 (#67 OR #68 OR #69)<BR/>
<BR/>#71 MeSH descriptor Patient Care Management explode all trees<BR/>
<BR/>#72 MeSH descriptor Quality of Health Care, this term only<BR/>
<BR/>#73 (#71 OR #72)<BR/>
<BR/>#74 (#14 AND #59)<BR/>
<BR/>#75 (#23 AND #44 AND #59)<BR/>
<BR/>#76 (#59 AND #63)<BR/>
<BR/>#77 (#59 AND #66)<BR/>
<BR/>#78 (#59 AND #70)<BR/>
<BR/>#79 (#59 AND #73 AND #44)<BR/>
<BR/>#80 (( #74 OR #75 OR #76 OR #77 OR #78 OR #79 ) AND NOT #6)</P>
<P>CAB Abstracts (via CAB Direct)<BR/>
<BR/>Search date: 14 June 2011S# Query &amp; results<BR/>
<BR/>S81 S53 and S80 13<BR/>
<BR/>S80 S75 or S76 or S77 or S78 or S79 337884<BR/>
<BR/>S79 TI (( &#8220;control* N1 clinical&#8221; or &#8220;control* N1 group*&#8221; or &#8220;control* N1 trial*&#8221; or &#8220;control* N1 study&#8221; or &#8220;control* N1 studies&#8221; or &#8220;control* N1 design*&#8221; or &#8220;control* N1 method*&#8221; ))or AB (( &#8220;control* N1 clinical&#8221; or &#8220;control* N1 group*&#8221; or &#8220;control* N1 trial*&#8221; or &#8220;control* N1 study&#8221; or &#8220;control* N1 studies&#8221; or &#8220;control* N1 design*&#8221; or &#8220;control* N1 method*&#8221; ))114905<BR/>
<BR/>S78 TI controlled or AB controlled 104753<BR/>
<BR/>S77 TI random* or AB random* 162227<BR/>
<BR/>S76 TI (( &#8220;clinical study&#8221; or &#8220;clinical studies&#8221; ))or AB (( &#8220;clinical study&#8221; or &#8220;clinical studies&#8221; ))12941<BR/>
<BR/>S75 TI ((multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*))or AB ((multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*))5402<BR/>
<BR/>S74 S53 and S73 31<BR/>
<BR/>S73 S54 or S55 or S56 or S57 or S58 or S59 or S60 or S61 or S62 or S63 or S64 or S65 or S66 or S67 or S68 or S69 or S70 or S71 or S72 461900<BR/>
<BR/>S72 TI ((time points n3 over) or (time points n3 multiple) or (time points n3 three) or (time points n3 four) or (time points n3 five) or (time points n3 six) or (time points n3 seven) or (time points n3 eight) or (time points n3 nine) or (time points n3 ten) or (time points n3 eleven) or (time points n3 twelve) or (time points n3 month*) or (time points n3 hour*) or (time points n3 day*) or (time points n3 "more than"))or AB ((time points n3 over) or (time points n3 multiple) or (time points n3 three) or (time points n3 four) or (time points n3 five) or (time points n3 six) or (time points n3 seven) or (time points n3 eight) or (time points n3 nine) or (time points n3 ten) or (time points n3 eleven) or (time points n3 twelve) or (time points n3 month*) or (time points n3 hour*) or (time points n3 day*) or (time points n3 "more than"))1219<BR/>
<BR/>S71 TI ((control w3 area) or (control w3 cohort*) or (control w3 compar*) or (control w3 condition) or (control w3 group*) or (control w3 intervention*) or (control w3 participant*) or (control w3 study))or AB ((control w3 area) or (control w3 cohort*) or (control w3 compar*) or (control w3 condition) or (control w3 group*) or (control w3 intervention*) or (control w3 participant*) or (control w3 study))87090<BR/>
<BR/>S70 TI ((multicentre or multicenter or multi-centre or multi-center))or AB ((multicentre or multicenter or multi-centre or multi-center))7471<BR/>
<BR/>S69 TI random* OR controlled 22117<BR/>
<BR/>S68 TI ((trial or (study n3 aim) or "our study"))or AB ((trial or (study n3 aim) or "our study"))171932<BR/>
<BR/>S67 TI ((pre-workshop or preworkshop or post-workshop or postworkshop) or (before n3 workshop) or (after n3 workshop))or AB ((pre-workshop or preworkshop or post-workshop or postworkshop) or (before n3 workshop) or (after n3 workshop))8874<BR/>
<BR/>S66 TI ((demonstration project OR demonstration projects OR preimplement* or pre-implement* or post-implement* or postimplement*))or AB ((demonstration project OR demonstration projects OR preimplement* or pre-implement* or post-implement* or postimplement*))840<BR/>
<BR/>S65 TX (intervention n6 clinician*) or (intervention n6 community) or (intervention n6 complex) or (intervention n6 design*) or (intervention n6 doctor*) or (intervention n6 educational) or (intervention n6 family doctor*) or (intervention n6 family physician*) or (intervention n6 family practitioner*) or (intervention n6 financial) or (intervention n6 GP) or (intervention n6 general practice*) Or (intervention n6 hospital*) or (intervention n6 impact*) Or (intervention n6 improv*) or (intervention n6 individualize*) Or (intervention n6 individualise*) or (intervention n6 individualizing) or (intervention n6 individualising) or (intervention n6 interdisciplin*) or (intervention n6 multicomponent) or (intervention n6 multi-component) or (intervention n6 multidisciplin*) or (intervention n6 multi-disciplin*) or (intervention n6 multifacet*) or (intervention n6 multi-facet*) or (intervention n6 multimodal*) or (intervention n6 multi-modal*) or (intervention n6 personalize*) or(intervention n6 personalise*) or (intervention n6 personalizing) or (intervention n6 personalising) or (intervention n6 pharmaci*) or (intervention n6 pharmacist*) or (intervention n6 pharmacy) or (intervention n6 physician*) or (intervention n6 practitioner*) Or (intervention n6 prescrib*) or (intervention n6 prescription*) or (intervention n6 primary care) or (intervention n6 professional*) or (intervention* n6 provider*) or (intervention* n6 regulatory) or (intervention n6 regulatory) or (intervention n6 tailor*) or (intervention n6 target*) or (intervention n6 team*) or (intervention n6 usual care) 19452<BR/>
<BR/>S64 TI ((collaborativ* or collaboration* or tailored or personalised or personalized))or AB ((collaborativ* or collaboration* or tailored or personalised or personalized))19849<BR/>
<BR/>S63 TI pilot 5667<BR/>
<BR/>S62 AB "before-and-after" 171176<BR/>
<BR/>S61 TI time series or AB time series 9749<BR/>
<BR/>S60 AB ( before* n10 during or before n10 after ) 18<BR/>
<BR/>S59 TI ((time point*) or (period* n4 interrupted) or (period* n4 multiple) or (period* n4 time) or (period* n4 various) or (period* n4 varying) or (period* n4 week*) or (period* n4 month*) or (period* n4 year*))or AB ((time point*) or (period* n4 interrupted) or (period* n4 multiple) or (period* n4 time) or (period* n4 various) or (period* n4 varying) or (period* n4 week*) or (period* n4 month*) or (period* n4 year*)) 116965<BR/>
<BR/>S58 TI (( quasi-experiment* or quasiexperiment* or quasi-random* or quasirandom* or quasi control* or quasicontrol* or quasi* W3 method* or quasi* W3 study or quasi* W3 studies or quasi* W3 trial or quasi* W3 design* or experimental W3 method* or experimental W3 study or experimental W3 studies or experimental W3 trial or experimental W3 design* ))or AB (( quasi-experiment* or quasiexperiment* or quasi-random* or quasirandom* or quasi control* or quasicontrol* or quasi* W3 method* or quasi* W3 study or quasi* W3 studies or quasi* W3 trial or quasi* W3 design* or experimental W3 method* or experimental W3 study or experimental W3 studies or experimental W3 trial or experimental W3 design* ))25483<BR/>
<BR/>S57 TI pre w7 post or AB pre w7 post 12418<BR/>
<BR/>S56 TI ((comparative N2 study) or (comparative N2 studies) or (evaluation study) or (evaluation studies ))or AB ((comparative N2 study) or (comparative N2 studies) or (evaluation study) or (evaluation studies ))22749<BR/>
<BR/>S55 TI ((pre-test* or pretest* or posttest* or post-test* or preimplement* or pre-implement*))or AB ((pre-test* or pretest* or posttest* or post-test* or preimplement* or pre-implement*))3636<BR/>
<BR/>S54 TI (( intervention* or multiintervention* or multi-intervention* or postintervention* or post-intervention* or preintervention* or pre-intervention* ))or AB (( intervention* or multiintervention* or multi-intervention* or postintervention* or post-intervention* or preintervention* or pre-intervention* ))72421<BR/>
<BR/>S53 S52 not S11 116<BR/>
<BR/>S52 S47 or S48 or S49 or S51 117<BR/>
<BR/>S51 S36 and S25 and S50 34<BR/>
<BR/>S50 DE "patient care" OR DE "home care" OR DE "hospice care" OR DE "hospital care" OR DE "intensive care" OR DE "long term care" OR DE "postoperative care" OR DE "preoperative care" OR DE "self care" 7996<BR/>
<BR/>S49 S36 and S42 67<BR/>
<BR/>S48 S21 and S25 and S36 41<BR/>
<BR/>S47 S15 and S36 13<BR/>
<BR/>S46 S43 or S44 or S45 16843<BR/>
<BR/>S45 TI ((applied learning or knowledge transfer* or knowledge translation))or AB ((applied learning or knowledge transfer* or knowledge translation))600<BR/>
<BR/>S44 TI ((evidence based N2 practice) or (evidence based N2 practitioner) or (evidence based N2 medicine) or (evidence based N2 medical) or (evidence based N2 treatment) or (evidence based N2 therap*) or (evidence based N2 nurse) or (evidence based N2 nurses) or (evidence based N2 nursing) or (evidence based N2 dentist*) or (evidence based N2 healthcare) or (evidence based N2 care))or AB ((evidence based N2 practice) or (evidence based N2 practitioner) or (evidence based N2 medicine) or (evidence based N2 medical) or (evidence based N2 treatment) or (evidence based N2 therap*) or (evidence based N2 nurse) or (evidence based N2 nurses) or (evidence based N2 nursing) or (evidence based N2 dentist*) or (evidence based N2 healthcare) or (evidence based N2 care))1169<BR/>
<BR/>S43 DE "guidelines" 15215<BR/>
<BR/>S42 S37 or S38 or S39 or S40 or S41 2006<BR/>
<BR/>S41 TI ((publication N2 guideline) or (publication N2 protocol) or (published N2 guideline) or (published N2 protocol))or AB ((publication N2 guideline) or (publication N2 protocol) or (published N2 guideline) or (published N2 protocol))120<BR/>
<BR/>S40 TI ((EBM N2 adher*) or (EBM N2 apply*) or (EBM N2 application) or (EBM N2 disseminat*) or (EBM N2 implement*) or (EBM N2 introduc*) or (EBM N2 publication) or (EBM N2 release) or (EBM N2 uptake))or AB ((EBM N2 adher*) or (EBM N2 apply*) or (EBM N2 application) or (EBM N2 disseminat*) or (EBM N2 implement*) or (EBM N2 introduc*) or (EBM N2 publication) or (EBM N2 release) or (EBM N2 uptake))13<BR/>
<BR/>S39 TI ((evidence N2 adher*) or (evidence N2 apply*) or (evidence N2 application) or (evidence N2 disseminat*) or (evidence N2 implement*) or (evidence N2 introduc*) or (evidence N2 publication) or (evidence N2 release) or (evidence N2 uptake))or AB ((evidence N2 adher*) or (evidence N2 apply*) or (evidence N2 application) or (evidence N2 disseminat*) or (evidence N2 implement*) or (evidence N2 introduc*) or (evidence N2 publication) or (evidence N2 release) or (evidence N2 uptake))1377<BR/>
<BR/>S38 TI ((best practice N2 adher*) or (best practice N2 apply*) or (best practice N2 application) or (best practice N2 disseminat*) or (best practice N2 implement*) or (best practice N2 introduc*) or (best practice N2 publication) or (best practice N2 release) or (best practice N2 uptake))or AB ((best practice N2 adher*) or (best practice N2 apply*) or (best practice N2 application) or (best practice N2 disseminat*) or (best practice N2 implement*) or (best practice N2 introduc*) or (best practice N2 publication) or (best practice N2 release) or (best practice N2 uptake))115<BR/>
<BR/>S37 TI ((guideline N2 adher*) or (guideline N2 apply*) or (guideline N2 application) or (guideline N2 disseminat*) or (guideline N2 implement*) or (guideline N2 introduc*) or (guideline N2 publication) or (guideline N2 release) or (guideline N2 uptake))or AB ((guideline N2 adher*) or (guideline N2 apply*) or (guideline N2 application) or (guideline N2 disseminat*) or (guideline N2 implement*) or (guideline N2 introduc*) or (guideline N2 publication) or (guideline N2 release) or (guideline N2 uptake))408<BR/>
<BR/>S36 S26 or S27 or S28 or S29 or S30 or S31 or S32 or S33 or S34 or S35 96152<BR/>
<BR/>S35 (DE "books" OR DE "textbooks" OR DE "monographs" OR DE "posters" OR DE "handbooks") 2748<BR/>
<BR/>S34 TI ((mail* N2 information) or (mail* N2 guideline) or (mail* N2 publication) or (mail* N2 protocol) or (mail* N2 practice guideline) or (mail* N2 therap* guideline) or (mail* N2 prescrib* guideline) or (mail* N2 article) or (mail* N2 articles) or (mail* N2 research) or (mail* N2 result) or (mail* N2 study) or (mail* N2 studies) or (mail* N2 journal) or (mail* N2 copy) or (mail* N2 copies))or AB ((mail* N2 information) or (mail* N2 guideline) or (mail* N2 publication) or (mail* N2 protocol) or (mail* N2 practice guideline) or (mail* N2 therap* guideline) or (mail* N2 prescrib* guideline) or (mail* N2 article) or (mail* N2 articles) or (mail* N2 research) or (mail* N2 result) or (mail* N2 study) or (mail* N2 studies) or (mail* N2 journal) or (mail* N2 copy) or (mail* N2 copies))293<BR/>
<BR/>S33 TI ((written material or written teaching or written learning))or AB ((written material or written teaching or written learning))or AB ((written material or written teaching or written learning))or AB ((written material or written teaching or written learning))58<BR/>
<BR/>S32 TI ((book or booklet or brochure or bulletin or handout or hand-out or "hard copy" or hardcopy or "hard copies" or hardcopies or monograph* or paper-based or "paper copy" or "paper copies" or print-based or pamphlet or poster))or AB ((book or booklet or brochure or bulletin or handout or hand-out or "hard copy" or hardcopy or "hard copies" or hardcopies or monograph* or paper-based or "paper copy" or "paper copies" or print-based or pamphlet or poster))92972<BR/>
<BR/>S31 TI (paper N5 format) or AB (paper N5 format) 53<BR/>
<BR/>S30 TI ((printed N4 diagram) or (printed N4 text))or AB ((printed N4 diagram) or (printed N4 text))14<BR/>
<BR/>S29 TI ((print N5 format) or (print N5 formats) or (printed N5 format) or (printed N5 formats)) or AB ((print N5 format) or (print N5 formats) or (printed N5 format) or (printed N5 formats)) 30<BR/>
<BR/>S28 TI ((paper N2 display) or (paper N2 document) or (paper N2 education* material) or (paper N2 format) or (paper N2 portfolio) or (paper N2 material) or (paper N2 media) or (paper N2 medium) or (paper N2 workshop material))or AB ((paper N2 display) or (paper N2 document) or (paper N2 education* material) or (paper N2 format) or (paper N2 portfolio) or (paper N2 material) or (paper N2 media) or (paper N2 medium) or (paper N2 workshop material))844<BR/>
<BR/>S27 TI ((printed N2 display) or (printed N2 document) or (printed N2 education* material) or (printed N2 format) or (printed N2 portfolio) or (printed N2 material) or (printed N2 media) or (printed N2 medium) or printed N2 workshop material))or AB ((printed N2 display) or (printed N2 document) or (printed N2 education* material) or (printed N2 format) or (printed N2 portfolio) or (printed N2 material) or (printed N2 media) or (printed N2 medium) or (printed N2 workshop material))117<BR/>
<BR/>S26 TI ((print N2 display) or (print N2 document) or (print N2 education* material) or (print N2 format) or (print N2 portfolio) or (print N2 material) or (print N2 media) or (print N2 medium) or (print N2 workshop material))or AB ((print N2 display) or (print N2 document) or (print N2 education* material) or (print N2 format) or (print N2 portfolio) or (print N2 material) or (print N2 media) or (print N2 medium) or (print N2 workshop material))309<BR/>
<BR/>S25 S22 OR S23 OR S24 29715<BR/>
<BR/>S24 (DE "physicians" OR DE "general practitioners" OR DE "pediatricians" OR DE "surgeons" OR DE "nurses" OR DE "nursing" OR DE "health care workers" OR DE "dentists" OR DE "medical auxiliaries") 16364<BR/>
<BR/>S23 TI (internship or intern or resident or residency or residencies) 3010<BR/>
<BR/>S22 TI (counsellor or dental aide or dental aides or dental hygienist or dentist or dietetic or dietician or doctor or general practitioner or health* professional or hospitalist or medical aide or medical aides or medical technician or nurse or nurses or nutritionist or orthodontist or pediatric* or paediatric* or pharmacist or physician or physiotherapist or psychiatrist or psychiatric aide or psychiatric aides or psychologist or practitioner or rheumatologist or surgeon or therapist) 15228<BR/>
<BR/>S21 S16 or S17 or S18 or S19 or S20 3285<BR/>
<BR/>S20 TI ((professional N2 education*) or (professional N2 training))or AB ((professional N2 education*) or (professional N2 training))1082<BR/>
<BR/>S19 TI ((professional N2 development*) or (professional N2 education*) or (professional N2 retrain*) or (professional N2 skill enhanc*) or (professional N2 training) or (professional N2 upgrade) or (professional N2 upgrading))or AB ((professional N2 development*) or (professional N2 education*) or (professional N2 retrain*) or (professional N2 skill enhanc*) or (professional N2 training) or (professional N2 upgrade) or (professional N2 upgrading))1630<BR/>
<BR/>S18 TI (continuing N2 education*) or AB (continuing N2 education*) 909<BR/>
<BR/>S17 TI ((educat* N2 clinical competenc*) or (educat* N2 practitioner) or (educat* N2 practice) or (educat* N2 general practi*) or (educat* N2 family doctor))or AB ((educat* N2 clinical competenc*) or (educat* N2 practitioner) or (educat* N2 practice) or (educat* N2 general practi*) or (educat* N2 family doctor))525<BR/>
<BR/>S16 TI ((train* N2 clinical competenc*) or (train* N2 practitioner) or (train* N2 practice) or (train* N2 general practi*) or (train* N2 family doctor))or AB ((train* N2 clinical competenc*) or (train* N2 practitioner) or (train* N2 practice) or (train* N2 general practi*) or (train* N2 family doctor))400<BR/>
<BR/>S15 S12 or S13 or S14 496<BR/>
<BR/>S14 TI CME or AB CME 317<BR/>
<BR/>S13 TI ((continuing education* N2 medical) or (continuing education* N2 nursing) or (continuing education* N2 pharma*) or (continuing education* N2 dental*) or (continuing education* N2 physician) or (continuing education* N2 doctor) or (continuing education* N2 surg*))or AB ((continuing education* N2 medical) or (continuing education* N2 nursing) or (continuing education* N2 pharma*) or (continuing education* N2 dental*) or (continuing education* N2 physician) or (continuing education* N2 doctor) or (continuing education* N2 surg*))211<BR/>
<BR/>S12 TI ((continuing N1 medical N2 education*) or (continuing N1 nursing N2 education*) or (continuing N1 pharma* N2 education*) or (continuing N1 dental* N2 education*) or (continuing N1 physician N2 ducation*) or (continuing N1 doctor N2 education*) or (continuing N1 surg* N2 education*))or AB ((continuing N1 medical N2 education*) or (continuing N1 nursing N2 education*) or (continuing N1 pharma* N2 education*) or (continuing N1 dental* N2 education*) or (continuing N1 physician N2 education*) or (continuing N1 doctor N2 education*) or (continuing N1 surg* N2 education*))207<BR/>
<BR/>S11 S1 or S2 or S3 or S4 or S5 or S6 or S7 or S8 or S9 or S10 115<BR/>
<BR/>S10 TI ((spiral bound or bound copy or bound copies))or AB ((spiral bound or bound copy or bound copies))40<BR/>
<BR/>S9 TI (postal N4 guideline) or AB (postal N4 guideline) 1<BR/>
<BR/>S8 TI paper-based education* or AB paper-based education* 2<BR/>
<BR/>S7 TI ((allied health* N2 written material) or (counsel?or N2 written material) or (doctor N2 written material) or (nurse N2 written material) or (nurses N2 written material) or (physician N2 written material) or (physiotherapist N2 written material) or (therapist N2 written material) or (dentist N2 written material) or (pharmacist N2 written material) or (health* worker N2 written material) or (health* staff N2 written material))or AB ((allied health* N2 written material) or (counsel?or N2 written material) or (doctor N2 written material) or (nurse N2 written material) or (nurses N2 written material) or (physician N2 written material) or (physiotherapist N2 written material) or (therapist N2 written material) or (dentist N2 written material) or (pharmacist N2 written material) or (health* worker N2 written material) or (health* staff N2 written material))1<BR/>
<BR/>S6 TI ((allied health* N2 brochure) or (counsel?or N2 brochure) or (doctor N2 brochure) or (nurse N2 brochure) or (nurses N2 brochure) or (physician N2 brochure) or (physiotherapist N2 brochure) or (therapist N2 brochure) or (dentist N2 brochure) or (pharmacist N2 brochure) or (health* worker N2 brochure) or (health* staff N2 brochure))or AB ((allied health* N2 brochure) or (counsel?or N2 brochure) or (doctor N2 brochure) or (nurse N2 brochure) or (nurses N2 brochure) or (physician N2 brochure) or (physiotherapist N2 brochure) or (therapist N2 brochure) or (dentist N2 brochure) or (pharmacist N2 brochure) or (health* worker N2 brochure) or (health* staff N2 brochure))1<BR/>
<BR/>S5 TI ((allied health* N2 poster) or (counsel?or N2 poster) or (doctor N2 poster) or (nurse N2 poster) or (nurses N2 poster) or (physician N2 poster) or (physiotherapist N2 poster) or (therapist N2 poster) or (dentist N2 poster) or (pharmacist N2 poster) or (health* worker N2 poster) or (health* staff N2 poster))or AB ((allied health* N2 poster) or (counsel?or N2 poster) or (doctor N2 poster) or (nurse N2 poster) or (nurses N2 poster) or (physician N2 poster) or (physiotherapist N2 poster) or (therapist N2 poster) or (dentist N2 poster) or (pharmacist N2 poster) or (health* worker N2 poster) or (health* staff N2 poster))1<BR/>
<BR/>S4 TI ((allied health* N2 booklet) or (counsel?or N2 booklet) or (doctor N2 booklet) or (nurse N2 booklet) or (nurses N2 booklet) or (physician N2 booklet) or (physiotherapist N2 booklet) or (therapist N2 booklet) or (dentist N2 booklet) or (pharmacist N2 booklet) or (health* worker N2 booklet) or (health* staff N2 booklet))or AB ((allied health* N2 booklet) or (counsel?or N2 booklet) or (doctor N2 booklet) or (nurse N2 booklet) or (nurses N2 booklet) or (physician N2 booklet) or (physiotherapist N2 booklet) or (therapist N2 booklet) or (dentist N2 booklet) or (pharmacist N2 booklet) or (health* worker N2 booklet) or (health* staff N2 booklet))1<BR/>
<BR/>S3 TI ((allied health* N2 pamphlet) or (counsel?or N2 pamphlet) or (doctor N2 pamphlet) or (nurse N2 pamphlet) or (nurses N2 pamphlet) or (physician N2 pamphlet) or (physiotherapist N2 pamphlet) or (therapist N2 pamphlet) or (dentist N2 pamphlet) or (pharmacist N2 pamphlet) or (health* worker N2 pamphlet) or (health* staff N2 pamphlet))or AB ((allied health* N2 pamphlet) or (counsel?or N2 pamphlet) or (doctor N2 pamphlet) or (nurse N2 pamphlet) or (nurses N2 pamphlet) or (physician N2 pamphlet) or (physiotherapist N2 pamphlet) or (therapist N2 pamphlet) or (dentist N2 pamphlet) or (pharmacist N2 pamphlet) or (health* orker N2 pamphlet) or (health* staff N2 pamphlet))1<BR/>
<BR/>S2 TI ((print N2 intervention) or (printed N2 intervention))or AB ((print N2 intervention) or (printed N2 intervention))27<BR/>
<BR/>S1 TI print* education* or AB print* education* 45<BR/>
<BR/>
<BR/>
</P>
<P>
<B>CINAHL (Ebsco)</B>
</P>
<P/>
<TABLE COLS="2" ROWS="151">
<TR>
<TD>
<P>
<B># </B>
</P>
</TD>
<TD>
<P>
<B>Query </B>14June 2011</P>
</TD>
</TR>
<TR>
<TD>
<P>S150</P>
</TD>
<TD>
<P>S149 and S111</P>
</TD>
</TR>
<TR>
<TD>
<P>S149</P>
</TD>
<TD>
<P>S148 not (S122 OR S120)</P>
</TD>
</TR>
<TR>
<TD>
<P>S148</P>
</TD>
<TD>
<P>S123 or S124 or S125 or S126 or S127 or S128 or S129 or S130 or S131 or S134 or S137 or S140 or S142 or S144 or S146 or S147</P>
</TD>
</TR>
<TR>
<TD>
<P>S147</P>
</TD>
<TD>
<P>TI (publication and (influenc* or impact or chang* or prescribing or physician behavio#r))</P>
</TD>
</TR>
<TR>
<TD>
<P>S146</P>
</TD>
<TD>
<P>S145 and S138</P>
</TD>
</TR>
<TR>
<TD>
<P>S145</P>
</TD>
<TD>
<P>TI publication</P>
</TD>
</TR>
<TR>
<TD>
<P>S144</P>
</TD>
<TD>
<P>S143 and S139</P>
</TD>
</TR>
<TR>
<TD>
<P>S143</P>
</TD>
<TD>
<P>(MM "Primary Health Care")</P>
</TD>
</TR>
<TR>
<TD>
<P>S142</P>
</TD>
<TD>
<P>S141 and S139</P>
</TD>
</TR>
<TR>
<TD>
<P>S141</P>
</TD>
<TD>
<P>(MH "Family Practice")</P>
</TD>
</TR>
<TR>
<TD>
<P>S140</P>
</TD>
<TD>
<P>S138 and S139</P>
</TD>
</TR>
<TR>
<TD>
<P>S139</P>
</TD>
<TD>
<P>(MH "Practice Guidelines")</P>
</TD>
</TR>
<TR>
<TD>
<P>S138</P>
</TD>
<TD>
<P>(MH "Practice Patterns")</P>
</TD>
</TR>
<TR>
<TD>
<P>S137</P>
</TD>
<TD>
<P>S135 and S136</P>
</TD>
</TR>
<TR>
<TD>
<P>S136</P>
</TD>
<TD>
<P>(MH "Patient Education")</P>
</TD>
</TR>
<TR>
<TD>
<P>S135</P>
</TD>
<TD>
<P>(MH "Education, Medical, Continuing") OR (MH "Education, Nursing, Continuing")</P>
</TD>
</TR>
<TR>
<TD>
<P>S134</P>
</TD>
<TD>
<P>S133 and S132</P>
</TD>
</TR>
<TR>
<TD>
<P>S133</P>
</TD>
<TD>
<P>TI publication or AB publication</P>
</TD>
</TR>
<TR>
<TD>
<P>S132</P>
</TD>
<TD>
<P>(MH "Drug Utilization")</P>
</TD>
</TR>
<TR>
<TD>
<P>S131</P>
</TD>
<TD>
<P>TI (guideline and disseminat*)</P>
</TD>
</TR>
<TR>
<TD>
<P>S130</P>
</TD>
<TD>
<P>TI (publication and evidence)</P>
</TD>
</TR>
<TR>
<TD>
<P>S129</P>
</TD>
<TD>
<P>TI (guideline and (notification or notify*))</P>
</TD>
</TR>
<TR>
<TD>
<P>S128</P>
</TD>
<TD>
<P>TI (impact and disseminat*)</P>
</TD>
</TR>
<TR>
<TD>
<P>S127</P>
</TD>
<TD>
<P>TI (impact and publication)</P>
</TD>
</TR>
<TR>
<TD>
<P>S126</P>
</TD>
<TD>
<P>TI (impact and bulletin)</P>
</TD>
</TR>
<TR>
<TD>
<P>S125</P>
</TD>
<TD>
<P>TI (effect* and guideline)</P>
</TD>
</TR>
<TR>
<TD>
<P>S124</P>
</TD>
<TD>
<P>TI (impact and guideline)</P>
</TD>
</TR>
<TR>
<TD>
<P>S123</P>
</TD>
<TD>
<P>TI (guideline and (impact or influence))</P>
</TD>
</TR>
<TR>
<TD>
<P>S122</P>
</TD>
<TD>
<P>S121 NOT S120</P>
</TD>
</TR>
<TR>
<TD>
<P>S121</P>
</TD>
<TD>
<P>S119 AND S104</P>
</TD>
</TR>
<TR>
<TD>
<P>S120</P>
</TD>
<TD>
<P>S119 AND S111</P>
</TD>
</TR>
<TR>
<TD>
<P>S119</P>
</TD>
<TD>
<P>S118 NOT S12</P>
</TD>
</TR>
<TR>
<TD>
<P>S118</P>
</TD>
<TD>
<P>S112 OR S113 OR S114 OR S115 OR S116 OR S117</P>
</TD>
</TR>
<TR>
<TD>
<P>S117</P>
</TD>
<TD>
<P>S56 AND S79 AND S43</P>
</TD>
</TR>
<TR>
<TD>
<P>S116</P>
</TD>
<TD>
<P>S56 AND S68</P>
</TD>
</TR>
<TR>
<TD>
<P>S115</P>
</TD>
<TD>
<P>S56 AND S64</P>
</TD>
</TR>
<TR>
<TD>
<P>S114</P>
</TD>
<TD>
<P>S56 AND S63</P>
</TD>
</TR>
<TR>
<TD>
<P>S113</P>
</TD>
<TD>
<P>S26 AND S43 AND S56</P>
</TD>
</TR>
<TR>
<TD>
<P>S112</P>
</TD>
<TD>
<P>S17 AND S56</P>
</TD>
</TR>
<TR>
<TD>
<P>S111</P>
</TD>
<TD>
<P>S105 or S106 or S107 or S108 or S109 or S110</P>
</TD>
</TR>
<TR>
<TD>
<P>S110</P>
</TD>
<TD>
<P>TI ( &#8220;control* N1 clinical&#8221; or &#8220;control* N1 group*&#8221; or &#8220;control* N1 trial*&#8221; or &#8220;control* N1 study&#8221; or &#8220;control* N1 studies&#8221; or &#8220;control* N1 design*&#8221; or &#8220;control* N1 method*&#8221; ) or AB ( &#8220;control* N1 clinical&#8221; or &#8220;control* N1 group*&#8221; or &#8220;control* N1 trial*&#8221; or &#8220;control* N1 study&#8221; or &#8220;control* N1 studies&#8221; or &#8220;control* N1 design*&#8221; or &#8220;control* N1 method*&#8221; )</P>
</TD>
</TR>
<TR>
<TD>
<P>S109</P>
</TD>
<TD>
<P>TI controlled or AB controlled</P>
</TD>
</TR>
<TR>
<TD>
<P>S108</P>
</TD>
<TD>
<P>TI random* or AB random*</P>
</TD>
</TR>
<TR>
<TD>
<P>S107</P>
</TD>
<TD>
<P>TI ( &#8220;clinical study&#8221; or &#8220;clinical studies&#8221; ) or AB ( &#8220;clinical study&#8221; or &#8220;clinical studies&#8221; )</P>
</TD>
</TR>
<TR>
<TD>
<P>S106</P>
</TD>
<TD>
<P>(MM "Clinical Trials+")</P>
</TD>
</TR>
<TR>
<TD>
<P>S105</P>
</TD>
<TD>
<P>TI ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) )</P>
</TD>
</TR>
<TR>
<TD>
<P>S104</P>
</TD>
<TD>
<P>S80 or S81 or S82 or S83 or S84 or S85 or S86 or S87 or S88 or S89 or S90 or S91 or S92 or S93 or S94 or S95 or S96 or S97 or S98 or S99 or S100 or S101 or S102 or S103</P>
</TD>
</TR>
<TR>
<TD>
<P>S103</P>
</TD>
<TD>
<P>TI ( (time points n3 over) or (time points n3 multiple) or (time points n3 three) or (time points n3 four) or (time points n3 five) or (time points n3 six) or (time points n3 seven) or (time points n3 eight) or (time points n3 nine) or (time points n3 ten) or (time points n3 eleven) or (time points n3 twelve) or (time points n3 month*) or (time points n3 hour*) or (time points n3 day*) or (time points n3 "more than") ) or AB ( (time points n3 over) or (time points n3 multiple) or (time points n3 three) or (time points n3 four) or (time points n3 five) or (time points n3 six) or (time points n3 seven) or (time points n3 eight) or (time points n3 nine) or (time points n3 ten) or (time points n3 eleven) or (time points n3 twelve) or (time points n3 month*) or (time points n3 hour*) or (time points n3 day*) or (time points n3 "more than") )</P>
</TD>
</TR>
<TR>
<TD>
<P>S102</P>
</TD>
<TD>
<P>TI ( (control w3 area) or (control w3 cohort*) or (control w3 compar*) or (control w3 condition) or (control w3 group*) or (control w3 intervention*) or (control w3 participant*) or (control w3 study) ) or AB ( (control w3 area) or (control w3 cohort*) or (control w3 compar*) or (control w3 condition) or (control w3 group*) or (control w3 intervention*) or (control w3 participant*) or (control w3 study) )</P>
</TD>
</TR>
<TR>
<TD>
<P>S101</P>
</TD>
<TD>
<P>TI ( multicentre or multicenter or multi-centre or multi-center ) or AB random*</P>
</TD>
</TR>
<TR>
<TD>
<P>S100</P>
</TD>
<TD>
<P>TI random* OR controlled</P>
</TD>
</TR>
<TR>
<TD>
<P>S99</P>
</TD>
<TD>
<P>TI ( trial or (study n3 aim) or "our study" ) or AB ( (study n3 aim) or "our study" )</P>
</TD>
</TR>
<TR>
<TD>
<P>S98</P>
</TD>
<TD>
<P>TI ( pre-workshop or preworkshop or post-workshop or postworkshop or (before n3 workshop) or (after n3 workshop) ) or AB ( pre-workshop or preworkshop or post-workshop or postworkshop or (before n3 workshop) or (after n3 workshop) )</P>
</TD>
</TR>
<TR>
<TD>
<P>S97</P>
</TD>
<TD>
<P>TI ( demonstration project OR demonstration projects OR preimplement* or pre-implement* or post-implement* or postimplement* ) or AB ( demonstration project OR demonstration projects OR preimplement* or pre-implement* or post-implement* or postimplement* )</P>
</TD>
</TR>
<TR>
<TD>
<P>S96</P>
</TD>
<TD>
<P>(intervention n6 clinician*) or (intervention n6 community) or (intervention n6 complex) or (intervention n6 design*) or (intervention n6 doctor*) or (intervention n6 educational) or (intervention n6 family doctor*) or (intervention n6 family physician*) or (intervention n6 family practitioner*) or (intervention n6 financial) or (intervention n6 GP) or (intervention n6 general practice*) Or (intervention n6 hospital*) or (intervention n6 impact*) Or (intervention n6 improv*) or (intervention n6 individualize*) Or (intervention n6 individualise*) or (intervention n6 individualizing) or (intervention n6 individualising) or (intervention n6 interdisciplin*) or (intervention n6 multicomponent) or (intervention n6 multi-component) or (intervention n6 multidisciplin*) or (intervention n6 multi-disciplin*) or (intervention n6 multifacet*) or (intervention n6 multi-facet*) or (intervention n6 multimodal*) or (intervention n6 multi-modal*) or (intervention n6 personalize*) or(intervention n6 personalise*) or (intervention n6 personalizing) or (intervention n6 personalising) or (intervention n6 pharmaci*) or (intervention n6 pharmacist*) or (intervention n6 pharmacy) or (intervention n6 physician*) or (intervention n6 practitioner*) Or (intervention n6 prescrib*) or (intervention n6 prescription*) or (intervention n6 primary care) or (intervention n6 professional*) or (intervention* n6 provider*) or (intervention* n6 regulatory) or (intervention n6 regulatory) or (intervention n6 tailor*) or (intervention n6 target*) or (intervention n6 team*) or (intervention n6 usual care)</P>
</TD>
</TR>
<TR>
<TD>
<P>S95</P>
</TD>
<TD>
<P>TI ( collaborativ* or collaboration* or tailored or personalised or personalized ) or AB ( collaborativ* or collaboration* or tailored or personalised or personalized )</P>
</TD>
</TR>
<TR>
<TD>
<P>S94</P>
</TD>
<TD>
<P>TI pilot</P>
</TD>
</TR>
<TR>
<TD>
<P>S93</P>
</TD>
<TD>
<P>(MH "Pilot Studies")</P>
</TD>
</TR>
<TR>
<TD>
<P>S92</P>
</TD>
<TD>
<P>AB "before-and-after"</P>
</TD>
</TR>
<TR>
<TD>
<P>S91</P>
</TD>
<TD>
<P>AB time series</P>
</TD>
</TR>
<TR>
<TD>
<P>S90</P>
</TD>
<TD>
<P>TI time series</P>
</TD>
</TR>
<TR>
<TD>
<P>S89</P>
</TD>
<TD>
<P>AB ( before* n10 during or before n10 after ) or AU ( before* n10 during or before n10 after )</P>
</TD>
</TR>
<TR>
<TD>
<P>S88</P>
</TD>
<TD>
<P>TI ( (time point*) or (period* n4 interrupted) or (period* n4 multiple) or (period* n4 time) or (period* n4 various) or (period* n4 varying) or (period* n4 week*) or (period* n4 month*) or (period* n4 year*) ) or AB ( (time point*) or (period* n4 interrupted) or (period* n4 multiple) or (period* n4 time) or (period* n4 various) or (period* n4 varying) or (period* n4 week*) or (period* n4 month*) or (period* n4 year*) )</P>
</TD>
</TR>
<TR>
<TD>
<P>S87</P>
</TD>
<TD>
<P>TI ( ( quasi-experiment* or quasiexperiment* or quasi-random* or quasirandom* or quasi control* or quasicontrol* or quasi* W3 method* or quasi* W3 study or quasi* W3 studies or quasi* W3 trial or quasi* W3 design* or experimental W3 method* or experimental W3 study or experimental W3 studies or experimental W3 trial or experimental W3 design* ) ) or AB ( ( quasi-experiment* or quasiexperiment* or quasi-random* or quasirandom* or quasi control* or quasicontrol* or quasi* W3 method* or quasi* W3 study or quasi* W3 studies or quasi* W3 trial or quasi* W3 design* or experimental W3 method* or experimental W3 study or experimental W3 studies or experimental W3 trial or experimental W3 design* ) )</P>
</TD>
</TR>
<TR>
<TD>
<P>S86</P>
</TD>
<TD>
<P>TI pre w7 post or AB pre w7 post</P>
</TD>
</TR>
<TR>
<TD>
<P>S85</P>
</TD>
<TD>
<P>MH "Multiple Time Series" or MH "Time Series"</P>
</TD>
</TR>
<TR>
<TD>
<P>S84</P>
</TD>
<TD>
<P>TI ( (comparative N2 study) or (comparative N2 studies) or evaluation study or evaluation studies ) or AB ( (comparative N2 study) or (comparative N2 studies) or evaluation study or evaluation studies )</P>
</TD>
</TR>
<TR>
<TD>
<P>S83</P>
</TD>
<TD>
<P>MH Experimental Studies or Community Trials or Community Trials or Pretest-Posttest Design + or Quasi-Experimental Studies + Pilot Studies or Policy Studies + Multicenter Studies</P>
</TD>
</TR>
<TR>
<TD>
<P>S82</P>
</TD>
<TD>
<P>TI ( pre-test* or pretest* or posttest* or post-test* ) or AB ( pre-test* or pretest* or posttest* or "post test* ) OR TI ( preimplement*" or pre-implement* ) or AB ( pre-implement* or preimplement* )</P>
</TD>
</TR>
<TR>
<TD>
<P>S81</P>
</TD>
<TD>
<P>TI ( intervention* or multiintervention* or multi-intervention* or postintervention* or post-intervention* or preintervention* or pre-intervention* ) or AB ( intervention* or multiintervention* or multi-intervention* or postintervention* or post-intervention* or preintervention* or pre-intervention* )</P>
</TD>
</TR>
<TR>
<TD>
<P>S80</P>
</TD>
<TD>
<P>(MH "Quasi-Experimental Studies")</P>
</TD>
</TR>
<TR>
<TD>
<P>S79</P>
</TD>
<TD>
<P>S69 or S70 or S71 or S72 or S73 or S74 or S75 or S76 or S77 or S78</P>
</TD>
</TR>
<TR>
<TD>
<P>S78</P>
</TD>
<TD>
<P>(MH "Quality of Health Care")</P>
</TD>
</TR>
<TR>
<TD>
<P>S77</P>
</TD>
<TD>
<P>(MH "Health Services Accessibility")</P>
</TD>
</TR>
<TR>
<TD>
<P>S76</P>
</TD>
<TD>
<P>(MH "Patient Selection")</P>
</TD>
</TR>
<TR>
<TD>
<P>S75</P>
</TD>
<TD>
<P>(MH "Practice Patterns")</P>
</TD>
</TR>
<TR>
<TD>
<P>S74</P>
</TD>
<TD>
<P>(MH "Medication Reconciliation")</P>
</TD>
</TR>
<TR>
<TD>
<P>S73</P>
</TD>
<TD>
<P>(MH "Disease Management")</P>
</TD>
</TR>
<TR>
<TD>
<P>S72</P>
</TD>
<TD>
<P>(MH "Critical Path")</P>
</TD>
</TR>
<TR>
<TD>
<P>S71</P>
</TD>
<TD>
<P>(MH "Patient Care Plans+") OR (MH "Nursing Care Plans+") OR (MH "Patient Centered Care")</P>
</TD>
</TR>
<TR>
<TD>
<P>S70</P>
</TD>
<TD>
<P>(MH "Managed Care Programs+")</P>
</TD>
</TR>
<TR>
<TD>
<P>S69</P>
</TD>
<TD>
<P>(MH "Health Care Delivery") OR (MH "Health Care Delivery, Integrated") OR (MH "Health Care Reform")</P>
</TD>
</TR>
<TR>
<TD>
<P>S68</P>
</TD>
<TD>
<P>S65 or S66 or S67</P>
</TD>
</TR>
<TR>
<TD>
<P>S67</P>
</TD>
<TD>
<P>(MH "Evidence-Based Dental Practice") OR (MH "Nursing Practice, Evidence-Based") OR (MH "Physical Therapy Practice, Evidence-Based")</P>
</TD>
</TR>
<TR>
<TD>
<P>S66</P>
</TD>
<TD>
<P>TI ( (applied learning or knowledge transfer* or knowledge translation) ) or AB ( (applied learning or knowledge transfer* or knowledge translation) )</P>
</TD>
</TR>
<TR>
<TD>
<P>S65</P>
</TD>
<TD>
<P>TI ( (evidence based N2 practice) or (evidence based N2 practitioner) or (evidence based N2 medicine) or (evidence based N2 medical) or (evidence based N2 treatment) or (evidence based N2 therap*) or (evidence based N2 nurse) or (evidence based N2 nurses) or (evidence based N2 nursing) or (evidence based N2 dentist*) or (evidence based N2 healthcare) or (evidence based N2 care) ) or AB ( (evidence based N2 practice) or (evidence based N2 practioner) or (evidence based N2 medicine) or (evidence based N2 medical) or (evidence based N2 treatment) or (evidence based N2 therap*) or (evidence based N2 nurse) or (evidence based N2 nurses) or (evidence based N2 nursing) or (evidence based N2 dentist*) or (evidence based N2 healthcare) or (evidence based N2 care) )</P>
</TD>
</TR>
<TR>
<TD>
<P>S64</P>
</TD>
<TD>
<P>(MH "Practice Guidelines")</P>
</TD>
</TR>
<TR>
<TD>
<P>S63</P>
</TD>
<TD>
<P>S57 or S58 or S59 or S60 or S61 or S62</P>
</TD>
</TR>
<TR>
<TD>
<P>S62</P>
</TD>
<TD>
<P>TI ( (publication N2 guideline) or (publication N2 protocol) or (published N2 guideline) or (published N2 protocol) ) or AB ( (publication N2 guideline) or (publication N2 protocol) or (published N2 guideline) or (published N2 protocol) )</P>
</TD>
</TR>
<TR>
<TD>
<P>S61</P>
</TD>
<TD>
<P>TI ( (EBM N2 adher*) or (EBM N2 apply*) or (EBM N2 application) or (EBM N2 disseminat*) or (EBM N2 implement*) or (EBM N2 introduc*) or (EBM N2 publication) or (EBM N2 release) or (EBM N2 uptake) ) or AB ( (EBM N2 adher*) or (EBM N2 apply*) or (EBM N2 application) or (EBM N2 disseminat*) or (EBM N2 implement*) or (EBM N2 introduc*) or (EBM N2 publication) or (EBM N2 release) or (EBM N2 uptake) )</P>
</TD>
</TR>
<TR>
<TD>
<P>S60</P>
</TD>
<TD>
<P>TI ( (evidence N2 adher*) or (evidence N2 apply*) or (evidence N2 application) or (evidence N2 disseminat*) or (evidence N2 implement*) or (evidence N2 introduc*) or (evidence N2 publication) or (evidence N2 release) or (evidence N2 uptake) ) or AB ( (evidence N2 adher*) or (evidence N2 apply*) or (evidence N2 application) or (evidence N2 disseminat*) or (evidence N2 implement*) or (evidence N2 introduc*) or (evidence N2 publication) or (evidence N2 release) or (evidence N2 uptake) )</P>
</TD>
</TR>
<TR>
<TD>
<P>S59</P>
</TD>
<TD>
<P>TI ( (best practice N2 adher*) or (best practice N2 apply*) or (best practice N2 application) or (best practice N2 disseminat*) or (best practice N2 implement*) or (best practice N2 introduc*) or (best practice N2 publication) or (best practice N2 release) or (best practice N2 uptake) ) or AB ( (best practice N2 adher*) or (best practice N2 apply*) or (best practice N2 application) or (best practice N2 disseminat*) or (best practice N2 implement*) or (best practice N2 introduc*) or (best practice N2 publication) or (best practice N2 release) or (best practice N2 uptake) )</P>
</TD>
</TR>
<TR>
<TD>
<P>S58</P>
</TD>
<TD>
<P>TI ( (guideline N2 adher*) or (guideline N2 apply*) or (guideline N2 application) or (guideline N2 disseminat*) or (guideline N2 implement*) or (guideline N2 introduc*) or (guideline N2 publication) or (guideline N2 release) or (guideline N2 uptake) ) or AB ( (guideline N2 adher*) or (guideline N2 apply*) or (guideline N2 application) or (guideline N2 disseminat*) or (guideline N2 implement*) or (guideline N2 introduc*) or (guideline N2 publication) or (guideline N2 release) or (guideline N2 uptake) )</P>
</TD>
</TR>
<TR>
<TD>
<P>S57</P>
</TD>
<TD>
<P>(MH "Guideline Adherence")</P>
</TD>
</TR>
<TR>
<TD>
<P>S56</P>
</TD>
<TD>
<P>S44 or S45 or S46 or S47 or S48 or S49 or S50 or S51 or S52 or S53 or S54 or S55</P>
</TD>
</TR>
<TR>
<TD>
<P>S55</P>
</TD>
<TD>
<P>(MH "Posters")</P>
</TD>
</TR>
<TR>
<TD>
<P>S54</P>
</TD>
<TD>
<P>(MH "Manuscripts") OR (MH "Pamphlets") OR (MH "Policy and Procedure Manuals") OR (MH "Reports") OR (MH "Print Materials")</P>
</TD>
</TR>
<TR>
<TD>
<P>S53</P>
</TD>
<TD>
<P>(MH "Books+")</P>
</TD>
</TR>
<TR>
<TD>
<P>S52</P>
</TD>
<TD>
<P>TI ( (mail* N2 information) or (mail* N2 guideline) or (mail* N2 publication) or (mail* N2 protocol) or (mail* N2 practice guideline) or (mail* N2 therap* guideline) or (mail* N2 prescrib* guideline) or (mail* N2 article) or (mail* N2 articles) or (mail* N2 research) or (mail* N2 result) or (mail* N2 study) or (mail* N2 studies) or (mail* N2 journal) or (mail* N2 copy) or (mail* N2 copies) ) or AB ( (mail* N2 information) or (mail* N2 guideline) or (mail* N2 publication) or (mail* N2 protocol) or (mail* N2 practice guideline) or (mail* N2 therap* guideline) or (mail* N2 prescrib* guideline) or (mail* N2 article) or (mail* N2 articles) or (mail* N2 research) or (mail* N2 result) or (mail* N2 study) or (mail* N2 studies) or (mail* N2 journal) or (mail* N2 copy) or (mail* N2 copies) )</P>
</TD>
</TR>
<TR>
<TD>
<P>S51</P>
</TD>
<TD>
<P>TI ( (written material or written teaching or written learning) ) or AB ( (written material or written teaching or written learning) )</P>
</TD>
</TR>
<TR>
<TD>
<P>S50</P>
</TD>
<TD>
<P>TI ( (book or booklet or brochure or bulletin or handout or hand-out or "hard copy" or hardcopy or "hard copies" or hardcopies or monograph* or paper-based or "paper copy" or "paper copies" or print-based or pamphlet or poster) ) or AB ( (book or booklet or brochure or bulletin or handout or hand-out or "hard copy" or hardcopy or "hard copies" or hardcopies or monograph* or paper-based or "paper copy" or "paper copies" or print-based or pamphlet or poster) )</P>
</TD>
</TR>
<TR>
<TD>
<P>S49</P>
</TD>
<TD>
<P>TI (paper N5 format) or AB (paper N5 format)</P>
</TD>
</TR>
<TR>
<TD>
<P>S48</P>
</TD>
<TD>
<P>TI ( (printed N4 diagram) or (printed N4 text) ) or AB ( (printed N4 diagram) or (printed N4 text) )</P>
</TD>
</TR>
<TR>
<TD>
<P>S47</P>
</TD>
<TD>
<P>TI ( (print N5 format) or (print N5 formats) or (printed N5 format) or (printed N5 formats) ) or AB ( (print N5 format) or (print N5 formats) or (printed N5 format) or (printed N5 formats) )</P>
</TD>
</TR>
<TR>
<TD>
<P>S46</P>
</TD>
<TD>
<P>TI ( (paper N2 display) or (paper N2 document) or (paper N2 education* material) or (paper N2 format) or (paper N2 portfolio) or (paper N2 material) or (paper N2 media) or (paper N2 medium) or (paper N2 workshop material) ) or AB ( (paper N2 display) or (paper N2 document) or (paper N2 education* material) or (paper N2 format) or (paper N2 portfolio) or (paper N2 material) or (paper N2 media) or (paper N2 medium) or (paper N2 workshop material) )</P>
</TD>
</TR>
<TR>
<TD>
<P>S45</P>
</TD>
<TD>
<P>TI ( (printed N2 display) or (printed N2 document) or (printed N2 education* material) or (printed N2 format) or (printed N2 portfolio) or (printed N2 material) or (printed N2 media) or (printed N2 medium) or (printed N2 workshop material) ) or AB ( (printed N2 display) or (printed N2 document) or (printed N2 education* material) or (printed N2 format) or (printed N2 portfolio) or (printed N2 material) or (printed N2 media) or (printed N2 medium) or (printed N2 workshop material) )</P>
</TD>
</TR>
<TR>
<TD>
<P>S44</P>
</TD>
<TD>
<P>TI ( (print N2 display) or (print N2 document) or (print N2 education* material) or (print N2 format) or (print N2 portfolio) or (print N2 material) or (print N2 media) or (print N2 medium) or (print N2 workshop material) ) or AB ( (print N2 display) or (print N2 document) or (print N2 education* material) or (print N2 format) or (print N2 portfolio) or (print N2 material) or (print N2 media) or (print N2 medium) or (print N2 workshop material) )</P>
</TD>
</TR>
<TR>
<TD>
<P>S43</P>
</TD>
<TD>
<P>(S27 or S28 or S29 or S30 or S31 or S32 or S33 or S34 or S35 or S36 or S37 or S38 or S39 or S40 or S41 or S42)</P>
</TD>
</TR>
<TR>
<TD>
<P>S42</P>
</TD>
<TD>
<P>TI (internship or intern or resident or residency or residencies)</P>
</TD>
</TR>
<TR>
<TD>
<P>S41</P>
</TD>
<TD>
<P>TI (counsellor or dental aide or dental aides or dental hygienist or dentist or dietetic or dietician or doctor or general practitioner or health* professional or hospitalist or medical aide or medical aides or medical technician or nurse or nurses or nutritionist or orthodontist or pediatric* or paediatric* or pharmacist or physician or physiotherapist or psychiatrist or psychiatric aide or psychiatric aides or psychologist or practitioner or rheumatologist or surgeon or therapist)</P>
</TD>
</TR>
<TR>
<TD>
<P>S40</P>
</TD>
<TD>
<P>(MH "Health Facility Administrators")</P>
</TD>
</TR>
<TR>
<TD>
<P>S39</P>
</TD>
<TD>
<P>(MH "Dental Auxiliaries+")</P>
</TD>
</TR>
<TR>
<TD>
<P>S38</P>
</TD>
<TD>
<P>(MH "Dentists")</P>
</TD>
</TR>
<TR>
<TD>
<P>S37</P>
</TD>
<TD>
<P>(MH "Laboratory Personnel")</P>
</TD>
</TR>
<TR>
<TD>
<P>S36</P>
</TD>
<TD>
<P>(MH "Pharmacists")</P>
</TD>
</TR>
<TR>
<TD>
<P>S35</P>
</TD>
<TD>
<P>(MH "Staff Nurses") OR (MH "Nursing Staff, Hospital")</P>
</TD>
</TR>
<TR>
<TD>
<P>S34</P>
</TD>
<TD>
<P>(MH "Medical Staff+")</P>
</TD>
</TR>
<TR>
<TD>
<P>S33</P>
</TD>
<TD>
<P>(MH "Health Occupations+")</P>
</TD>
</TR>
<TR>
<TD>
<P>S32</P>
</TD>
<TD>
<P>(MH "Allied Health Personnel") OR (MH "Audiologists") OR (MH "Cardiopulmonary Technicians") OR (MH "Cardiovascular Technicians") OR (MH "Dental Auxiliaries+") OR (MH "Dialysis Technicians") OR (MH "Dietetic Technicians, Registered") OR (MH "Dietitians") OR (MH "Electroneurodiagnostic Technologists") OR (MH "Emergency Medical Technicians") OR (MH "Laboratory Personnel+") OR (MH "Medical Assistants") OR (MH "Occupational Therapists") OR (MH "Occupational Therapy Assistants") OR (MH "Ophthalmic Technologists") OR (MH "Orthopedic Technologists") OR (MH "Pharmacy Technicians") OR (MH "Physical Therapist Assistants") OR (MH "Physical Therapists") OR (MH "Physician Assistants") OR (MH "Radiology Personnel+") OR (MH "Respiratory Therapists") OR (MH "Speech-Language Pathologists") OR (MH "Speech-Language Pathology Assistants") OR (MH "Surgical Technologists")</P>
</TD>
</TR>
<TR>
<TD>
<P>S31</P>
</TD>
<TD>
<P>(MH "Clinical Competence")</P>
</TD>
</TR>
<TR>
<TD>
<P>S30</P>
</TD>
<TD>
<P>(MH "Preceptorship")</P>
</TD>
</TR>
<TR>
<TD>
<P>S29</P>
</TD>
<TD>
<P>(MH "Internship and Residency")</P>
</TD>
</TR>
<TR>
<TD>
<P>S28</P>
</TD>
<TD>
<P>(MH "Advanced Practice Nurses+") OR (MH "Nurse Administrators+") OR (MH "Nurse Anesthetists") OR (MH "Nurse Midwives") OR (MH "Emergency Nurse Practitioners") OR (MH "Gerontologic Nurse Practitioners") OR (MH "Practical Nurses") OR (MH "Nurses, Male")</P>
</TD>
</TR>
<TR>
<TD>
<P>S27</P>
</TD>
<TD>
<P>(MH "Physicians+")</P>
</TD>
</TR>
<TR>
<TD>
<P>S26</P>
</TD>
<TD>
<P>S18 or S19 or S20 or S21 or S22 or S23 or S24 or S25</P>
</TD>
</TR>
<TR>
<TD>
<P>S25</P>
</TD>
<TD>
<P>TI ( (professional N2 education*) or (professional N2 training) ) or AB ( (professional N2 education*) or (professional N2 training) )</P>
</TD>
</TR>
<TR>
<TD>
<P>S24</P>
</TD>
<TD>
<P>TI professional N2 skill N2 improv* or AB professional N2 skill N2 improv*</P>
</TD>
</TR>
<TR>
<TD>
<P>S23</P>
</TD>
<TD>
<P>TI ( (professional N2 development*) or (professional N2 education*) or (professional N2 retrain*) or (professional N2 skill enhanc*) or (professional N2 training) or (professional N2 upgrade) or (professional N2 upgrading) ) or AB ( (professional N2 development*) or (professional N2 education*) or (professional N2 retrain*) or (professional N2 skill enhanc*) or (professional N2 training) or (professional N2 upgrade) or (professional N2 upgrading) )</P>
</TD>
</TR>
<TR>
<TD>
<P>S22</P>
</TD>
<TD>
<P>TI (continuing N2 education*) or AB (continuing N2 education*)</P>
</TD>
</TR>
<TR>
<TD>
<P>S21</P>
</TD>
<TD>
<P>TI ( (educat* N2 clinical competenc*) or (educat* N2 practitioner) or (educat* N2 practice) or (educat* N2 general practi*) or (educat* N2 family doctor) ) or AB ( (educat* N2 clinical competenc*) or (educat* N2 practitioner) or (educat* N2 practice) or (educat* N2 general practi*) or (educat* N2 family doctor) )</P>
</TD>
</TR>
<TR>
<TD>
<P>S20</P>
</TD>
<TD>
<P>TI ( (train* N2 clinical competenc*) or (train* N2 practitioner) or (train* N2 practice) or (train* N2 general practi*) or (train* N2 family doctor) ) or AB ( (train* N2 clinical competenc*) or (train* N2 practitioner) or (train* N2 practice) or (train* N2 general practi*) or (train* N2 family doctor) )</P>
</TD>
</TR>
<TR>
<TD>
<P>S19</P>
</TD>
<TD>
<P>(MH "Refresher Courses")</P>
</TD>
</TR>
<TR>
<TD>
<P>S18</P>
</TD>
<TD>
<P>(MH "Education, Continuing")</P>
</TD>
</TR>
<TR>
<TD>
<P>S17</P>
</TD>
<TD>
<P>(S13 or S14 or S15 or S16)</P>
</TD>
</TR>
<TR>
<TD>
<P>S16</P>
</TD>
<TD>
<P>TI CME or AB CME</P>
</TD>
</TR>
<TR>
<TD>
<P>S15</P>
</TD>
<TD>
<P>TI ( (continuing education* N2 medical) or (continuing education* N2 nursing) or (continuing education* N2 pharma*) or (continuing education* N2 dental*) or (continuing education* N2 physician) or (continuing education* N2 doctor) or (continuing education* N2 surg*) ) or AB ( (continuing education* N2 medical) or (continuing education* N2 nursing) or (continuing education* N2 pharma*) or (continuing education* N2 dental*) or (continuing education* N2 physician) or (continuing education* N2 doctor) or (continuing education* N2 surg*) )</P>
</TD>
</TR>
<TR>
<TD>
<P>S14</P>
</TD>
<TD>
<P>TI ( (continuing N1 medical N2 education*) or (continuing N1 nursing N2 education*) or (continuing N1 pharma* N2 education*) or (continuing N1 dental* N2 education*) or (continuing N1 physician N2 education*) or (continuing N1 doctor N2 education*) or (continuing N1 surg* N2 education*) ) or AB ( (continuing N1 medical N2 education*) or (continuing N1 nursing N2 education*) or (continuing N1 pharma* N2 education*) or (continuing N1 dental* N2 education*) or (continuing N1 physician N2 education*) or (continuing N1 doctor N2 education*) or (continuing N1 surg* N2 education*) )</P>
</TD>
</TR>
<TR>
<TD>
<P>S13</P>
</TD>
<TD>
<P>(MH "Education, Medical, Continuing") OR (MH "Education, Nursing, Continuing")</P>
</TD>
</TR>
<TR>
<TD>
<P>S12</P>
</TD>
<TD>
<P>(S1 or S2 or S3 or S4 or S5 or S6 or S7 or S8 or S9 or S10 or S11)</P>
</TD>
</TR>
<TR>
<TD>
<P>S11</P>
</TD>
<TD>
<P>TI postal N4 guideline or AB postal N4 guideline</P>
</TD>
</TR>
<TR>
<TD>
<P>S10</P>
</TD>
<TD>
<P>TI paper-based education or AB paper-based education</P>
</TD>
</TR>
<TR>
<TD>
<P>S9</P>
</TD>
<TD>
<P>TI ( (allied health* N2 print) or (counsellor N2 print) or (doctor N2 print) or (nurse N2 print) or (nurses N2 print) or (physician N2 print) or (physiotherapist N2 print) or (therapist N2 print) or (dentist N2 print) or (pharmacist N2 print) or (health* worker N2 print) or (health* staff N2 print) ) or AB ( (allied health* N2 print) or (counsellor N2 print) or (doctor N2 print) or (nurse N2 print) or (nurses N2 print) or (physician N2 print) or (physiotherapist N2 print) or (therapist N2 print) or (dentist N2 print) or (pharmacist N2 print) or (health* worker N2 print) or (health* staff N2 print) )</P>
</TD>
</TR>
<TR>
<TD>
<P>S8</P>
</TD>
<TD>
<P>TI ( (allied health* N2 printed) or (counsellor N2 printed) or (doctor N2 printed) or (nurse N2 printed) or (nurses N2 printed) or (physician N2 printed) or (physiotherapist N2 printed) or (therapist N2 printed) or (dentist N2 printed) or (pharmacist N2 printed) or (health* worker N2 printed) or (health* staff N2 printed) ) or AB ( (allied health* N2 printed) or (counsellor N2 printed) or (doctor N2 printed) or (nurse N2 printed) or (nurses N2 printed) or (physician N2 printed) or (physiotherapist N2 printed) or (therapist N2 printed) or (dentist N2 printed) or (pharmacist N2 printed) or (health* worker N2 printed) or (health* staff N2 printed) )</P>
</TD>
</TR>
<TR>
<TD>
<P>S7</P>
</TD>
<TD>
<P>TI ( (allied health* N2 written material) or (counsellor N2 written material) or (doctor N2 written material) or (nurse N2 written material) or (nurses N2 written material) or (physician N2 written material) or (physiotherapist N2 written material) or (therapist N2 written material) or (dentist N2 written material) or (pharmacist N2 written material) or (health* worker N2 written material) or (health* staff N2 written material) ) or AB ( (allied health* N2 written material) or (counsellor N2 written material) or (doctor N2 written material) or (nurse N2 written material) or (nurses N2 written material) or (physician N2 written material) or (physiotherapist N2 written material) or (therapist N2 written material) or (dentist N2 written material) or (pharmacist N2 written material) or (health* worker N2 written material) or (health* staff N2 written material) )</P>
</TD>
</TR>
<TR>
<TD>
<P>S6</P>
</TD>
<TD>
<P>TI ( (allied health* N2 brochure) or (counsellor N2 brochure) or (doctor N2 brochure) or (nurse N2 brochure) or (nurses N2 brochure) or (physician N2 brochure) or (physiotherapist N2 brochure) or (therapist N2 brochure) or (dentist N2 brochure) or (pharmacist N2 brochure) or (health* worker N2 brochure) or (health* staff N2 brochure) ) or AB ( (allied health* N2 brochure) or (counsellor N2 brochure) or (doctor N2 brochure) or (nurse N2 brochure) or (nurses N2 brochure) or (physician N2 brochure) or (physiotherapist N2 brochure) or (therapist N2 brochure) or (dentist N2 brochure) or (pharmacist N2 brochure) or (health* worker N2 brochure) or (health* staff N2 brochure) )</P>
</TD>
</TR>
<TR>
<TD>
<P>S5</P>
</TD>
<TD>
<P>TI ( (allied health* N2 poster) or (counsellor N2 poster) or (doctor N2 poster) or (nurse N2 poster) or (nurses N2 poster) or (physician N2 poster) or (physiotherapist N2 poster) or (therapist N2 poster) or (dentist N2 poster) or (pharmacist N2 poster) or (health* worker N2 poster) or (health* staff N2 poster) ) or AB ( (allied health* N2 poster) or (counsellor N2 poster) or (doctor N2 poster) or (nurse N2 poster) or (nurses N2 poster) or (physician N2 poster) or (physiotherapist N2 poster) or (therapist N2 poster) or (dentist N2 poster) or (pharmacist N2 poster) or (health* worker N2 poster) or (health* staff N2 poster) )</P>
</TD>
</TR>
<TR>
<TD>
<P>S4</P>
</TD>
<TD>
<P>TI ( (allied health* N2 booklet) or (counsellor N2 booklet) or (doctor N2 booklet) or (nurse N2 booklet) or (nurses N2 booklet) or (physician N2 booklet) or (physiotherapist N2 booklet) or (therapist N2 booklet) or (dentist N2 booklet) or (pharmacist N2 booklet) or (health* worker N2 booklet) or (health* staff N2 booklet) ) or AB ( (allied health* N2 booklet) or (counsellor N2 booklet) or (doctor N2 booklet) or (nurse N2 booklet) or (nurses N2 booklet) or (physician N2 booklet) or (physiotherapist N2 booklet) or (therapist N2 booklet) or (dentist N2 booklet) or (pharmacist N2 booklet) or (health* worker N2 booklet) or (health* staff N2 booklet) )</P>
</TD>
</TR>
<TR>
<TD>
<P>S3</P>
</TD>
<TD>
<P>TI ( (allied health* N2 pamphlet) or (counsellor N2 pamphlet) or (doctor N2 pamphlet) or (nurse N2 pamphlet) or (nurses N2 pamphlet) or (physician N2 pamphlet) or (physiotherapist N2 pamphlet) or (therapist N2 pamphlet) or (dentist N2 pamphlet) or (pharmacist N2 pamphlet) or (health* worker N2 pamphlet) or (health* staff N2 pamphlet) ) or AB ( (allied health* N2 pamphlet) or (counsellor N2 pamphlet) or (doctor N2 pamphlet) or (nurse N2 pamphlet) or (nurses N2 pamphlet) or (physician N2 pamphlet) or (physiotherapist N2 pamphlet) or (therapist N2 pamphlet) or (dentist N2 pamphlet) or (pharmacist N2 pamphlet) or (health* worker N2 pamphlet) or (health* staff N2 pamphlet) )</P>
</TD>
</TR>
<TR>
<TD>
<P>S2</P>
</TD>
<TD>
<P>TI ( (print N2 intervention) or (printed N2 intervention) ) or AB ( (print N2 intervention) or (printed N2 intervention) )</P>
</TD>
</TR>
<TR>
<TD>
<P>S1</P>
</TD>
<TD>
<P>TI print* education* or AB print* education*</P>
</TD>
</TR>
</TABLE>
<P/>
<P> </P>
<P>
<B>ERIC (Education Resources Information Center) via Wilson</B>
<BR/>
<BR/>Limit: Journal<BR/>
<BR/>TI: (printed educational material) OR (bulletin or brochure or pamphlet or poster ormonograph or booklet or journal article or hardcopy or guideline or print) OR ((disseminate or dissemination or distribute or distribution or mail or mailed or mailingor posted or postal) AND (impact or effect or effectiveness or efficacy or influence or alteror change))<BR/>
<BR/>AND<BR/>
<BR/>KW: counsellor? or doctor? or nurs* or physician? or practitioner? or therapist? or dentist? or dental aide? or dental auxiliaries or surgeon? or health* workers or health*professionals or nutritionist? or pharmacist? or<BR/>paediatrician? or psychologist? or psychiatrist?</P>
<P>
<B>EPOC register (Reference Manager)</B>
<BR/>
<BR/>Truncation of all terms was automatic.<BR/>
<BR/>ALL FIELDS: Print Intervention<BR/>
<BR/>TITLE: disseminat or distribute or mail or posted or postal or sent or receive or distribution or bulletin or guideline or letter or publication or print or written or brochure or pamphlet or protocol or hardcop or research or<BR/>printed or material<BR/>AND<BR/>ALL FIELDS: counsellor or doctor or physician or practitioner or nurse or therapist or psychologist or pscyhiatrist or dentist or dental or dietician or surgeon or healthcare worker or health care worker or nutritionist<BR/>ALL FIELDS: effect or impact or influence or efficacy or alter or change<BR/>
<BR/>Total 297</P>
<P>
<B>Global Health Database (via CAB Direct)</B>
<BR/>
<BR/>Search Date: June 17, 2011<BR/>
<BR/>title:("dissemination" Or "disseminate" OR mail OR "distribution" OR "distribute" OR "protocol" OR "protocols" OR "guideline" OR "guidelines" OR "letter" OR "letters" OR "bulletin" OR "posted" OR "postal" OR "publication") AND title:("impact" OR "effect" OR "effectiveness" OR "efficacy")<BR/>
<BR/>OR<BR/>
<BR/>title:(("counsel" OR "dental aide" OR "dental aides" OR "dental hygienist" OR "dentist" OR "dietetic" OR "dietician" OR "doctor" OR "general practitioner" OR "healthcare professional" OR "health care professional" OR "hospitalist" OR "medical aide" OR "medical aides" OR "medical technician" OR "nurse" OR "nurse" OR "nutritionist" OR "orthodontist" OR "pediatrician" OR "paediatrician" OR "pharmacist" OR "physician" OR "physiotherapist" OR "psychiatrist" OR "psychiatric aide" OR "psychiatric aides" OR "psychologist" OR "practitioner" OR "rheumatologist" OR "surgeon" OR "therapist")) AND title:(("book" OR "books" OR "booklet" OR "booklets" OR "brochure" OR "brochures" OR "bulletin" OR "bulletins" OR "handout" OR "handouts" OR "hand-out" Or "hand-outs" OR "hard copy" OR "hardcopy" OR "hard copies" OR "hardcopies" OR "monographs" OR "monograph" OR "paper-based" OR "paper copy" OR "paper copies" OR "print-based" OR "pamphlet" OR "pamphlets" OR "poster" OR "posters" OR "guideline" OR "guidelines" OR "protocol" OR "protocols" OR "manual" OR "manuals"))<BR/>
<BR/>OR<BR/>
<BR/>title:(("counsel" OR "dental aide" OR "dental aides" OR "dental hygienists" OR "dentists" OR "dietetics" OR "dieticians" OR "doctors" OR "general practitioners" OR "healthcare professionals" OR "health care professionals" OR "hospitalists" OR "medical aide" OR "medical aides" OR "medical technicians" OR "nurse" OR "nurses" OR "nutritionists" OR "orthodontists" OR "pediatricians" OR "paediatricians" OR "pharmacists" OR "physicians" OR "physiotherapists" OR "psychiatrists" OR "psychiatric aide" OR "psychiatric aides" OR "psychologists" OR "practitioners" OR "rheumatologists" OR "surgeons" OR "therapists")) AND title:(("book" OR "books" OR "booklet" OR "booklets" OR "brochure" OR "brochures" OR "bulletin" OR "bulletins" OR "handout" OR "handouts" OR "hand-out" Or "hand-outs" OR "hard copy" OR "hardcopy" OR "hard copies" OR "hardcopies" OR "monographs" OR "monograph" OR "paper-based" OR "paper copy" OR "paper copies" OR "print-based" OR "pamphlet" OR "pamphlets" OR "poster" OR "posters" OR "guideline" OR "guidelines" OR "protocol" OR "protocols" OR "manual" OR "manuals"))<BR/>
<BR/>OR<BR/>
<BR/>title:(printed AND education) OR title:(printed AND intervention)</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2012-04-30 20:45:14 -0400" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2012-04-04 11:06:41 -0400" MODIFIED_BY="[Empty name]">Search strategy per original review</TITLE>
<APPENDIX_BODY MODIFIED="2012-04-04 11:06:48 -0400" MODIFIED_BY="[Empty name]">
<P>teaching materials/ OR ((education$ or teach$) adj (material$ or book$ or monograph$ or pamphlet$ or journal$ or guidelines$ or publication$ or serial$ or papers$ or information)).tw. OR education$ intervention$.tw. OR exp education/mt<BR/>
<BR/>AND print$.tw.</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2012-09-10 11:19:25 -0400" MODIFIED_BY="Anik Giguere" NO="3">
<TITLE MODIFIED="2012-04-30 20:40:18 -0400" MODIFIED_BY="Anik Giguere">Listing of the printed educational material evaluated in the included studies</TITLE>
<APPENDIX_BODY MODIFIED="2012-09-10 11:19:25 -0400" MODIFIED_BY="[Empty name]">
<TABLE COLS="3" ROWS="46">
<TR>
<TH>
<P>
<B>Study / PEM label(s)</B>
</P>
</TH>
<TH>
<P>
<B>PEM description</B>
</P>
</TH>
<TH>
<P>
<B>Availability</B>
</P>
</TH>
</TR>
<TR>
<TD>
<P>Austin 2003 / HERS trial report</P>
<P> </P>
</TD>
<TD>
<P>Publication in peer-reviewed journal:</P>
<P> </P>
<P>HERS: Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998;280:605-13</P>
<P/>
</TD>
<TD>
<P>HERS is available</P>
<P> </P>
</TD>
</TR>
<TR>
<TD>
<P>Austin 2004-A / WHI trial report</P>
<P> </P>
</TD>
<TD>
<P>Publication in peer-reviewed journal:</P>
<P> </P>
<P>Writing Group for the Women&#8217;s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women&#8217;s Health Initiative randomized controlled trial. JAMA 2002; 288:321-33</P>
<P/>
</TD>
<TD>
<P>WHI is available</P>
</TD>
</TR>
<TR>
<TD>
<P>Austin 2004-B / ALLHAT trial report</P>
<P> </P>
</TD>
<TD>
<P>Publication in peer-reviewed journal:</P>
<P> </P>
<P>ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group.</P>
<P>Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting</P>
<P>enzyme inhibitor or calcium channel blocker vs. diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).  JAMA 2002;288:2981-97</P>
<P> </P>
</TD>
<TD>
<P>ALLHAT is available</P>
</TD>
</TR>
<TR>
<TD>
<P>Austin 2005 / REVERSAL, PROVE IT&#8211;TIMI22 trials reports</P>
<P> </P>
</TD>
<TD>
<P>2 publications in peer-reviewed journals:</P>
<P> </P>
<P>REVERSAL: Nissen SE, Tuzcu EM, Schoenhagen P, Brown BG, Ganz P, Vogel RA, Crowe T, Howard G, Cooper CJ, Brodie B, Grines CL, DeMaria AN, for the REVERSAL Investigators. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 2004;291:1071&#8211;80</P>
<P> </P>
<P>PROVEIT-TIMI22: Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004;350:1495-504</P>
<P/>
</TD>
<TD>
<P>REVERSAL, PROVE IT&#8211;TIMI22 are available</P>
</TD>
</TR>
<TR>
<TD>
<P>Avorn 1983 / FDA Bulletin</P>
</TD>
<TD>
<P>Bulletin patterned after the <I>Federal Drug Administration Drug Bulletin</I> describing alternatives to targeted drugs </P>
<P> </P>
</TD>
<TD>
<P>Not available</P>
</TD>
</TR>
<TR>
<TD>
<P>Azocar 2003 / UBH guidelines</P>
</TD>
<TD>
<P>US United Behavioral Health (UBH) best practice guidelines for the treatment of major depression</P>
<P/>
</TD>
<TD>
<P>Not available</P>
</TD>
</TR>
<TR>
<TD>
<P>Barbaglia 2009 / WHI trial report</P>
<P> </P>
</TD>
<TD>
<P>Publication in peer-reviewed journal:</P>
<P> </P>
<P>Writing Group for the Women&#8217;s Health Initiative Investigators. Risk and benefits of estrogens plus progestin in healthy postmenopausal women: principal results from the Women&#8217;s Health Initiative Randomized Controlled Trial. J<I>AMA </I>2002;288:321-33</P>
<P/>
</TD>
<TD>
<P>WHI is available</P>
</TD>
</TR>
<TR>
<TD>
<P>Beaulieu 2004 / Guidelines summary</P>
</TD>
<TD>
<P>1 page summary of Quebec provincial guidelines (Canada) for anti-anginal therapy</P>
</TD>
<TD>
<P>Not available</P>
</TD>
</TR>
<TR>
<TD>
<P>Bearcroft 1993/ UK guidelines</P>
</TD>
<TD>
<P>Guidelines for referrals for chest radiography for general practitioners</P>
</TD>
<TD>
<P>Not available</P>
</TD>
</TR>
<TR>
<TD>
<P>Bjornson 1990 / VA trial report</P>
</TD>
<TD>
<P>Publication in peer-reviewed journal:</P>
<P> </P>
<P>Cohn JN, Archibald DG, Ziesche S, Franciosa JA, Harston WE, Tristani FE, Dunkman WB, Jacobs W, Francis GS, Flohr KH, Goldman S, Cobb FR, Shah PM, Saunders R, Fletcher RD, Loeb HS, Hughes VC, Baker B. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med 986;314:1547-52</P>
<P/>
</TD>
<TD>
<P>VA available</P>
<P> </P>
<P> </P>
</TD>
</TR>
<TR>
<TD>
<P>Black 2002 / EHC-OM</P>
</TD>
<TD>
<P>EHC-OM: National Health Service (NHS). The treatment of persistent glue ear in children. Effective Health Care (Bulletin) November 1992, Number 4</P>
<P/>
</TD>
<TD>
<P>EHC-OM is available</P>
</TD>
</TR>
<TR>
<TD>
<P>Buyle 2010/ Belgian guidelines</P>
<P> </P>
</TD>
<TD>
<P>Belgian guidelines for sequential antibiotic therapy (intravenous to oral with fluoroquinolones) published in Pharmacotherapeutic Committee drug letter (October 2003)</P>
<P/>
</TD>
<TD>
<P>Available</P>
</TD>
</TR>
<TR>
<TD>
<P>Coopersmith 2002/self-study module</P>
<P> </P>
</TD>
<TD>
<P>10-page self-study module on risk factors and practice modifications involved in catheter-related infections  for registered nurses</P>
<P/>
</TD>
<TD>
<P>Not available</P>
</TD>
</TR>
<TR>
<TD>
<P>Denig 1990/Dutch drug bulletin</P>
</TD>
<TD>
<P>Dutch drug bulletin <I>Geneesmiddelenbulletin </I>for physicians and pharmacists</P>
<P/>
</TD>
<TD>
<P>Not available</P>
</TD>
</TR>
<TR>
<TD>
<P>Dormuth 2004/Canadian drug bulletin</P>
</TD>
<TD>
<P>12 issues of the drug bulletin <I>Therapeutics Letter</I>
</P>
<P/>
</TD>
<TD>
<P>Not available</P>
</TD>
</TR>
<TR>
<TD>
<P>Fijn 2000/Dutch national recommendations</P>
</TD>
<TD>
<P>Dutch national recommendations on antithrombotic prophylaxis of ischaemic heart disease</P>
<P/>
</TD>
<TD>
<P>Not available</P>
</TD>
</TR>
<TR>
<TD>
<P>Fonarow 2009/MIRACL, PROVE-IT TIMI 22, AHA-AHA-NS and ACC-AHA-STEMI</P>
<P> </P>
</TD>
<TD>
<P>2 publications in peer-reviewed journals:</P>
<P> </P>
<P>MIRACL: Schwartz GG, Olsson AG, Ezekowitz MD, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 2001;285:1711-8</P>
<P> </P>
<P>PROVEIT-TIMI22: Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004;350:1495-504</P>
<P> </P>
<P>2 guidelines:</P>
<P> </P>
<P>AHA-AHA-NS : ACC/AHA 2002 guideline update for the management of patients with unstable angina and non&#8211;ST-segment elevation myocardial infarction</P>
<P> </P>
<P>ACC-AHA-STEMI:  ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction</P>
<P/>
</TD>
<TD>
<P>MIRACL, PROVE-IT TIMI 22, AHA-AHA-NS, ACC-AHA-STEMI are available</P>
</TD>
</TR>
<TR>
<TD>
<P>Fukuda 2009/Japanese guidelines on breast cancer</P>
<P> </P>
</TD>
<TD>
<P>Japanese evidence-based clinical practice guidelines for treatment of early-stage breast cancer</P>
<P/>
</TD>
<TD>
<P>Not available</P>
</TD>
</TR>
<TR>
<TD>
<P>Guay 2007 / WHI trial report</P>
<P> </P>
</TD>
<TD>
<P>Publication in peer-reviewed journal:</P>
<P> </P>
<P>Writing Group for the Women&#8217;s Health Initiative Investigators. Risk and benefits of estrogens plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative Randomized Controlled Trial. <I>JAMA </I>2002;288:321-33</P>
<P/>
</TD>
<TD>
<P>WHI is available</P>
</TD>
</TR>
<TR>
<TD>
<P>Haas 2004 / HERS and WHI trials reports</P>
<P> </P>
</TD>
<TD>
<P>2 publications in peer-reviewed journals:</P>
<P> </P>
<P>HERS: Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998;280:605-13.</P>
<P> </P>
<P>WHI: Writing Group for the Women&#8217;s Health Initiative Investigators. Risk and benefits of estrogens plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative Randomized Controlled Trial. JAMA 2002;288:321-33</P>
<P/>
</TD>
<TD>
<P>HERS, WHI are available</P>
</TD>
</TR>
<TR>
<TD>
<P>Hersh 2004 / HERS, HERS II, WHI trials reports</P>
<P> </P>
</TD>
<TD>
<P>3 publications in peer-reviewed journals:</P>
<P> </P>
<P>HERS: Hulley S, Grady D, Bush T, et al. Randomized trial </P>
<P>of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA  1998;280:605-13</P>
<P> </P>
<P>HERS II: Grady D, Herrington D, Bittner V, et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy<I>. </I>JAMA  2002;288:49-57</P>
<P> </P>
<P>WHI: Writing Group for the Women&#8217;s Health Initiative Investigators. Risk and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33</P>
<P/>
</TD>
<TD>
<P>HERS, HERS II, WHI are available</P>
</TD>
</TR>
<TR>
<TD>
<P>Jackevicius 2001/4S trial report</P>
<P> </P>
</TD>
<TD>
<P>Publication in peer-reviewed journal:</P>
<P> </P>
<P>Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9</P>
<P/>
</TD>
<TD>
<P>4S Available</P>
</TD>
</TR>
<TR>
<TD>
<P>Jameson 2010/ NICE guidelines for orthopaedic surgery</P>
<P> </P>
</TD>
<TD>
<P>The National Institute for Health and Clinical Excellence's recommendations and guideline on prophylaxis for venous thromboembolism in orthopaedic surgery</P>
<P/>
</TD>
<TD>
<P>Not available</P>
</TD>
</TR>
<TR>
<TD>
<P>Jousimaa 2002 / Finnish guidelines</P>
<P> </P>
</TD>
<TD>
<P>Collection of Finnish clinical practice guidelines  for primary and ambulatory care <I>Evidence-Based Medicine Guidelines</I> (previously <I>Physician's Desk Reference and Database</I>)</P>
<P/>
</TD>
<TD>
<P>Not available</P>
</TD>
</TR>
<TR>
<TD>
<P>Juurlink 2004 / RALES trial report</P>
</TD>
<TD>
<P>Publication in peer-reviewed journal:</P>
<P> </P>
<P>Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999;341:709-17</P>
<P/>
</TD>
<TD>
<P>RALES is available</P>
</TD>
</TR>
<TR>
<TD>
<P>Kabir 2007 / LIFE, ALLHAT and VALUE trials reports</P>
<P> </P>
<P> </P>
</TD>
<TD>
<P>3 publications in peer-reviewed journals:</P>
<P> </P>
<P>LIFE: Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, deFaire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, LIFE Study Group. Cardiovascular morbidity and </P>
<P>mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002;359:995&#8211;1003</P>
<P> </P>
<P>ALLHAT: ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002;288:2981&#8211;97</P>
<P> </P>
<P>VALUE: Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, Hua T, Laragh J, McInnes GT, Mitchell L, Plat F, Schork A, Smith B, Zanchetti A, VALUE trial group. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet 2004;363:2022&#8211;31</P>
<P/>
</TD>
<TD>
<P>ALLHAT, VALUE, LIFE are available</P>
</TD>
</TR>
<TR>
<TD>
<P>Kajita 2012/ Japanese guidelines on osteoporosis</P>
<P> </P>
</TD>
<TD>
<P>Japanese evidence-based guideline <I>Evidence-based guideline for the prevention of osteoporosis and osteoporotic fractures in community health</I>
</P>
<P/>
</TD>
<TD>
<P>Not available</P>
</TD>
</TR>
<TR>
<TD>
<P>Kottke 1989/Smoking cessation booklet</P>
<P/>
</TD>
<TD>
<P>Smoking cessation booklet <I>Quit-and-win</I>
</P>
</TD>
<TD>
<P>Available</P>
</TD>
</TR>
<TR>
<TD>
<P>Lam 2009 / 4D trial report</P>
<P> </P>
</TD>
<TD>
<P>Publication in peer-reviewed journal:</P>
<P> </P>
<P>Wanner C, Krane V, Marz W et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 2005;353:238&#8211;48</P>
<P/>
</TD>
<TD>
<P>4D is available</P>
</TD>
</TR>
<TR>
<TD>
<P>Majumdar 2003/ HOPE and RALES trials reports</P>
<P> </P>
</TD>
<TD>
<P>2 studies published in peer-reviewed journals:</P>
<P> </P>
<P>HOPE study published in:</P>
<UL>
<LI>The Heart Outcomes Prevention Evaluation Study (HOPE): Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000;342:145&#8211;53</LI>
<LI>Francis GS. ACE inhibition in cardiovascular disease. N Engl J Med 2000;342:201&#8211;2</LI>
</UL>
<P/>
<P>Randomized Aldactone Evaluation Study (RALES):</P>
<UL>
<LI>Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999;341:709-17</LI>
<LI>Weber KT. Aldosterone and spironolactone in heart failure. N Engl J Med 1999;341:753&#8211;5</LI>
</UL>
<P/>
</TD>
<TD>
<P>HOPE and RALES trials publications are available</P>
<P/>
<P/>
<P/>
<P>Available</P>
</TD>
</TR>
<TR>
<TD>
<P>Majumdar 2004 / WHI trial report</P>
<P> </P>
</TD>
<TD>
<P>Publication in peer-reviewed journal:</P>
<P> </P>
<P>Writing Group for the Women&#8217;s Health Initiative Investigators. Risk and benefits of estrogens plus progestin in healthy postmenopausal women: principal results from the Women&#8217;s Health Initiative Randomized Controlled Trial. J<I>AMA </I>2002;288:321-33</P>
<P/>
</TD>
<TD>
<P>WHI is available</P>
</TD>
</TR>
<TR>
<TD>
<P>Mason 1998 / EHC-D</P>
<P> </P>
</TD>
<TD>
<P>EHC-D: National Health Service (NHS). The treatment of depression in primary care. Effective Health Care (Bulletin) March 1993, Number 5</P>
<P/>
</TD>
<TD>
<P>EHC-D is available</P>
</TD>
</TR>
<TR>
<TD>
<P>Mason 2001 / EHC-OM</P>
<P> </P>
</TD>
<TD>
<P>EHC-OM: National Health Service (NHS). The treatment of persistent glue ear in children. Effective Health Care (Bulletin) November 1992, Number 4</P>
<P/>
</TD>
<TD>
<P>EHC-OM is available</P>
</TD>
</TR>
<TR>
<TD>
<P>Matowe 2002/ UK Royal college of radiologists guidelines</P>
<P> </P>
</TD>
<TD>
<P>Royal College of Radiologists. <I>Making the Best Use of a Department of Radiology: Guidelines for Doctors.</I> London: Royal College of Radiologists, 1998</P>
<P/>
</TD>
<TD>
<P>Not available</P>
</TD>
</TR>
<TR>
<TD>
<P>Meyer 2007/ German guidelines for the ICU</P>
</TD>
<TD>
<P>Guidelines on empirical antibiotic treatment in the Intensive Care Unit (ICU)</P>
<P/>
</TD>
<TD>
<P>Not available</P>
</TD>
</TR>
<TR>
<TD>
<P>Oakeshott 1994/UK Royal college of radiologists guidelines</P>
</TD>
<TD>
<P>Royal College of Radiologists. <I>Making the Best Use of a Department of Radiology: Guidelines for Doctors.</I> London: Royal College of Radiologists, 1990</P>
<P/>
</TD>
<TD>
<P>Not available</P>
</TD>
</TR>
<TR>
<TD>
<P>Perria 2007/ Italian guidelines</P>
</TD>
<TD>
<P>Italian evidence-based guidelines for the management of non-complicated type 2 diabetes mellitus</P>
<P/>
</TD>
<TD>
<P>Not available</P>
</TD>
</TR>
<TR>
<TD>
<P>Roberts 2007/NICE guidelines for primary hip replacement</P>
<P> </P>
</TD>
<TD>
<P>National Institute for Health and Clinical Excellence (NICE).  <I>Guidelines on the Selection of Prostheses for Primary Hip Replacement. </I>London: NHS, April 2000</P>
<P/>
</TD>
<TD>
<P>Available</P>
</TD>
</TR>
<TR>
<TD>
<P>Santerre 1996/ACOG guidelines</P>
<P> </P>
</TD>
<TD>
<P>American College of Obstetricians and Gynecologists (ACOG) clinical management guidelines for vaginal birth after cesarean delivery (VBAC)</P>
<P/>
</TD>
<TD>
<P>Not available</P>
</TD>
</TR>
<TR>
<TD>
<P>Shah 2008/Nissen and al. study report</P>
<P> </P>
</TD>
<TD>
<P>Publication in peer-reviewed journal:</P>
<P> </P>
<P>Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. New Engl J Med 2007;356:2457&#8211;71</P>
<P/>
</TD>
<TD>
<P>Available</P>
</TD>
</TR>
<TR>
<TD>
<P>Stafford 2004 / ALLHAT trial report</P>
<P> </P>
</TD>
<TD>
<P>Publication in peer-reviewed journal:</P>
<P> </P>
<P>ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group.</P>
<P>Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting</P>
<P>enzyme inhibitor or calcium channel blocker vs. diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002;288:2981-97</P>
<P/>
</TD>
<TD>
<P>ALLHAT is available</P>
</TD>
</TR>
<TR>
<TD>
<P>Tsuji  2009/Guidelines for physician depression</P>
<P> </P>
</TD>
<TD>
<P>Depression diagnosis and treatment guide for primary care physicians</P>
<P/>
</TD>
<TD>
<P>Not available</P>
</TD>
</TR>
<TR>
<TD>
<P>Wang 2005/ADA and ATP III trials reports</P>
</TD>
<TD>
<P>ADA: American Diabetes Association (ADA) guidelines published in January 1998 advocated an LDL cholesterol goal under 100 mg/dl for patients with diabetes</P>
<P> </P>
<P>Publication in peer-reviewed journal:</P>
<P> </P>
<P>ATP III: Expert Panel on Detection, Evaluation,</P>
<P>and Treatment of High Blood Cholesterol in Adults: Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in  Adults (Adult Treatment Panel III). JAMA 2001;285:2486&#8211;97</P>
<P/>
</TD>
<TD>
<P>ATP III is available</P>
</TD>
</TR>
<TR>
<TD>
<P>Watson 2001/Guidelines for musculoskeletal disorder</P>
</TD>
<TD>
<P>Guidelines for the use of oral Non-Steroidal Antiinflammatory drugs (NSAIDs) in the management of musculoskeletal disorders</P>
</TD>
<TD>
<P>Available:</P>
<P> </P>
<P>Watson M. The Development, Implementation And Evaluation Of Prescribing Guidelines In General Practice. 1998; PhD Thesis</P>
<P> </P>
<P>Algorithm</P>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Weiss 2011/Quebec guidelines on antibiotics</P>
<P> </P>
</TD>
<TD>
<P>Eleven 2-page graphic user-friendly guidelines providing clinical information  and antibiotic recommendations</P>
<P/>
</TD>
<TD>
<P>Available</P>
</TD>
</TR>
</TABLE>
<P/>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-04" MODIFIED="2012-09-13 12:38:11 -0400" MODIFIED_BY="Alain Mayhew" NO="4">
<TITLE MODIFIED="2012-09-12 17:09:05 -0400" MODIFIED_BY="Alain Mayhew">Full-text papers assessed for eligibility but excluded from the review</TITLE>
<APPENDIX_BODY MODIFIED="2012-09-13 12:38:11 -0400" MODIFIED_BY="Alain Mayhew">
<P>Reference List</P>
<P> </P>
<P>     (1)   Effective IEC approaches for Asia. JOICFP News 1995 Feb;(248):7. [PM: 12288395]</P>
<P>     (2)   Special report: the publication of new evidence and effect on physician prescribing behaviors. Technology Evaluation Center Assessment Program 2004 Dec;19(11):1-3. [PM: 15651133]</P>
<P>     (3)   Standards on verbal orders rank high among common compliance problems. ED Management 2009 May;21(5):Suppl 1-2. [PM: 19552346]</P>
<P>     (4)   Adam C, Rosser D, Manji M. Impact of introducing a sedation management guideline in intensive care. Anaesthesia 2006 Mar;61(3):260-3. [PM: 16480351]</P>
<P>     (5)   Adams A, Ockene JK, Wheller EV, Hurley TG. Alcohol counseling: physicians will do it. Journal of General Internal Medicine 1998 Oct;13(10):692-8. [PM: 9798817]</P>
<P>     (6)   Adank K, Barras JP, Biland L, Bollinger A, Galeazzi R, Kampf R, et al. Guidelines for the evaluation of the therapeutic effects of peripheral vasoactive drugs in arterial occlusive disease. Vasa 1981;10(4):337-41. [PM: 7032111]</P>
<P>     (7)   Afghani B, Ngo T, Leu SY, Wu FL, Cecilio M, Aron-Johnson P, et al. The effect of an interventional program on adherence to the american academy of pediatrics guidelines for palivizumab prophylaxis. Pediatric Infectious Disease Journal 2006 Nov;25(11):1019-24. [PM: 17072124]</P>
<P>     (8)   Aghaie-Jaladerany H, Cowell D, Geddes CC. The early impact of the United Kingdom Chronic Kidney Disease (CKD) guidelines on the number of new attendances at renal clinics. Scottish Medical Journal 2007 Nov;52(4):28-31. [PM: 18092634]</P>
<P>     (9)   Akers L, Gordon JS, Andrews JA, Barckley M, Lichtenstein E, Severson HH. Cost effectiveness of changing health professionals' behavior: training dental hygienists in brief interventions for smokeless tobacco cessation. Preventive Medicine 2006 Dec;43(6):482-7. [PM: 16920184]</P>
<P>    (10)   Al-Dabagh H, Archer J, Newton M, Kwagyan J, Nunlee-Bland G. Osteoporosis awareness protocol for patients with fragility fractures. Journal of the National Medical Association 2009 Feb;101(2):145-50. [PM: 19378631]</P>
<P>    (11)   Alerany C, Campany D, Monterde J, Semeraro C. Impact of local guidelines and an integrated dispensing system on antibiotic prophylaxis quality in a surgical centre. Journal of Hospital Infection 2005 Jun;60(2):111-7. [PM: 15866008]</P>
<P>    (12)   Amamra N, Touzet S, Colin C, Ponchon T. Impact of guidelines for endoscopy in patients with Barrett's esophagus: a multifaceted interventional study. Gastroenterologie Clinique et Biologique 2009 Jun;33(6-7):470-7. [PM: 19443156]</P>
<P>    (13)   Ammendolia C, Hogg-Johnson S, Pennick V, Glazier R, Bombardier C. Implementing evidence-based guidelines for radiography in acute low back pain: a pilot study in a chiropractic community. Journal of Manipulative &amp; Physiological Therapeutics 2004 Mar;27(3):170-9. [PM: 15129199]</P>
<P>    (14)   Ammerman A, Caggiula A, Elmer PJ, Kris-Etherton P, Keyserling T, Lewis C, et al. Putting medical practice guidelines into practice: the cholesterol model. American Journal of Preventive Medicine 1994 Jul;10(4):209-16. [PM: 7803063]</P>
<P>    (15)   Amodio-Groton M, Sinnett MJ, Culshaw D, Leviton IM. Antibiotic guidelines for community-acquired pneumonia: Are they effective and do physicians comply? Drug Benefit Trends 2003;15(8):40-6. [EM 2003371758]</P>
<P>    (16)   Anwar RM, Dhanji A, Fish A, Singh S. Impact of protocol-based guidelines on the management and outcome of acute upper gastrointestinal hemorrhage in a district general hospital. Canadian Journal of Gastroenterology 2003 Feb;17(2):97-100. [PM: 12605245]</P>
<P>    (17)   Applegate H, Kelley ML, Applegate BW, Jayasinghe IK, Venters CL. Clinical case study: pediatric residents' discussions of and interventions for children's behavioral and emotional problems. Journal of Pediatric Psychology 2003 Jul;28(5):315-21. [PM: 12808008]</P>
<P>    (18)   Arabi YM, Haddad S, Tamim HM, Al-Dawood A, Al-Qahtani S, Ferayan A, et al. Mortality reduction after implementing a clinical practice guidelines-based management protocol for severe traumatic brain injury. Journal of Critical Care 2010 Jun;25(2):190-5. [PM: 19592201]</P>
<P>    (19)   Arenas MD, Alvarez-Ude F, Gil MT, Moledous A, Malek T, Nunez C, et al. Implementation of 'K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease' after the introduction of cinacalcet in a population of patients on chronic haemodialysis. Nephrology Dialysis Transplantation 2007 Jun;22(6):1639-44. [PM: 17277339]</P>
<P>    (20)   Armon K, MacFaul R, Hemingway P, Werneke U, Stephenson T. The impact of presenting problem based guidelines for children with medical problems in an accident and emergency department. Archives of Disease in Childhood 2004 Feb;89(2):159-64. [PM: 14736635]</P>
<P>    (21)   Armstrong EP, Langley PC. The impact of a disease management intervention on the treatment of infectious disease in a managed care organization. Disease Management 1999;2(3):61-77. [EM 1999346560]</P>
<P>    (22)   Armstrong EP, Langley PC. Treatment of pneumonias in a managed care organisation. The impact of a treatment guideline promotion on physician prescribing behaviour. Disease Management and Health Outcomes 1999;6(3):159-73. [EM 1999334207]</P>
<P>    (23)   Armstrong EP. Clinical and economic outcomes of an ambulatory urinary tract infection disease management program. American Journal of Managed Care 2001 Mar;7(3):269-80. [PM: 11258144]</P>
<P>    (24)   Armstrong G, Blashki G, Joubert L, Bland R, Moulding R, Gunn J, et al. An evaluation of the effect of an educational intervention for Australian social workers on competence in delivering brief cognitive behavioural strategies: a randomised controlled trial. BMC Health Services Research 2010;10(304). [PM: 21050497]</P>
<P>    (25)   Asaro PV, Sheldahl AL, Char DM. Physician perspective on computerized order-sets with embedded guideline information in a commercial emergency department information system. Annual Symposium Proceedings 2005;6-10. [PM: 16778991]</P>
<P>    (26)   Assanasen S, Edmond M, Bearman G. Impact of 2 different levels of performance feedback on compliance with infection control process measures in 2 intensive care units. American Journal of Infection Control 2008 Aug;36(6):407-13. [PM: 18675146]</P>
<P>    (27)   Atkinson MH, Menard HA, Kalish GH. Assessment of salsalate, a nonacetylated salicylate, in the treatment of patients with arthritis. Clinical Therapeutics 1995 Sep;17(5):827-37. [PM: 8595635]</P>
<P>    (28)   Aubin M, Vezina L, Maziade J, Robitaille NM. Control of arterial hypertension: effectiveness of an intervention performed by family practitioners. Canadian Family Physician 1994 Oct;40:1742-52. [PM: 7950469]</P>
<P>    (29)   Aucott JN, Pelecanos E, Dombrowski R, Fuehrer SM, Laich J, Aron DC. Implementation of local guidelines for cost-effective management of hypertension. A trial of the firm system. Journal of General Internal Medicine 1996 Mar;11(3):139-46. [PM: 8667090]</P>
<P>    (30)   Auleley GR, Ravaud P, Giraudeau B, Kerboull L, Nizard R, Massin P, et al. Implementation of the Ottawa ankle rules in France. A multicenter randomized controlled trial. JAMA 1997 Jun 25;277(24):1935-9. [PM: 9200633]</P>
<P>    (31)   Avanzini F, Tognoni G, Alli C, Colombo F, Herxheimer A. How informed general practitioners manage mild hypertension: a survey of readers of drug bulletins in 7 countries. International Society of Drug Bulletins (ISDB). European Journal of Clinical Pharmacology 1996;49(6):445-50. [PM: 8706768]</P>
<P>    (32)   Avila-Aguero ML, Umana MA, Jimenez AL, Faingezicht I, Paris MM. Handwashing practices in a tertiary-care, pediatric hospital and the effect on an educational program. Clinical Performance &amp; Quality Health Care 1998 Apr;6(2):70-2. [PM: 10180124]</P>
<P>    (33)   Bahrami M, Deery C, Clarkson JE, Pitts NB, Johnston M, Ricketts I, et al. Effectiveness of strategies to disseminate and implement clinical guidelines for the management of impacted and unerupted third molars in primary dental care, a cluster randomised controlled trial. British Dental Journal 2004 Dec 11;197(11):691-6. [PM: 15592551]</P>
<P>    (34)   Bakemeier RF, Beck S, Murphy JR. Educational and consultative functions, topics, and methods of hospital general tumor conferences. Journal of Cancer Education 1995;9(4):217-25. [PM: 7734286]</P>
<P>    (35)   Baker JA, Lovell K, Harris N. The impact of a good practice manual on professional practice associated with psychotropic PRN in acute mental health wards: an exploratory study. International Journal of Nursing Studies 2008 Oct;45(10):1403-10. [PM: 18313059]</P>
<P>    (36)   Baker R, Reddish S, Robertson N, Hearnshaw H, Jones B. Randomised controlled trial of tailored strategies to implement guidelines for the management of patients with depression in general practice. British Journal of General Practice 2001 Sep;51(470):737-41. [PM: 11593835]</P>
<P>    (37)   Baker R, Falconer SJ, Lambert PC. Randomised controlled trial of the effectiveness of feedback in improving test ordering in general practice. Scandinavian Journal of Primary Health Care 2003 Dec;21(4):219-23. [PM: 14695072]</P>
<P>    (38)   Baker R, Fraser RC, Stone M, Lambert P, Stevenson K, Shiels C. Randomised controlled trial of the impact of guidelines, prioritized review criteria and feedback on implementation of recommendations for angina and asthma. British Journal of General Practice 2003 Apr;53(489):284-91. [PM: 12879828]</P>
<P>    (39)   Ballard PE. New pamphlet enables dentists to take offensive. Journal - Mississippi Dental Association 1973 Nov;29(4):-13. [PM: 4587132]</P>
<P>    (40)   Banait G, Sibbald B, Thompson D, Summerton C, Hann M, Talbot S, et al. Modifying dyspepsia management in primary care: a cluster randomised controlled trial of educational outreach compared with passive guideline dissemination. British Journal of General Practice 2003 Feb;53(487):94-100. [PM: 12817353]</P>
<P>    (41)   Bankole OO, Aderinokun GA, Denloye OO. Evaluation of a photo-poster on nurses' perceptions of teething problems in South-western Nigeria. Public Health 2005 Apr;119(4):276-82. [PM: 15733687]</P>
<P>    (42)   Barazzoni F, Grilli R, Amicosante AM, Brescianini S, Marca MA, Baggi M, et al. Impact of end user involvement in implementing guidelines on routine pre-operative tests. International Journal for Quality in Health Care 2002 Aug;14(4):321-7. [PM: 12201191]</P>
<P>    (43)   Barner CW, Wylle-Rosett J, Gans K. WAVE: a pocket guide for a brief nutrition dialogue in primary care. Diabetes Educator 2001 May;27(3):352-8. [PM: 11912796]</P>
<P>    (44)   Barnes K, Itzkowitz S, Brown K. Teaching clinical management skills for genetic testing of hereditary nonpolyposis colorectal cancer using a Web-based tutorial. Genetics in Medicine 2003 Jan;5(1):43-8. [PM: 12544475]</P>
<P>    (45)   Barnes S. Preparing for surgery: providing the details. Journal of PeriAnesthesia Nursing 2001 Feb;16(1):31-2. [PM: 11266642]</P>
<P>    (46)   Barry HC, Ebell MH, Shaughnessy AF, Slawson DC, Nietzke F. Family physicians' use of medical abstracts to guide decision making: style or substance? Journal of the American Board of Family Practice 2001 Nov;14(6):437-42. [PM: 11757886]</P>
<P>    (47)   Bartholomew LK, Cushman WC, Cutler JA, Davis BR, Dawson G, Einhorn PT, et al. Getting clinical trial results into practice: design, implementation, and process evaluation of the ALLHAT Dissemination Project. Clinical Trials 2009 Aug;6(4):329-43. [PM: 19587068]</P>
<P>    (48)   Baskin C, Seetharamu N, Mazure B, Vassallo L, Steinberg H, Kerpen H, et al. Effect of a CD-ROM-based educational intervention on resident knowledge and adherence to deep venous thrombosis prophylaxis guidelines. Journal of Hospital Medicine (Online) 2008 Jan;3(1):42-7. [PM: 18257045]</P>
<P>    (49)   Beaulieu MD, Rivard M, Hudon E, Beaudoin C, Saucier D, Remondin M. Comparative trial of a short workshop designed to enhance appropriate use of screening tests by family physicians. CMAJ Canadian Medical Association Journal 2002 Nov 26;167(11):1241-6. [PM: 12451077]</P>
<P>    (50)   Becker A, Leonhardt C, Kochen MM, Keller S, Wegscheider K, Baum E, et al. Effects of two guideline implementation strategies on patient outcomes in primary care: a cluster randomized controlled trial. Spine 2008 Mar 1;33(5):473-80. [PM: 18317189]</P>
<P>    (51)   Bedlow AJ, Cliff S, Melia J, Moss SM, Seyan R, Harland CC. Impact of skin cancer education on general practitioners' diagnostic skills. Clinical &amp; Experimental Dermatology 2000 Mar;25(2):115-8. [PM: 10733633]</P>
<P>    (52)   Beilby J, Wutzke SE, Bowman J, Mackson JM, Weekes LM. Evaluation of a national quality use of medicines service in Australia: an evolving model. Journal of Evaluation in Clinical Practice 2006 Apr;12(2):202-17. [PM: 16579830]</P>
<P>    (53)   Bekkering GE HHTvKMKDORBL. Effectiveness of an active intervention strategy for the implementation of the Dutch physiotherapy guideline on low back pain. Nederlands Tijdschrift Fysiotherapie 2005;115(3):62-7.</P>
<P>    (54)   Bekkering GE, Hendriks HJ, van Tulder MW, Knol DL, Hoeijenbos M, Oostendorp RA, et al. Effect on the process of care of an active strategy to implement clinical guidelines on physiotherapy for low back pain: a cluster randomised controlled trial. Quality &amp; Safety in Health Care 2005 Apr;14(2):107-12. [PM: 15805455]</P>
<P>    (55)   Bekkering GE, van Tulder MW, Hendriks EJ, Koopmanschap MA, Knol DL, Bouter LM, et al. Implementation of clinical guidelines on physical therapy for patients with low back pain: randomized trial comparing patient outcomes after a standard and active implementation strategy. Physical Therapy 2005 Jun;85(6):544-55. [PM: 15921475]</P>
<P>    (56)   Bell DS, Fonarow GC, Hays RD, Mangione CM. Self-study from web-based and printed guideline materials. A randomized, controlled trial among resident physicians. Annals of Internal Medicine 2000 Jun 20;132(12):938-46. [PM: 10858176]</P>
<P>    (57)   Bellavance M, Rohlicek CV, Bigras JL, Cote JM, Paquet M, Lebel MH, et al. Palivizumab use among children with congenital heart disease in Quebec: Impact of Canadian guidelines on clinical practice. Paediatrics &amp; Child Health 2006 Jan;11(1):19-23. [PM: 19030237]</P>
<P>    (58)   Belongia EA, Knobloch MJ, Kieke BA, Davis JP, Janette C, Besser RE. Impact of statewide program to promote appropriate antimicrobial drug use. Emerging Infectious Diseases 2005 Jun;11(6):912-20. [PM: 15963287]</P>
<P>    (59)   Benhamou D, Gross E, Brosseau M. Blood transfusion in adults: description of a quality assurance program. Annales Francaises d Anesthesie et de Reanimation 2001 Jan;20(1):57-69. [PM: 11234582]</P>
<P>    (60)   Benjamin EM, Schneider MS, Hinchey KT. Implementing practice guidelines for diabetes care using problem-based learning. A prospective controlled trial using firm systems. Diabetes Care 1999 Oct;22(10):1672-8. [PM: 10526733]</P>
<P>    (61)   Beno L, Hinchman J, Kibbe D, Trowbridge F. Design and implementation of training to improve management of pediatric overweight. Journal of Continuing Education in the Health Professions 2005;25(4):248-58. [PM: 16365897]</P>
<P>    (62)   Bernal-Delgado E, Galeote-Mayor M, Pradas-Arnal F, Peiro-Moreno S. Evidence based educational outreach visits: effects on prescriptions of non-steroidal anti-inflammatory drugs. Journal of Epidemiology &amp; Community Health 2002 Sep;56(9):653-8. [PM: 12177080]</P>
<P>    (63)   Berti A, Bregani ER, Manenti F, Pizzi C. Outcome of severely malnourished children treated according to UNICEF 2004 guidelines: a one-year experience in a zone hospital in rural Ethiopia. Transactions of the Royal Society of Tropical Medicine &amp; Hygiene 2008 Sep;102(9):939-44. [PM: 18597802]</P>
<P>    (64)   Bertoni AG, Bonds DE, Chen H, Hogan P, Crago L, Rosenberger E, et al. Impact of a multifaceted intervention on cholesterol management in primary care practices: guideline adherence for heart health randomized trial. Archives of Internal Medicine 2009 Apr 13;169(7):678-86. [PM: 19364997]</P>
<P>    (65)   Bertsche T, Bertsche A, Krieg EM, Kunz N, Bergmann K, Hanke G, et al. Prospective pilot intervention study to prevent medication errors in drugs administered to children by mouth or gastric tube: a programme for nurses, physicians and parents. Quality &amp; Safety in Health Care 2010 Oct;19(5):e26. [PM: 20378618]</P>
<P>    (66)   Bialasiewicz AA, Breidenbach K, Ganesh A, Al-Saeidi R, Ganguly SS, International Standards Organization. Conceiving and implementing an ISO 9001:2000 quality management system: quality improvement and efficiency increase over 3 years at the Dept. of Ophthalmology, Sultan Qaboos University in Oman. Ophthalmologe 2006 Oct;103(10):877-87. [PM: 16821074]</P>
<P>    (67)   Bialasiewicz AA, Breidenbach K, Ganesh A, Al-Saeidi R, Ganguly SS. Conceiving and implementing an ISO 9001:2000 quality management system. Quality improvement and efficiency increase over 3 years at the Dept. of Ophthalmology, Sultan Qaboos University in Oman. Ophthalmologe 2006;103(10):877-87. [EM 2006521136]</P>
<P>    (68)   Biermann M, Pixberg MK, Dorr U, Dietlein M, Schlemmer H, Grimm J, et al. Guidelines on radioiodine therapy for differentiated thyroid carcinoma: impact on clinical practice. Nuclear-Medizin 2005;44(6):229-34. [PM: 16400382]</P>
<P>    (69)   Billi JE, Duran-Arenas L, Wise CG, Bernard AM, McQuillan M, Stross JK. The effects of a low-cost intervention program on hospital costs. Journal of General Internal Medicine 1992 Jul;7(4):411-7. [PM: 1506947]</P>
<P>    (70)   Billings JA, Keeley A, Bauman J, Cist A, Coakley E, Dahlin C, et al. Merging cultures: palliative care specialists in the medical intensive care unit. Critical Care Medicine 2006 Nov;34(Suppl):S388-93. [PM: 17057603]</P>
<P>    (71)   Bingham C, Costenbader K, Bender S, Duch D, Weinblatt M. Educating primary care providers on rheumatoid arthritis translates to changes in practice and referrals: Results from the RAPID continuing medical education program [Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 10 Philadelphia, PA United States]. Arthritis and Rheumatism 2010. [EM 70380806]</P>
<P>    (72)   Bishop PB, Quon JA, Fisher CG, Dvorak MF. The Chiropractic Hospital-based Interventions Research Outcomes (CHIRO) study: a randomized controlled trial on the effectiveness of clinical practice guidelines in the medical and chiropractic management of patients with acute mechanical low back pain. Spine Journal 2010 Dec;10(12):1055-64. [PM: 20889389]</P>
<P>    (73)   Bittenbender P, Nortier N, O'Brien C, Oosterheert J, Smoes J. Emergencies happen, MERTs to the rescue! NASN school nurse 2009 Nov;24(6):268-78. [PM: 20440943]</P>
<P>    (74)   Bjerrum L, Munck A, Gahrn-Hansen B, Hansen MP, Jarboel D, Llor C, et al. Health Alliance for Prudent Prescribing, Yield and Use of Antimicrobial Drugs in the Treatment of Respiratory Tract Infections (HAPPY AUDIT). BMC Family Practice 2010;11(29). [PM: 20416034]</P>
<P>    (75)   Black RE. Communication for improved health services. Development Communication Report 1985;(51):1-2. [PM: 12340537]</P>
<P>    (76)   Blais R, Laurier C, Pare M. Effect of feedback letters to physicians and pharmacists on the appropriate use of medication in the treatment of asthma. Journal of Asthma 2008 Apr;45(3):227-31. [PM: 18415831]</P>
<P>    (77)   Bland DR, Dugan E, Cohen SJ, Preisser J, Davis CC, McGann PE, et al. The effects of implementation of the Agency for Health Care Policy and Research urinary incontinence guidelines in primary care practices. Journal of the American Geriatrics Society 2003 Jul;51(7):979-84. [PM: 12834518]</P>
<P>    (78)   Blauer C, Schierz-Hungerbuhler J, Trachsel E, Spirig R, Frei IA. A nurse-led multidisciplinary malnutrition program to assess and treat patients with malnutrition or those at risk of malnutrition. Pflege 2008 Aug;21(4):225-34. [PM: 18677686]</P>
<P>    (79)   Bleakney GM, McErlain S. Infant feeding guidelines: An evaluation of their effect on health professionals' knowledge and attitudes. Journal of Human Nutrition and Dietetics 1996;9(6):437-50. [EM 1997041598]</P>
<P>    (80)   Block PC. Achieving effective cardiac care. ACC Current Journal Review 2004;13(7):16-7. [EM 2004400227]</P>
<P>    (81)   Bobbio M, Malavasi P, Negri G, Salera M, Sapigni E, Carossino P, et al. The role of public health pharmacists in promoting information on benefits and risks of drugs: Evaluation of the impact of a new information strategy for primary care groups. Giornale Italiano di Farmacia Clinica 2011;25(1):12-24. [EM 2011282726]</P>
<P>    (82)   Boddy J, Lai N, Lynch C, Shahzad SA, Doherty AP, Wallace DMA, et al. The role of active surveillance in the management of early prostate cancer and the impact of the NICE guidelines. British Journal of Medical and Surgical Urology 2010;3(3):101-5. [EM 2010208033]</P>
<P>    (83)   Bolon MK, Arnold AD, Feldman HA, Goldmann DA, Wright SB. An antibiotic order form intervention does not improve or reduce vancomycin use. Pediatric Infectious Disease Journal 2005 Dec;24(12):1053-8. [PM: 16371865]</P>
<P>    (84)   Bonetti D, Johnston M, Pitts NB, Deery C, Ricketts I, Bahrami M, et al. Can psychological models bridge the gap between clinical guidelines and clinicians' behaviour? A randomised controlled trial of an intervention to influence dentists' intention to implement evidence-based practice. British Dental Journal 2003 Oct 11;195(7):403-7. [PM: 14551633]</P>
<P>    (85)   Bonner A, MacCulloch P, Gardner T, Chase CW. A student-led demonstration project on fall prevention in a long-term care facility. Geriatric Nursing 2007 Sep;28(5):312-8. [PM: 17923288]</P>
<P>    (86)   Bonson M, Phillips A. Designing and implementing an intravenous therapy book. Nursing Times 2006 Jul 18;102(29):34-5. [PM: 16895248]</P>
<P>    (87)   Boolchand V, Olds G, Singh J, Singh P, Chak A, Cooper GS. Colorectal screening after polypectomy: a national survey study of primary care physicians. Annals of Internal Medicine 2006 Nov 7;145(9):654-9. [PM: 17088578]</P>
<P>    (88)   Boonmak P, Boonmak S, Srichaipanha S, Poomsawat S. Knowledge and skill after brief ACLS training. Journal of the Medical Association of Thailand 2004 Nov;87(11):1311-4. [PM: 15825705]</P>
<P>    (89)   Boonstra E, Lindbaek M, Khulumani P, Ngome E, Fugelli P. Adherence to treatment guidelines in primary health care facilities in Botswana. Tropical Medicine &amp; International Health 2002 Feb;7(2):178-86. [PM: 11841708]</P>
<P>    (90)   Boonstra E, Lindbaek M, Ngome E. Adherence to management guidelines in acute respiratory infections and diarrhoea in children under 5 years old in primary health care in Botswana. International Journal for Quality in Health Care 2005 Jun;17(3):221-7. [PM: 15723818]</P>
<P>    (91)   Borntrager CF, Chorpita BF, Higa-McMillan C, Weisz JR. Provider attitudes toward evidence-based practices: are the concerns with the evidence or with the manuals? Psychiatric Services 2009 May;60(5):677-81. [PM: 19411357]</P>
<P>    (92)   Botash AS, Galloway AE, Booth T, Ploutz-Snyder R, Hoffman-Rosenfeld J, Cahill L. Continuing medical education in child sexual abuse: cognitive gains but not expertise. Archives of Pediatrics &amp; Adolescent Medicine 2005 Jun;159(6):561-6. [PM: 15939856]</P>
<P>    (93)   Boufous S, Kelleher PW, Pain CH, Dann LM, Ieraci S, Jalaludin BB, et al. Impact of a chest-pain guideline on clinical decision-making. Medical Journal of Australia 2003 Apr 21;178(8):375-80. [PM: 12697008]</P>
<P>    (94)   Bould MD, Hayter MA, Campbell D, Chandra D, Joo HS, Naik V. A cognitive aid for neonatal resuscitation: A randomized controlled trial [Conference 2009 CAS Annual Meeting Vancouver, BC Canada]. Canadian Journal of Anesthesia 2009;56:s16. [EM 70078698]</P>
<P>    (95)   Bould MD, Hayter MA, Campbell DM, Chandra DB, Joo HS, Naik VN. Cognitive aid for neonatal resuscitation: a prospective single-blinded randomized controlled trial. British Journal of Anaesthesia 2009 Oct;103(4):570-5. [PM: 19689979]</P>
<P>    (96)   Boursnell M, Prosser S. Putting children in the picture: improving responses to domestic violence in the emergency department. DEVELOPING PRACT 2001;(23):56-63.</P>
<P>    (97)   Bowman MA, Russell NK, Boekeloo BO, Rafi IZ, Rabin DL. The effect of educational preparation on physician performance with a sexually transmitted disease-simulated patient. Archives of Internal Medicine 1992 Sep;152(9):1823-8. [PM: 1520049]</P>
<P>    (98)   Bradley WG, Anderson F, Gowda N, Miller RG, ALS CARE Study Group. Changes in the management of ALS since the publication of the AAN ALS practice parameter 1999. Amyotrophic Lateral Sclerosis &amp; Other Motor Neuron Disorders 2004 Dec;5(4):240-4. [PM: 15799554]</P>
<P>    (99)   Branch C, Kolovetsios T, Apampa B, Ndawula E. Compliance with prophylactic antibiotic guidelines during elective orthopaedic surgery in a foundation trust hospital: An audit [Conference: British Pharmaceutical Conference 2009 Manchester United Kingdom]. International Journal of Pharmacy Practice 2009;17(S2):B56-7. [EM 70139969]</P>
<P>  (100)   Brattebo G, Hofoss D, Flaatten H, Muri AK, Gjerde S, Plsek PE. Effect of a scoring system and protocol for sedation on duration of patients' need for ventilator support in a surgical intensive care unit. BMJ 2002 Jun 8;324(7350):1386-9. [PM: 12052813]</P>
<P>  (101)   Brimmer DJ, McCleary KK, Lupton TA, Faryna KM, Reeves WC. Continuing medical education challenges in chronic fatigue syndrome. BMC Medical Education 2009;9(70). [PM: 19954535]</P>
<P>  (102)   Britto MT, Schoettker PJ, Pandzik GM, Weiland J, Mandel KE. Improving influenza immunisation for high-risk children and adolescents. Quality &amp; Safety in Health Care 2007 Oct;16(5):363-8. [PM: 17913778]</P>
<P>  (103)   Brown JB, Shye D, McFarland BH, Nichols GA, Mullooly JP, Johnson RE. Controlled trials of CQI and academic detailing to implement a clinical practice guideline for depression. Joint Commission Journal on Quality Improvement 2000 Jan;26(1):39-54. [PM: 10677821]</P>
<P>  (104)   Brown R, Bratton SL, Cabana MD, Kaciroti N, Clark NM. Physician asthma education program improves outcomes for children of low-income families. Chest 2004 Aug;126(2):369-74. [PM: 15302719]</P>
<P>  (105)   Buchan H, Lourey E, D'Este C, Sanson-Fisher R. Effectiveness of strategies to encourage general practitioners to accept an offer of free access to online evidence-based information: a randomised controlled trial. Implementation Science 2009;4(68). [PM: 19840400]</P>
<P>  (106)   Buckley C, Sharrard H. Lithium monitoring for patients with learning disability: The role of the general practitioner. Quality in Primary Care 2003;11(4):329-31. [EM 2004017977]</P>
<P>  (107)   Burke SM. Creating competency for home healthcare. Case management manual: a work-in-progress. Home Healthcare Nurse Manager 1999 Nov;3(6):2-7. [PM: 10876502]</P>
<P>  (108)   Button D, Roe B, Webb C, Frith T, Colin-Thome D, Gardner L. Consensus guidelines for the promotion and management of continence by primary health care teams: development, implementation and evaluation. NHS Executive Nursing Directorate. J ADV NURS 1998 Jan;27(1):91-9. [PM: 9515613]</P>
<P>  (109)   Callegari S, Pini M, Andreoli L. Guidelines and clinical practice: anticoagulant therapy and cardioversion in atrial fibrillation. Giornale Italiano di Cardiologia 1999 Oct;29(10):1157-63. [PM: 10546125]</P>
<P>  (110)   Callen J, Georgiou A, Prgomet M, Paoloni R, Westbrook J. A qualitative analysis of Emergency Department physicians' practices and perceptions in relation to test result follow-up. Studies in Health Technology &amp; Informatics 2010;160(Pt 2):1241-5. [PM: 20841882]</P>
<P>  (111)   Calvo CB, Rubinstein A. Influence of new evidence on prescription patterns. Journal of the American Board of Family Practice 2002 Nov;15(6):457-62. [PM: 12463291]</P>
<P>  (112)   Campina CS, Neto M, Trindade M. Beta-lactam hypersensitivity: from guidelines to daily practice. Journal of Investigational Allergology &amp; Clinical Immunology 2010;20(2):175-6. [PM: 20461978]</P>
<P>  (113)   Campione JR, Sleath B, Biddle AK, Weinberger M. The influence of physicians' guideline compliance on patients' statin adherence: a retrospective cohort study. American Journal of Geriatric Pharmacotherapy 2005 Dec;3(4):229-39. [PM: 16503318]</P>
<P>  (114)   Caniza MA, Maron G, Moore EJ, Quintana Y, Liu T. Effective hand hygiene education with the use of flipcharts in a hospital in El Salvador. Journal of Hospital Infection 2007 Jan;65(1):58-64. [PM: 17147972]</P>
<P>  (115)   Cannon DS, Allen SN. A comparison of the effects of computer and manual reminders on compliance with a mental health clinical practice guideline. Journal of the American Medical Informatics Association 2000 Mar;7(2):196-203. [PM: 10730603]</P>
<P>  (116)   Cauffman JG, Forsyth RA, Clark VA, Foster JP, Martin KJ, Lapsys FX, et al. Randomized controlled trials of continuing medical education: what makes them most effective? Journal of Continuing Education in the Health Professions 2002;22(4):214-21. [PM: 12613056]</P>
<P>  (117)   Cave MT, Clandinin DJ. Revisiting the journal club. Medical Teacher 2007 May;29(4):365-70. [PM: 17786752]</P>
<P>  (118)   Cayten CG, Staroscik R, Walker K, Morganroth J, Oler J. Impact of prehospital cardiac algorithms on ventricular fibrillation survival rates. Annals of Emergency Medicine 1981 Aug;10(8):432-6. [PM: 7258758]</P>
<P>  (119)   Chalmers J. Implementation of guidelines for management of hypertension. Clinical &amp; Experimental Hypertension (New York) 1999 Jul;21(5-6):647-57. [PM: 10423089]</P>
<P>  (120)   Chan JK, Sleat G, Sharma S, Phoenix G, Graham A. Gastroprotection in trauma patients receiving non-steroidal anti-inflammatory drugs. Surgeon Journal of the Royal Colleges of Surgeons of Edinburgh &amp; Ireland 2010 Aug;8(4):206-10. [PM: 20569940]</P>
<P>  (121)   Cheater FM, Baker R, Reddish S, Spiers N, Wailoo A, Gillies C, et al. Cluster randomized controlled trial of the effectiveness of audit and feedback and educational outreach on improving nursing practice and patient outcomes. Medical Care 2006 Jun;44(6):542-51. [PM: 16708003]</P>
<P>  (122)   Cheng C, Umland E. Practical therapeutics: an innovative residency drug education curriculum. Family Medicine 2004 Apr;36(4):236-8. [PM: 15057610]</P>
<P>  (123)   Cheng G, Wong HF, Chan A, Chui CH. The effects of a self-educating blood component request form and enforcements of transfusion guidelines on FFP and platelet usage. Queen Mary Hospital, Hong Kong. British Committee for Standards in Hematology (BCSH). Clinical &amp; Laboratory Haematology 1996 Jun;18(2):83-7. [PM: 8866139]</P>
<P>  (124)   Chevalier C, Giral P, Oger C, Costedoat-Rouchet G, Carzon M, Trutt B. Changes in biological test practices after publication of national guidelines for lipid management among patients under statin treatment. Revue d Epidemiologie et de Sante Publique 2005 Sep;53(4):393-7. [PM: 16353514]</P>
<P>  (125)   Chitre MM, Hayes W. 3-year results of a member and physician intervention to reduce risk associated with glucocorticoid-induced osteoporosis in a health plan. Journal of Managed Care Pharmacy 2008 Apr;14(3):281-90. [PM: 18439050]</P>
<P>  (126)   Chowdhury AK, Khan OF, Matin MA, Begum K, Galib MA. Effect of standard treatment guidelines with or without prescription audit on prescribing for acute respiratory tract infection (ARI) and diarrhoea in some thana health complexes (THCs) of Bangladesh. Bangladesh Medical Research Council Bulletin 2007 Apr;33(1):21-30. [PM: 18246731]</P>
<P>  (127)   Coenen S, Dirven K, Michiels B, Denekens J, Van RP. Implementing a clinical practice guideline on acute cough in general practice: a Belgian experience with academic detailing. Medecine et Maladies Infectieuses 2005 Jun;35(Suppl 2):S97-9. [PM: 15978401]</P>
<P>  (128)   Cohen SM, Kataoka-Yahiro M. Provider adherence to clinical guidelines related to lipid-lowering medications. Military Medicine 2010 Feb;175(2):122-6. [PM: 20180482]</P>
<P>  (129)   Cole S, Raju M, Barrett J, Gerrity M, Dietrich A. The MacArthur Foundation Depression Education Program for Primary Care Physicians: background and rationale. General Hospital Psychiatry 2000 Sep;22(5):299-358. [PM: 11203035]</P>
<P>  (130)   Coleman CI, Reddy P, Laster-Bradley NM, Dorval S, Munagala B, White CM. Effect of practitioner education on adherence to asthma treatment guidelines. Annals of Pharmacotherapy 2003 Jul;37(7-8):956-61. [PM: 12841800]</P>
<P>  (131)   Coleman EA, Lord J, Heard J, Coon S, Cantrell M, Mohrmann C, et al. The Delta project: increasing breast cancer screening among rural minority and older women by targeting rural healthcare providers. ONCOL NURS FORUM 2003 Jul;30(4):669-77. [PM: 12861326]</P>
<P>  (132)   Coll-Vinent B, Pacheco G, Junyent M, Benito L, Hoyo J, Garcia A, et al. Impact of implementing common guidelines at different care levels in a healthcare area on the improvement of atrial fibrillation treatment. Revista Espanola de Cardiologia 2007 Apr;60(4):392-403. [PM: 17521548]</P>
<P>  (133)   Comer JB, Emanuelsen KL, Drezner AD, Knauft RF. Developing guidelines for thrombolytic therapy. American Journal of Hospital Pharmacy 1984 Nov;41(11):2374-7. [PM: 6548871]</P>
<P>  (134)   Concato J, Horwitz RI. Clinical practice guidelines and scientific evidence. JAMA 2009 Jul 8;302(2):145-7. [PM: 19584341]</P>
<P>  (135)   Cook DA, Dupras DM, Thompson WG, Pankratz VS. Web-based learning in residents' continuity clinics: a randomized, controlled trial. Academic Medicine 2005 Jan;80(1):90-7. [PM: 15618102]</P>
<P>  (136)   Cooke M, Mattick RP, Walsh RA. Differential uptake of a smoking cessation programme disseminated to doctors and midwives in antenatal clinics. Addiction 2001 Mar;96(3):495-505. [PM: 11255588]</P>
<P>  (137)   Cosmi E, Bevilacqua G, Maranghi L, Anceschi MM. The policy of antenatal corticosteroid administration in Italy vs. other European countries. Journal of Maternal-Fetal &amp; Neonatal Medicine 2004 Nov;16(Suppl 2):1-3. [PM: 15590424]</P>
<P>  (138)   Costa A, Santos C, Ayres-de-Campos D, Costa C, Bernardes J. Access to computerised analysis of intrapartum cardiotocographs improves clinicians' prediction of newborn umbilical artery blood pH. BJOG: An International Journal of Obstetrics &amp; Gynaecology 2010 Sep;117(10):1288-93. [PM: 20618316]</P>
<P>  (139)   Couturier J, Isserlin L, Lock J. Family-based treatment for adolescents with anorexia nervosa: a dissemination study. Brunner-Mazel Eating Disorders Monograph Series 2010 May;18(3):199-209. [PM: 20419524]</P>
<P>  (140)   Couzigou C, Lamory J, Salmon-Ceron D, Figard J, Vidal-Trecan GM. Short peripheral venous catheters: effect of evidence-based guidelines on insertion, maintenance and outcomes in a university hospital. Journal of Hospital Infection 2005 Mar;59(3):197-204. [PM: 15694976]</P>
<P>  (141)   Cowin L, Davies R, Estall G, Berlin T, Fitzgerald M, Hoot S. De-escalating aggression and violence in the mental health setting. International Journal of Mental Health Nursing 2003 Mar;12(1):64-73. [PM: 14685961]</P>
<P>  (142)   Creedon SA. Healthcare workers' hand decontamination practices: compliance with recommended guidelines. J ADV NURS 2005 Aug;51(3):208-16. [PM: 16033588]</P>
<P>  (143)   Creedon SA. Health care workers' hand decontamination practices: an Irish study. Clinical Nursing Research 2006 Feb;15(1):6-26. [PM: 16410620]</P>
<P>  (144)   Crits-Christoph P, Gibbons MB, Ring-Kurtz S, Gallop R, Present J. A pilot study of community-friendly manual-guided drug counseling. Journal of Substance Abuse Treatment 2009 Jul;37(1):8-16. [PM: 19038525]</P>
<P>  (145)   Croudace T, Evans J, Harrison G, Sharp DJ, Wilkinson E, McCann G, et al. Impact of the ICD-10 Primary Health Care (PHC) diagnostic and management guidelines for mental disorders on detection and outcome in primary care. Cluster randomised controlled trial. British Journal of Psychiatry 2003 Jan;182:20-30. [PM: 12509314]</P>
<P>  (146)   Cullen W, Stanley J, Langton D, Kelly Y, Staines A, Bury G. Hepatitis C infection among injecting drug users in general practice: a cluster randomised controlled trial of clinical guidelines' implementation. British Journal of General Practice 2006 Nov;56(532):848-56. [PM: 17132352]</P>
<P>  (147)   Cummings SR, Richard RJ, Duncan CL, Hansen B, Vander MR, Gerbert B, et al. Training physicians about smoking cessation: a controlled trial in private practice. Journal of General Internal Medicine 1989 Nov;4(6):482-9. [PM: 2685206]</P>
<P>  (148)   Cummings SR, Coates TJ, Richard RJ, Hansen B, Zahnd EG, VanderMartin R, et al. Training physicians in counseling about smoking cessation. A randomized trial of the "Quit for Life" program. Annals of Internal Medicine 1989 Apr 15;110(8):640-7. [PM: 2930094]</P>
<P>  (149)   Cunningham CM, Hanley GE, Morgan S. Patterns in the use of benzodiazepines in British Columbia: examining the impact of increasing research and guideline cautions against long-term use. Health Policy 2010 Oct;97(2-3):122-9. [PM: 20413177]</P>
<P>  (150)   Currie JD, Chrischilles EA, Kuehl AK, Buser RA. Effect of a training program on community pharmacists' detection of and intervention in drug-related problems. Journal of the American Pharmaceutical Association 1997 Mar;NS37(2):182-91. [PM: 9069692]</P>
<P>  (151)   D'Escrivan T, Lemaire JS, Ivanov E, Boulo M, Soubrier S, Mille FX, et al. Surgical antimicrobial prophylaxis: compliance to guidelines and impact of targeted information program. Annales Francaises d Anesthesie et de Reanimation 2005 Jan;24(1):19-23. [PM: 15661460]</P>
<P>  (152)   Dancey JE. From quality of publication to quality of care: translating trials to practice. Journal of the National Cancer Institute 2010 May 19;102(10):670-1. [PM: 20410467]</P>
<P>  (153)   Danchaivijitr S, Pichiensatian W, Apisarnthanarak A, Kachintorn K, Cherdrungsi R. Strategies to improve hand hygiene practices in two university hospitals. Journal of the Medical Association of Thailand 2005 Dec;88(Suppl 10):S155-60. [PM: 16850662]</P>
<P>  (154)   Danhauer JL, Johnson CE, Rotan SN, Snelson TA, Stockwell JS. National survey of pediatricians' opinions about and practices for acute otitis media and xylitol use. Journal of the American Academy of Audiology 2010 May;21(5):329-46. [PM: 20569667]</P>
<P>  (155)   Dartnell JG, Allen B, McGrath KM, Moulds RF. Prescriber guidelines improve initiation of anticoagulation. Medical Journal of Australia 1995 Jan 16;162(2):70-3. [PM: 7530800]</P>
<P>  (156)   David A, Banerjee S. Effectiveness of "palliative care information booklet" in enhancing nurses' knowledge. Indian Journal of Palliative Care 2010 Sep;16(3):164-7. [PM: 21218007]</P>
<P>  (157)   Davies J, Hillman E. Eczema and prescribing. Community Practitioner 2008 Oct;81(10):36-7. [PM: 18853887]</P>
<P>  (158)   Davis D, Galbraith R, American College of Chest Physicians Health and Science Policy Committee. Continuing medical education effect on practice performance: effectiveness of continuing medical education: American College of Chest Physicians Evidence-Based Educational Guidelines. Chest 2009 Mar;135(Suppl 3):42S-8S. [PM: 19265075]</P>
<P>  (159)   Davis J, Roberts R, Davidson DL, Norman A, Ogston S, Grimshaw JM, et al. Implementation strategies for a Scottish national epilepsy guideline in primary care: results of the Tayside Implementation of Guidelines in Epilepsy Randomized (TIGER) trial. Epilepsia 2004 Jan;45(1):28-34. [PM: 14692904]</P>
<P>  (160)   De SG, Harvey KJ, Howard D, Mashford ML, Moulds RF. Improving the quality of antibiotic prescription patterns in general practice. The role of educational intervention. Medical Journal of Australia 1994 Apr 18;160(8):502-5. [PM: 8170427]</P>
<P>  (161)   de VW, Schelvis M, Rustemeijer I, Bierens JJ. Self-training in the use of automated external defibrillators: the same results for less money. Resuscitation 2008 Jan;76(1):76-82. [PM: 17714851]</P>
<P>  (162)   Demoly P, Concas V, Urbinelli R, Allaert FA. Spreading and impact of the World Health Organization's Allergic Rhinitis and its impact on asthma guidelines in everyday medical practice in France. Ernani survey. Clinical &amp; Experimental Allergy 2008 Nov;38(11):1803-7. [PM: 18721255]</P>
<P>  (163)   Dempsey J. Falls prevention revisited: a call for a new approach. Journal of Clinical Nursing 2004 May;13(4):479-85. [PM: 15086634]</P>
<P>  (164)   Denoeud L, Mazieres B, Payen-Champenois C, Ravaud P. First line treatment of knee osteoarthritis in outpatients in France: adherence to the EULAR 2000 recommendations and factors influencing adherence. Annals of the Rheumatic Diseases 2005 Jan;64(1):70-4. [PM: 15608302]</P>
<P>  (165)   Deuster S, Roten I, Muehlebach S. Implementation of treatment guidelines to support judicious use of antibiotic therapy. Journal of Clinical Pharmacy &amp; Therapeutics 2010 Feb;35(1):71-8. [PM: 20175814]</P>
<P>  (166)   Devine SG, Harrison SL, Buettner PG. Building capacity of maternity staff to discourage the use of sunlight therapy in the post-partum period and infancy. Women &amp; Birth: Journal of the Australian College of Midwives 2008 Sep;21(3):107-11. [PM: 18653392]</P>
<P>  (167)   Devlin JW, Holbrook AM, Fuller HD. The effect of ICU sedation guidelines and pharmacist interventions on clinical outcomes and drug cost. Annals of Pharmacotherapy 1997 Jun;31(6):689-95. [PM: 9184706]</P>
<P>  (168)   Dewar B, Tocher R, Watson W. Enhancing partnerships with relatives in care settings. Nursing Standard 2003 Jun 18;17(40):33-9. [PM: 12854194]</P>
<P>  (169)   Dey P, Simpson CW, Collins SI, Hodgson G, Dowrick CF, Simison AJ, et al. Implementation of RCGP guidelines for acute low back pain: a cluster randomised controlled trial. British Journal of General Practice 2004 Jan;54(498):33-7. [PM: 14965404]</P>
<P>  (170)   Dheda K, Crawford A, Hagan G, Roberts CM. Implementation of British Thoracic Society guidelines for acute exacerbation of chronic obstructive pulmonary disease: impact on quality of life. Postgraduate Medical Journal 2004 Mar;80(941):169-71. [PM: 15016940]</P>
<P>  (171)   Di Spiezio SA, Spinelli M, Sosa Fernandez LM, Scognamiglio M, Lisbino M, Cirillo P, et al. Comparison of textbook versus educational video for training in office operative hysteroscopy: A randomized, controlled trial [Conference: 19th Annual Congress of the European Society for Gynaecological Endoscopy, ESGE Barcelona Spain]. Gynecological Surgery 2010;7:S46-S47. [EM 70299246]</P>
<P>  (172)   di MP, Ban KM, Bartoloni A, Fowler KE, Saint S, Mannelli F. Assessing the sustainability of hand hygiene adherence prior to patient contact in the emergency department: A 1-year postintervention evaluation. American Journal of Infection Control 2011 Feb;39(1):14-8. [PM: 20965610]</P>
<P>  (173)   Dickerson M. Mandatory educational programs: a decentralized approach. Journal of Nursing Staff Development 1987;3(2):84-6. [PM: 3647109]</P>
<P>  (174)   Didomenico RJ, Perez A, Schumann HM, Fontana DR, Kondos GT, Schumock GT. Impact of treatment guidelines on clinical and economic outcomes of acute decompensated heart failure. Annals of Pharmacotherapy 2008 Mar;42(3):327-33. [PM: 18303142]</P>
<P>  (175)   Dietrich AJ, Olson AL, Sox CH, Winchell CW, Grant-Petersson J, Collison DW. Sun protection counseling for children: primary care practice patterns and effect of an intervention on clinicians. Archives of Family Medicine 2000 Feb;9(2):155-9. [PM: 10693733]</P>
<P>  (176)   Dijkema LM, Geelkerken RH, Brouwers PJ, de SP, van Det RJ. The number of carotid artery operations in the Twente Medical Spectrum before and after the publication of relevant international research on the benefits of the relief of carotid stenosis. Nederlands Tijdschrift voor Geneeskunde 1998 Sep 12;142(37):2043-7. [PM: 9856210]</P>
<P>  (177)   Dijkstra RF, Niessen LW, Braspenning JC, Adang E, Grol RT. Patient-centred and professional-directed implementation strategies for diabetes guidelines: a cluster-randomized trial-based cost-effectiveness analysis. Diabetic Medicine 2006 Feb;23(2):164-70. [PM: 16433714]</P>
<P>  (178)   DiTusa L, Luzier AB, Jarosz DE, Snyder BD, Izzo JL, Jr. Treatment of hypertension in a managed care setting. American Journal of Managed Care 2001 May;7(5):520-4. [PM: 11388131]</P>
<P>  (179)   Doherty SR, Jones PD, Davis L, Ryan NJ, Treeve V. Evidence-based implementation of adult asthma guidelines in the emergency department: a controlled trial. Emergency Medicine Australasia 2007 Feb;19(1):31-8. [PM: 17305658]</P>
<P>  (180)   Doig GS, Simpson F, Finfer S, Delaney A, Davies AR, Mitchell I, et al. Effect of evidence-based feeding guidelines on mortality of critically ill adults: a cluster randomized controlled trial. JAMA 2008 Dec 17;300(23):2731-41. [PM: 19088351]</P>
<P>  (181)   Dolovich L, Levine M, Tarajos R, Duku E. Promoting optimal antibiotic therapy for otitis media using commercially sponsored evidence-based detailing: A prospective controlled trial. Drug Information Journal 1999;33(4):1067-77. [EM 1999412071]</P>
<P>  (182)   Dolovich L, Sabharwal M, Agro K, Foster G, Lee A, McCarthy L, et al. The effect of pharmacist education on asthma treatment plans for simulated patients. Pharmacy World &amp; Science 2007 Jun;29(3):228-39. [PM: 17242854]</P>
<P>  (183)   Donovan JL, Schroeder WS, Tran MT, Foster K, Forrest A, Lee TB, et al. Assessment of eptifibatide dosing in renal impairment before and after in-service education provided by pharmacists. Journal of Managed Care Pharmacy 2007 Sep;13(7):598-606. [PM: 17874866]</P>
<P>  (184)   Douglas AE, Holley A, Udy A, Lipman J, Gomersall CD, Joynt GM, et al. Can learning to sustain life be BASIC? Teaching for the initial management of the critically ill in Australia and New Zealand. Anaesthesia &amp; Intensive Care 2010 Nov;38(6):1043-51. [PM: 21226436]</P>
<P>  (185)   Du Pen AR, Du PS, Hansberry J, Miller-Kraybill B, Millen J, Everly R, et al. An educational implementation of a cancer pain algorithm for ambulatory care. Pain Management Nursing 2000 Dec;1(4):116-28. [PM: 11709865]</P>
<P>  (186)   Dupont C, Touzet S, Colin C, Deneux-Tharaux C, Rabilloud M, Clement HJ, et al. Incidence and management of postpartum haemorrhage following the dissemination of guidelines in a network of 16 maternity units in France. International Journal of Obstetric Anesthesia 2009 Oct;18(4):320-7. [PM: 19733052]</P>
<P>  (187)   Durand M, Labarere J, Brunet E, Pons JC. Evaluation of a training program for healthcare professionals about breast-feeding. European Journal of Obstetrics, Gynecology, &amp; Reproductive Biology 2003 Feb 10;106(2):134-8. [PM: 12551778]</P>
<P>  (188)   Dykes PC, Acevedo K, Boldrighini J, Boucher C, Frumento K, Gray P, et al. Clinical practice guideline adherence before and after implementation of the HEARTFELT (HEART Failure Effectiveness &amp; Leadership Team) intervention. Journal of Cardiovascular Nursing 2005 Sep;20(5):306-14. [PM: 16141775]</P>
<P>  (189)   Eakin EG, Brown WJ, Marshall AL, Mummery K, Larsen E. Physical activity promotion in primary care: bridging the gap between research and practice. American Journal of Preventive Medicine 2004 Nov;27(4):297-303. [PM: 15488359]</P>
<P>  (190)   Eccles M, Steen N, Grimshaw J, Thomas L, McNamee P, Soutter J, et al. Effect of audit and feedback, and reminder messages on primary-care radiology referrals: a randomised trial. Lancet 2001 May 5;357(9266):1406-9. [PM: 11356439]</P>
<P>  (191)   Edlich RF, Wilder BJ, Silloway KA, Nichter LS, Bryant CA. Quality assessment of tetanus prophylaxis in the wounded patient. American Surgeon 1986 Oct;52(10):544-7. [PM: 3767140]</P>
<P>  (192)   Elnour AA, Ellahham NH, Al Qassas HI. Raising the awareness of inpatient nursing staff about medication errors. Pharmacy World &amp; Science 2008 Apr;30(2):182-90. [PM: 17882532]</P>
<P>  (193)   Emerson CR, Antonopoulos MS, Marzella N, Grossman SS. Economic impact of implementing pneumonia treatment guidelines for intravenous to oral conversion. Hospital Pharmacy 2008;43(11):886-94. [EM 2008574646]</P>
<P>  (194)   Emery J, Morris H, Goodchild R, Fanshawe T, Prevost AT, Bobrow M, et al. The GRAIDS Trial: a cluster randomised controlled trial of computer decision support for the management of familial cancer risk in primary care. British Journal of Cancer 2007 Aug 20;97(4):486-93. [PM: 17700548]</P>
<P>  (195)   Emslie C, Grimshaw J, Templeton A. Do clinical guidelines improve general practice management and referral of infertile couples? BMJ 1993 Jun 26;306(6894):1728-31. [PM: 8280213]</P>
<P>  (196)   Erramouspe J, Bailey JM, Cleveland KW, Casperson K, Hunt TL, Cady PS. Counter sampling combined with medical provider education: do they alter prescribing behavior? Consultant Pharmacist 2006 Aug;21(8):636-42. [PM: 17076590]</P>
<P>  (197)   Evans AT, Rogers LQ, Peden JG, Jr., Seelig CB, Layne RD, Levine MA, et al. Teaching dietary counseling skills to residents: patient and physician outcomes. The CADRE Study Group. American Journal of Preventive Medicine 1996 Jul;12(4):259-65. [PM: 8874689]</P>
<P>  (198)   Evans DW, Breen AC, Pincus T, Sim J, Underwood M, Vogel S, et al. The effectiveness of a posted information package on the beliefs and behavior of musculoskeletal practitioners: the UK Chiropractors, Osteopaths, and Musculoskeletal Physiotherapists Low Back Pain ManagemENT (COMPLeMENT) randomized trial. Spine 2010 Apr 15;35(8):858-66. [PM: 20308941]</P>
<P>  (199)   Fang J, Alderman MH. Revascularization among patients with acute myocardial infarction complicated by cardiogenic shock and impact of American College of Cardiology/American Heart Association guidelines. American Journal of Cardiology 2004 Nov 15;94(10):1281-5. [PM: 15541246]</P>
<P>  (200)   Fauci JM, Schneider KE, Whitworth JM, Subramaniam A, Erickson BK, Kim K, et al. Referral patterns and incidence of cervical intraepithelial neoplasia in adolescent and pregnant patients: the impact of the 2006 guidelines. Journal of Lower Genital Tract Disease 2011 Apr;15(2):124-7. [PM: 21478699]</P>
<P>  (201)   Feder G, Griffiths C, Highton C, Eldridge S, Spence M, Southgate L. Do clinical guidelines introduced with practice based education improve care of asthmatic and diabetic patients? A randomised controlled trial in general practices in east London. BMJ 1995 Dec 2;311(7018):1473-8. [PM: 8520339]</P>
<P>  (202)   Fender GR, Prentice A, Gorst T, Nixon RM, Duffy SW, Day NE, et al. Randomised controlled trial of educational package on management of menorrhagia in primary care: the Anglia menorrhagia education study. BMJ 1999 May 8;318(7193):1246-50. [PM: 10231255]</P>
<P>  (203)   Fendler KJ, Gumbhir AK, Sall K. The impact of drug bulletins on physician prescribing habits in a health maintenance organization. Drug Intelligence &amp; Clinical Pharmacy 1984 Jul;18(7-8):627-31. [PM: 6430661]</P>
<P>  (204)   Ferrando A, Pagano E, Scaglione L, Petrinco M, Gregori D, Ciccone G. A decision-tree model to estimate the impact on cost-effectiveness of a venous thromboembolism prophylaxis guideline. Quality &amp; Safety in Health Care 2009 Aug;18(4):309-13. [PM: 19651937]</P>
<P>  (205)   Fessler J, Gross J, Papendick H, Schubert I. Qualitative and economic impact of implementing GP guidelines in a medical practitioners' network. Zeitschrift fur Arztliche Fortbildung und Qualitatssicherung 2006;100(2):107-12. [EM 2006183663]</P>
<P>  (206)   Fick DM, Maclean JR, Rodriguez NA, Short L, Heuvel RV, Waller JL, et al. A randomized study to decrease the use of potentially inappropriate medications among community-dwelling older adults in a southeastern managed care organization. American Journal of Managed Care 2004 Nov;10(11 Pt 1):761-8. [PM: 15623266]</P>
<P>  (207)   Figueiras A, Sastre I, Tato F, Rodriguez C, Lado E, Caamano F, et al. One-to-one versus group sessions to improve prescription in primary care: a pragmatic randomized controlled trial. Medical Care 2001 Feb;39(2):158-67. [PM: 11176553]</P>
<P>  (208)   Finch RG, Metlay JP, Davey PG, Baker LJ. Educational interventions to improve antibiotic use in the community: Report from the International Forum on Antibiotic Resistance (IFAR) colloquium, 2002. Lancet Infectious Diseases 2004;4(1):44-53. [EM 2004021363]</P>
<P>  (209)   Finkelstein JA, Davis RL, Dowell SF, Metlay JP, Soumerai SB, Rifas-Shiman SL, et al. Reducing antibiotic use in children: a randomized trial in 12 practices. Pediatrics 2001 Jul;108(1):1-7. [PM: 11433046]</P>
<P>  (210)   Finnerty M, Gregory C. Impact of a palliative care nursing educational program in a Veterans Administration medical center. J HOSP PALLIAT NURS 2001;12(6):370-7.</P>
<P>  (211)   Fischer N, Steurer MA, Adams M, Berger TM, Swiss NN. Survival rates of extremely preterm infants (gestational age &lt;26 weeks) in Switzerland: impact of the Swiss guidelines for the care of infants born at the limit of viability. Archives of Disease in Childhood Fetal &amp; Neonatal Edition 2009 Nov;94(6):F407-13. [PM: 19357122]</P>
<P>  (212)   Fitzgerald ST, Hill M, Santamaria B, Howard C, Jadack R. Diagnosis and management of asthma: occupational health nurses' awareness and use of national consensus practice guidelines. Aaohn journal 1996 Feb;44(2):78-83. [PM: 8694979]</P>
<P>  (213)   Fitzpatrick KR, Pantle AC, McLaws ML, Hughes CF. Culture change for hand hygiene: clean hands save lives, part II. Medical Journal of Australia 2009 Oct 19;191(Suppl 8):S13-7. [PM: 19835526]</P>
<P>  (214)   Flenady V, Macphail J, New K, Devenish-Meares P, Smith J. Implementation of a clinical practice guideline for smoking cessation in a public antenatal care setting. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology 2008 Dec;48(6):552-8. [PM: 19133042]</P>
<P>  (215)   Florence Z. Printed educational materials: effects on professional practice and healthcare outcomes. J ADV NURS 2001;65(6):1183-4.</P>
<P>  (216)   Flottorp S, Havelsrud K, Oxman AD. Process evaluation of a cluster randomized trial of tailored interventions to implement guidelines in primary care--why is it so hard to change practice? Family Practice 2003 Jun;20(3):333-9. [PM: 12738704]</P>
<P>  (217)   Flynn ER, Wolf ZR, McGoldrick TB, Jablonski RA, Dean LM, McKee EP. Effect of three teaching methods on a nursing staff's knowledge of medication error risk reduction strategies. Journal of Nursing Staff Development 1996 Jan;12(1):19-26. [PM: 8699272]</P>
<P>  (218)   Fontaine A, Mahe I, Bergmann JF, Fiessinger JN, Dhote R, Cohen P, et al. Effectiveness of written guidelines on the appropriateness of thromboprophylaxis prescriptions for medical patients: a prospective randomized study. Journal of Internal Medicine 2006 Oct;260(4):369-76. [PM: 16961674]</P>
<P>  (219)   Fox J, Hendrickson S, Miller N, Parry C, Youngman D. A cooperative approach to standardizing care for patients with AMI or heart failure. Joint Commission Journal on Quality &amp; Patient Safety 2006 Dec;32(12):682-7. [PM: 17220157]</P>
<P>  (220)   Foy R, Penney GC, Grimshaw JM, Ramsay CR, Walker AE, MacLennan G, et al. A randomised controlled trial of a tailored multifaceted strategy to promote implementation of a clinical guideline on induced abortion care. BJOG: An International Journal of Obstetrics &amp; Gynaecology 2004 Jul;111(7):726-33. [PM: 15198764]</P>
<P>  (221)   Francis JJ, Grimshaw JM, Zwarenstein M, Eccles MP, Shiller S, Godin G, et al. Testing a TheoRY-inspired MEssage ('TRY-ME'): a sub-trial within the Ontario Printed Educational Message (OPEM) trial. Implementation Science 2007;2(39). [PM: 18039363]</P>
<P>  (222)   Fransen J, Laan RF, Van Der Laar MA, Huizinga TW, Van Riel PL. Influence of guideline adherence on outcome in a randomised controlled trial on the efficacy of methotrexate with folate supplementation in rheumatoid arthritis. Annals of the Rheumatic Diseases 2004 Oct;63(10):1222-6. [PM: 15361375]</P>
<P>  (223)   Franssen MT, Korevaar JC, van d, V, Boer K, Leschot NJ, Goddijn M. Management of recurrent miscarriage: evaluating the impact of a guideline. Human Reproduction 2007 May;22(5):1298-303. [PM: 17317720]</P>
<P>  (224)   Freeborn DK, Shye D, Mullooly JP, Eraker S, Romeo J. Primary care physicians' use of lumbar spine imaging tests: effects of guidelines and practice pattern feedback. Journal of General Internal Medicine 1997 Oct;12(10):619-25. [PM: 9346458]</P>
<P>  (225)   Freemantle N, Johnson R, Dennis J, Kennedy A, Marchment M. Sleeping with the enemy? A randomized controlled trial of a collaborative health authority/industry intervention to influence prescribing practice. British Journal of Clinical Pharmacology 2000 Feb;49(2):174-9. [PM: 10671913]</P>
<P>  (226)   French JA, Stevenson CH, Eglinton J, Bailey JE. Effect of information about waiting lists on referral patterns of general practitioners. British Journal of General Practice 1990 May;40(334):186-9. [PM: 2114133]</P>
<P>  (227)   Fretheim A, Oxman AD, Treweek S, Bjorndal A. Rational Prescribing in Primary Care (RaPP-trial). A randomised trial of a tailored intervention to improve prescribing of antihypertensive and cholesterol-lowering drugs in general practice [ISRCTN48751230. BMC Health Services Research 2003 Feb 27;3(1):5. [PM: 12657163]</P>
<P>  (228)   Friedl R, Hoppler H, Ecard K, Scholz W, Hannekum A, Ochsner W, et al. Multimedia-driven teaching significantly improves students' performance when compared with a print medium. Annals of Thoracic Surgery 2006 May;81(5):1760-6. [PM: 16631668]</P>
<P>  (229)   Frijling BD, Lobo CM, Hulscher ME, Akkermans RP, van Drenth BB, Prins A, et al. Intensive support to improve clinical decision making in cardiovascular care: a randomised controlled trial in general practice. Quality &amp; Safety in Health Care 2003 Jun;12(3):181-7. [PM: 12792007]</P>
<P>  (230)   Fukui T, Takashi O, Rahman M, Iino K, Uchitomi Y, Ogawa S, et al. Clinical effectiveness of evidence-based guidelines for pain management of terminal cancer patients in Japan. Japan Medical Association Journal 2005;48(5):216-23. [EM 2005325975]</P>
<P>  (231)   Ganeshalingam Y, Cooper C, Livingston G. Referral patterns and acetylcholinesterase inhibitor prescribing for cognitive impairment (1999-2007): Impact of NICE guidelines. Psychiatric Bulletin 2008;32(7):265-7. [EM 2008323129]</P>
<P>  (232)   Garcia JC, Ferreira Filho OF, Grion CM, Carrilho CM. Impact of the implementation of a therapeutic guideline on the treatment of nosocomial pneumonia acquired in the intensive care unit of a university hospital. Jornal Brasileiro De Pneumologia 2007 Apr;33(2):175-84. [PM: 17724537]</P>
<P>  (233)   Gask L, Dowrick C, Dixon C, Sutton C, Perry R, Torgerson D, et al. A pragmatic cluster randomized controlled trial of an educational intervention for GPs in the assessment and management of depression. Psychological Medicine 2004 Jan;34(1):63-72. [PM: 14971627]</P>
<P>  (234)   Gauthier M, Chevalier I, Gouin S, Lamarre V, Abela A. Ceftriaxone for refractory acute otitis media: impact of a clinical practice guideline. Pediatric Emergency Care 2009 Nov;25(11):739-43. [PM: 19864968]</P>
<P>  (235)   Gaylis FD, Van SJ, Daneshvar MA, Gaylis GM, Gaylis JB, Sheela RB, et al. Preprinted Standardized Orders Promote Venous Thromboembolism Prophylaxis Compared With Traditional Handwritten Orders: An Endorsement of Standardized Evidence-Based Practice. American Journal of Medical Quality 2010;25(6):449-56. [EM 20805424]</P>
<P>  (236)   Gazarian M, Henry RL, Wales SR, Micallef BE, Rood EM, O'Meara MW, et al. Evaluating the effectiveness of evidence-based guidelines for the use of spacer devices in children with acute asthma. Medical Journal of Australia 2001;174(8):394-7. [EM 2001160350]</P>
<P>  (237)   Geraedts M, Selbmann HK, Meisner C. Effects of a regional intervention to promote asthma guidelines implementation. Gesundheitswesen 2002;64(5):235-41. [EM 2002182551]</P>
<P>  (238)   Gerbert B, Bronstone A, Wolff M, Maurer T, Berger T, Pantilat S, et al. Improving primary care residents' proficiency in the diagnosis of skin cancer. Journal of General Internal Medicine 1998;13(2):91-7. [EM 1998065598]</P>
<P>  (239)   Giardino AP, Burns KM, Giardino ER. The educational value of pediatric emergency transport: By design or by default? Pediatric Emergency Care 1993;9(5):275-80. [EM 1993306392]</P>
<P>  (240)   Gibbins RL, Owens DR, Allen JC, Eastman L. Practical application of the European Field Guide in screening for diabetic retinopathy by using ophthalmoscopy and 35 mm retinal slides. Diabetologia 1998 Jan;41(1):59-64. [PM: 9498631]</P>
<P>  (241)   Gifford DR, Mittman BS, Fink A, Lanto AB, Lee ML, Vickrey BG. Can a specialty society educate its members to think differently about clinical decisions? Results of a randomized trial. Journal of General Internal Medicine 1996 Nov;11(11):664-72. [PM: 9120652]</P>
<P>  (242)   Gifford WA, Davies B, Graham ID, Lefebre N, Tourangeau A, Woodend K. A mixed methods pilot study with a cluster randomized control trial to evaluate the impact of a leadership intervention on guideline implementation in home care nursing. Implementation Science 2008;3(51). [PM: 19077199]</P>
<P>  (243)   Gildenhuys J, Lee M, Isbister GK. Does implementation of a paediatric asthma clinical practice guideline worksheet change clinical practice? International Journal of Emergency Medicine 2009 Apr;2(1):33-9. [PM: 19390915]</P>
<P>  (244)   Gill JM, Mainous AG, III, Koopman RJ, Player MS, Everett CJ, Chen YX, et al. Impact of EHR-based clinical decision support on adherence to guidelines for patients on NSAIDs: a randomized controlled trial. Annals of Family Medicine 2011 Jan;9(1):22-30. [PM: 21242557]</P>
<P>  (245)   Girotti MJ, Fodoruk S, Irvine-Meek J, Rotstein OD. Antibiotic handbook and pre-printed perioperative order forms for surgical antibiotic prophylaxis: do they work? Canadian Journal of Surgery 1990 Oct;33(5):385-8. [PM: 2224658]</P>
<P>  (246)   Glazier RH, Badley EM, Lineker SC, Wilkins AL, Bell MJ. Getting a Grip on Arthritis: an educational intervention for the diagnosis and treatment of arthritis in primary care. Journal of Rheumatology 2005 Jan;32(1):137-42. [PM: 15630739]</P>
<P>  (247)   Goebel LJ. A peer review feedback method of promoting compliance with preventive care guidelines in a resident ambulatory care clinic. Joint Commission Journal on Quality Improvement 1997 Apr;23(4):196-202. [PM: 9142611]</P>
<P>  (248)   Goff DC, Jr., Massing MW, Bertoni AG, Davis J, Ambrosius WT, McArdle J, et al. Enhancing quality of heart failure care in managed Medicare and Medicaid in North Carolina: results of the North Carolina Achieving Cardiac Excellence (NC ACE) Project. American Heart Journal 2005 Oct;150(4):717-24. [PM: 16209973]</P>
<P>  (249)   Goldberg HI, Wagner EH, Fihn SD, Martin DP, Horowitz CR, Christensen DB, et al. A randomized controlled trial of CQI teams and academic detailing: can they alter compliance with guidelines? Joint Commission Journal on Quality Improvement 1998 Mar;24(3):130-42. [PM: 9568553]</P>
<P>  (250)   Goldstein MK, Lavori P, Coleman R, Advani A, Hoffman BB. Improving adherence to guidelines for hypertension drug prescribing: cluster-randomized controlled trial of general versus patient-specific recommendations. American Journal of Managed Care 2005 Nov;11(11):677-85. [PM: 16268751]</P>
<P>  (251)   Gonnah R, Hegazi MO, Hmdy I, Shenoda MM. Can a change in policy reduce emergency hospital admissions? Effect of admission avoidance team, guideline implementation and maximising the observation unit. Emergency Medicine Journal 2008 Sep;25(9):575-8. [PM: 18723706]</P>
<P>  (252)   Gopal RG, Jeanes A, Russell H, Wilson D, Atere-Roberts E, O'Sullivan D, et al. Effectiveness of short-term, enhanced, infection control support in improving compliance with infection control guidelines and practice in nursing homes: a cluster randomized trial. Epidemiology &amp; Infection 2009 Oct;137(10):1465-71. [PM: 19257913]</P>
<P>  (253)   Gopinath RM, Suzuki NT. Clinical training program for staff pharmacists. Hospital Pharmacy 1985 Jun;20(6):395-8. [PM: 10271921]</P>
<P>  (254)   Gora-Harper ML, Hessel E, Shadick D. Effect of prescribing guidelines on the use of neuromuscular blocking agents. American Journal of Health-System Pharmacy 1995 Sep 1;52(17):1900-4. [PM: 8528853]</P>
<P>  (255)   Gordon DB, Jones HD, Goshman LM, Foley DK, Bland SE. A quality improvement approach to reducing use of meperidine. Joint Commission Journal on Quality Improvement 2000 Dec;26(12):686-99. [PM: 11143208]</P>
<P>  (256)   Gorecki W, Grochowska E, Krysta M, Wojciechowski P, Taczanowska A, Stanek B. A prospective comparison of antibiotic usage in pediatric surgical patients: the safety, advantage, and effectiveness of the Surgical Infection Society guidelines versus a common practice. Journal of Pediatric Surgery 2002 Oct;37(10):1430-4. [PM: 12378448]</P>
<P>  (257)   Gorton TA, Cranford CO, Golden WE, Walls RC, Pawelak JE. Primary care physicians' response to dissemination of practice guidelines. Archives of Family Medicine 1995 Feb;4(2):135-42. [PM: 7842151]</P>
<P>  (258)   Gove S. Integrated management of childhood illness: conclusions. WHO Division of Child Health and Development. Bulletin of the World Health Organization 1997;75(Suppl 1):119-28. [PM: 9529725]</P>
<P>  (259)   Grange F, Hedelin G, Halna JM, Grall JC, Kirstetter H, Guillaume JC, et al. Assessment of a general practitioner training campaign for early detection of cutaneous melanoma in the Haut-Rhin department of France. Annales de Dermatologie et de Venereologie 2005 Dec;132(12 Pt 1):956-61. [PM: 16446636]</P>
<P>  (260)   Grene N, Pointereau-Bellanger A, Conort O, Fontan JE, Le MF, Madelaine I, et al. Multicenter study of the impact of prescription guidelines on the use of colony stimulating factors. Anti-Cancer Drugs 2000 Feb;11(2):109-15. [PM: 10789593]</P>
<P>  (261)   Griffith HM, Dickey L, Kamerow DB. Put prevention into practice: a systematic approach. Journal of Public Health Management &amp; Practice 1995;1(3):9-15. [PM: 10186631]</P>
<P>  (262)   Griffiths CE, Taylor H, Collins SI, Hobson JE, Collier PA, Chalmers RJ, et al. The impact of psoriasis guidelines on appropriateness of referral from primary to secondary care: a randomized controlled trial. British Journal of Dermatology 2006 Aug;155(2):393-400. [PM: 16882180]</P>
<P>  (263)   Griggs WM, Morris RW, Runciman WB, Osborne GA, Paix AD. Trauma: development of a sub-algorithm. Quality &amp; Safety in Health Care 2005 Jun;14(3):e21. [PM: 15933295]</P>
<P>  (264)   Grimshaw JM, Zwarenstein M, Tetroe JM, Godin G, Graham ID, Lemyre L, et al. Looking inside the black box: a theory-based process evaluation alongside a randomised controlled trial of printed educational materials (the Ontario printed educational message, OPEM) to improve referral and prescribing practices in primary care in Ontario, Canada. Implementation Science 2007;2(38). [PM: 18039362]</P>
<P>  (265)   Guadagnoli E, Normand SL, DiSalvo TG, Palmer RH, McNeil BJ. Effects of treatment recommendations and specialist intervention on care provided by primary care physicians to patients with myocardial infarction or heart failure. American Journal of Medicine 2004 Sep 15;117(6):371-9. [PM: 15380493]</P>
<P>  (266)   Guay MP, Dragomir A, Pilon D, Moride Y, Perreault S. Changes in pattern of use, clinical characteristics and persistence rate of hormone replacement therapy among postmenopausal women after the WHI publication. Pharmacoepidemiology &amp; Drug Safety 2007 Jan;16(1):17-27. [PM: 16794994]</P>
<P>  (267)   Guest JF, Varney SJ, Diggle J. Impact of the British Thoracic Society chronic obstructive pulmonary disease guidelines on patients' health status, healthcare resource use and health-related quality of life. Primary Care Respiratory Journal 2005 Oct;14(5):242-51. [PM: 16701737]</P>
<P>  (268)   Gulati M, Patel S, Jaffe AS, Joseph AJ, Calvin JE, Jr. Impact of contemporary guideline compliance on risk stratification models for acute coronary syndromes in The Registry of Acute Coronary Syndromes. American Journal of Cardiology 2004 Oct 1;94(7):873-8. [PM: 15464668]</P>
<P>  (269)   Gunderson EW, Levin FR, Owen P. Impact of a brief training on medical resident screening for alcohol misuse and illicit drug use. American Journal on Addictions 2008 Mar;17(2):149-54. [PM: 18393059]</P>
<P>  (270)   Gunn J, Southern D, Chondros P, Thomson P, Robertson K. Guidelines for assessing postnatal problems: introducing evidence-based guidelines in Australian general practice. Family Practice 2003 Aug;20(4):382-9. [PM: 12876107]</P>
<P>  (271)   Gunter MJ, Brixner D, von WA, Carter S, Gregory C. Impact of a seizure disorder disease management program on patient-reported quality of life. Disease Management 2004;7(4):333-47. [PM: 15671790]</P>
<P>  (272)   Guterman JJ, Chernof BA, Mares B, Gross-Schulman SG, Gan PG, Thomas D. Modifying provider behavior: a low-tech approach to pharmaceutical ordering. Journal of General Internal Medicine 2002 Oct;17(10):792-6. [PM: 12390556]</P>
<P>  (273)   Guterman SJ, VanRooyan MJ. Cost-effective medicine: the financial impact that practice guidelines have on outpatient hospital charges in the emergency department. Journal of Emergency Medicine 1998 Mar;16(2):215-9. [PM: 9543404]</P>
<P>  (274)   Haas JS, Kaplan CP, Gerstenberger EP, Kerlikowske K. Summaries for patients. Changes in the use of postmenopausal hormone replacement therapy after the publication of study results. Annals of Internal Medicine 2004 Feb 3;140(3):I50. [PM: 14757633]</P>
<P>  (275)   Hachemi M, Attof Y, Flamens C, Bastien O, Bouletreau P, Chambrier C, et al. Impact of the guidelines on clinical practice of artificial nutrition in intensive care unit after cardiovascular and thoracic surgery. Annales Francaises d Anesthesie et de Reanimation 2006 Oct;25(10):1034-40. [PM: 17005359]</P>
<P>  (276)   Hagaman JT, Yurkowski P, Trott A, Rouan GW. Getting physicians to make "the switch": the role of clinical guidelines in the management of community-acquired pneumonia. American Journal of Medical Quality 2005 Jan;20(1):15-21. [PM: 15782751]</P>
<P>  (277)   Hak E, Hermens RP, Hoes AW, Verheij TJ, Kuyvenhoven MM, van Essen GA. Effectiveness of a co-ordinated nation-wide programme to improve influenza immunisation rates in The Netherlands. Scandinavian Journal of Primary Health Care 2000 Dec;18(4):237-41. [PM: 11205093]</P>
<P>  (278)   Hall L, Eccles M, Barton R, Steen N, Campbell M. Is untargeted outreach visiting in primary care effective? A pragmatic randomized controlled trial. Journal of Public Health Medicine 2001 Jun;23(2):109-13. [PM: 11450926]</P>
<P>  (279)   Hamley JH, MacGregor SH, Dunbar JA, Cromarty JA. Integrating clinical pharmacists into the primary health care team: a framework for rational and cost-effective prescribing. Scottish Medical Journal 1997 Feb;42(1):4-7. [PM: 9226769]</P>
<P>  (280)   Hammond CS, Wasson JH, Walker-Corkery E, Fowler FJ, Barry MJ. A frequently used patient and physician-directed educational intervention does nothing to improve primary care of prostate conditions. Urology 2001 Dec;58(6):875-81. [PM: 11744449]</P>
<P>  (281)   Hamrin EK, Lindmark B. The effect of systematic care planning after acute stroke in general hospital medical wards. J ADV NURS 1990 Oct;15(10):1146-53. [PM: 2258521]</P>
<P>  (282)   Hanbury A, Wallace L, Clark M. Use of a time series design to test effectiveness of a theory-based intervention targeting adherence of health professionals to a clinical guideline. British Journal of Health Psychology 2009 Sep;14(Pt 3):505-18. [PM: 18851769]</P>
<P>  (283)   Hannon R. Audit and feedback and educational outreach did not differ from printed educational materials for improving community nursing practice. Evidence-Based Nursing 2007 Jan;10(1):26. [PM: 17218300]</P>
<P>  (284)   Harrington SS, Walker BL. A comparison of computer-based and instructor-led training for long-term care staff. Journal of Continuing Education in Nursing 2002 Jan;33(1):39-45. [PM: 15887359]</P>
<P>  (285)   Harris RH, MacKenzie TD, Leeman-Castillo B, Corbett KK, Batal HA, Maselli JH, et al. Optimizing antibiotic prescribing for acute respiratory tract infections in an urban urgent care clinic. Journal of General Internal Medicine 2003 May;18(5):326-34. [PM: 12795730]</P>
<P>  (286)   Hayes RP, Baker DW, Luthi JC, Baggett RL, McClellan W, Fitzgerald D, et al. The effect of external feedback on the management of medicare inpatients with congestive heart failure. American Journal of Medical Quality 2002 Nov;17(6):225-35. [PM: 12487338]</P>
<P>  (287)   Hazard RG, Haugh LD, Reid S, McFarlane G, MacDonald L. Early physician notification of patient disability risk and clinical guidelines after low back injury: a randomized, controlled trial. Spine 1997 Dec 15;22(24):2951-8. [PM: 9431632]</P>
<P>  (288)   Healey KM, Hoffman MA. Self-instructional posters: one way to save time and money. Journal of Continuing Education in Nursing 1991 May;22(3):123-5. [PM: 1907297]</P>
<P>  (289)   Helsper CW, van Essen GA, Bonten MJ, de Wit NJ. A support programme for primary care leads to substantial improvements in the effectiveness of a public hepatitis C campaign. Family Practice 2010 Jun;27(3):328-32. [PM: 20223833]</P>
<P>  (290)   Helton KJ, Strife JL, Warner BW, Byczkowski TL, Donovan EF. The impact of a clinical guideline on imaging children with hypertrophic pyloric stenosis. Pediatric Radiology 2004 Sep;34(9):733-6. [PM: 15316693]</P>
<P>  (291)   Hendricson WD, Wood PR, Hidalgo HA, Kromer ME, Parcel GS, Ramirez AG. Implementation of a physician education intervention. The Childhood Asthma Project. Archives of Pediatrics &amp; Adolescent Medicine 1994 Jun;148(6):595-601. [PM: 8193683]</P>
<P>  (292)   Henkel V, Althaus D, Hegerl U. Lessons from the Hampshire Depression Project. Lancet 2000 May 6;355(9215):1641. [PM: 10821382]</P>
<P>  (293)   Hepner KA, Rowe M, Rost K, Hickey SC, Sherbourne CD, Ford DE, et al. The effect of adherence to practice guidelines on depression outcomes. Annals of Internal Medicine 2007 Sep 4;147(5):320-9. [PM: 17785487]</P>
<P>  (294)   Herrick DE, Lowe CR, Micalizzi JG, Kerby GS. The impact of an evidence-based continuing education course on participant self-efficacy and asthma educator-certified (AE-C) accreditation. [2011 American Academy of Allergy, Asthma and Immunology, AAAAI Annual Meeting San Francisco, CA]. Journal of Allergy and Clinical Immunology 2011;127(2 Suppl 1):AB67. [EM 70358984]</P>
<P>  (295)   Herschell AD, McNeil CB, Urquiza AJ, McGrath JM, Zebell NM, Timmer SG, et al. Evaluation of a treatment manual and workshops for disseminating, parent-child interaction therapy. Administration &amp; Policy in Mental Health 2009 Jan;36(1):63-81. [PM: 19016321]</P>
<P>  (296)   Heyman E, Tyner R, Phipps C, Cave L, Owen DC. Is the hospital setting the place for teaching breast self-examination? Cancer Nursing 1991 Feb;14(1):35-40. [PM: 2013050]</P>
<P>  (297)   Higgins R, Hogg P. Patient preparation for diagnostic nuclear medicine imaging procedures: An analysis of ward nurse knowledge. Radiography 2002;8(3):139-47. [EM 2002393734]</P>
<P>  (298)   Hill-Smith I. Sharing resources to create a district drug formulary: a countywide controlled trial. British Journal of General Practice 1996 May;46(406):271-5. [PM: 8762741]</P>
<P>  (299)   Hobolth L, Krag A, Malchow-Moller A, Gancho V, Jensen SM, Bendtsen F. Adherence to guidelines in bleeding oesophageal varices and the effect on outcome-comparison between a specialized unit and a community hospital [60th Annual Meeting of the American Association for the Study of Liver Diseases, 2009 Boston]. Hepatology 2009;50:442A. [EM 70073707]</P>
<P>  (300)   Hoeijenbos M, Bekkering T, Lamers L, Hendriks E, van TM, Koopmanschap M. Cost-effectiveness of an active implementation strategy for the Dutch physiotherapy guideline for low back pain. Health Policy 2005 Dec;75(1):85-98. [PM: 16298231]</P>
<P>  (301)   Holroyd BR, Wilson D, Rowe BH, Mayes DC, Noseworthy T. Uptake of validated clinical practice guidelines: experience with implementing the Ottawa Ankle Rules. American Journal of Emergency Medicine 2004 May;22(3):149-55. [PM: 15138948]</P>
<P>  (302)   Holt RD, Rule DC, Basker RM, Davenport JC, Ralph JP, Murray JJ, et al. The influence on partial denture design of a teaching video for general dental practitioners. British Dental Journal 1994 May 21;176(10):379-80. [PM: 8011375]</P>
<P>  (303)   Horwood C, Vermaak K, Rollins N, Haskins L, Nkosi P, Qazi S. Paediatric HIV management at primary care level: an evaluation of the integrated management of childhood illness (IMCI) guidelines for HIV. BMC Pediatrics 2009;9(59). [PM: 19772599]</P>
<P>  (304)   Hoskins G, Neville RG, McCowan C, Smith B, Clark RA, Ricketts IW. Scottish Asthma Management Initiative. Health Bulletin 2000 Nov;58(6):478-88. [PM: 12813780]</P>
<P>  (305)   Hover AR, Cornwell V, Stevenson S, Sponenberg D. Evaluation of the American Academy of Pediatrics Principles on Management of Common Office Infections in a managed care setting. Missouri Medicine 2000 Dec;97(12):541-4. [PM: 11138431]</P>
<P>  (306)   Hulscher ME, van Drenth BB, van der Wouden JC, Mokkink HG, van WC, Grol RP. Changing preventive practice: a controlled trial on the effects of outreach visits to organise prevention of cardiovascular disease. Quality in Health Care 1997 Mar;6(1):19-24. [PM: 10166597]</P>
<P>  (307)   Humair JP, Cornuz J. A new curriculum using active learning methods and standardized patients to train residents in smoking cessation. Journal of General Internal Medicine 2003 Dec;18(12):1023-7. [PM: 14687261]</P>
<P>  (308)   Hung CS, Lin JW, Hwang JJ, Tsai RY, Li AT. Using paper chart based clinical reminders to improve guideline adherence to lipid management. Journal of Evaluation in Clinical Practice 2008 Oct;14(5):861-6. [PM: 19018919]</P>
<P>  (309)   Hunskaar S, Hannestad YS, Backe B, Matheson I. Direct mailing of consensus recommendations did not alter GPs' knowledge and prescription of oestrogen in the menopause. Scandinavian Journal of Primary Health Care 1996 Dec;14(4):203-8. [PM: 8956447]</P>
<P>  (310)   Hutt E, Radcliff TA, Oman KS, Fink R, Ruscin JM, Linnebur S, et al. Impact of NHAP guideline implementation intervention on staff and resident vaccination rates. Journal of the American Medical Directors Association 2010 Jun;11(5):365-70. [PM: 20511104]</P>
<P>  (311)   Hux JE, Melady MP, DeBoer D. Confidential prescriber feedback and education to improve antibiotic use in primary care: a controlled trial. CMAJ Canadian Medical Association Journal 1999 Aug 24;161(4):388-92. [PM: 10478162]</P>
<P>  (312)   Ilett KF, Johnson S, Greenhill G, Mullen L, Brockis J, Golledge CL, et al. Modification of general practitioner prescribing of antibiotics by use of a therapeutics adviser (academic detailer). British Journal of Clinical Pharmacology 2000 Feb;49(2):168-73. [PM: 10671912]</P>
<P>  (313)   Iregui M, Ward S, Clinikscale D, Clayton D, Kollef MH. Use of a handheld computer by respiratory care practitioners to improve the efficiency of weaning patients from mechanical ventilation. Critical Care Medicine 2002 Sep;30(9):2038-43. [PM: 12352038]</P>
<P>  (314)   Jabbari H, Bakhshian F. Preventing nosocomial infection transmit in gynecology and midwifery service providers in Tabriz (experience of educational interventions). Medical Sciences Journal of Islamic Azad University 2008;18(4):e259-64.</P>
<P>  (315)   Jackevicius CA, Chapman KR. Inhaler education for hospital-based pharmacists: how much is required? Canadian Respiratory Journal 1999 May;6(3):237-44. [PM: 10393285]</P>
<P>  (316)   Jacobs EM, Meulendijks CF, Elving L, van der Wilt GJ, Swinkels DW. Impact of the introduction of a guideline on the targeted detection of hereditary haemochromatosis. Netherlands Journal of Medicine 2005 Jun;63(6):205-14. [PM: 16011012]</P>
<P>  (317)   Jafar TH, Hatcher J, Poulter N, Islam M, Hashmi S, Qadri Z, et al. Community-based interventions to promote blood pressure control in a developing country: a cluster randomized trial. Annals of Internal Medicine 2009 Nov 3;151(9):593-601. [PM: 19884620]</P>
<P>  (318)   Jain MK, Heyland D, Dhaliwal R, Day AG, Drover J, Keefe L, et al. Dissemination of the Canadian clinical practice guidelines for nutrition support: results of a cluster randomized controlled trial. Critical Care Medicine 2006 Sep;34(9):2362-9. [PM: 16850001]</P>
<P>  (319)   Jamileh Y, Pedlar J. Effect of clinical guidelines on practice for extraction of lower third molars: study of referrals in 1997 and 2000. British Journal of Oral &amp; Maxillofacial Surgery 2003 Dec;41(6):371-5. [PM: 14614863]</P>
<P>  (320)   Janmeja AK, Mohapatra PR, Kumar M. The impact of "World Health Organization - Government of India guidelines on chronic obstructive pulmonary diseases-2003" on quality of life. Lung India 2009 Oct;26(4):102-5. [PM: 20531989]</P>
<P>  (321)   Jans MP, Schellevis FG, Van HW, van Eijk JT. Improving general practice care of patients with asthma or chronic obstructive pulmonary disease: evaluation of a quality system. Effective Clinical Practice 2000 Jan;3(1):16-24. [PM: 10788032]</P>
<P>  (322)   Jans MP, Schellevis FG, Le Coq EM, Bezemer PD, van Eijk JT. Health outcomes of asthma and COPD patients: the evaluation of a project to implement guidelines in general practice. International Journal for Quality in Health Care 2001 Feb;13(1):17-25. [PM: 11330439]</P>
<P>  (323)   Jantti H, Kuisma M, Uusaro A. The effects of changes to the ERC resuscitation guidelines on no flow time and cardiopulmonary resuscitation quality: a randomised controlled study on manikins. Resuscitation 2007 Nov;75(2):338-44. [PM: 17628319]</P>
<P>  (324)   Jardri R, Maron M, Pelta J, Thomas P, Codaccioni X, Goudemand M, et al. Impact of midwives' training on postnatal depression screening in the first week post delivery: a quality improvement report. Midwifery 2010 Dec;26(6):622-9. [PM: 19211177]</P>
<P>  (325)   Jeba J, George R, Thangakunam B, Christopher DJ. Pain assessment and analgesic prescription for cancer patients in a medical ward: the influence of an educational intervention. National Medical Journal of India 2009 Jul;22(4):177-80. [PM: 20120990]</P>
<P>  (326)   Jennett PA, Wilson TW, Hayton RC, Mainprize GW, Laxdal OE. Desirable behaviours in the office management of hypertension addressed through continuing medical education. Canadian Journal of Public Health 1989 Sep;80(5):359-62. [PM: 2804866]</P>
<P>  (327)   Jiang SL, Ji XP, Zhang C, Wang XR, Zhang M, Zhang Y. Impact of Chinese guidelines for management of patients with acute myocardial infarction on outcomes of hospitalized patients. Chinese Medical Journal 2006 Jan 5;119(1):26-31. [PM: 16454978]</P>
<P>  (328)   Joffres MR, Kamath TV, Williams GR, Casey J, Svenson LW. Impact of guidelines on health care use for the management of dyslipidemia in two Canadian provinces, Alberta and Nova Scotia, from 1990 to 2001. Canadian Journal of Cardiology 2004 Jun;20(8):767-72. [PM: 15229757]</P>
<P>  (329)   Johnson CC, Martin M. Effectiveness of a physician education program in reducing consumption of hospital resources in elective total hip replacement. Southern Medical Journal 1996 Mar;89(3):282-9. [PM: 8604457]</P>
<P>  (330)   Johnson DW, Craig W, Brant R, Mitton C, Svenson L, Klassen TP. A cluster randomized controlled trial comparing three methods of disseminating practice guidelines for children with croup [ISRCTN73394937. Implementation Science 2006;1(10). [PM: 16722541]</P>
<P>  (331)   Johnson E, Rolfs RT, Sauer BC, Porucznik CA. Utah's education campaign for prescription opioids [Conference: 25th Annual Meeting of the American Academy of Pain Medicine, AAPM Honolulu, HI United States]. Pain Medicine 2009;10(1):272-3. [EM 70205027]</P>
<P>  (332)   Johnson RE, Campbell WH, Azevedo DJ, Christensen DB. Studying the impact of patient drug profiles in an HMO. Medical Care 1976 Oct;14(10):799-807. [PM: 972558]</P>
<P>  (333)   Jones RH, Lydeard S, Dunleavey J. Problems with implementing guidelines: a randomised controlled trial of consensus management of dyspepsia. Quality in Health Care 1993 Dec;2(4):217-21. [PM: 10132454]</P>
<P>  (334)   Jouclas VM. Manuals in the organization of nursing services. Revista Enfermagem Em Novas Dimensoes 1978 Jan;4(1):47-52. [PM: 243953]</P>
<P>  (335)   Junghans C, Feder G, Timmis AD, Eldridge S, Sekhri N, Black N, et al. Effect of patient-specific ratings vs conventional guidelines on investigation decisions in angina: Appropriateness of Referral and Investigation in Angina (ARIA) Trial. Archives of Internal Medicine 2007 Jan 22;167(2):195-202. [PM: 17242322]</P>
<P>  (336)   Kahan NR, Kahan E, Waitman DA, Kitai E, Chintz DP. The tools of an evidence-based culture: implementing clinical-practice guidelines in an Israeli HMO. Academic Medicine 2009 Sep;84(9):1217-25. [PM: 19707060]</P>
<P>  (337)   Kaneshiro M, Ho A, Chan M, Cohen H, Spiegel BM. Colonoscopy yields fewer polyps as the day progresses despite using social influence theory to reverse the trend. Gastrointestinal Endoscopy 2010 Dec;72(6):1233-40. [PM: 21111873]</P>
<P>  (338)   Kattwinkel J, Nowacek GA, Cook LJ, Hurt H, Short JG. Perinatal outreach education. A continuation strategy for a basic program. American Journal of Perinatology 1984 Jul;1(4):335-40. [PM: 6518071]</P>
<P>  (339)   Keay L, Stapleton F. Development and evaluation of evidence-based guidelines on contact lens-related microbial keratitis. Contact Lens &amp; Anterior Eye 2008 Feb;31(1):3-12. [PM: 18032091]</P>
<P>  (340)   Kennedy A, Nelson E, Reeves D, Richardson G, Roberts C, Robinson A, et al. A randomised controlled trial to assess the impact of a package comprising a patient-orientated, evidence-based self-help guidebook and patient-centred consultations on disease management and satisfaction in inflammatory bowel disease. Health Technology Assessment (Winchester, England) 2003;7(28):1-113. [PM: 14567905]</P>
<P>  (341)   Kenyon S, Taylor DJ. The effect of the publication of a major clinical trial in a high impact journal on clinical practise: the ORACLE Trial experience. BJOG: An International Journal of Obstetrics &amp; Gynaecology 2002 Dec;109(12):1341-3. [PM: 12504968]</P>
<P>  (342)   Kerry S, Oakeshott P, Dundas D, Williams J. Influence of postal distribution of the Royal College of Radiologists' guidelines, together with feedback on radiological referral rates, on X-ray referrals from general practice: a randomized controlled trial. Family Practice 2000 Feb;17(1):46-52. [PM: 10673488]</P>
<P>  (343)   Khachi H, Burman M, Walters L, Sinha-Ray R, Antoniou S, Mandal S. The impact of a multidisciplinary educational programme on the prescribing of oxygen in an acute trust [Conference: British Thoracic Society Winter Meeting 2010 London United Kingdom]. Thorax 2010;65:A113. [EM 70325941]</P>
<P>  (344)   Kim CJ, Kang DH. Utility of a Web-based intervention for individuals with type 2 diabetes: the impact on physical activity levels and glycemic control. CIN: Computers, Informatics, Nursing 2006 Nov;24(6):337-45. [PM: 17108753]</P>
<P>  (345)   Kim J, Chang S, Lee S, Jun E, Kim Y. An experimental study of students' self-learning of the San-Yin-Jiao pressure procedure using CD-ROM or printed materials. Journal of Nursing Education 2003 Aug;42(8):371-6. [PM: 12938901]</P>
<P>  (346)   King S. Personalized medicine: what nurses need to know... Oncology Nursing Society 31st Annual Congress podium and poster abstracts. ONCOL NURS FORUM 2001;33(2):448.</P>
<P>  (347)   Kinmonth AL, Woodcock A, Griffin S, Spiegal N, Campbell MJ. Randomised controlled trial of patient centred care of diabetes in general practice: impact on current wellbeing and future disease risk. The Diabetes Care From Diagnosis Research Team. BMJ 1998 Oct 31;317(7167):1202-8. [PM: 9794859]</P>
<P>  (348)   Kirby T. Atul Gawande--making surgery safer worldwide. Lancet 2010 Sep 25;376(9746):1045. [PM: 20870085]</P>
<P>  (349)   Kirscht JP, Kirscht JL, Rosenstock IM. A test of interventions to increase adherence to hypertensive medical regimens. Health Education Quarterly 1981;8(3):261-72. [PM: 7333851]</P>
<P>  (350)   Kirshbaum M. Translation to practice: a randomised, controlled study of an evidence-based booklet for breast-care nurses in the United Kingdom. Worldviews on Evidence-Based Nursing 2008;5(2):60-74. [PM: 18559019]</P>
<P>  (351)   Knox AB, Underbaake G, McBride PE, Mejicano GC. Organization development strategies for continuing medical education. Journal of Continuing Education in the Health Professions 2001;21(1):15-23. [PM: 11291581]</P>
<P>  (352)   Kocher MS, Mandiga R, Murphy JM, Goldmann D, Harper M, Sundel R, et al. A clinical practice guideline for treatment of septic arthritis in children: efficacy in improving process of care and effect on outcome of septic arthritis of the hip. Journal of Bone &amp; Joint Surgery - American Volume 2003 Jun;85-A(6):994-9. [PM: 12783993]</P>
<P>  (353)   Korn R. The health information manager: the next generation. Journal of Ahima 1995 Oct;66(9):56-9. [PM: 10151133]</P>
<P>  (354)   Koskinen H, Rautakorpi UM, Sintonen H, Honkanen P, Huikko S, Huovinen P, et al. Cost-effectiveness of implementing national guidelines in the treatment of acute otitis media in children. International Journal of Technology Assessment in Health Care 2006;22(4):454-9. [PM: 16984678]</P>
<P>  (355)   Kotagal UR, Robbins JM, Kini NM, Schoettker PJ, Atherton HD, Kirschbaum MS. Impact of a bronchiolitis guideline: a multisite demonstration project. Chest 2002 Jun;121(6):1789-97. [PM: 12065340]</P>
<P>  (356)   Kotilampi M. The use of professional literature by nurses. Sairaanhoidon Vuosikirja 1972;9:58-86. [PM: 4483501]</P>
<P>  (357)   Kreuter MW, Chheda SG, Bull FC. How does physician advice influence patient behavior? Evidence for a priming effect. Archives of Family Medicine 2000 May;9(5):426-33. [PM: 10810947]</P>
<P>  (358)   Kwan T, Lin F, Ngai B, Loeb M. Vancomycin use in 2 Ontario tertiary care hospitals: a survey. Clinical &amp; Investigative Medicine 1999 Dec;22(6):256-64. [PM: 10664867]</P>
<P>  (359)   Labarere J, Bosson JL, Brion JP, Fabre M, Imbert B, Carpentier P, et al. Validation of a clinical guideline on prevention of venous thromboembolism in medical inpatients: a before-and-after study with systematic ultrasound examination. Journal of Internal Medicine 2004 Oct;256(4):338-48. [PM: 15367177]</P>
<P>  (360)   Lagerlov P, Loeb M, Andrew M, Hjortdahl P. Improving doctors' prescribing behaviour through reflection on guidelines and prescription feedback: a randomised controlled study. Quality in Health Care 2000 Sep;9(3):159-65. [PM: 10980076]</P>
<P>  (361)   Lamas GA, Pfeffer MA, Hamm P, Wertheimer J, Rouleau JL, Braunwald E. Do the results of randomized clinical trials of cardiovascular drugs influence medical practice? The SAVE Investigators. New England Journal of Medicine 1992 Jul 23;327(4):241-7. [PM: 1535419]</P>
<P>  (362)   Landgren FT, Harvey KJ, Mashford ML, Moulds RF, Guthrie B, Hemming M. Changing antibiotic prescribing by educational marketing. Medical Journal of Australia 1988 Dec 5;149(11-12):595-9. [PM: 3200183]</P>
<P>  (363)   Lang E, Kastner S, Liebig K, Neundorfer B. Interventions for improvement of primary care in patients with low back pain: how effective are advice to primary care physicians on therapies and a multimodal therapy program arising out of cooperation of outpatient health care structures? Der Schmerz 2002 Feb;16(1):22-33. [PM: 11845338]</P>
<P>  (364)   Lang WP, Farghaly MM, Woolfolk MW, Ziemiecki TL, Faja BW. Educating dentists about fissure sealants: effects on knowledge, attitudes, and use. Journal of Public Health Dentistry 1991;51(3):164-9. [PM: 1920269]</P>
<P>  (365)   Langsford MJ, Dobbs FF, Morrison GM, Dance DA. The effect of introduction of a guideline on the management of vaginal discharge and in particular bacterial vaginosis in primary care. Family Practice 2001 Jun;18(3):253-7. [PM: 11356730]</P>
<P>  (366)   Lanoir D, Chambrier C, Vergnon P, Meynaud-Kraemer L, Wilkinson J, Mcpherson K, et al. Perioperative artificial nutrition in elective surgery: an impact study of French guidelines. Clinical Nutrition 1998 Aug;17(4):153-7. [PM: 10205333]</P>
<P>  (367)   Lanoir D, Chambrier C, Vergnon P, Meynaud-Kraemer L, Wilkinson J, Mcpherson K, et al. Perioperative artificial nutrition in elective surgery: An impact study of French guidelines. Clinical Nutrition 1998;17(4):153-7. [EM 1998325930]</P>
<P>  (368)   LaPointe NM, DeLong ER, Chen A, Hammill BG, Muhlbaier LH, Califf RM, et al. Multifaceted intervention to promote beta-blocker use in heart failure. American Heart Journal 2006 May;151(5):992-8. [PM: 16644320]</P>
<P>  (369)   Lasby K, Dressler-Mund D. Making the literature palatable at the bedside: Reference poster promotes oral feeding best practice. Advances in Neonatal Care 2011 Feb;11(1):17-24. [PM: 21285652]</P>
<P>  (370)   Laurie-Shaw B, Taylor W, Roach C. Focus on clinical best practices, patient safety and operational efficiency. Healthcare Quarterly 2006;10:50-6. [PM: 17163118]</P>
<P>  (371)   Law M, Teplicky R, King S, King G, Kertoy M, Moning T, et al. Family-centred service: moving ideas into practice. Child: Care, Health &amp; Development 2005 Nov;31(6):633-42. [PM: 16207220]</P>
<P>  (372)   Lazovich D, Curry SJ, Beresford SA, Kristal AR, Wagner EH. Implementing a dietary intervention in primary care practice: a process evaluation. American Journal of Health Promotion 2000 Nov;15(2):118-25. [PM: 11194695]</P>
<P>  (373)   Lee E, McNally DL, Zuckerman IH. Evaluation of a physician-focused educational intervention on medicaid children with asthma. Annals of Pharmacotherapy 2004 Jun;38(6):961-6. [PM: 15122003]</P>
<P>  (374)   Lefevre F, Blum A, Bracard S, Regent D, Stines J, Guillemin F, et al. Impact of PACS implementation in a university center on radiology practice profile. Journal de Radiologie 2009 Sep;90(9 Pt 1):1046-54. [PM: 19752808]</P>
<P>  (375)   Legare F, O'Connor AM, Graham ID, Wells GA, Jacobsen MJ, Elmslie T, et al. The effect of decision aids on the agreement between women's and physicians' decisional conflict about hormone replacement therapy. Patient Education &amp; Counseling 2003 Jun;50(2):211-21. [PM: 12781936]</P>
<P>  (376)   Lehmann DF, Guharoy R, Page N, Hirschman K, Ploutz-Snyder R, Medicis J. Formulary management as a tool to improve medication use and gain physician support. American Journal of Health-System Pharmacy 2007 Mar 1;64(5):464-6. [PM: 17322158]</P>
<P>  (377)   Leichtnam-Dugarin L, Carretier J, Delavigne V, Brusco S, Hoarau H, Philip T, et al. The SOR SAVOIR Patient, a project of patient information and education. Cancer Radiotherapie 2003 Jun;7(3):210-2. [PM: 12834779]</P>
<P>  (378)   Leopold SS, Morgan HD, Kadel NJ, Gardner GC, Schaad DC, Wolf FM. Impact of educational intervention on confidence and competence in the performance of a simple surgical task. Journal of Bone &amp; Joint Surgery - American Volume 2005 May;87(5):1031-7. [PM: 15866966]</P>
<P>  (379)   Letton AH, Bard M, Boyd JD, Crosson K, Ganz P, Loeb V, Jr., et al. Breakout III. Concerns of the patient and the public. Cancer 1990 May 15;65(Suppl 10):2411-2. [PM: 2334882]</P>
<P>  (380)   Leung KY, Ling M, Tang GW. Use of hormone replacement therapy in the Hong Kong public health sector after the Women's Health Initiative trial. Maturitas 2005 Nov;52(3-4):277-85. [PM: 15950409]</P>
<P>  (381)   Lewis C, Amador EC, Ward BL, Russell RP. Directory of high blood pressure resources available to physicians. Maryland State Medical Journal 1984 Mar;33(3):216-23. [PM: 6371394]</P>
<P>  (382)   Lewis CE, Freeman HE, Kaplan SH, Corey CR. The impact of a program to enhance the competencies of primary care physicians in caring for patients with AIDS. Journal of General Internal Medicine 1986 Sep;1(5):287-94. [PM: 3772617]</P>
<P>  (383)   Lewis CE, Bursch B, Klau M, Konitsney D, Conrow S. Continuing medical education for AIDS: an organizational response. AIDS Education &amp; Prevention 1993;5(3):263-71. [PM: 8217478]</P>
<P>  (384)   Liaw ST, Sulaiman ND, Barton CA, Chondros P, Harris CA, Sawyer S, et al. An interactive workshop plus locally adapted guidelines can improve general practitioners asthma management and knowledge: a cluster randomised trial in the Australian setting. BMC Family Practice 2008;9(22). [PM: 18423050]</P>
<P>  (385)   Linden M, Westram A, Schmidt LG, Haag C. Impact of the WHO depression guideline on patient care by psychiatrists: a randomized controlled trial. European Psychiatry 2008 Sep;23(6):403-8. [PM: 18583105]</P>
<P>  (386)   Little P, Roberts L, Blowers H, Garwood J, Cantrell T, Langridge J, et al. Should we give detailed advice and information booklets to patients with back pain? A randomized controlled factorial trial of a self-management booklet and doctor advice to take exercise for back pain. Spine 2001 Oct 1;26(19):2065-72. [PM: 11698879]</P>
<P>  (387)   Liu J, Ma JP, Huang JH, Wang L. A study of the influence of the guideline on the treatment of chronic congestive heart failure in the elderly. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue [Chinese Critical Care Medicine] 2010 Oct;22(10):606-9. [PM: 20977844]</P>
<P>  (388)   Loeb M, Brazil K, Lohfeld L, McGeer A, Simor A, Stevenson K, et al. Effect of a multifaceted intervention on number of antimicrobial prescriptions for suspected urinary tract infections in residents of nursing homes: cluster randomised controlled trial. BMJ 2005 Sep 24;331(7518):669. [PM: 16150741]</P>
<P>  (389)   Loeches YB, de Lorenzo-Caceres AA. Information leaflets for primary care patients. Atencion Primaria 2004 Feb 28;33(3):165. [PM: 14987506]</P>
<P>  (390)   Lomas J, Sisk JE, Stocking B. From evidence to practice in the United States, the United Kingdom, and Canada. Milbank Quarterly 1993;71(3):405-10. [PM: 8413068]</P>
<P>  (391)   Lopes MHB, del Monte MCC, Barbosa M, Moromizato SS, Fayan ALN, de Souza EP, et al. Updating measures on universal precautions: a new approach methodology [Portuguese]. REV LAT AM ENFERMAGEM 2001;5(2):83-91. [PMID: 9370759]</P>
<P>  (392)   Luciak-Donsberger C, Piribauer F, Taylor NC. Enabling general physicians to perform periodontal screening during nationwide periodic health examinations. The Journal of Evidencebased Dental Practice 2008 Sep;8(3):186-94. [PM: 18783766]</P>
<P>  (393)   Luitjes SH, Wouters MG, Franx A, Scheepers HC, Coupe VM, Wollersheim H, et al. Study protocol: Cost effectiveness of two strategies to implement the NVOG guidelines on hypertension in pregnancy: An innovative strategy including a computerised decision support system compared to a common strategy of professional audit and feedback, a randomized controlled trial. Implementation Science 2010;5(68). [PM: 20819222]</P>
<P>  (394)   Lundberg GD. Passive dissemination of printed educational materials in medicine has no or negligible effect on patient outcomes. Medscape journal of medicine 2008;10(11):255. [PM: 19099005]</P>
<P>  (395)   Macfarlane J, Holmes W, Gard P, Thornhill D, Macfarlane R, Hubbard R. Reducing antibiotic use for acute bronchitis in primary care: blinded, randomised controlled trial of patient information leaflet. BMJ 2002 Jan 12;324(7329):91-4. [PM: 11786454]</P>
<P>  (396)   Mackain-Bremner AA, Owens K, Wylde V, Bannister GC, Blom AW. Adherence to recommendations designed to decrease intra-operative wound contamination. Annals of the Royal College of Surgeons of England 2008 Jul;90(5):412-6. [PM: 18634740]</P>
<P>  (397)   Macmillan N. Rising to the information challenge. IDRC Reports 1996 Jan;23(4):18-9. [PM: 12296168]</P>
<P>  (398)   Maffei FH, Sato AC, Torggler FF, Silva SC, Atallah A. Effect of the implementation of a guideline for venous thromboembolism prophylaxis in surgical patients. Revista Da Associacao Medica Brasileira 2009 Sep;55(5):587-92. [PM: 19918661]</P>
<P>  (399)   Majumdar SR, Johnson JA, McAlister FA, Bellerose D, Russell AS, Hanley DA, et al. Multifaceted intervention to improve diagnosis and treatment of osteoporosis in patients with recent wrist fracture: a randomized controlled trial. CMAJ Canadian Medical Association Journal 2008 Feb 26;178(5):569-75. [PM: 18299546]</P>
<P>  (400)   Malhotra A, Aziz K, Freston JW. Colorectal cancer screening: A retrospective study of compliance with guidelines in a university-based primary care practice. Quality in Primary Care 2007;15(3):151-5. [EM 2007321457]</P>
<P>  (401)   Mallet HP, Njikam A, Scouflaire SM. Evaluation of prescription practices and of the rational use of medicines in Niger. Sante 2001 Jul;11(3):185-93. [PM: 11641083]</P>
<P>  (402)   Manchikanti L, Rivera JJ, Pampati V, Beyer C, Damron K, Barnhill RC. Effectiveness of clinical guidelines in interventional pain management. Pain Physician 2002 Apr;5(2):127-32. [PM: 16902663]</P>
<P>  (403)   Marks MK, Hynson JL, Karabatsos G. Asthma: communication between hospital and general practitioners. Journal of Paediatrics &amp; Child Health 1999 Jun;35(3):251-4. [PM: 10404444]</P>
<P>  (404)   Marmion RM, Evans CF. Instant inservice: a poster program. Journal of Nursing Staff Development 1988;4(1):33-4. [PM: 2450975]</P>
<P>  (405)   Marshall AL, Booth ML, Bauman AE. Promoting physical activity in Australian general practices: a randomised trial of health promotion advice versus hypertension management. Patient Education &amp; Counseling 2005 Mar;56(3):283-90. [PM: 15721970]</P>
<P>  (406)   Marshall WR, Rothenberger LA, Bunnell SL. The efficacy of personalized audiovisual patient-education materials. Journal of Family Practice 1984 Nov;19(5):659-63. [PM: 6208312]</P>
<P>  (407)   Martens JD, Winkens RA, van der Weijden T, de BD, Severens JL. Does a joint development and dissemination of multidisciplinary guidelines improve prescribing behaviour: a pre/post study with concurrent control group and a randomised trial. BMC Health Services Research 2006;6(145). [PM: 17081285]</P>
<P>  (408)   Martin CM, Doig GS, Heyland DK, Morrison T, Sibbald WJ, Southwestern Ontario Critical Care Research Network. Multicentre, cluster-randomized clinical trial of algorithms for critical-care enteral and parenteral therapy (ACCEPT). CMAJ Canadian Medical Association Journal 2004 Jan 20;170(2):197-204. [PM: 14734433]</P>
<P>  (409)   Matowe L, Ramsay CR, Grimshaw JM, Gilbert FJ, Macleod MJ, Needham G. Effects of mailed dissemination of the Royal College of Radiologists' guidelines on general practitioner referrals for radiography: a time series analysis. Clinical Radiology 2002 Jul;57(7):575-8. [PM: 12096854]</P>
<P>  (410)   Matthews JC, Johnson ML, Koelling TM. The impact of patient-specific quality-of-care report cards on guideline adherence in heart failure. American Heart Journal 2007 Dec;154(6):1174-83. [PM: 18035092]</P>
<P>  (411)   Maxwell AE, Jo AM, Chin SY, Lee KS, Bastani R. Impact of a print intervention to increase annual mammography screening among Korean American women enrolled in the National Breast and Cervical Cancer Early Detection Program. Cancer Detection &amp; Prevention 2008;32(3):229-35. [PM: 18799271]</P>
<P>  (412)   Mayer C, Andrusyszyn MA, Iwasiw C. Codman Award Paper: self-efficacy of staff nurses for health promotion counselling of patients at risk for stroke. Axon 2005 Jun;26(4):14-21. [PM: 16028726]</P>
<P>  (413)   McBee MJ. Pocket guide to ED orientation. Journal of Emergency Nursing 1996 Oct;22(5):446-50. [PM: 8997972]</P>
<P>  (414)   McCabe M. Pharmacists should work with nurses in using educational tools. Hospital Management 1969 Jan;107(1):35-7. [PM: 5782899]</P>
<P>  (415)   McClennan S, Worster A, MacMillan H. Caring for victims of intimate partner violence: a survey of Canadian emergency departments. CJEM Canadian Journal of Emergency Medical Care 2008 Jul;10(4):325-8. [PM: 18652722]</P>
<P>  (416)   McDonnell M, Cullen A, Kiberd B, Mehanni M, Matthews T. A national model of care service for professionals dealing with sudden infant death. Irish Journal of Medical Science 1999 Oct;168(4):237-41. [PM: 10624360]</P>
<P>  (417)   McDougal WS, Lunz ME, Hirst G. Postgraduate education: does it improve the knowledge base of practitioners with time? Journal of Urology 1998 Aug;160(2):502-4. [PM: 9679913]</P>
<P>  (418)   McGregor AH, Dore CJ, Morris TP, Morris S, Jamrozik K. Function after spinal treatment, exercise and rehabilitation (FASTER): improving the functional outcome of spinal surgery. BMC Musculoskeletal Disorders 2010;11(17). [PM: 20102625]</P>
<P>  (419)   Mertz D, Koller M, Haller P, Lampert ML, Plagge H, Hug B, et al. Outcomes of early switching from intravenous to oral antibiotics on medical wards. Journal of Antimicrobial Chemotherapy 2009 Jul;64(1):188-99. [PM: 19401304]</P>
<P>  (420)   Mettes TG, van der Sanden WJ, Bronkhorst E, Grol RP, Wensing M, Plasschaert AJ. Impact of guideline implementation on patient care: a cluster RCT. Journal of Dental Research 2010 Jan;89(1):71-6. [PM: 19966044]</P>
<P>  (421)   Michel K, Valach L. Suicide prevention: spreading the gospel to general practitioners. British Journal of Psychiatry 1992 Jun;160:757-60. [PM: 1617356]</P>
<P>  (422)   Miller L. Doctor's orders. Mental Health Today 2010 Mar;30. [PM: 20429111]</P>
<P>  (423)   Misrahi L, Colin C, Lanoir D, Chambrier C, Jolivet A, Bouletreau P. Economic impact of the consensus conference guidelines on postoperative artificial nutrition in the Rhone-Alps region. Annales Francaises d Anesthesie et de Reanimation 1999 Feb;18(2):270-9. [PM: 10207604]</P>
<P>  (424)   Mitchell ML, Courtney M. An intervention study to improve the transfer of ICU patients to the ward -- evaluation by family members. AUST CRIT CARE 2001;18(2):61.</P>
<P>  (425)   Mitchell ML, Courtney M. Improving transfer from the intensive care unit: the development, implementation and evaluation of a brochure based on Knowles' Adult Learning Theory. International Journal of Nursing Practice 2005 Dec;11(6):257-68. [PM: 16255737]</P>
<P>  (426)   Mockiene V, Suominen T, Valimaki M, Razbadauskas A, Martinkenas A, Caplinskas S. The impact of an education intervention to change nurses' HIV-related knowledge and attitudes in Lithuania: a randomized controlled trial. Journal of the Association of Nurses in AIDS Care 2011 Mar;22(2):140-9. [PM: 21123087]</P>
<P>  (427)   Mollon DL, Fields WL. Is this the right patient? An educational initiative to improve compliance with two patient identifiers. Journal of Continuing Education in Nursing 2009 May;40(5):221-7. [PM: 19489521]</P>
<P>  (428)   Moran WP, Chen GJ, Watters C, Poehling G, Millman F. Using a collaborative approach to reduce postoperative complications for hip-fracture patients: a three-year follow-up. Joint Commission Journal on Quality &amp; Patient Safety 2006 Jan;32(1):16-23. [PM: 16514935]</P>
<P>  (429)   Morris AH, Orme J, Jr., Truwit JD, Steingrub J, Grissom C, Lee KH, et al. A replicable method for blood glucose control in critically Ill patients. Critical Care Medicine 2008 Jun;36(6):1787-95. [PM: 18520641]</P>
<P>  (430)   Morrison J, Carroll L, Twaddle S, Cameron I, Grimshaw J, Leyland A, et al. Pragmatic randomised controlled trial to evaluate guidelines for the management of infertility across the primary care-secondary care interface. BMJ 2001 May 26;322(7297):1282-4. [PM: 11375232]</P>
<P>  (431)   Morse L, McDonald M. Failure of a poster-based educational programme to improve compliance with peripheral venous catheter care in a tertiary hospital. A clinical audit. Journal of Hospital Infection 2009 Jul;72(3):221-6. [PM: 19464755]</P>
<P>  (432)   Morton E, Tambor E, Rimer BK, Tessaro I, Farrell D, Siegler IC. Impact of National Cancer Institute revised mammography screening guidelines on women 40-49. Womens Health Issues 1996 Sep;6(5):246-54. [PM: 8870503]</P>
<P>  (433)   Murawski MM, Abdelgawad T. Exploration of the impact of preferred drug lists on hospital and physician visits and the costs to Medicaid. American Journal of Managed Care 2005 Jan;11(Special no.):35-42. [PM: 15700908]</P>
<P>  (434)   Narasimhaswamy S, Vedi C, Xavier Y, Tseng CH, Shine D. Effect of implementing pain management standards. Journal of General Internal Medicine 2006 Jul;21(7):689-93. [PM: 16808767]</P>
<P>  (435)   Noirot LA, Hollands JM, Reichley RM, Dunagan WC, Bailey TC. Long-term effectiveness of an automated guideline adherence monitor for secondary prevention of acute myocardial infarction. Annual Symposium Proceedings/AMIA Symposium 2007;1061. [PM: 18694159]</P>
<P>  (436)   Nucci M, Landau M, Silveira F, Spector N, Pulcheri W. Application of the IDSA guidelines for the use of antimicrobial agents in neutropenic patients: impact on reducing the use of glycopeptides. Infection Control &amp; Hospital Epidemiology 2001 Oct;22(10):651-3. [PM: 11776354]</P>
<P>  (437)   O'Brien K, Wright J, Conboy F, Bagley L, Lewis D, Read M, et al. The effect of orthodontic referral guidelines: a randomised controlled trial. British Dental Journal 2000 Apr 8;188(7):392-7. [PM: 10816930]</P>
<P>  (438)   O'Cathain A, Walters SJ, Nicholl JP, Thomas KJ, Kirkham M. Use of evidence based leaflets to promote informed choice in maternity care: randomised controlled trial in everyday practice. BMJ 2002 Mar 16;324(7338):643. [PM: 11895822]</P>
<P>  (439)   O'Connor PJ, Sperl-Hillen J, Johnson PE, Rush WA, Crain AL. Customized feedback to patients and providers failed to improve safety or quality of diabetes care: a randomized trial. Diabetes Care 2009 Jul;32(7):1158-63. [PM: 19366977]</P>
<P>  (440)   O'Hanrahan M. The educational value of printed information for hypertensive patients: an assessment. Irish Journal of Medical Science 1981;150(4).</P>
<P>  (441)   Overhage JM, Tierney WM, McDonald CJ. Computer reminders to implement preventive care guidelines for hospitalized patients. Archives of Internal Medicine 1996 Jul 22;156(14):1551-6. [PM: 8687263]</P>
<P>  (442)   Owen PS, Golightly LK, MacLaren R, Ferretti KA, Badesch DB. Formulary management of recombinant factor VIIa at an academic medical center. Annals of Pharmacotherapy 2008 Jun;42(6):771-6. [PM: 18477731]</P>
<P>  (443)   Ozgun H, Ertugrul BM, Soyder A, Ozturk B, Aydemir M. Peri-operative antibiotic prophylaxis: adherence to guidelines and effects of educational intervention. International Journal Of Surgery 2010;8(2):159-63. [PM: 20026001]</P>
<P>  (444)   Pagaiya N, Garner P. Primary care nurses using guidelines in Thailand: a randomized controlled trial. Tropical Medicine &amp; International Health 2005 May;10(5):471-7. [PM: 15860094]</P>
<P>  (445)   Palmer S, Bader MK, Qureshi A, Palmer J, Shaver T, Borzatta M, et al. The impact on outcomes in a community hospital setting of using the AANS traumatic brain injury guidelines. Americans Associations for Neurologic Surgeons. Journal of Trauma-Injury Infection &amp; Critical Care 2001 Apr;50(4):657-64. [PM: 11303160]</P>
<P>  (446)   Paxton R, MacDonald F, Allott R, Mitford P, Proctor S, Smith M. Improving general practitioners' assessment and management of suicide risk. International Journal of Health Care Quality Assurance Incorporating Leadership in Health Services 2001;14(2-3):133-8. [PM: 11436749]</P>
<P>  (447)   Pazirandeh M. Does patient partnership in continuing medical education (CME) improve the outcome in osteoporosis management? Journal of Continuing Education in the Health Professions 2002;22(3):142-51. [PM: 12227236]</P>
<P>  (448)   Perez-Cuevas R, Reyes-Morales H, Flores-Hernandez S, Wacher-Rodarte N. Effect of a clinical practice guideline for the management of diabetes type 2. Revista Medica del Instituto Mexicano del Seguro Social 2007 Jul;45(4):353-60. [PM: 17949573]</P>
<P>  (449)   Perez A, Dennis RJ, Rodriguez B, Castro AY, Delgado V, Lozano JM, et al. An interrupted time series analysis of parenteral antibiotic use in Colombia. Journal of Clinical Epidemiology 2003 Oct;56(10):1013-20. [PM: 14568634]</P>
<P>  (450)   Peterson GM, Drake CI, Jupe DM, Vial JH, Wilkinson S. Educational campaign to improve the prevention of postoperative venous thromboembolism. Journal of Clinical Pharmacy &amp; Therapeutics 1999 Aug;24(4):279-87. [PM: 10475986]</P>
<P>  (451)   Planas M, Penalva A, Burgos R, Puiggros C, Perez-Portabella C, Espin E, et al. Guidelines for colorectal cancer: effects on nutritional intervention. Clinical Nutrition 2007 Dec;26(6):691-7. [PM: 18029063]</P>
<P>  (452)   Premi J, Shannon SI. Randomized controlled trial of a combined video-workbook educational program for CME. Academic Medicine 1993 Oct;68(Suppl 10):S13-5. [PM: 8216618]</P>
<P>  (453)   Ray-Coquard I, Philip T, de LG, Froger X, Suchaud JP, Voloch A, et al. A controlled "before-after" study: impact of a clinical guidelines programme and regional cancer network organization on medical practice. British Journal of Cancer 2002 Feb 1;86(3):313-21. [PM: 11875690]</P>
<P>  (454)   Rebbeck T, Maher CG, Refshauge KM. Evaluating two implementation strategies for whiplash guidelines in physiotherapy: a cluster randomised trial. Australian Journal of Physiotherapy 2006;52(3):165-74. [PM: 16942451]</P>
<P>  (455)   Reid J. The Play@Home programme. Practising Midwife 2001 Feb;4(2):32-5. [PM: 12026298]</P>
<P>  (456)   Richardson B, Kitchen G, Livingston G. The effect of education on knowledge and management of elder abuse: a randomized controlled trial. Age &amp; Ageing 2002 Sep;31(5):335-41. [PM: 12242194]</P>
<P>  (457)   Rieber U. Representation of pediatric nursing in the picture book. Kinderkrankenschwester 2008 Sep;27(9):368-72. [PM: 18841638]</P>
<P>  (458)   Ripouteau C, Conort O, Lamas JP, Auleley GR, Hazebroucq G, Durieux P. Effect of multifaceted intervention promoting early switch from intravenous to oral acetaminophen for postoperative pain: controlled, prospective, before and after study. BMJ 2000 Dec 9;321(7274):1460-3. [PM: 11110743]</P>
<P>  (459)   Rippon A. Caring is knowing. Nursing Standard 2010 Apr 7;24(31):26-7. [PM: 20441031]</P>
<P>  (460)   Rood E, Bosman RJ, van der Spoel JI, Taylor P, Zandstra DF. Use of a computerized guideline for glucose regulation in the intensive care unit improved both guideline adherence and glucose regulation. Journal of the American Medical Informatics Association 2005 Mar;12(2):172-80. [PM: 15561795]</P>
<P>  (461)   Rosier PK, Wall B, Discoe A. Posters: valuable educational tool. Journal of Continuing Education in Nursing 1989 Sep;20(5):238. [PM: 2507605]</P>
<P>  (462)   Roski J, Jeddeloh R, An L, Lando H, Hannan P, Hall C, et al. The impact of financial incentives and a patient registry on preventive care quality: increasing provider adherence to evidence-based smoking cessation practice guidelines. Preventive Medicine 2003 Mar;36(3):291-9. [PM: 12634020]</P>
<P>  (463)   Rossignol M, Allaert FA, Rozenberg S, Valat JP, Avouac B, Peres G, et al. Measuring the contribution of pharmacological treatment to advice to stay active in patients with subacute low-back pain: a randomised controlled trial. Pharmacoepidemiology &amp; Drug Safety 2005 Dec;14(12):861-7. [PM: 15991263]</P>
<P>  (464)   Roth EJ, Plastaras CT, Mullin MS, Fillmore J, Moses ML. A simple institutional educational intervention to decrease use of selected expensive medications. Archives of Physical Medicine &amp; Rehabilitation 2001 May;82(5):633-6. [PM: 11346840]</P>
<P>  (465)   Rusnak M, Janciak I, Majdan M, Wilbacher I, Mauritz W, Australian Severe TBI Study Investigators. Severe traumatic brain injury in Austria VI: effects of guideline-based management. Wiener Klinische Wochenschrift 2007 Feb;119(1-2):64-71. [PM: 17318752]</P>
<P>  (466)   Salahuddin M, Anwar MN. Study on effectiveness of guidelines and high dependency unit management on diabetic ketoacidosis patients. JPMI - Journal of Postgraduate Medical Institute 2009;23(2):120-3. [EM 2010579111]</P>
<P>  (467)   Sanders DS, Carter MJ, D'Silva J, James G, Bolton RP, Willemse PJ, et al. Percutaneous endoscopic gastrostomy: a prospective audit of the impact of guidelines in two district general hospitals in the United Kingdom. American Journal of Gastroenterology 2002 Sep;97(9):2239-45. [PM: 12358239]</P>
<P>  (468)   Sanders KM, Satyvavolu A. Improving blood pressure control in diabetes: limitations of a clinical reminder in influencing physician behavior. Journal of Continuing Education in the Health Professions 2002;22(1):23-32. [PM: 12004637]</P>
<P>  (469)   Sandrick K. Beyond RxD2: linking pharmacists doctors and nurses. Health Management Technology 1998 Nov;19(12):26-8. [PM: 10187101]</P>
<P>  (470)   Sauro A, Scalzitti F, Buono N, Siringano R, Petrazzuoli F, Diodati G, et al. Spirometry is really useful and feasible in the GP's daily practice but guidelines alone are not. European Journal of General Practice 2005 Mar;11(1):29-31. [PM: 15841063]</P>
<P>  (471)   Sayre MR, Cantrell SA, White LJ, Hiestand BC, Keseg DP, Koser S. Impact of the 2005 American Heart Association cardiopulmonary resuscitation and emergency cardiovascular care guidelines on out-of-hospital cardiac arrest survival. Prehospital Emergency Care 2009 Oct;13(4):469-77. [PM: 19731159]</P>
<P>  (472)   Schaffner W, Ray WA, Federspiel CF, Miller WO. Improving antibiotic prescribing in office practice. A controlled trial of three educational methods. JAMA 1983 Oct 7;250(13):1728-32. [PM: 6350633]</P>
<P>  (473)   Scheeres K, Wensing M, Mes C, Bleijenberg G. The impact of informational interventions about cognitive behavioral therapy for chronic fatigue syndrome on GPs referral behavior. Patient Education &amp; Counseling 2007 Sep;68(1):29-32. [PM: 17521842]</P>
<P>  (474)   Schlechter I. The ward manual--an aid to practical work on the ward? Krankenpflege 1987 Feb;41(2):45-9. [PM: 3102845]</P>
<P>  (475)   Schoenfeld P, Chey WD. An evidence-based approach to clinical practice guidelines: diagnosis and treatment of irritable bowel syndrome. Clinical Gastroenterology &amp; Hepatology 2003 Jul;1(4):322-7. [PM: 15017675]</P>
<P>  (476)   Schuster RJ, Terwoord NA, Tasosa J. Changing physician practice behavior to measure and improve clinical outcomes. American Journal of Medical Quality 2006 Nov;21(6):394-400. [PM: 17077421]</P>
<P>  (477)   Schwartz DN, Abiad H, DeMarais PL, Armeanu E, Trick WE, Wang Y, et al. An educational intervention to improve antimicrobial use in a hospital-based long-term care facility. Journal of the American Geriatrics Society 2007 Aug;55(8):1236-42. [PM: 17661963]</P>
<P>  (478)   Schwartzberg JG, Guttman R. Effect of training on physician attitudes and practices in home and community care of the elderly. Archives of Family Medicine 1997 Sep;6(5):439-44. [PM: 9305686]</P>
<P>  (479)   Selby ML, Riportella-Muller R, Sorenson JR, Quade D, Luchok KJ. Increasing participation by private physicians in the EPSDT Program in rural North Carolina. Public Health Reports 1992 Sep;107(5):561-8. [PM: 1410238]</P>
<P>  (480)   Sellier E, Labarere J, Bosson JL, Auvray M, Barrellier MT, Le HC, et al. Effectiveness of a guideline for venous thromboembolism prophylaxis in elderly post-acute care patients: a multicenter study with systematic ultrasonographic examination. Archives of Internal Medicine 2006 Oct 23;166(19):2065-71. [PM: 17060535]</P>
<P>  (481)   Seve P, Mackey J, Sawyer M, Lesimple T, de La FC, Broussolle C, et al. Impact of clinical practice guidelines on the management for carcinomas of unknown primary site: a controlled "before-after" study. Bulletin du Cancer 2009 Apr;96(4):E7-17. [PM: 19435692]</P>
<P>  (482)   Shah BR, Juurlink DN, Austin PC, Mamdani MM. New use of rosiglitazone decreased following publication of a meta-analysis suggesting harm. Diabetic Medicine 2008 Jul;25(7):871-4. [PM: 18644075]</P>
<P>  (483)   Shalansky SJ. Antibiotic interchange through educational interventions in a community hospital. American Journal of Hospital Pharmacy 1991 Dec;48(12):2655-7. [PM: 1814215]</P>
<P>  (484)   Shekelle PG, Kravitz RL, Beart J, Marger M, Wang M, Lee M. Are nonspecific practice guidelines potentially harmful? A randomized comparison of the effect of nonspecific versus specific guidelines on physician decision making. Health Services Research 2000 Mar;34(7):1429-48. [PM: 10737446]</P>
<P>  (485)   Shrake KL, Scaggs JE, England KR, Henkle JQ, Eagleton LE. Benefits associated with a respiratory care assessment-treatment program: results of a pilot study. Respiratory Care 1994 Jul;39(7):715-24. [PM: 10146052]</P>
<P>  (486)   Shulkin DJ, McGourty ME, Bourret J. Involving physicians in efforts to control pharmaceutical expenditures. Medical Interface 1995 Aug;8(8):85-7. [PM: 10144777]</P>
<P>  (487)   Simon SR, Rodriguez HP, Majumdar SR, Kleinman K, Warner C, Salem-Schatz S, et al. Economic analysis of a randomized trial of academic detailing interventions to improve use of antihypertensive medications. Journal of Clinical Hypertension 2007 Jan;9(1):15-20. [PM: 17215654]</P>
<P>  (488)   Singer NJ, Willman J, Penzkowski D. Tools for meeting core measures for heart failure best practice [6th Annual Meeting of the American Association of Heart Failure Nurses, AAHFN 2010]. Heart and Lung 2010;39(4):364-5. [EM 70238139]</P>
<P>  (489)   Singh R, Kishore J, Mathur RG, Mandal K, Puri S. The role of an information booklet on bio-medical waste management for nurses. Nursing Journal of India 2002 Dec;93(12):271-2. [PM: 12718116]</P>
<P>  (490)   Slora EJ, Steffes JM, Harris D, Clegg HW, Norton D, Darden PM, et al. Improving pediatric practice immunization rates through distance-based quality improvement: a feasibility trial from PROS. Clinical Pediatrics 2008 Jan;47(1):25-36. [PM: 17693592]</P>
<P>  (491)   Smabrekke L, Berild D, Giaever A, Myrbakk T, Fuskevag A, Ericson JU, et al. Educational intervention for parents and healthcare providers leads to reduced antibiotic use in acute otitis media. Scandinavian Journal of Infectious Diseases 2002;34(9):657-9. [PM: 12374355]</P>
<P>  (492)   Smith AJ, Law CH, Khalifa MA, Hsieh ET, Hanna SS, Wright FC, et al. Multimodal CME for surgeons and pathologists improves colon cancer staging. Journal of Cancer Education 2003;18(2):81-6. [PM: 12888381]</P>
<P>  (493)   Smith CJ, Gribbin J, Challen KB, Hubbard RB. The impact of the 2004 NICE guideline and 2003 General Medical Services contract on COPD in primary care in the UK. QJM 2008 Feb;101(2):145-53. [PM: 18180254]</P>
<P>  (494)   Smith L, McClenahan J. User groups. View finders. Health Service Journal 1998 Feb 12;108(5591):33. [PM: 10176478]</P>
<P>  (495)   Smith M. A physician's reference booklet helps RNS. Nursing Management 1991 Jun;22(6):52. [PM: 2052254]</P>
<P>  (496)   Soler N, Ballester E, Martin A, Gobartt E, Miravitlles M, Torres A. Changes in management of chronic obstructive pulmonary disease (COPD) in primary care: EMMEPOC study. Respiratory Medicine 2010 Jan;104(1):67-75. [PM: 20122630]</P>
<P>  (497)   Sondergaard J, Andersen M, Vach K, Kragstrup J, Maclure M, Gram LF. Detailed postal feedback about prescribing to asthma patients combined with a guideline statement showed no impact: a randomised controlled trial. European Journal of Clinical Pharmacology 2002 May;58(2):127-32. [PM: 12012145]</P>
<P>  (498)   Sondergaard J, Foged A, Kragstrup J, Gaist D, Gram LF, Sindrup SH, et al. Intensive community pharmacy intervention had little impact on triptan consumption: a randomized controlled trial. Scandinavian Journal of Primary Health Care 2006 Mar;24(1):16-21. [PM: 16464810]</P>
<P>  (499)   Spitz B, Fraker C, Meyer CP, Peterson T. Evolution of evidence-based guidelines for home care: Wisconsin's experience. Home Healthcare Nurse 2007 May;25(5):327-34. [PM: 17495563]</P>
<P>  (500)   Stamos TD, Shaltoni H, Girard SA, Parrillo JE, Calvin JE. Effectiveness of chart prompts to improve physician compliance with the National Cholesterol Education Program guidelines. American Journal of Cardiology 2001 Dec 15;88(12):1420-3. [PM: 11741565]</P>
<P>  (501)   Suchyta MR, Dean NC, Narus S, Hadlock CJ. Effects of a practice guideline for community-acquired pneumonia in an outpatient setting. American Journal of Medicine 2001 Mar;110(4):306-9. [PM: 11239849]</P>
<P>  (502)   Suisted P, Seneviratne S, Burgess C. Management of cardiac failure - Do practitioners follow guidelines? Journal of Pharmacy Technology 2005;21(1):16-20. [EM 2005025106]</P>
<P>  (503)   Svarstad BL, Mount JK. Chronic benzodiazepine use in nursing homes: effects of federal guidelines, resident mix, and nurse staffing. Journal of the American Geriatrics Society 2001 Dec;49(12):1673-8. [PM: 11844002]</P>
<P>  (504)   Swayne LC, Lam SC, Filippone AL, Ambrose RB. Credentialing of crossover privileges in fluoroscopy for nonradiologists. Radiology 1994 Jan;190(1):281-2. [PM: 8259420]</P>
<P>  (505)   Swoboda S, Lichtenstern C, Ober MC, Taylor LA, Storzinger D, Michel A, et al. Implementation of practice guidelines for antifungal therapy in a surgical intensive care unit and its impact on use and costs. Chemotherapy 2009;55(6):418-24. [PM: 19996586]</P>
<P>  (506)   Terry P, Pheley A, Williams D, Strickland S. The result of an educational intervention for physicians providing HIV-antibody testing and counseling. Minnesota Medicine 1992 Apr;75(4):37-9. [PM: 1584157]</P>
<P>  (507)   Teza SL, DeVito AV, Hiss RG. Resource manual to help your program meet the national standards. Diabetes Educator 1987 May;13:210-28. [PM: 3646957]</P>
<P>  (508)   Thomas LG, Corwin EJ. The readability of printed education materials regarding hormone replacement therapy. Journal of the American Academy of Nurse Practitioners 1998 Oct;10(10):447-52. [PM: 10085857]</P>
<P>  (509)   Thomas M, Gillespie W, Krauss J, Harrison S, Medeiros R, Hawkins M, et al. Focus group data as a tool in assessing effectiveness of a hand hygiene campaign. American Journal of Infection Control 2005 Aug;33(6):368-73. [PM: 16061144]</P>
<P>  (510)   Thomas RE, Grimshaw JM, Mollison J, McClinton S, McIntosh E, Deans H, et al. Cluster randomized trial of a guideline-based open access urological investigation service. Family Practice 2003 Dec;20(6):646-54. [PM: 14701887]</P>
<P>  (511)   Thompson C, Kinmonth AL, Stevens L, Peveler RC, Stevens A, Ostler KJ, et al. Effects of a clinical-practice guideline and practice-based education on detection and outcome of depression in primary care: Hampshire Depression Project randomised controlled trial. Lancet 2000 Jan 15;355(9199):185-91. [PM: 10675118]</P>
<P>  (512)   Thomson RG. Consensus publication guidelines: the next step in the science of quality improvement? Quality &amp; Safety in Health Care 2005 Oct;14(5):317-8. [PM: 16195562]</P>
<P>  (513)   Toh A, Mullin A, Grainger J, Uppal H. Indications for tonsillectomy: are we documenting them? Annals of the Royal College of Surgeons of England 2009 Nov;91(8):697-9. [PM: 19909613]</P>
<P>  (514)   Tomasini J. A nursing care plan for dealing with anxiety. Soins; La Revue de Reference Infirmiere 1998 Dec;(631):16-8. [PM: 10095741]</P>
<P>  (515)   Torrey WC, Drake RE, Dixon L, Burns BJ, Flynn L, Rush AJ, et al. Implementing evidence-based practices for persons with severe mental illnesses. Psychiatric Services 2001 Jan;52(1):45-50. [PM: 11141527]</P>
<P>  (516)   Tsuyuki RT, Ackman ML, Montague TJ, Clinical Quality Improvement Network Investigators. Effects of the 1994 Canadian Cardiovascular Society clinical practice guidelines for congestive heart failure. Canadian Journal of Cardiology 2002 Feb;18(2):147-52. [PM: 11875584]</P>
<P>  (517)   Turnbull DA, Beilby JJ, Ziaian T, Qureshi F, Nelson M, Tonkin AL, et al. Disease management for hypertension: A pilot cluster randomized trial of 67 Australian general practices. Disease Management and Health Outcomes 2006;14(1):27-35. [EM 2006082375]</P>
<P>  (518)   Turnbull F. Managing cardiovascular risk factors: the gap between evidence and practice. PLoS Medicine / Public Library of Science 2005 May;2(5):e131. [PM: 15916459]</P>
<P>  (519)   Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. New England Journal of Medicine 2008 Jan 17;358(3):252-60. [PM: 18199864]</P>
<P>  (520)   Tyrer P. Practice-based education did not increase recognition of depression by primary-care physicians nor improve the outcome of depression. ACP Journal Club 2000;133(2):74.</P>
<P>  (521)   Uberfeldt E. Initial positive results of the German Nurses' Association's pamphlet action "Humanism in the hospital". Krankenpflege 1980 Jan;34(1):5-6. [PM: 6767116]</P>
<P>  (522)   Vallano A, Llinares J, Amau JM, Martorell M, Girona L, Laporte JR. Impact of analgesic drug-use guidelines for the management of postoperative pain: a drug utilization study. International Journal of Clinical Pharmacology &amp; Therapeutics 2003 Apr;41(4):165-70. [PM: 12712962]</P>
<P>  (523)   van Vliet EP, Steyerberg EW, Otten HJ, Rudolphus A, Knoester PD, Hoogsteden HC, et al. The effects of guideline implementation for proton pump inhibitor prescription on two pulmonary medicine wards. Alimentary Pharmacology &amp; Therapeutics 2009 Jan;29(2):213-21. [PM: 19006542]</P>
<P>  (524)   van Zwanenberg TD, Grant GB, Gregory DA. Can rational prescribing be assessed? Journal of the Royal College of General Practitioners 1987 Jul;37(300):308-10. [PM: 3449633]</P>
<P>  (525)   van LA, van Schaik DJ, Dekker JJ, Beekman AT. Effectiveness of an intercultural module added to the treatment guidelines for Moroccan and Turkish patients with depressive and anxiety disorders. BMC Psychiatry 2011;11(13). [PM: 21247455]</P>
<P>  (526)   Verkaik R, Francke AL, van MB, Spreeuwenberg PM, Ribbe MW, Bensing JM. The effects of a nursing guideline on depression in psychogeriatric nursing home residents with dementia. International Journal of Geriatric Psychiatry 2011 Jul;26(7):723-32. [PM: 21495077]</P>
<P>  (527)   Vernon SA, Ghosh G. Do locally agreed guidelines for optometrists concerning the referral of glaucoma suspects influence referral practice? Eye 2001 Aug;15(Pt 4):458-63. [PM: 11767019]</P>
<P>  (528)   Viereck C, Boudes P. An analysis of the impact of FDA's guidelines for addressing cardiovascular risk of drugs for type 2 diabetes on clinical development. Contemporary Clinical Trials 2011 May;32(3):324-32. [PM: 21266202]</P>
<P>  (529)   Vittoria PM. The quality use of nimodipine: Assessing the impact of consensus guidelines. Australian Journal of Hospital Pharmacy 1999;29(3):137-41. [EM 1999229606]</P>
<P>  (530)   Vukic M, Negovetic L, Kovac D, Ghajar J, Glavic Z, Gopcevic A. The effect of implementation of guidelines for the management of severe head injury on patient treatment and outcome. Acta Neurochirurgica 1999;141(11):1203-8. [PM: 10592121]</P>
<P>  (531)   Waldron T. Managed care's atypical response. New antipsychotics show promise, but are they getting into enough hands? Behavioral Healthcare Tomorrow 1999 Apr;8(2):28-31. [PM: 10351297]</P>
<P>  (532)   Walker EA, Engel SS, Zybert PA. Dissemination of diabetes care guidelines: lessons learned from community health centers. Diabetes Educator 2001 Jan;27(1):101-10. [PM: 11912611]</P>
<P>  (533)   Ward MM, Doebbeling BN, Vaughn TE, Uden-Holman T, Clarke WR, Woolson RF, et al. Effectiveness of a nationally implemented smoking cessation guideline on provider and patient practices. Preventive Medicine 2003 Mar;36(3):265-71. [PM: 12634017]</P>
<P>  (534)   Webb K. Nursing Times guide to care planning: nurse's little helper. Nursing Times 1987 May 6;83(18):39-12. [PM: 3647442]</P>
<P>  (535)   West RR. Evidence based medicine overviews, bulletins, guidelines, and the new consensus. Postgraduate Medical Journal 2000 Jul;76(897):383-9. [PM: 10878193]</P>
<P>  (536)   West YR, Kendrick BJL, Williamson DM. Evaluation of the impact of orthopaedic guidelines on referrals from primary care to a specialist department. Quality in Primary Care 2007;15(1):27-31. [EM 2007125021]</P>
<P>  (537)   Wettermark B, Pehrsson A, Juhasz-Haverinen M, Veg A, Edlert M, Tornwall-Bergendahl G, et al. Financial incentives linked to self-assessment of prescribing patterns: a new approach for quality improvement of drug prescribing in primary care. Quality in Primary Care 2009;17(3):179-89. [PM: 19622268]</P>
<P>  (538)   Wight NE. Resources for physicians. Web sites, books, and organizations. Pediatric Clinics of North America 2001 Apr;48(2):539-46. [PM: 11339172]</P>
<P>  (539)   Wijsman BP, Adrichem CM, Van't Hooft FM, Leuven JAG, Van der Laarse A, Smelt AHM. Diverse effects of the Dutch guidelines for a healthy diet on serum lipids of male patients with type IIA and type IIB hyperlipoproteinemia. European Journal of Internal Medicine 1993;4(2):115-22. [EM 1993352011]</P>
<P>  (540)   Williams C, George L, Lowry M. A framework for patient assessment. Nursing Standard 1994 Jun 15;8(38):29-33. [PM: 8080753]</P>
<P>  (541)   Williams JK, McCarthy AM, Bragadottir H, Reed D. School nurses' experiences, concerns, and knowledge of growth disorders in children: development of a monograph. Journal of School Nursing 2002 Feb;18(1):25-32. [PM: 11853372]</P>
<P>  (542)   Williams KS, Crichton NJ, Roe B. Disseminating research evidence. A controlled trial in continence care. J ADV NURS 1997 Apr;25(4):691-8. [PM: 9104664]</P>
<P>  (543)   Williams ML, Hill G, Jackson M. The impact of an acute myocardial infarction guideline and pathway on racial outcomes at a university hospital. Ethnicity &amp; Disease 2006;16(3):653-8. [PM: 16937601]</P>
<P>  (544)   Willis K, Singer M. Prevention as intervention: development of evidence based Lymphedema Risk Assessment Tool and practice guidelines... Oncology Nursing Society 31st Annual Congress podium and poster abstracts. ONCOL NURS FORUM 2001;33(2):406.</P>
<P>  (545)   Wishart GC, Chetty U. Introduction to sessions on guidelines and endocrine therapy, the influence of breast screening on number of mastectomies and the challenge between molecular science and traditional dogma in the treatment of breast cancer. Introduction to Session 6. Breast Cancer Research 2009;11(Suppl 3):S17. [PM: 20030868]</P>
<P>  (546)   Witt K, Knudsen E, Ditlevsen S, Hollnagel H. Academic detailing has no effect on prescribing of asthma medication in Danish general practice: a 3-year randomized controlled trial with 12-monthly follow-ups. Family Practice 2004 Jun;21(3):248-53. [PM: 15128684]</P>
<P>  (547)   Wojs DJ, Jr. What do you do if no one knows what to do? Journal of Trauma Nursing 2010 Apr;17(2):109-11. [PM: 20559059]</P>
<P>  (548)   Wolters R, Wensing M, Klomp M, Lagro-Jansen T, Weel C, Grol R. Effects of distance learning on clinical management of LUTS in primary care: a randomised trial. Patient Education &amp; Counseling 2005 Nov;59(2):212-8. [PM: 16257627]</P>
<P>  (549)   Wong EK, Truong PT, Kader HA, Nichol AM, Salter L, Petersen R, et al. Consistency in seroma contouring for partial breast radiotherapy: impact of guidelines. International Journal of Radiation Oncology, Biology, Physics 2006 Oct 1;66(2):372-6. [PM: 16965989]</P>
<P>  (550)   Woodcock AJ, Kinmonth AL, Campbell MJ, Griffin SJ, Spiegal NM. Diabetes care from diagnosis: effects of training in patient-centred care on beliefs, attitudes and behaviour of primary care professionals. Patient Education &amp; Counseling 1999 May;37(1):65-79. [PM: 10640121]</P>
<P>  (551)   Woolery-Antill M. Granulocyte-macrophage colony-stimulating factor: a teaching program for staff and patients. Journal of Pediatric Oncology Nursing 1990 Apr;7(2):61. [PM: 2194506]</P>
<P>  (552)   Worrall CL, Anger BP, Simpson KN, Leon SM. Impact of a hospital-acquired/ventilator-associated/healthcare-associated pneumonia practice guideline on outcomes in surgical trauma patients. Journal of Trauma - Injury, Infection and Critical Care 2010;68(2):382-6. [EM 2010128886]</P>
<P>  (553)   Wright J, Bibby J, Eastham J, Harrison S, McGeorge M, Patterson C, et al. Multifaceted implementation of stroke prevention guidelines in primary care: cluster-randomised evaluation of clinical and cost effectiveness. Quality &amp; Safety in Health Care 2007 Feb;16(1):51-9. [PM: 17301206]</P>
<P>  (554)   Yealy DM, Auble TE, Stone RA, Lave JR, Meehan TP, Graff LG, et al. Effect of increasing the intensity of implementing pneumonia guidelines: a randomized, controlled trial. Annals of Internal Medicine 2005 Dec 20;143(12):881-94. [PM: 16365469]</P>
<P>  (555)   Yeh ML, Chen HH, Liu PH. Effects of multimedia with printed nursing guide in education on self-efficacy and functional activity and hospitalization in patients with hip replacement. Patient Education &amp; Counseling 2005 May;57(2):217-24. [PM: 15911196]</P>
<P>  (556)   Yeo GT, de Burgh SP, Letton T, Shaw J, Donnelly N, Swinburn ME, et al. Educational visiting and hypnosedative prescribing in general practice. Family Practice 1994 Mar;11(1):57-61. [PM: 7913452]</P>
<P>  (557)   Yeoh BS, Taylor DM, Taylor SE. Education initiative improves the evidence-based use of metoclopramide following morphine administration in the emergency department. Emergency Medicine Australasia 2009 Jun;21(3):178-83. [PM: 19527276]</P>
<P>  (558)   Yeung JH, Cheung NK, Graham CA, Rainer TH. Reduced time on the spinal board-effects of guidelines and education for emergency department staff. Injury 2006 Jan;37(1):53-6. [PM: 16246337]</P>
<P>  (559)   Zack JE, Garrison T, Trovillion E, Clinkscale D, Coopersmith CM, Fraser VJ, et al. Effect of an education program aimed at reducing the occurrence of ventilator-associated pneumonia. Critical Care Medicine 2002 Nov;30(11):2407-12. [PM: 12441746]</P>
<P>  (560)   Zeliadt SB, Hoffman RM, Etzioni R, Gore JL, Kessler LG, Lin DW. Influence of publication of US and European prostate cancer screening trials on PSA testing practices. Journal of the National Cancer Institute 2011 Mar 16;103(6):520-3. [PM: 21357307]</P>
<P>  (561)   Zernikow B, Hasan C, Hechler T, Huebner B, Gordon D, Michel E. Stop the pain! A nation-wide quality improvement programme in paediatric oncology pain control. European Journal of Pain 2008 Oct;12(7):819-33. [PM: 18222100]</P>
<P>  (562)   Zhang W, Shen X, Wang Y, Chen Y, Huang M, Zeng Q, et al. Antibiotic use in five children's hospitals during 2002-2006: the impact of antibiotic guidelines issued by the Chinese Ministry of Health. Pharmacoepidemiology &amp; Drug Safety 2008 Mar;17(3):306-11. [PM: 18165944]</P>
<P>  (563)   Zidek W. Revised guidelines for antihypertensive treatment. What is relevant for the general practitioner? MMW Fortschritte der Medizin 2004 Jan 15;146(1-2):37-8. [PM: 18437867]</P>
<P>  (564)   Zimetbaum P, Reynolds MR, Ho KK, Gaziano T, McDonald MJ, McClennen S, et al. Impact of a practice guideline for patients with atrial fibrillation on medical resource utilization and costs. American Journal of Cardiology 2003 Sep 15;92(6):677-81. [PM: 12972105]</P>
<P> </P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS MODIFIED="2012-02-29 08:52:43 -0500" MODIFIED_BY="[Empty name]">

<EXTENSION ID="AFF_2FDF112982E26AA20139CB72EA4C566C_1" NAME="PERSON" REVMAN_VERSION="5.1.0" TYPE="ADDRESS"><ALIAS ALIAS_ID="2FDF112982E26AA20139CB72EA4C566C"><ADDRESS><DEPARTMENT>Research Center of the Centre d'excellence sur le vieillissement de Quebec</DEPARTMENT><ORGANISATION>CHU de Quebec, St-Sacrement Hospital</ORGANISATION><CITY>Quebec City</CITY><ZIP>G1L 3L5</ZIP><REGION>QC</REGION><COUNTRY CODE="CA">Canada</COUNTRY></ADDRESS></ALIAS></EXTENSION></EXTENSIONS>
</COCHRANE_REVIEW>